Hits from PDB	Structure Title	EC number
3QX7	CRYSTAL STRUCTURE OF PYROPHOSPHATASE FROM BACTEROIDES THETAIOTAOMICRON COMPLEXED WITH PHOSPHATE, A CLOSED CAP CONFORMATION	3.6.1.1
3QX8	CRYSTAL STRUCTURE OF MID DOMAIN FROM HAGO2 IN COMPLEX WITH M7GPPPG	3.1.26
3QX9	CRYSTAL STRUCTURE OF MID DOMAIN FROM HAGO2 IN COMPLEX WITH ATP	3.1.26
3QXF	STRUCTURE OF THE BACTERIAL CELLULOSE SYNTHASE SUBUNIT Z	3.2.1.4
3QXG	CRYSTAL STRUCTURE OF PYROPHOSPHATASE FROM BACTEROIDES THETAIOTAOMICRON COMPLEXED WITH CALCIUM, A CLOSED CAP CONFORMATION	3.6.1.1
3QXQ	STRUCTURE OF THE BACTERIAL CELLULOSE SYNTHASE SUBUNIT Z IN COMPLEX WITH CELLOPENTAOSE	3.2.1.4
3QY4	CRYSTALLIZATION AND IN SITU DATA COLLECTION OF LYSOZYME USING THE CRYSTAL FORMER	3.2.1.17
3QY6	CRYSTAL STRUCTURES OF YWQE FROM BACILLUS SUBTILIS AND CPSB FROM STREPTOCOCCUS PNEUMONIAE, UNIQUE METAL-DEPENDENT TYROSINE PHOSPHATASES	3.1.3.48
3QY7	CRYSTAL STRUCTURES OF YWQE FROM BACILLUS SUBTILIS AND CPSB FROM STREPTOCOCCUS PNEUMONIAE, UNIQUE METAL-DEPENDENT TYROSINE PHOSPHATASES	3.1.3.48
3QY8	CRYSTAL STRUCTURES OF YWQE FROM BACILLUS SUBTILIS AND CPSB FROM STREPTOCOCCUS PNEUMONIAE, UNIQUE METAL-DEPENDENT TYROSINE PHOSPHATASES	3.1.3.48
3QYP	CRYSTAL STRUCTURE OF PYROPHOSPHATASE FROM BACTEROIDES THETAIOTAOMICRON, GLU47ASN MUTANT COMPLEXED WITH CALCIUM AND PHOSPHATE	3.6.1.1
3QZU	CRYSTAL STRUCTURE OF BACILLUS SUBTILIS LIPASE A 7-FOLD MUTANT; THE OUTCOME OF DIRECTED EVOLUTION TOWARDS THERMOSTABILITY	3.1.1.3
3R0D	CRYSTAL STRUCTURE OF CYTOSINE DEAMINASE FROM ESCHERICHIA COLI COMPLEXED WITH TWO ZINC ATOMS IN THE ACTIVE SITE	3.5.4.1 3.5.4
3R0W	CRYSTAL STRUCTURES OF MULTIDRUG-RESISTANT HIV-1 PROTEASE IN COMPLEX WITH MECHANISM-BASED ASPARTYL PROTEASE INHIBITORS.	2.7.7.49 3.1.26.13
3R0Y	CRYSTAL STRUCTURES OF MULTIDRUG-RESISTANT HIV-1 PROTEASE IN COMPLEX WITH MECHANISM-BASED ASPARTYL PROTEASE INHIBITORS	2.7.7.49 3.1.26.13
3R1G	STRUCTURE BASIS OF ALLOSTERIC INHIBITION OF BACE1 BY AN EXOSITE-BINDING ANTIBODY	3.4.23.46
3R1M	STRUCTURE OF BIFUNCTIONAL FRUCTOSE 1,6-BISPHOSPHATE ALDOLASE/PHOSPHATASE (ALDOLASE FORM)	3.1.3.11 4.1.2.13
3R24	CRYSTAL STRUCTURE OF NSP10/NSP16 COMPLEX OF SARS CORONAVIRUS	2.1.1 3.4.19.12 3.4.22.69 3.4.22 2.7.7.48 3.6.4.12 3.6.4.13 3.1.13 3.1
3R2F	CRYSTAL STRUCTURE OF BETA-SITE APP-CLEAVING ENZYME 1 (BACE-WT) COMPLEX WITH BMS-693391 AKA (2S)-2-((3R)-3-ACETAMIDO-3-ISOBUTYL-2-OXO-1-PYRROLIDINYL)-N-((1S,2R)-1-(3,5-DIFLUOROBENZYL)-2-HYDROXY-2-((2R,4R)-4-PROPOXY-2-PYRROLIDINYL)ETHYL)-4-PHENYLBUTANAMIDE	3.4.23.46
3R2J	CRYSTAL STRUCTURE OF PNC1 FROM L. INFANTUM IN COMPLEX WITH NICOTINATE	3.5.1.19
3R2N	CRYSTAL STRUCTURE OF CYTIDINE DEAMINASE FROM MYCOBACTERIUM LEPRAE	3.5.4.5
3R32	CRYSTAL STRUCTURE OF ARTHROBACTER SP. STRAIN SU 4-HYDROXYBENZOYL COA THIOESTERASE MUTANT E73A COMPLEXED WITH 4-HYDROXYPHENACYL COA	3.1.2.23
3R34	CRYSTAL STRUCTURE OF ARTHROBACTER SP. STRAIN SU 4-HYDROXYBENZOYL COA THIOESTERASE MUTANT E73D COMPLEXED WITH COA	3.1.2.23
3R35	CRYSTAL STRUCTURE OF ARTHROBACTER SP. STRAIN SU 4-HYDROXYBENZOYL COA THIOESTERASE MUTANT E73D COMPLEXED WITH 4-HYDROXYPHENACYL COA	3.1.2.23
3R36	CRYSTAL STRUCTURE OF ARTHROBACTER SP. STRAIN SU 4-HYDROXYBENZOYL COA THIOESTERASE MUTANT E73Q COMPLEXED WITH 4-HYDROXYBENZOIC ACID	3.1.2.23
3R37	CRYSTAL STRUCTURE OF ARTHROBACTER SP. STRAIN SU 4-HYDROXYBENZOYL COA THIOESTERASE MUTANT E73Q COMPLEXED WITH 4-HYDROXYPHENACYL COA	3.1.2.23
3R3A	CRYSTAL STRUCTURE OF ARTHROBACTER SP. STRAIN SU 4-HYDROXYBENZOYL COA THIOESTERASE MUTANT Q58A COMPLEXED WITH 4-HYDROXYBENZOIC ACID AND COA	3.1.2.23
3R3B	CRYSTAL STRUCTURE OF ARTHROBACTER SP. STRAIN SU 4-HYDROXYBENZOYL COA THIOESTERASE MUTANT Q58A COMPLEXED WITH 4-HYDROXYPHENACYL COA	3.1.2.23
3R3C	CRYSTAL STRUCTURE OF ARTHROBACTER SP. STRAIN SU 4-HYDROXYBENZOYL COA THIOESTERASE MUTANT H64A COMPLEXED WITH 4-HYDROXYPHENACYL COA	3.1.2.23
3R3D	CRYSTAL STRUCTURE OF ARTHROBACTER SP. STRAIN SU 4-HYDROXYBENZOYL COA THIOESTERASE MUTANT T77S COMPLEXED WITH 4-HYDROXYPHENACYL COA	3.1.2.23
3R3F	CRYSTAL STRUCTURE OF ARTHROBACTER SP. STRAIN SU 4-HYDROXYBENZOYL COA THIOESTERASE MUTANT T77A COMPLEXED WITH 4-HYDROXYPHENACYL COA	3.1.2.23
3R3G	STRUCTURE OF HUMAN THROMBIN WITH RESIDUES 145-150 OF MURINE THROMBIN.	3.4.21.5
3R3L	STRUCTURE OF NP PROTEIN FROM LASSA AV STRAIN	3.1.13
3R3O	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS T62A AT CRYOGENIC TEMPERATURE AND WITH HIGH REDUNDANCY	3.1.31.1
3R3U	CRYSTAL STRUCTURE OF THE FLUOROACETATE DEHALOGENASE RPA1163 - WT/APO	3.8.1.3
3R3V	CRYSTAL STRUCTURE OF THE FLUOROACETATE DEHALOGENASE RPA1163 - ASP110ASN/FLUOROACETATE	3.8.1.3
3R3W	CRYSTAL STRUCTURE OF THE FLUOROACETATE DEHALOGENASE RPA1163 - ASP110ASN/CHLOROACETATE	3.8.1.3
3R3X	CRYSTAL STRUCTURE OF THE FLUOROACETATE DEHALOGENASE RPA1163 - ASP110ASN/BROMOACETATE	3.8.1.3
3R3Y	CRYSTAL STRUCTURE OF THE FLUOROACETATE DEHALOGENASE RPA1163 - HIS280ASN/FLUOROACETATE	3.8.1.3
3R3Z	CRYSTAL STRUCTURE OF THE FLUOROACETATE DEHALOGENASE RPA1163 - WT/GLYCOLATE	3.8.1.3
3R40	CRYSTAL STRUCTURE OF THE FLUOROACETATE DEHALOGENASE RPA1163 - ASP110ASN/APO	3.8.1.3
3R41	CRYSTAL STRUCTURE OF THE FLUOROACETATE DEHALOGENASE RPA1163 - HIS280ASN/APO	3.8.1.3
3R4B	CRYSTAL STRUCTURE OF WILD-TYPE HIV-1 PROTEASE IN COMPLEX WITH TMC310911	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
3R4S	CELL ENTRY OF BOTULINUM NEUROTOXIN TYPE C IS DEPENDENT UPON INTERACTION WITH TWO GANGLIOSIDE MOLECULES	3.4.24.69
3R4U	CELL ENTRY OF BOTULINUM NEUROTOXIN TYPE C IS DEPENDENT UPON INTERACTION WITH TWO GANGLIOSIDE MOLECULES	3.4.24.69
3R4V	STRUCTURE OF THE PHAGE TUBULIN PHUZ-GDP	3.6.5
3R4Y	CRYSTAL STRUCTURE OF ALPHA-NEOAGAROBIOSE HYDROLASE (ALPHA-NABH) FROM SACCHAROPHAGUS DEGRADANS 2-40	3.2.1
3R4Z	CRYSTAL STRUCTURE OF ALPHA-NEOAGAROBIOSE HYDROLASE (ALPHA-NABH) IN COMPLEX WITH ALPHA-D-GALACTOPYRANOSE FROM SACCHAROPHAGUS DEGRADANS 2-40	3.2.1
3R5J	CRYSTAL STRUCTURE OF ACTIVE CASPASE-2 BOUND WITH AC-ADVAD-CHO	3.4.22.55
3R5K	A DESIGNED REDOX-CONTROLLED CASPASE-7	3.4.22.60
3R5U	THE STRUCTURE OF MANGANESE BOUND THERMOCOCCUS THIOREDUCENS INORGANIC PYROPHOSPHATASE	3.6.1.1
3R5V	THE STRUCTURE OF CALCIUM BOUND THERMOCOCCUS THIOREDUCENS INORGANIC PYROPHOSPHATASE AT 298K	3.6.1.1
3R6E	THE STRUCTURE OF THERMOCOCCUS THIOREDUCENS' INORGANIC PYROPHOSPHATASE BOUND TO SULFATE	3.6.1.1
3R6G	CRYSTAL STRUCTURE OF ACTIVE CASPASE-2 BOUND WITH AC-VDVAD-CHO	3.4.22.55
3R6L	CASPASE-2 T380A BOUND WITH AC-VDVAD-CHO	3.4.22 3.4.22.55
3R77	CRYSTAL STRUCTURE OF THE D38A MUTANT OF ISOCHORISMATASE PHZD FROM PSEUDOMONAS FLUORESCENS 2-79 IN COMPLEX WITH 2-AMINO-2-DESOXYISOCHORISMATE ADIC	3.3.2.1 3.3.2.15
3R7B	CASPASE-2 BOUND TO ONE COPY OF AC-DVAD-CHO	3.4.22.55
3R7N	CASPASE-2 BOUND WITH TWO COPIES OF AC-DVAD-CHO	3.4.22 3.4.22.55
3R7P	THE CRYSTAL STRUCTURE OF I-LTRI	3.1.21.1
3R7S	CRYSTAL STRUCTURE OF APO CASPASE2	3.4.22.55
3RAJ	CRYSTAL STRUCTURE OF HUMAN CD38 IN COMPLEX WITH THE FAB FRAGMENT OF ANTIBODY HB7	3.2.2.5 3.2.2.6 2.4.99.20
3RAP	THE SMALL G PROTEIN RAP2 IN A NON CATALYTIC COMPLEX WITH GTP	3.6.5.2
3RAR	X-RAY STRUCTURE OF A BOUND PHOSPHONATE TRANSITION STATE ANALOG AND ENANTIOSELECTIVITY OF CANDIDA RUGOSA LIPASE TOWARD CHIRAL CARBOXYLIC ACIDS	3.1.1.3
3RAT	EFFECTS OF TEMPERATURE ON PROTEIN STRUCTURE AND DYNAMICS: X-RAY CRYSTALLOGRAPHIC STUDIES OF THE PROTEIN RIBONUCLEASE-A AT NINE DIFFERENT TEMPERATURES FROM 98 TO 320 K	3.1.27.5 4.6.1.18
3RAU	CRYSTAL STRUCTURE OF THE HD-PTP BRO1 DOMAIN	3.1.3.48
3RB8	STRUCTURE OF THE PHAGE TUBULIN PHUZ(SEMET)-GDP	3.6.5
3RBU	N-TERMINALLY AVITEV-TAGGED HUMAN GLUTAMATE CARBOXYPEPTIDASE II IN COMPLEX WITH 2-PMPA	3.4.17.21
3RC3	HUMAN MITOCHONDRIAL HELICASE SUV3	3.6.4.13
3RC4	MOLECULAR MECHANISMS OF VIRAL AND HOST-CELL SUBSTRATE RECOGNITION BY HCV NS3/4A PROTEASE	3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48
3RC5	MOLECULAR MECHANISMS OF VIRAL AND HOST-CELL SUBSTRATE RECOGNITION BY HCV NS3/4A PROTEASE	3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48
3RC6	MOLECULAR MECHANISMS OF VIRAL AND HOST-CELL SUBSTRATE RECOGNITION BY HCV NS3/4A PROTEASE	2.7.7.48 3.4.21.98 3.6.1.15 3.6.4.13
3RC8	HUMAN MITOCHONDRIAL HELICASE SUV3 IN COMPLEX WITH SHORT RNA FRAGMENT	3.6.4.13
3RCM	CRYSTAL STRUCTURE OF EFI TARGET 500140:TATD FAMILY HYDROLASE FROM PSEUDOMONAS PUTIDA	3.1.21
3RCN	CRYSTAL STRUCTURE OF BETA-N-ACETYLHEXOSAMINIDASE FROM ARTHROBACTER AURESCENS	3.2.1.52
3RDK	PROTEIN CRYSTAL STRUCTURE OF XYLANASE A1 OF PAENIBACILLUS SP. JDR-2	3.2.1.8
3RDR	STRUCTURE OF THE CATALYTIC DOMAIN OF XLYA	3.5.1.28
3RDZ	CRYSTAL STRUCTURE OF RBTI-TRYPSIN COMPLEX AT 2.26 ANGSTROM RESOLUTION	3.4.21.4
3RF0	CRYSTAL STRUCTURE OF EXOPOLYPHOSPHATASE FROM YERSINIA PESTIS	3.6.1.11
3RGA	CRYSTAL STRUCTURE OF EPOXIDE HYDROLASE FOR POLYETHER LASALOCID A BIOSYNTHESIS	3.3.2 5.5.1
3RGO	CRYSTAL STRUCTURE OF PTPMT1	3.1.3.16 3.1.3.48 3.1.3.27
3RGQ	CRYSTAL STRUCTURE OF PTPMT1 IN COMPLEX WITH PI(5)P	3.1.3.16 3.1.3.48 3.1.3.27
3RGY	CRYSTAL STRUCTURE OF C-LOBE OF BOVINE LACTOFERRIN COMPLEXED WITH LIPOPOLYSACCHARIDE AT 2.0 A RESOLUTION	3.4.21
3RH1	X-RAY STRUCTURE OF A CIS-PROLINE (P114) TO ALANINE VARIANT OF RIBONUCLEASE A	3.1.27.5 4.6.1.18
3RHN	HISTIDINE TRIAD NUCLEOTIDE-BINDING PROTEIN (HINT) FROM RABBIT COMPLEXED WITH GMP	3
3RHY	CRYSTAL STRUCTURE OF THE DIMETHYLARGININE DIMETHYLAMINOHYDROLASE ADDUCT WITH 4-CHLORO-2-HYDROXYMETHYLPYRIDINE	3.5.3.18
3RI8	XYLANASE C FROM ASPERGILLUS KAWACHII D37N MUTANT	3.2.1.8
3RI9	XYLANASE C FROM ASPERGILLUS KAWACHII F131W MUTANT	3.2.1.8
3RID	X-RAY STRUCTURE OF THE C-TERMINAL SWAPPED DIMER OF P114A VARIANT OF RIBONUCLEASE A	3.1.27.5 4.6.1.18
3RIG	SIRT5 IS AN NAD-DEPENDENT PROTEIN LYSINE DEMALONYLASE AND DESUCCINYLASE	3.5.1 2.3.1
3RII	CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF UCHL5, A PROTEASOME-ASSOCIATED HUMAN DEUBIQUITINATING ENZYME, REVEALS AN UNPRODUCTIVE FORM OF THE ENZYME	3.4.19.12
3RIK	THE ACID BETA-GLUCOSIDASE ACTIVE SITE EXHIBITS PLASTICITY IN BINDING 3,4,5,6-TETRAHYDROXYAZEPANE-BASED INHIBITORS: IMPLICATIONS FOR PHARMACOLOGICAL CHAPERONE DESIGN FOR GAUCHER DISEASE	3.2.1.45 2.4.1 3.2.1
3RIL	THE ACID BETA-GLUCOSIDASE ACTIVE SITE EXHIBITS PLASTICITY IN BINDING 3,4,5,6-TETRAHYDROXYAZEPANE-BASED INHIBITORS: IMPLICATIONS FOR PHARMACOLOGICAL CHAPERONE DESIGN FOR GAUCHER DISEASE	3.2.1.45 2.4.1 3.2.1
3RIS	CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF UCHL5, A PROTEASOME-ASSOCIATED HUMAN DEUBIQUITINATING ENZYME, REVEALS AN UNPRODUCTIVE FORM OF THE ENZYME	3.4.19.12
3RIY	SIRT5 IS AN NAD-DEPENDENT PROTEIN LYSINE DEMALONYLASE AND DESUCCINYLASE	3.5.1 2.3.1
3RJM	CASPASE2 IN COMPLEX WITH CHDI LIGAND 33C	3.4.22.55
3RJO	CRYSTAL STRUCTURE OF ERAP1 PEPTIDE BINDING DOMAIN	3.4.11
3RJX	CRYSTAL STRUCTURE OF HYPERTHERMOPHILIC ENDO-BETA-1,4-GLUCANASE	3.2.1.4
3RJY	CRYSTAL STRUCTURE OF HYPERTHERMOPHILIC ENDO-BETA-1,4-GLUCANASE IN COMPLEX WITH SUBSTRATE	3.2.1.4
3RK4	STRUCTURE OF RHODOCOCCUS RHODOCHROUS HALOALKANE DEHALOGENASE MUTANT DHAA31	3.8.1.5
3RKJ	CRYSTAL STRUCTURE OF NEW DELHI METALLO-BETA-LACTAMASE-1 FROM KLEBSIELLA PNUEUMONIAE	3.5.2.6
3RKK	CRYSTAL STRUCTURE OF NEW DELHI METALLO-BETA-LACTAMASE-1 FROM KLEBSIELLA PNEUMONIAE	3.5.2.6
3RL3	RAT METALLOPHOSPHODIESTERASE MPPED2	3.1
3RL4	RAT METALLOPHOSPHODIESTERASE MPPED2 G252H MUTANT	3.1
3RL5	RAT METALLOPHOSPHODIESTERASE MPPED2 H67R MUTANT	3.1
3RL9	CRYSTAL STRUCTURE OF THE COMPLEX OF TYPE I RIP WITH THE HYDROLYZED PRODUCT OF DATP, ADENINE AT 1.9 A RESOLUTION	3.2.2.22
3RLA	ALTERING THE BINUCLEAR MANGANESE CLUSTER OF ARGINASE DIMINISHES THERMOSTABILITY AND CATALYTIC FUNCTION	3.5.3.1
3RLF	CRYSTAL STRUCTURE OF THE MALTOSE-BINDING PROTEIN/MALTOSE TRANSPORTER COMPLEX IN AN OUTWARD-FACING CONFORMATION BOUND TO MGAMPPNP	3.6.3.19 7.5.2.1
3RLG	CRYSTAL STRUCTURE OF LOXOSCELES INTERMEDIA PHOSPHOLIPASE D ISOFORM 1 H12A MUTANT	3.1.4.41 4.6.1
3RLH	CRYSTAL STRUCTURE OF A CLASS II PHOSPHOLIPASE D FROM LOXOSCELES INTERMEDIA VENOM	3.1.4.41 4.6.1
3RLI	CRYSTAL STRUCTURE OF MONOACYLGLYCEROL LIPASE FROM BACILLUS SP. H257 IN COMPLEX WITH PMSF	3.1.1.23
3RLW	HUMAN THROMBIN IN COMPLEX WITH MI328	3.4.21.5
3RLY	HUMAN THROMBIN IN COMPLEX WITH MI329	3.4.21.5
3RM0	HUMAN THROMBIN IN COMPLEX WITH MI354	3.4.21.5
3RM2	HUMAN THROMBIN IN COMPLEX WITH MI003	3.4.21.5
3RM3	CRYSTAL STRUCTURE OF MONOACYLGLYCEROL LIPASE FROM BACILLUS SP. H257	3.1.1.23
3RM4	AMCASE IN COMPLEX WITH COMPOUND 1	3.2.1.14
3RM8	AMCASE IN COMPLEX WITH COMPOUND 2	3.2.1.14
3RM9	AMCASE IN COMPLEX WITH COMPOUND 3	3.2.1.14
3RMB	CRYSTAL STRUCTURE OF A REPLICATIVE DNA POLYMERASE BOUND TO DNA CONTAINING THYMINE GLYCOL	2.7.7.7 3.1.11
3RME	AMCASE IN COMPLEX WITH COMPOUND 5	3.2.1.14
3RML	HUMAN THROMBIN IN COMPLEX WITH MI331	3.4.21.5
3RMM	HUMAN THROMBIN IN COMPLEX WITH MI332	3.4.21.5
3RMN	HUMAN THROMBIN IN COMPLEX WITH MI341	3.4.21.5
3RMO	HUMAN THROMBIN IN COMPLEX WITH MI004	3.4.21.5
3RMX	CRYSTAL STRUCTURE OF HCR/D F1240A MUTANT	3.4.24.69
3RN3	SEGMENTED ANISOTROPIC REFINEMENT OF BOVINE RIBONUCLEASE A BY THE APPLICATION OF THE RIGID-BODY TLS MODEL	3.1.27.5 4.6.1.18
3RN6	CRYSTAL STRUCTURE OF CYTOSINE DEAMINASE FROM ESCHERICHIA COLI COMPLEXED WITH ZINC AND ISOGUANINE	3.5.4.1 3.5.4
3RNT	CRYSTAL STRUCTURE OF GUANOSINE-FREE RIBONUCLEASE T1, COMPLEXED WITH VANADATE(V), SUGGESTS CONFORMATIONAL CHANGE UPON SUBSTRATE BINDING	3.1.27.3 4.6.1.24
3RNV	STRUCTURE OF THE AUTOCATALYTIC CYSTEINE PROTEASE DOMAIN OF POTYVIRUS HELPER-COMPONENT PROTEINASE	3.4.22.45 3.4 3.6.4 3.4.22.44 2.7.7.48
3RNX	CRYSTAL STRUCTURE OF LYSOZYME IN 30% ETHANOL	3.2.1.17
3RNZ	CRYSTAL STRUCTURE OF BACILLUS AMYLOLIQUEFACIENS PYROGLUTAMYL PEPTIDASE I	3.4.19.3
3RO0	CRYSTAL STRUCTURE OF BACILLUS AMYLOLIQUEFACIENS PYROGLUTAMYL PEPTIDASE I AND TERPYRIDINE PLATINUM(II)	3.4.19.3
3RO1	CRYSTAL STRUCTURE OF THE COMPLEX OF THE ARCHAEAL SULFOLOBUS PTP-FOLD PHOSPHATASE WITH TERPYRIDINE PLATINUM(II)	3.1.3.48
3RO8	CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF XYNA1 FROM PAENIBACILLUS SP. JDR-2	3.2.1.8
3ROF	CRYSTAL STRUCTURE OF THE S. AUREUS PROTEIN TYROSINE PHOSPHATASE PTPA	3.1.3.48
3ROJ	D-FRUCTOSE 1,6-BISPHOSPHATASE CLASS 2/SEDOHEPTULOSE 1,7-BISPHOSPHATASE OF SYNECHOCYSTIS SP. PCC 6803	3.1.3.11 3.1.3.37
3ROK	CRYSTAL STRUCTURE OF HUMAN CD38 IN COMPLEX WITH COMPOUND CZ-27	3.2.2.5 3.2.2.6 2.4.99.20
3ROM	CRYSTAL STRUCTURE OF HUMAN CD38 IN COMPLEX WITH COMPOUND CZ-48	3.2.2.5 3.2.2.6 2.4.99.20
3ROP	CRYSTAL STRUCTURE OF HUMAN CD38 IN COMPLEX WITH COMPOUND CZ-50B	3.2.2.5 3.2.2.6 2.4.99.20
3ROR	CRYSTAL STRUCTURE OF C105S MUTANT OF MYCOBACTERIUM TUBERCULOSIS METHIONINE AMINOPEPTIDASE	3.4.11.18
3RP2	THE STRUCTURE OF RAT MAST CELL PROTEASE II AT 1.9-ANGSTROMS RESOLUTION	3.4.21
3RPL	D-FRUCTOSE 1,6-BISPHOSPHATASE CLASS 2/SEDOHEPTULOSE 1,7-BISPHOSPHATASE OF SYNECHOCYSTIS SP. PCC 6803 IN COMPLEX WITH FRUCTOSE-1,6-BISPHOSPHATE	3.1.3.11 3.1.3.37
3RPM	CRYSTAL STRUCTURE OF THE FIRST GH20 DOMAIN OF A NOVEL BETA-N-ACETYL-HEXOSAMINIDASE STRH FROM STREPTOCOCCUS PNEUMONIAE R6	3.2.1.52
3RPT	CRYSTAL STRUCTURE OF THE ANTI-HIV B12 SCAFFOLD PROTEIN	3.2.1.4
3RQD	IDEAL THIOLATE-ZINC COORDINATION GEOMETRY IN DEPSIPEPTIDE BINDING TO HISTONE DEACETYLASE 8	3.5.1.98
3RRM	S. CEREVISIAE DBP5 L327V BOUND TO NUP159, GLE1 H337R, IP6 AND ADP	3.6.4.13
3RRN	S. CEREVISIAE DBP5 L327V BOUND TO GLE1 H337R AND IP6	3.6.4.13
3RRX	CRYSTAL STRUCTURE OF Q683A MUTANT OF EXO-1,3/1,4-BETA-GLUCANASE (EXOP) FROM PSEUDOALTEROMONAS SP. BB1	3.2.1
3RRY	H-RAS CROSSLINKED CONTROL, SOAKED IN AQUEOUS SOLUTION: ONE OF 10 IN MSCS SET	3.6.5.2
3RRZ	H-RAS IN 70% GLYCEROL: ONE OF 10 IN MSCS SET	3.6.5.2
3RS0	H-RAS SOAKED IN NEAT CYCLOPENTANOL: ONE OF 10 IN MSCS SET	3.6.5.2
3RS2	H-RAS SOAKED IN 50% 2,2,2-TRIFLUOROETHANOL: ONE OF 10 IN MSCS SET	3.6.5.2
3RS3	H-RAS SOAKED IN NEAT HEXANE: 1 OF 10 IN MSCS SET	3.6.5.2
3RS4	H-RAS SOAKED IN 60% 1,6-HEXANEDIOL: 1 OF 10 IN MSCS SET	3.6.5.2
3RS5	H-RAS SOAKED IN 55% DIMETHYLFORMAMIDE: 1 OF 10 IN MSCS SET	3.6.5.2
3RS7	H-RAS SOAKED IN 50% ISOPROPANOL: 1 OF 10 IN MSCS SET	3.6.5.2
3RSD	STRUCTURE OF THE D121N VARIANT OF RIBONUCLEASE A	3.1.27.5 4.6.1.18
3RSJ	STRUCTURE OF HCRF IN COMPLEX WITH GANGLIOSIDE GD1A	3.4.24.69
3RSK	STRUCTURE OF THE K7A/R10A/K66A VARIANT OF RIBONUCLEASE A	3.1.27.5 4.6.1.18
3RSL	H-RAS SOAKED IN 90% R,S,R-BISFURANOL: ONE OF 10 IN MSCS SET	3.6.5.2
3RSO	H-RAS SOAKED IN 20% S,R,S-BISFURANOL: 1 OF 10 IN MSCS SET	3.6.5.2
3RSP	STRUCTURE OF THE P93G VARIANT OF RIBONUCLEASE A	3.1.27.5 4.6.1.18
3RSV	STRUCTURE OF BACE-1 (BETA-SECRETASE) IN COMPLEX WITH (R)-3-(2-AMINO-6-O-TOLYLQUINOLIN-3-YL)-N-((R)-2,2-DIMETHYLTETRAHYDRO-2H-PYRAN-4-YL)-2-METHYLPROPANAMIDE	3.4.23.46
3RSX	STRUCTURE OF BACE-1 (BETA-SECRETASE) IN COMPLEX WITH 6-(THIOPHEN-3-YL)QUINOLIN-2-AMINE	3.4.23.46
3RT0	CRYSTAL STRUCTURE OF PYL10-HAB1 COMPLEX IN THE ABSENCE OF ABSCISIC ACID (ABA)	3.1.3.16
3RT5	LYSOZYME IN 30% PROPANOL	3.2.1.17
3RTH	STRUCTURE OF BACE-1 (BETA-SECRETASE) IN COMPLEX WITH 6-(2-(3,3-DIMETHYLBUT-1-YNYL)PHENYL)QUINOLIN-2-AMINE	3.4.23.46
3RTI	CRYSTAL STRUCTURE OF RICIN BOUND WITH FORMYCIN MONOPHOSPHATE	3.2.2.22
3RTJ	CRYSTAL STRUCTURE OF RICIN BOUND WITH DINUCLEOTIDE APG	3.2.2.22
3RTM	STRUCTURE OF BACE-1 (BETA-SECRETASE) IN COMPLEX WITH 3-(2-AMINOQUINOLIN-3-YL)-N-CYCLOHEXYL-N-METHYLPROPANAMIDE	3.4.23.46
3RTN	STRUCTURE OF BACE-1 (BETA-SECRETASE) IN COMPLEX WITH 3-(2-AMINO-6-O-TOLYLQUINOLIN-3-YL)-N-CYCLOHEXYLPROPANAMIDE	3.4.23.46
3RTS	HUMAN MMP-12 CATALYTIC DOMAIN IN COMPLEX WITH*N*-HYDROXY-2-(2-PHENYLETHYLSULFONAMIDO)ACETAMIDE	3.4.24.65
3RTT	HUMAN MMP-12 CATALYTIC DOMAIN IN COMPLEX WITH*(R)-N*-HYDROXY-1-(PHENETHYLSULFONYL)PYRROLIDINE-2-CARBOXAMIDE	3.4.24.65
3RTX	CRYSTAL STRUCTURE OF MAMMALIAN CAPPING ENZYME (MCE1) AND POL II CTD COMPLEX	2.7.7.50 3.1.3.33
3RU1	STRUCTURE OF BACE-1 (BETA-SECRETASE) IN COMPLEX WITH 3-(2-AMINOQUINOLIN-3-YL)-N-(CYCLOHEXYLMETHYL)PROPANAMIDE	3.4.23.46
3RU5	SILVER METALLATED HEN EGG WHITE LYSOZYME AT 1.35 A	3.2.1.17
3RUN	NEW STRATEGY TO ANALYZE STRUCTURES OF GLYCOPEPTIDE ANTIBIOTIC-TARGET COMPLEXES	3.2.1.17
3RUO	COMPLEX STRUCTURE OF HEVB EV93 MAIN PROTEASE 3C WITH RUPINTRIVIR (AG7088)	3.4.22.28 3.4.22.29 3.6.1.15 2.7.7.48
3RUZ	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS V74K AT CRYOGENIC TEMPERATURE	3.1.31.1
3RVA	CRYSTAL STRUCTURE OF ORGANOPHOSPHORUS ACID ANHYDROLASE FROM ALTEROMONAS MACLEODII	3.1.8.2 3.4.13.9
3RVB	THE STRUCTURE OF HCV NS3 HELICASE (HELI-80) BOUND WITH INHIBITOR ITMN-3479	3.6.4.13 3.4.22 3.4.21.98 3.6.1.15 2.7.7.48
3RVI	STRUCTURE OF BACE-1 (BETA-SECRETASE) IN COMPLEX WITH 2-((2-AMINO-6-O-TOLYLQUINOLIN-3-YL)METHYL)-N-(CYCLOHEXYLMETHYL)PENTANAMIDE	3.4.23.46
3RVV	CRYSTAL STRUCTURE OF DER F 1 COMPLEXED WITH FAB 4C1	3.4.22.65
3RVW	CRYSTAL STRUCTURE OF DER P 1 COMPLEXED WITH FAB 4C1	3.4.22.65
3RVX	CRYSTAL STRUCTURE OF DER P 1 COMPLEXED WITH FAB 4C1	3.4.22.65
3RW8	CRYSTAL STRUCTURE OF LYSOZYME IN 40% ETHANOL	3.2.1.17
3RWK	FIRST CRYSTAL STRUCTURE OF AN ENDO-INULINASE, FROM ASPERGILLUS FICUUM: STRUCTURAL ANALYSIS AND COMPARISON WITH OTHER GH32 ENZYMES.	3.2.1.7
3RWU	RB69 DNA POLYMERASE (Y567A) TERNARY COMPLEX WITH DATP OPPOSITE DIFLUOROTOLUENE NUCLEOSIDE	2.7.7.7 3.1.11
3RX5	STRUCTURE OF AACEL9A IN COMPLEX WITH CELLOTRIOSE-LIKE ISOFAGOMINE	3.2.1.4
3RX7	STRUCTURE OF AACEL9A IN COMPLEX WITH CELLOTETRAOSE-LIKE ISOFAGOMINE	3.2.1.4
3RX8	STRUCTURE OF AACEL9A IN COMPLEX WITH CELLOBIOSE-LIKE ISOFAGOMINE	3.2.1.4
3RXA	CRYSTAL STRUCTURE OF TRYPSIN COMPLEXED WITH CYCLOHEPTANAMINE	3.4.21.4
3RXB	CRYSTAL STRUCTURE OF TRYPSIN COMPLEXED WITH 4-GUANIDINOBUTANOIC ACID	3.4.21.4
3RXC	CRYSTAL STRUCTURE OF TRYPSIN COMPLEXED WITH 2-AMINOPYRIDINE	3.4.21.4
3RXD	CRYSTAL STRUCTURE OF TRYPSIN COMPLEXED WITH (3-METHOXYPHENYL)METHANAMINE	3.4.21.4
3RXE	CRYSTAL STRUCTURE OF TRYPSIN COMPLEXED WITH BENZAMIDE	3.4.21.4
3RXF	CRYSTAL STRUCTURE OF TRYPSIN COMPLEXED WITH 4-AMINOPYRIDINE	3.4.21.4
3RXG	CRYSTAL STRUCTURE OF TRYPSIN COMPLEXED WITH 4-AMINOCYCLOHEXANOL	3.4.21.4
3RXH	CRYSTAL STRUCTURE OF TRYPSIN COMPLEXED WITH 2-(1H-IMIDAZOL-4-YL)ETHANAMINE	3.4.21.4
3RXI	CRYSTAL STRUCTURE OF TRYPSIN COMPLEXED WITH 2-(1H-INDOL-3-YL)ETHANAMINE	3.4.21.4
3RXJ	CRYSTAL STRUCTURE OF TRYPSIN COMPLEXED WITH 4-GUANIDINOBENZOIC ACID	3.4.21.4
3RXK	CRYSTAL STRUCTURE OF TRYPSIN COMPLEXED WITH METHYL 4-AMINO-1-METHYL-PYRROLIDINE-2-CARBOXYLATE	3.4.21.4
3RXL	CRYSTAL STRUCTURE OF TRYPSIN COMPLEXED WITH (2,5-DIMETHYL-3-FURYL)METHANAMINE	3.4.21.4
3RXM	CRYSTAL STRUCTURE OF TRYPSIN COMPLEXED WITH [2-(2-THIENYL)THIAZOL-4-YL]METHANAMINE	3.4.21.4
3RXO	CRYSTAL STRUCTURE OF TRYPSIN COMPLEXED WITH (3-PYRROL-1-YLPHENYL)METHANAMINE	3.4.21.4
3RXP	CRYSTAL STRUCTURE OF TRYPSIN COMPLEXED WITH (1,5-DIMETHYLPYRAZOL-3-YL)METHANAMINE	3.4.21.4
3RXQ	CRYSTAL STRUCTURE OF TRYPSIN COMPLEXED WITH BENZAMIDE (F01 AND F05, COCKTAIL EXPERIMENT)	3.4.21.4
3RXR	CRYSTAL STRUCTURE OF TRYPSIN COMPLEXED WITH CYCLOHEPTANAMINE (F01 AND F03, COCKTAIL EXPERIMENT)	3.4.21.4
3RXS	CRYSTAL STRUCTURE OF TRYPSIN COMPLEXED WITH (3-METHOXYPHENYL)METHANAMINE (F04 AND A06, COCKTAIL EXPERIMENT)	3.4.21.4
3RXT	CRYSTAL STRUCTURE OF TRYPSIN COMPLEXED WITH (3-METHOXYPHENYL)METHANAMIN (F04 AND F03, COCKTAIL EXPERIMENT)	3.4.21.4
3RXU	CRYSTAL STRUCTURE OF TRYPSIN COMPLEXED WITH BENZAMIDE (F05 AND A06, COCKTAIL EXPERIMENT)	3.4.21.4
3RXV	CRYSTAL STRUCTURE OF TRYPSIN COMPLEXED WITH BENZAMIDE (F05 AND F03, COCKTAIL EXPERIMENT)	3.4.21.4
3RXW	KPC-2 CARBAPENEMASE IN COMPLEX WITH PSR3-226	3.5.2.6
3RXX	KPC-2 CARBAPENEMASE IN COMPLEX WITH 3-NPBA	3.5.2.6
3RYD	CRYSTAL STRUCTURE OF CA BOUND IMPASE FAMILY PROTEIN FROM STAPHYLOCOCCUS AUREUS	3.1.3.25
3RYS	THE CRYSTAL STRUCTURE OF ADENINE DEAMINASE (AAUR1117) FROM ARTHROBACTER AURESCENS	3.5.4.4 3.5.4.2
3RZ2	CRYSTAL OF PRL-1 COMPLEXED WITH PEPTIDE	3.1.3.48
3RZ4	HEN EGG-WHITE LYSOZYME IN HEPES BUFFER AT PH 7.5	3.2.1.17
3RZE	STRUCTURE OF THE HUMAN HISTAMINE H1 RECEPTOR IN COMPLEX WITH DOXEPIN	3.2.1.17
3RZU	THE CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF AMSH	3.4.19
3RZV	THE CRYSTAL STRUCTURE OF A E280A MUTANT OF THE CATALYTIC DOMAIN OF AMSH	3.4.19
3S04	CRYSTAL STRUCTURE OF ESCHERICHIA COLI TYPE I SIGNAL PEPTIDASE IN COMPLEX WITH AN ARYLOMYCIN LIPOGLYCOPEPTIDE ANTIBIOTIC	3.4.21.89
3S0N	CRYSTAL STRUCTURE OF HUMAN CHYMASE WITH BENZIMIDAZOLONE INHIBITOR	3.4.21.39
3S0Q	PEPTIDASE MODULE OF THE PEPTIDOGLYCAN HYDROLASE RIPA (RV1477) FROM MYCOBACTERIUM TUBERCULOSIS, CATALYTIC SITE MUTANT (CYS383ALA) AT 1.45 RESOLUTION	3.4
3S0X	THE CRYSTAL STRUCTURE OF GXGD MEMBRANE PROTEASE FLAK	3.4.23.52
3S1Y	AMP-C BETA-LACTAMASE (PSEUDOMONAS AERUGINOSA) IN COMPLEX WITH A BETA-LACTAMASE INHIBITOR	3.5.2.6
3S22	AMP-C BETA-LACTAMASE (PSEUDOMONAS AERUGINOSA) IN COMPLEX WITH AN INHIBITOR	3.5.2.6
3S24	CRYSTAL STRUCTURE OF HUMAN MRNA GUANYLYLTRANSFERASE	3.1.3.33 2.7.7.50
3S2O	FRAGMENT BASED DISCOVERY AND OPTIMISATION OF BACE-1 INHIBITORS	3.4.23.46
3S2S	THE CRYSTAL STRUCTURE OF PYRAZINAMIDASE/NICOTINAMIDASE FROM STREPTOCOCCUS MUTANS UA159	3.5.1.19
3S2Z	CRYSTAL STRUCTURE OF THE LACTOBACILLUS JOHNSONII CINNAMOYL ESTERASE LJ0536 S106A MUTANT IN COMPLEX WITH CAFFEIC ACID	3.1.1
3S3E	CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF PTP10D FROM DROSOPHILA MELANOGASTER	3.1.3.48
3S3F	CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF PTP10D FROM DROSOPHILA MELANOGASTER WITH A SMALL MOLECULE INHIBITOR VANADATE	3.1.3.48
3S3H	CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF PTP10D FROM DROSOPHILA MELANOGASTER WITH A PHOSPHOPEPTIDE SUBSTRATE GP4	3.1.3.48
3S3K	CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF PTP10D FROM DROSOPHILA MELANOGASTER WITH A SMALL MOLECULAR INHIBITOR PARA-NITROCATECHOL SULPHATE	3.1.3.48
3S3M	CRYSTAL STRUCTURE OF THE PROTOTYPE FOAMY VIRUS (PFV) INTASOME IN COMPLEX WITH MAGNESIUM AND DOLUTEGRAVIR (S/GSK1349572)	2.7.7 2.7.7.49 2.7.7.7 3.1.26.4 3.4.23 3.1
3S3N	CRYSTAL STRUCTURE OF THE PROTOTYPE FOAMY VIRUS (PFV) S217H MUTANT INTASOME IN COMPLEX WITH MAGNESIUM AND DOLUTEGRAVIR (S/GSK1349572)	2.7.7 2.7.7.49 2.7.7.7 3.1.26.4 3.4.23 3.1
3S3O	CRYSTAL STRUCTURE OF THE PROTOTYPE FOAMY VIRUS (PFV) N224H MUTANT INTASOME IN COMPLEX WITH MAGNESIUM AND DOLUTEGRAVIR (S/GSK1349572)	2.7.7 2.7.7.49 2.7.7.7 3.1.26.4 3.4.23 3.1
3S3Q	STRUCTURE OF CATHEPSIN B1 FROM SCHISTOSOMA MANSONI IN COMPLEX WITH K11017 INHIBITOR	3.4.22.1
3S3R	STRUCTURE OF CATHEPSIN B1 FROM SCHISTOSOMA MANSONI IN COMPLEX WITH K11777 INHIBITOR	3.4.22.1
3S43	HIV-1 PROTEASE TRIPLE MUTANTS V32I, I47V, V82I WITH ANTIVIRAL DRUG AMPRENAVIR	3.4.23.16
3S45	WILD-TYPE HIV-2 PROTEASE WITH ANTIVIRAL DRUG AMPRENAVIR	3.4.23.47
3S4E	CRYSTAL STRUCTRUE OF A NOVEL MITOGEN-ACTIVATED PROTEIN KINASE PHOSPHATASE, SKRP1	3.1.3.16 3.1.3.48
3S4K	STRUCTURE OF A PUTATIVE ESTERASE RV1847/MT1895 FROM MYCOBACTERIUM TUBERCULOSIS	3.1.2
3S4L	THE CRISPR-ASSOCIATED CAS3 HD DOMAIN PROTEIN MJ0384 FROM METHANOCALDOCOCCUS JANNASCHII	3.1
3S4O	PROTEIN TYROSINE PHOSPHATASE (PUTATIVE) FROM LEISHMANIA MAJOR	3.1.3.48
3S4X	CRYSTAL STRUCTURE OF THE ASN152GLY MUTANT OF P99 BETA-LACTAMASE	3.5.2.6
3S53	HIV-1 PROTEASE TRIPLE MUTANTS V32I, I47V, V82I WITH ANTIVIRAL DRUG DARUNAVIR IN SPACE GROUP P212121	3.4.23.16
3S54	HIV-1 PROTEASE TRIPLE MUTANTS V32I, I47V, V82I WITH ANTIVIRAL DRUG DARUNAVIR IN SPACE GROUP P21212	3.4.23.16
3S56	HIV-1 PROTEASE TRIPLE MUTANTS V32I, I47V, V82I WITH ANTIVIRAL DRUG SAQUINAVIR	3.4.23.16
3S5B	CRYSTAL STRUCTURE OF CED-3 PROTEASE SUPPRESSOR-6 (CPS-6) FROM CAENORHABDITIS ELEGANS	3.1.30
3S5H	CRYSTAL STRUCTURES OF FALCILYSIN, A M16 METALLOPROTEASE FROM THE MALARIA PARASITE PLASMODIUM FALCIPARUM	3.4.24.55
3S5I	CRYSTAL STRUCTURES OF FALCILYSIN, A M16 METALLOPROTEASE FROM THE MALARIA PARASITE PLASMODIUM FALCIPARUM	3.4.24.55
3S5K	CRYSTAL STRUCTURES OF FALCILYSIN, A M16 METALLOPROTEASE FROM THE MALARIA PARASITE PLASMODIUM FALCIPARUM	3.4.24.55
3S5M	CRYSTAL STRUCTURES OF FALCILYSIN, A M16 METALLOPROTEASE FROM THE MALARIA PARASITE PLASMODIUM FALCIPARUM	3.4.24.55
3S5Y	PHARMACOLOGICAL CHAPERONING IN HUMAN ALPHA-GALACTOSIDASE	3.2.1.22 3.2.1.47
3S5Z	PHARMACOLOGICAL CHAPERONING IN HUMAN ALPHA-GALACTOSIDASE	3.2.1.22 3.2.1.47
3S69	CRYSTAL STRUCTURE OF SAXTHROMBIN	3.4.21
3S6B	CRYSTAL STRUCTURE OF METHIONINE AMINOPEPTIDASE 1B FROM PLASMODIUM FALCIPARUM, PF10_0150	3.4.11.18
3S6I	SCHIZOSACCAROMYCES POMBE 3-METHYLADENINE DNA GLYCOSYLASE (MAG1) IN COMPLEX WITH ABASIC-DNA.	3.2.2.21
3S6O	CRYSTAL STRUCTURE OF A POLYSACCHARIDE DEACETYLASE FAMILY PROTEIN FROM BURKHOLDERIA PSEUDOMALLEI	3.5.1
3S6T	CRYSTAL STRUCTURE OF INSECT BETA-N-ACETYL-D-HEXOSAMINIDASE OFHEX1 V327G COMPLEXED WITH PUGNAC	3.2.1.52
3S70	CRYSTAL STRUCTURE OF ACTIVE CASPASE-6 BOUND WITH AC-VEID-CHO SOLVED BY AS-SAD	3.4.22.59
3S7H	STRUCTURE OF THROMBIN MUTANT Y225P IN THE E* FORM	3.4.21.5
3S7K	STRUCTURE OF THROMBIN MUTANT Y225P IN THE E FORM	3.4.21.5
3S7L	PYRAZOLYL AND THIENYL AMINOHYDANTOINS AS POTENT BACE1 INHIBITORS	3.4.23.46
3S7M	PYRAZOLYL AND THIENYL AMINOHYDANTOINS AS POTENT BACE1 INHIBITORS	3.4.23.46
3S85	DISCOVERY OF NEW HIV PROTEASE INHIBITORS WITH POTENTIAL FOR CONVENIENT DOSING AND REDUCED SIDE EFFECTS: A-790742 AND A-792611.	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
3S86	CRYSTAL STRUCTURE OF TM0159 WITH BOUND IMP	3.6.1.15 3.6.1.66
3S8E	PHOSPHORYLATION REGULATES ASSEMBLY OF THE CASPASE-6 SUBSTRATE-BINDING GROOVE	3.4.22.59
3S8I	THE RETROVIRAL-LIKE PROTEASE (RVP) DOMAIN OF HUMAN DDI1	3.4.23
3S8R	CRYSTAL STRUCTURES OF GLUTARYL 7-AMINOCEPHALOSPORANIC ACID ACYLASE: INSIGHT INTO AUTOPROTEOLYTIC ACTIVATION	3.5.1.93
3S8Y	BROMIDE SOAKED STRUCTURE OF AN ESTERASE FROM THE OIL-DEGRADING BACTERIUM OLEISPIRA ANTARCTICA	3.1.1.2 3.1.2.12
3S97	PTPRZ CNTN1 COMPLEX	3.1.3.48
3S9A	RUSSELL'S VIPER VENOM SERINE PROTEINASE, RVV-V (CLOSED-FORM)	3.4.21.95
3S9B	RUSSELL'S VIPER VENOM SERINE PROTEINASE, RVV-V (OPEN-FORM)	3.4.21.95
3S9C	RUSSELL'S VIPER VENOM SERINE PROTEINASE, RVV-V IN COMPLEX WITH THE FRAGMENT (RESIDUES 1533-1546) OF HUMAN FACTOR V	3.4.21.95
3S9H	RB69 DNA POLYMERASE TRIPLE MUTANT(L561A/S565G/Y567A) TERNARY COMPLEX WITH DUPNPP AND A DIDEOXY-TERMINATED PRIMER IN THE PRESENCE OF CA2+	2.7.7.7 3.1.11
3S9Q	CRYSTAL STRUCTURE OF NATIVE TYPE 1 RIBOSOME INACTIVATING PROTEIN FROM MOMORDICA BALSAMINA AT 1.67 A RESOLUTION	3.2.2.22
3S9W	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS M98G BOUND TO CA2+ AND THYMIDINE-5',3'-DIPHOSPHATE AT CRYOGENIC TEMPERATURE	3.1.31.1
3SAF	CRYSTAL STRUCTURE OF THE HUMAN RRP6 CATALYTIC DOMAIN WITH D313N MUTATION IN THE ACTIVE SITE	3.1.13
3SAG	CRYSTAL STRUCTURE OF THE HUMAN RRP6 CATALYTIC DOMAIN WITH D313N MUTATION IN THE ACTIVE SITE	3.1.13
3SAH	CRYSTAL STRUCTURE OF THE HUMAN RRP6 CATALYTIC DOMAIN WITH Y436A MUTATION IN THE CATALYTIC SITE	3.1.13
3SAL	CRYSTAL STRUCTURE OF INFLUENZA A VIRUS NEURAMINIDASE N5	3.2.1.18
3SAN	CRYSTAL STRUCTURE OF INFLUENZA A VIRUS NEURAMINIDASE N5 COMPLEXED WITH ZANAMIVIR	3.2.1.18
3SAR	MUTM SLANTED COMPLEX 1	3.2.2.23 4.2.99.18
3SAS	MUTM SLANTED COMPLEX 4 WITH R112A MUTATION	4.2.99.18 3.2.2.23
3SAT	MUTM SLANTED COMPLEX 6 WITH R112A MUTATION	4.2.99.18 3.2.2.23
3SAU	MUTM INTERROGATION COMPLEX 6	4.2.99.18 3.2.2.23
3SAV	MUTM SLANTED COMPLEX 8	4.2.99.18 3.2.2.23
3SAW	MUTM SLANTED COMPLEX 8 WITH R112A MUTATION	4.2.99.18 3.2.2.23
3SB5	ZN-MEDIATED TRIMER OF T4 LYSOZYME R125C/E128C BY SYNTHETIC SYMMETRIZATION	3.2.1.17
3SB6	CU-MEDIATED DIMER OF T4 LYSOZYME D61H/K65H/R76H/R80H BY SYNTHETIC SYMMETRIZATION	3.2.1.17
3SB7	CU-MEDIATED TRIMER OF T4 LYSOZYME D61H/K65H/R76H/R80H BY SYNTHETIC SYMMETRIZATION	3.2.1.17
3SB8	CU-MEDIATED DIMER OF T4 LYSOZYME D61H/K65H BY SYNTHETIC SYMMETRIZATION	3.2.1.17
3SB9	CU-MEDIATED DIMER OF T4 LYSOZYME R76H/R80H BY SYNTHETIC SYMMETRIZATION	3.2.1.17
3SBA	ZN-MEDIATED HEXAMER OF T4 LYSOZYME R76H/R80H BY SYNTHETIC SYMMETRIZATION	3.2.1.17
3SBB	DISULPHIDE-MEDIATED TETRAMER OF T4 LYSOZYME R76C/R80C BY SYNTHETIC SYMMETRIZATION	3.2.1.17
3SBD	CRYSTAL STRUCTURE OF RAC1 P29S MUTANT	3.6.5.2
3SBE	CRYSTAL STRUCTURE OF RAC1 P29S MUTANT	3.6.5.2
3SBJ	MUTM SLANTED COMPLEX 7	3.2.2.23 4.2.99.18
3SBK	RUSSELL'S VIPER VENOM SERINE PROTEINASE, RVV-V (PPACK-BOUND FORM)	3.4.21.95
3SBL	CRYSTAL STRUCTURE OF NEW DELHI METAL-BETA-LACTAMASE-1 FROM KLEBSIELLA PNEUMONIAE	3.5.2.6
3SBX	CRYSTAL STRUCTURE OF A PUTATIVE UNCHARACTERIZED PROTEIN FROM MYCOBACTERIUM MARINUM BOUND TO ADENOSINE 5'-MONOPHOSPHATE AMP	3.2.2
3SC2	REFINED ATOMIC MODEL OF WHEAT SERINE CARBOXYPEPTIDASE II AT 2.2-ANGSTROMS RESOLUTION	3.4.16.1 3.4.16.6
3SC7	FIRST CRYSTAL STRUCTURE OF AN ENDO-INULINASE, FROM ASPERGILLUS FICUUM: STRUCTURAL ANALYSIS AND COMPARISON WITH OTHER GH32 ENZYMES.	3.2.1.7
3SCI	CRYSTAL STRUCTURE OF SPIKE PROTEIN RECEPTOR-BINDING DOMAIN FROM A PREDICTED SARS CORONAVIRUS HUMAN STRAIN COMPLEXED WITH HUMAN RECEPTOR ACE2	3.4.17.23 3.4.17
3SCJ	CRYSTAL STRUCTURE OF SPIKE PROTEIN RECEPTOR-BINDING DOMAIN FROM A PREDICTED SARS CORONAVIRUS CIVET STRAIN COMPLEXED WITH HUMAN RECEPTOR ACE2	3.4.17.23 3.4.17
3SCK	CRYSTAL STRUCTURE OF SPIKE PROTEIN RECEPTOR-BINDING DOMAIN FROM A PREDICTED SARS CORONAVIRUS CIVET STRAIN COMPLEXED WITH HUMAN-CIVET CHIMERIC RECEPTOR ACE2	3.4.17.23 3.4.17
3SCL	CRYSTAL STRUCTURE OF SPIKE PROTEIN RECEPTOR-BINDING DOMAIN FROM SARS CORONAVIRUS EPIDEMIC STRAIN COMPLEXED WITH HUMAN-CIVET CHIMERIC RECEPTOR ACE2	3.4.17.23 3.4.17
3SCN	CRYSTAL STRUCTURE OF RICE BGLU1 E386G MUTANT	3.2.1.21
3SCO	CRYSTAL STRUCTURE OF RICE BGLU1 E386G MUTANT COMPLEXED WITH ALPHA-GLUCOSYL FLUORIDE	3.2.1.21
3SCP	CRYSTAL STRUCTURE OF RICE BGLU1 E386A MUTANT	3.2.1.21
3SCQ	CRYSTAL STRUCTURE OF RICE BGLU1 E386A MUTANT COMPLEXED WITH ALPHA-GLUCOSYL FLUORIDE	3.2.1.21
3SCR	CRYSTAL STRUCTURE OF RICE BGLU1 E386S MUTANT	3.2.1.21
3SCS	CRYSTAL STRUCTURE OF RICE BGLU1 E386S MUTANT COMPLEXED WITH ALPHA-GLUCOSYL FLUORIDE	3.2.1.21
3SCT	CRYSTAL STRUCTURE OF RICE BGLU1 E386G MUTANT COMPLEXED WITH CELLOTETRAOSE	3.2.1.21
3SCU	CRYSTAL STRUCTURE OF RICE BGLU1 E386G MUTANT COMPLEXED WITH CELLOPENTAOSE	3.2.1.21
3SCV	CRYSTAL STRUCTURE OF RICE BGLU1 E386G/S334A MUTANT COMPLEXED WITH CELLOTETRAOSE	3.2.1.21
3SCW	CRYSTAL STRUCTURE OF RICE BGLU1 E386G/Y341A MUTANT COMPLEXED WITH CELLOTETRAOSE	3.2.1.21
3SCX	RB69 DNA POLYMERASE TRIPLE MUTANT(L561A/S565G/Y567A) TERNARY COMPLEX WITH DUPNPP AND A DEOXY-TERMINATED PRIMER IN THE PRESENCE OF CA2+	2.7.7.7 3.1.11
3SD7	1.7 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF PUTATIVE PHOSPHATASE FROM CLOSTRIDIUM DIFFICILE	3.1.3
3SD9	CRYSTAL STRUCTURE OF SERRATIA FONTICOLA SFH-I: SOURCE OF THE NUCLEOPHILE IN THE CATALYTIC MECHANISM OF MONO-ZINC METALLO-BETA-LACTAMASES	3.5.2.6
3SDF	CRYSTAL STRUCTURE OF C-LOBE OF BOVINE LACTOFERRIN COMPLEXED WITH LIPOTEICHOIC ACID AT 2.1 A RESOLUTION	3.4.21
3SDZ	STRUCTURAL CHARACTERIZATION OF THE SUBUNIT A MUTANT F427W OF THE A-ATP SYNTHASE FROM PYROCOCCUS HORIKOSHII	3.6.3.14 7.1.2.2 3.1
3SE0	STRUCTURAL CHARACTERIZATION OF THE SUBUNIT A MUTANT F508W OF THE A-ATP SYNTHASE FROM PYROCOCCUS HORIKOSHII	3.6.3.14 7.1.2.2 3.1
3SE6	CRYSTAL STRUCTURE OF THE HUMAN ENDOPLASMIC RETICULUM AMINOPEPTIDASE 2	3.4.11
3SF0	STRUCTURE OF RECOMBINANT HAEMOPHILUS INFLUENZAE E(P4) ACID PHOSPHATASE MUTANT D64N COMPLEXED WITH 5'AMP	3.1.3.2
3SF8	STRUCTURAL INSIGHTS INTO THIOL STABILIZATION OF DJ-1	3.4 3.1.2 3.5.1 3.5.1.124
3SFC	STRUCTURE-BASED OPTIMIZATION OF POTENT 4- AND 6-AZAINDOLE-3-CARBOXAMIDES AS RENIN INHIBITORS	3.4.23.15
3SFF	CRYSTAL STRUCTURE OF HUMAN HDAC8 INHIBITOR COMPLEX, AN AMINO ACID DERIVED INHIBITOR	3.5.1.98
3SFG	CRYSTAL STRUCTURE OF MURINE NOROVIRUS RNA DEPENDENT RNA POLYMERASE IN COMPLEX WITH 2THIOURIDINE(2TU)	2.7.7.48 3.4.22.66 3.6.1.15
3SFH	CRYSTAL STRUCTURE OF HUMAN HDAC8 INHIBITOR COMPLEX, AN AMINO ACID DERIVED INHIBITOR	3.5.1.98
3SFP	CRYSTAL STRUCTURE OF THE MONO-ZINC-BOUNDFORM OF NEW DELHI METALLO-BETA-LACTAMASE-1 FROM KLEBSIELLA PNEUMONIAE	3.5.2.6
3SFT	CRYSTAL STRUCTURE OF THERMOTOGA MARITIMA CHEB METHYLESTERASE CATALYTIC DOMAIN	3.1.1.61 3.5.1.44
3SFW	CRYSTAL STRUCTURE OF DIHYDROPYRIMIDINASE FROM BREVIBACILLUS AGRI NCHU1002	3.5.2.2
3SGA	STRUCTURES OF PRODUCT AND INHIBITOR COMPLEXES OF STREPTOMYCES GRISEUS PROTEASE A AT 1.8 ANGSTROMS RESOLUTION. A MODEL FOR SERINE PROTEASE CATALYSIS	3.4.21.80
3SGB	STRUCTURE OF THE COMPLEX OF STREPTOMYCES GRISEUS PROTEASE B AND THE THIRD DOMAIN OF THE TURKEY OVOMUCOID INHIBITOR AT 1.8 ANGSTROMS RESOLUTION	3.4.21.81
3SGQ	GLN 18 VARIANT OF TURKEY OVOMUCOID INHIBITOR THIRD DOMAIN COMPLEXED WITH STREPTOMYCES GRISEUS PROTEINASE B AT PH 10.7	3.4.21.81
3SH7	CRYSTAL STRUCTURE OF FLUOROPHORE-LABELED BETA-LACTAMASE PENP	3.5.2.6
3SH8	CRYSTAL STRUCTURE OF FLUOROPHORE-LABELED BETA-LACTAMASE PENP IN COMPLEX WITH CEPHALORIDINE	3.5.2.6
3SH9	CRYSTAL STRUCTURE OF FLUOROPHORE-LABELED BETA-LACTAMASE PENP IN COMPLEX WITH CEFOTAXIME	3.5.2.6
3SHA	HUMAN THROMBIN IN COMPLEX WITH UBTHR97	3.4.21.5
3SHC	HUMAN THROMBIN IN COMPLEX WITH UBTHR101	3.4.21.5
3SHD	CRYSTAL STRUCTURE OF NUDIX HYDROLASE ORF153, YMFB, FROM ESCHERICHIA COLI K-1	3.6.1
3SHI	CRYSTAL STRUCTURE OF HUMAN MMP1 CATALYTIC DOMAIN AT 2.2 A RESOLUTION	3.4.24.7
3SHL	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS V74KL25A AT CRYOGENIC TEMPERATURE	3.1.31.1
3SHQ	CRYSTAL STRUCTURE OF UBLCP1	3.1.3.16
3SHY	CRYSTAL STRUCTURE OF THE PDE5A1 CATALYTIC DOMAIN IN COMPLEX WITH NOVEL INHIBITORS	3.1.4.35
3SHZ	CRYSTAL STRUCTURE OF THE PDE5A1 CATALYTIC DOMAIN IN COMPLEX WITH NOVEL INHIBITORS	3.1.4.35
3SI3	HUMAN THROMBIN IN COMPLEX WITH UBTHR103	3.4.21.5
3SI4	HUMAN THROMBIN IN COMPLEX WITH UBTHR104	3.4.21.5
3SI6	RB69 DNA POLYMERASE TRIPLE MUTANT (L561A/S565G/Y567A) TERNARY COMPLEX WITH DUPNPP AND A DEOXY-TERMINATED PRIMER IN THE PRESENCE OF MG2+	2.7.7.7 3.1.11
3SI7	THE CRYSTAL STRUCTURE OF THE NBD1 DOMAIN OF THE MOUSE CFTR PROTEIN, DELTAF508 MUTANT	3.6.3.49 5.6.1.6
3SIC	MOLECULAR RECOGNITION AT THE ACTIVE SITE OF SUBTILISIN BPN': CRYSTALLOGRAPHIC STUDIES USING GENETICALLY ENGINEERED PROTEINACEOUS INHIBITOR SSI (STREPTOMYCES SUBTILISIN INHIBITOR)	3.4.21.62
3SIE	CRYSTAL STRUCTURE OF THE PDE5A1 CATALYTIC DOMAIN IN COMPLEX WITH NOVEL INHIBITORS	3.1.4.35
3SIG	THE X-RAY CRYSTAL STRUCTURE OF POLY(ADP-RIBOSE) GLYCOHYDROLASE (PARG) BOUND TO ADP-RIBOSE FROM THERMOMONOSPORA CURVATA	3.2.1.143
3SIH	THE X-RAY CRYSTAL STRUCTURE OF POLY(ADP-RIBOSE) GLYCOHYDROLASE (PARG) FROM THERMOMONOSPORA CURVATA	3.2.1.143
3SII	THE X-RAY CRYSTAL STRUCTURE OF POLY(ADP-RIBOSE) GLYCOHYDROLASE BOUND TO THE INHIBITOR ADP-HPD FROM THERMOMONOSPORA CURVATA	3.2.1.143
3SIJ	THE X-RAY CRYSTAL STRUCTURE OF POLY(ADP-RIBOSE) GLYCOHYDROLASE E115A MUTANT FROM THERMOMONOSPORA CURVATA	3.2.1.143
3SIL	SIALIDASE FROM SALMONELLA TYPHIMURIUM	3.2.1.18
3SIP	CRYSTAL STRUCTURE OF DRICE AND DIAP1-BIR1 COMPLEX	3.4.22
3SIR	CRYSTAL STRUCTURE OF DRICE	3.4.22
3SJ6	CRYSTAL STRUCTURE OF THE COMPLEX OF TYPE I RIBOSOME INACTIVATING PROTEIN FROM MOMORDICA BALSAMINA WITH 5-(HYDROXYMETHYL)OXALANE-2,3,4-TRIOL AT 1.6 A RESOLUTION	3.2.2.22
3SJ8	CRYSTAL STRUCTURE OF THE 3C PROTEASE FROM COXSACKIEVIRUS A16	3.4.22.28
3SJ9	CRYSTAL STRUCTURE OF THE C147A MUTANT 3C OF CVA16 IN COMPLEX WITH FAGLRQAVTQ PEPTIDE	3.4.22.28
3SJB	CRYSTAL STRUCTURE OF S. CEREVISIAE GET3 IN THE OPEN STATE IN COMPLEX WITH GET1 CYTOSOLIC DOMAIN	3.6
3SJC	CRYSTAL STRUCTURE OF S.CEREVISIAE GET3 IN THE SEMI-OPEN STATE IN COMPLEX WITH GET1 CYTOSOLIC DOMAIN	3.6
3SJD	CRYSTAL STRUCTURE OF S. CEREVISIAE GET3 WITH BOUND ADP-MG2+ IN COMPLEX WITH GET2 CYTOSOLIC DOMAIN	3.6
3SJE	X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (THE E424A INACTIVE MUTANT) IN COMPLEX WITH N-ACETYL-ASPARTYL-AMINONONANOIC ACID	3.4.17.21
3SJF	X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II IN COMPLEX WITH A UREA-BASED INHIBITOR (A25)	3.4.17.21
3SJG	HUMAN GLUTAMATE CARBOXYPEPTIDASE II (E424A INACTIVE MUTANT ) IN COMPLEX WITH N-ACETYL-ASPARTYL-AMINOOCTANOIC ACID	3.4.17.21
3SJI	CRYSTAL STRUCTURE OF CVA16 3C IN COMPLEX WITH RUPINTRIVIR (AG7088)	3.4.22.28
3SJJ	RB69 DNA POLYMERASE TRIPLE MUTANT (L561A/S565G/Y567A) TERNARY COMPLEX WITH DUPNPP AND A DEOXY-TERMINATED PRIMER IN THE PRESENCE OF MN2+	2.7.7.7 3.1.11
3SJK	CRYSTAL STRUCTURE OF THE C147A MUTANT 3C FROM ENTEROVIRUS 71	3.4.22.28 3.4.22.29 3.6.1.15 2.7.7.48
3SJO	STRUCTURE OF EV71 3C IN COMPLEX WITH RUPINTRIVIR (AG7088)	3.4.22.28 3.4.22.29 3.6.1.15 2.7.7.48
3SJT	CRYSTAL STRUCTURE OF HUMAN ARGINASE I IN COMPLEX WITH THE INHIBITOR ME-ABH, RESOLUTION 1.60 A, TWINNED STRUCTURE	3.5.3.1
3SJX	X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (THE E424A INACTIVE MUTANT) IN COMPLEX WITH N-ACETYL-ASPARTYL-METHIONINE	3.4.17.21
3SJZ	THE STRUCTURE OF AIF2GAMMA SUBUNIT DELTA 41-45 FROM ARCHAEON SULFOLOBUS SOLFATARICUS COMPLEXED WITH GDP AND GDPNP	3.6.5.3
3SK0	STRUCTURE OF RHODOCOCCUS RHODOCHROUS HALOALKANE DEHALOGENASE DHAA MUTANT DHAA12	3.8.1.5
3SK4	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS D21N/V23E AT CRYOGENIC TEMPERATURE	3.1.31.1
3SK5	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS V39D AT CRYOGENIC TEMPERATURE	3.1.31.1
3SK6	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+NVIAGLA V23K/L36E AT CRYOGENIC TEMPERATURE	3.1.31.1
3SK8	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS M98G APO PROTEIN AT CRYOGENIC TEMPERATURE	3.1.31.1
3SK9	CRYSTAL STRUCTURE OF THE THERMUS THERMOPHILUS CAS3 HD DOMAIN	3.1 3.6.4
3SKA	I. NOVEL HCV NS5B POLYMERASE INHIBITORS: DISCOVERY OF INDOLE 2- CARBOXYLIC ACIDS WITH C3-HETEROCYCLES	2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13
3SKD	CRYSTAL STRUCTURE OF THE THERMUS THERMOPHILUS CAS3 HD DOMAIN IN THE PRESENCE OF NI2+	3.1 3.6.4
3SKE	I. NOVEL HCV NS5B POLYMERASE INHIBITORS: DISCOVERY OF INDOLE 2- CARBOXYLIC ACIDS WITH C3-HETEROCYCLES	2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13
3SKF	CRYSTAL STRUCTURE OF BETA-SITE APP-CLEAVING ENZYME 1 (BACE-WT) COMPLEX WITH (2S)-2-((3S)-3-(ACETYLAMINO)-3-(BUTAN-2-YL)-2-OXOPYRROLIDIN-1-YL)-N-((2S,3R)-3-HYDROXY-4-((3-METHOXYBENZYL)AMINO)-1-PHENYLBUTAN-2-YL)-4-PHENYLBUTANAMIDE	3.4.23.46
3SKG	CRYSTAL STRUCTURE OF BETA-SITE APP-CLEAVING ENZYME 1 (BACE-WT) COMPLEX WITH (2S)-2-((3R)-3-ACETAMIDO-3-ISOBUTYL-2-OXO-1-PYRROLIDINYL)-N-((1S,2R)-1-(3,5-DIFLUOROBENZYL)-2-HYDROXY-2-(1,2,3,4-TETRAHYDRO-3-ISOQUINOLINYL)ETHYL)-4-PHENYLBUTANAMIDE	3.4.23.46
3SKH	I. NOVEL HCV NS5B POLYMERASE INHIBITORS: DISCOVERY OF INDOLE 2- CARBOXYLIC ACIDS WITH C3-HETEROCYCLES	2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13
3SKK	CRYSTAL STRUCTURE OF HUMAN ARGINASE I IN COMPLEX WITH THE INHIBITOR FABH, RESOLUTION 1.70 A, TWINNED STRUCTURE	3.5.3.1
3SKX	CRYSTAL STRUCTURE OF THE ATP BINDING DOMAIN OF ARCHAEOGLOBUS FULGIDUS COPB	3.6.3.4 7.2.2.9
3SKY	2.1A CRYSTAL STRUCTURE OF THE PHOSPHATE BOUND ATP BINDING DOMAIN OF ARCHAEOGLOBUS FULGIDUS COPB	3.6.3.4 7.2.2.9
3SL0	CRYSTAL STRUCTURE OF P. FALCIPARUM ARGINASE COMPLEXED WITH 2-AMINO-6-BORONO-2-(DIFLUOROMETHYL)HEXANOIC ACID	3.5.3.1
3SL1	CRYSTAL STRUCTURE OF P. FALCIPARUM ARGINASE COMPLEXED WITH 2-AMINO-6-BORONO-2-METHYLHEXANOIC ACID	3.5.3.1
3SL3	CRYSTAL STRUCTURE OF THE APO FORM OF THE CATALYTIC DOMAIN OF PDE4D2	3.1.4.17 3.1.4.53
3SL4	CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF PDE4D2 WITH COMPOUND 10D	3.1.4.17 3.1.4.53
3SL5	CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF PDE4D2 COMPLEXED WITH COMPOUND 10D	3.1.4.17 3.1.4.53
3SL6	CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF PDE4D2 WITH COMPOUND 12C	3.1.4.17 3.1.4.53
3SL8	CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF PDE4D2 WITH COMPOUND 10O	3.1.4.17 3.1.4.53
3SLI	LEECH INTRAMOLECULAR TRANS-SIALIDASE COMPLEXED WITH 2,7-ANHYDRO-NEU5AC PREPARED BY SOAKING WITH 3'-SIALYLLACTOSE	3.2.1.18 4.2.2.15
3SLJ	PRE-CLEAVAGE STRUCTURE OF THE AUTOTRANSPORTER ESPP - N1023A MUTANT	3.4.21
3SLO	PRE-CLEAVAGE STRUCTURE OF THE AUTOTRANSPORTER ESPP - N1023D MUTANT	3.4.21
3SLT	PRE-CLEAVAGE STRUCTURE OF THE AUTOTRANSPORTER ESPP - N1023S MUTANT	3.4.21
3SLZ	THE CRYSTAL STRUCTURE OF XMRV PROTEASE COMPLEXED WITH TL-3	2.7.7.49 2.7.7.7 3.1.26.4
3SM1	THE CRYSTAL STRUCTURE OF XMRV PROTEASE COMPLEXED WITH PEPSTATIN A	2.7.7.49 2.7.7.7 3.1.26.4
3SM2	THE CRYSTAL STRUCTURE OF XMRV PROTEASE COMPLEXED WITH AMPRENAVIR	2.7.7.49 2.7.7.7 3.1.26.4
3SM4	CRYSTAL STRUCTURE OF THE K131A MUTANT OF LAMBDA EXONUCLEASE IN COMPLEX WITH A 5'-PHOSPHORYLATED 14-MER/12-MER DUPLEX AND MAGNESIUM	3.1.11.3
3SMD	CRYSTAL STRUCTURE OF A MUT/NUDIX FAMILY PROTEIN FROM BACILLUS THURINGIENSIS	3.6.1
3SME	STRUCTURE OF PTP1B INACTIVATED BY H2O2/BICARBONATE	3.1.3.48
3SN7	HIGHLY POTENT, SELECTIVE, AND ORALLY ACTIVE PHOSPHODIESTARASE 10A INHIBITORS	3.1.4.17 3.1.4.35
3SN8	CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PROTEASE COMPLEXED WITH CM-FF-H (SOAKING)	3.4.22 3.4.19.12 3.4.22.69
3SNA	CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PROTEASE COMPLEXED WITH AC-NSFSQ-H (SOAKING)	3.4.22 3.4.19.12 3.4.22.69 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1
3SNB	CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PROTEASE COMPLEXED WITH AC-DSFDQ-H (SOAKING)	3.4.22 3.4.19.12 3.4.22.69 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1
3SNC	CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PROTEASE COMPLEXED WITH AC-NSTSQ-H (SOAKING)	3.4.22 3.4.19.12 3.4.22.69 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1
3SND	CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PROTEASE COMPLEXED WITH AC-ESTLQ-H (COCRYSTALLIZATION)	3.4.22 3.4.19.12 3.4.22.69 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1
3SNE	CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PROTEASE COMPLEXED WITH AC-ESTLQ-H (SOAKING)	3.4.22 3.4.19.12 3.4.22.69 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1
3SNF	ONCONASE, ATOMIC RESOLUTION CRYSTAL STRUCTURE	3.1.27
3SNG	X-RAY STRUCTURE OF FULLY GLYCOSYLATED BIFUNCTIONAL NUCLEASE TBN1 FROM SOLANUM LYCOPERSICUM (TOMATO)	3.1.30 3.1.30.1
3SNH	CRYSTAL STRUCTURE OF NUCLEOTIDE-FREE HUMAN DYNAMIN1	3.6.5.5
3SNI	HIGHLY POTENT, SELECTIVE, AND ORALLY ACTIVE PHOSPHODIESTARASE 10A INHIBITORS	3.1.4.17 3.1.4.35
3SNL	HIGHLY POTENT, SELECTIVE, AND ORALLY ACTIVE PHOSPHODIESTARASE 10A INHIBITORS	3.1.4.17 3.1.4.35
3SNN	RB69 DNA POLYMERASE (L561A/S565G/Y567A) TERNARY COMPLEX WITH DCTP OPPOSITE DG IN THE PRESENCE OF MG2+	2.7.7.7 3.1.11
3SO2	CHLORELLA DUTPASE	3.6.1.23
3SO3	STRUCTURES OF FAB-PROTEASE COMPLEXES REVEAL A HIGHLY SPECIFIC NON-CANONICAL MECHANISM OF INHIBITION.	3.4.21.109
3SO9	DARUNAVIR IN COMPLEX WITH A HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 PROTEASE VARIANT	3.4.23.16 2.7.7.49 3.1.26.13
3SOI	CRYSTALLOGRAPHIC STRUCTURE OF BACILLUS LICHENIFORMIS BETA-LACTAMASE W210F/W229F/W251F AT 1.73 ANGSTROM RESOLUTION	3.5.2.6
3SOP	CRYSTAL STRUCTURE OF HUMAN SEPTIN 3 GTPASE DOMAIN	3.6.5
3SOR	FACTOR XIA IN COMPLEX WITH A CLOROPHENYL-TETRAZOLE INHIBITOR	3.4.21.27
3SOS	BENZOTHIAZINONE INHIBITOR IN COMPLEX WITH FXIA	3.4.21.27
3SP3	LYSOZYME IN 20% SUCROSE	3.2.1.17
3SP4	CRYSTAL STRUCTURE OF APRATAXIN ORTHOLOG HNT3 FROM SCHIZOSACCHAROMYCES POMBE	3.6.1.71 3.6.1.72
3SPD	CRYSTAL STRUCTURE OF APRATAXIN ORTHOLOG HNT3 IN COMPLEX WITH DNA	3.6.1.71 3.6.1.72
3SPK	TIPRANAVIR IN COMPLEX WITH A HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 PROTEASE VARIANT	3.4.23.16 2.7.7.49 3.1.26.13
3SPL	CRYSTAL STRUCTURE OF APRATAXIN ORTHOLOG HNT3 IN COMPLEX WITH DNA AND AMP	3.6.1.71 3.6.1.72
3SPS	CRYSTAL STRUCTURE OF APO-HEXAMERIC ACYL-COA THIOESTERASE	3.1.2
3SPU	APO NDM-1 CRYSTAL STRUCTURE	3.5.2.6
3SPY	RB69 DNA POLYMERASE(L415A/L561A/S565G/Y567A) TERNARY COMPLEX WITH DUPCPP OPPOSITE DA	2.7.7.7 3.1.11
3SPZ	DNA POLYMERASE(L415A/L561A/S565G/Y567A) TERNARY COMPLEX WITH DUPCPP OPPOSITE DA (CA2+)	2.7.7.7 3.1.11
3SQ0	DNA POLYMERASE(L561A/S565G/Y567A) TERNARY COMPLEX WITH DUPNPP OPPOSITE DA (MN2+)	2.7.7.7 3.1.11
3SQ1	RB69 DNA POLYMERASE TERNARY COMPLEX WITH DUPCPP OPPOSITE DA	2.7.7.7 3.1.11
3SQ2	RB69 DNA POLYMERASE TERNARY COMPLEX WITH DTTP OPPOSITE 2AP (AT RICH SEQUENCE)	2.7.7.7 3.1.11
3SQ3	CRYSTAL STRUCTURE ANALYSIS OF THE YEAST TYROSYL-DNA PHOSPHODIESTERASE H182A MUTANT	3.1.4
3SQ4	RB69 DNA POLYMERASE TERNARY COMPLEX WITH DTTP OPPOSITE 2AP (GC RICH SEQUENCE)	2.7.7.7 3.1.11
3SQ5	CRYSTAL STRUCTURE ANALYSIS OF THE YEAST TYROSYL-DNA PHOSPHODIESTERASE H432N MUTANT	3.1.4
3SQ7	CRYSTAL STRUCTURE ANALYSIS OF THE YEAST TYROSYL-DNA PHOSPHODIESTERASE H432N_GLU MUTANT	3.1.4
3SQ8	CRYSTAL STRUCTURE ANALYSIS OF THE YEAST TYROSYL-DNA PHOSPHODIESTERASE 1 H432R MUTANT (SCAN1 MUTANT)	3.1.4
3SQE	CRYSTAL STRUCTURE OF PRETHROMBIN-2 MUTANT S195A IN THE ALTERNATIVE FORM	3.4.21.5
3SQF	CRYSTAL STRUCTURE OF MONOMERIC M-PMV RETROVIRAL PROTEASE	3.4.23 3.6.1.23
3SQH	CRYSTAL STRUCTURE OF PRETHROMBIN-2 MUTANT S195A IN THE THE OPEN FORM	3.4.21.5
3SQO	PCSK9 J16 FAB COMPLEX	3.4.21
3SQW	STRUCTURE OF MSS116P (NTE DELETION) BOUND TO SSRNA AND AMP-PNP	3.6.4.13
3SQX	STRUCTURE OF MSS116P (NTE AND C-TAIL DOUBLE DELETION) BOUND TO SSRNA AND AMP-PNP	3.6.4.13
3SR1	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS A69G BOUND TO CA2+ AND THYMIDINE-5',3'-DIPHOSPHATE AT CRYOGENIC TEMPERATURE	3.1.31.1
3SR9	CRYSTAL STRUCTURE OF MOUSE PTPSIGMA	3.1.3.48
3SRA	STRUCTURE OF PSEUDOMONAS AERUGIONSA PVDQ COVALENTLY ACYLATED WITH MYRISTIC ACID FROM PVDIQ	3.5.1.97
3SRB	STRUCTURE OF PSEUDOMONAS AERUGINOSA PVDQ BOUND TO SMER28	3.5.1.97
3SRC	STRUCTURE OF PSEUDOMONAS AERUGINOSA PVDQ BOUND TO NS2028	3.5.1.97
3SRE	SERUM PARAOXONASE-1 BY DIRECTED EVOLUTION AT PH 6.5	3.1.1.2
3SRG	SERUM PARAOXONASE-1 BY DIRECTED EVOLUTION AT PH 6.5 IN COMPLEX WITH 2-HYDROXYQUINOLINE	3.1.1.2
3SRN	STRUCTURAL CHANGES THAT ACCOMPANY THE REDUCED CATALYTIC EFFICIENCY OF TWO SEMISYNTHETIC RIBONUCLEASE ANALOGS	3.1.27.5 4.6.1.18
3SRP	STRUCTURE OF RIVAX: A HUMAN RICIN VACCINE	3.2.2.22
3SRX	NEW DELHI METALLO-BETA-LACTAMASE-1 COMPLEXED WITH CD	3.5.2.6
3SS3	CRYSTAL STRUCTURE OF MOUSE GLUTAMINASE C, LIGAND-FREE FORM	3.5.1.2
3SS4	CRYSTAL STRUCTURE OF MOUSE GLUTAMINASE C, PHOSPHATE-BOUND FORM	3.5.1.2
3SS5	CRYSTAL STRUCTURE OF MOUSE GLUTAMINASE C, L-GLUTAMATE-BOUND FORM	3.5.1.2
3SSA	CRYSTAL STRUCTURE OF SUBUNIT B MUTANT N157T OF THE A1AO ATP SYNTHASE	3.6.3.14
3SSB	STRUCTURE OF INSECT METALLOPROTEINASE INHIBITOR IN COMPLEX WITH THERMOLYSIN	3.4.24.27
3SSC	DNA BINDING DOMAIN OF RESTRICTION ENDONUCLEASE BOUND TO DNA	3.1.21
3SSD	DNA BINDING DOMAIN OF RESTRICTION ENDONUCLEASE BOUND TO DNA	3.1.21
3SSE	DNA BINDING DOMAIN OF RESTRICTION ENDONUCLEASE BOUND TO DNA	3.1.21
3ST5	CRYSTAL STRUCTURE OF WILD-TYPE HIV-1 PROTEASE WITH C3-SUBSTITUTED HEXAHYDROCYCLOPENTAFURANYL URETHANE AS P2-LIGAND, GRL-0489A	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
3ST9	CRYSTAL STRUCTURE OF CLPP IN HEPTAMERIC FORM FROM STAPHYLOCOCCUS AUREUS	3.4.21.92
3STI	CRYSTAL STRUCTURE OF THE PROTEASE DOMAIN OF DEGQ FROM ESCHERICHIA COLI	3.4.21 3.4.21.107
3STR	STREP PEPTIDE DEFORMYLASE WITH A TIME DEPENDENT THIAZOLIDINE HYDROXAMIC ACID	3.5.1.88
3SU0	CRYSTAL STRUCTURE OF NS3/4A PROTEASE VARIANT R155K IN COMPLEX WITH DANOPREVIR	2.7.7.48 3.4.21.98 3.6.1.15 3.6.4.13
3SU1	CRYSTAL STRUCTURE OF NS3/4A PROTEASE VARIANT D168A IN COMPLEX WITH DANOPREVIR	2.7.7.48 3.4.21.98 3.6.1.15 3.6.4.13
3SU2	CRYSTAL STRUCTURE OF NS3/4A PROTEASE VARIANT A156T IN COMPLEX WITH DANOPREVIR	2.7.7.48 3.4.21.98 3.6.1.15 3.6.4.13
3SU3	CRYSTAL STRUCTURE OF NS3/4A PROTEASE IN COMPLEX WITH VANIPREVIR	2.7.7.48 3.4.21.98 3.6.1.15 3.6.4.13
3SU4	CRYSTAL STRUCTURE OF NS3/4A PROTEASE VARIANT R155K IN COMPLEX WITH VANIPREVIR	3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48
3SU5	CRYSTAL STRUCTURE OF NS3/4A PROTEASE VARIANT D168A IN COMPLEX WITH VANIPREVIR	2.7.7.48 3.4.21.98 3.6.1.15 3.6.4.13
3SU6	CRYSTAL STRUCTURE OF NS3/4A PROTEASE VARIANT A156T IN COMPLEX WITH VANIPREVIR	2.7.7.48 3.4.21.98 3.6.1.15 3.6.4.13
3SU8	CRYSTAL STRUCTURE OF A TRUNCATED INTRACELLULAR DOMAIN OF PLEXIN-B1 IN COMPLEX WITH RAC1	3.6.5.2
3SUD	CRYSTAL STRUCTURE OF NS3/4A PROTEASE IN COMPLEX WITH MK-5172	2.7.7.48 3.4.21.98 3.6.1.15 3.6.4.13
3SUE	CRYSTAL STRUCTURE OF NS3/4A PROTEASE VARIANT R155K IN COMPLEX WITH MK-5172	2.7.7.48 3.4.21.98 3.6.1.15 3.6.4.13
3SUF	CRYSTAL STRUCTURE OF NS3/4A PROTEASE VARIANT D168A IN COMPLEX WITH MK-5172	2.7.7.48 3.4.21.98 3.6.1.15 3.6.4.13
3SUG	CRYSTAL STRUCTURE OF NS3/4A PROTEASE VARIANT A156T IN COMPLEX WITH MK-5172	2.7.7.48 3.4.21.98 3.6.1.15 3.6.4.13
3SUN	RB69 DNA POLYMERASE (Y567A) TERNARY COMPLEX WITH DTTP OPPOSITE 2AP (AT RICH SEQUENCE)	2.7.7.7 3.1.11
3SUO	RB69 DNA POLYMERASE (Y567A) TERNARY COMPLEX WITH DTTP OPPOSITE 2AP (GC RICH SEQUENCE)	2.7.7.7 3.1.11
3SUP	RB69 DNA POLYMERASE (Y567A) TERNARY COMPLEX WITH DCTP OPPOSITE 2AP (GC RICH SEQUENCE)	2.7.7.7 3.1.11
3SUQ	RB69 DNA POLYMERASE (Y567A) TERNARY COMPLEX WITH DCTP OPPOSITE 2AP (AT RICH SEQUENCE)	2.7.7.7 3.1.11
3SUR	CRYSTAL STRUCTURE OF BETA-HEXOSAMINIDASE FROM PAENIBACILLUS SP. TS12 IN COMPLEX WITH NAG-THIAZOLINE.	3.2.1.52
3SUS	CRYSTAL STRUCTURE OF BETA-HEXOSAMINIDASE FROM PAENIBACILLUS SP. TS12 IN COMPLEX WITH GAL-NAG-THIAZOLINE	3.2.1.52
3SUT	CRYSTAL STRUCTURE OF BETA-HEXOSAMINIDASE FROM PAENIBACILLUS SP. TS12 IN COMPLEX WITH PUGNAC	3.2.1.52
3SUU	CRYSTAL STRUCTURE OF BETA-HEXOSAMINIDASE FROM PAENIBACILLUS SP. TS12 IN COMPLEX WITH GAL-PUGNAC	3.2.1.52
3SUV	CRYSTAL STRUCTURE OF BETA-HEXOSAMINIDASE FROM PAENIBACILLUS SP. TS12 IN COMPLEX WITH NHAC-DNJ	3.2.1.52
3SUW	CRYSTAL STRUCTURE OF BETA-HEXOSAMINIDASE FROM PAENIBACILLUS SP. TS12 IN COMPLEX WITH NHAC-CAS	3.2.1.52
3SV2	HUMAN THROMBIN IN COMPLEX WITH UBTHR105	3.4.21.5
3SV6	CRYSTAL STRUCTURE OF NS3/4A PROTEASE IN COMPLEX WITH TELAPREVIR	2.7.7.48 3.4.21.98 3.6.1.15 3.6.4.13
3SV7	CRYSTAL STRUCTURE OF NS3/4A PROTEASE VARIANT R155K IN COMPLEX WITH TELAPREVIR	2.7.7.48 3.4.21.98 3.6.1.15 3.6.4.13
3SV8	CRYSTAL STRUCTURE OF NS3/4A PROTEASE VARIANT D168A IN COMPLEX WITH TELAPREVIR	2.7.7.48 3.4.21.98 3.6.1.15 3.6.4.13
3SV9	CRYSTAL STRUCTURE OF NS3/4A PROTEASE VARIANT A156T IN COMPLEX WITH TELAPREVIR	2.7.7.48 3.4.21.98 3.6.1.15 3.6.4.13
3SVJ	STREP PEPTIDE DEFORMYLASE WITH A TIME DEPENDENT THIAZOLIDINE AMIDE	3.5.1.88
3SW2	X-RAY CRYSTAL STRUCTURE OF HUMAN FXA IN COMPLEX WITH 6-CHLORO-N-((3S)-2-OXO-1-(2-OXO-2-((5S)-8-OXO-5,6-DIHYDRO-1H-1,5-METHANOPYRIDO[1,2-A][1,5]DIAZOCIN-3(2H,4H,8H)-YL)ETHYL)PIPERIDIN-3-YL)NAPHTHALENE-2-SULFONAMIDE	3.4.21.6
3SW3	EDTA-FREE CRYSTAL STRUCTURE OF THE MUTANT C221D OF CARBAPENEMASE CPHA FROM AEROMONAS HYDROPHILA	3.5.2.6
3SW5	CRYSTAL STRUCTURE OF INORGANIC PYROPHOSPHATASE FROM BARTONELLA HENSELAE	3.6.1.1
3SW8	STREP PEPTIDE DEFORMYLASE WITH A TIME DEPENDENT DICHLOROBENZAMIDE-REVERSE HYDROXAMIC ACID	3.5.1.88
3SWW	CRYSTAL STRUCTURE OF HUMAN DPP-IV IN COMPLEX WITH SA-(+)-3-(AMINOMETHYL)-4-(2,4-DICHLOROPHENYL)-6-(2-METHOXYPHENYL)- 2-METHYL-5H-PYRROLO[3,4-B]PYRIDIN-7(6H)-ONE	3.4.14.5
3SX4	CRYSTAL STRUCTURE OF HUMAN DPP-IV IN COMPLEX WITH SA-(+)-3-(AMINOMETHYL)-4-(2,4-DICHLOROPHENYL)-6-(2-METHOXYPHENYL)- 2-METHYL-5H-PYRROLO[3,4-B]PYRIDIN-7(6H)-ONE	3.4.14.5
3SXH	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS I92AL103A AT CRYOGENIC TEMPERATURE	3.1.31.1
3SY7	IMPROVED CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA OPRD	3.4.21
3SYJ	CRYSTAL STRUCTURE OF THE HAEMOPHILUS INFLUENZAE HAP ADHESIN	3.4.21
3SYU	RE-REFINED COORDINATES FOR PDB ENTRY 1DET - RIBONUCLEASE T1 CARBOXYMETHYLATED AT GLU 58 IN COMPLEX WITH 2'GMP	3.1.27.3 4.6.1.24
3SZ7	CRYSTAL STRUCTURE OF THE SGT2 TPR DOMAIN FROM ASPERGILLUS FUMIGATUS	3.1.3.16
3SZE	CRYSTAL STRUCTURE OF THE PASSENGER DOMAIN OF THE E. COLI AUTOTRANSPORTER ESPP	3.4.21
3SZN	CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PROTEASE COMPLEXED WITH AN ALPHA, BETA-UNSATURATED ETHYL ESTER SG75	3.4.22 3.4.19.12 3.4.22.69 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1
3SZQ	STRUCTURE OF AN S. POMBE APTX/DNA/AMP/ZN COMPLEX	3 3.6.1.71 3.6.1.72
3SZY	CRYSTAL STRUCTURE OF PHOSPHONOACETATE HYDROLASE FROM SINORHIZOBIUM MELILOTI 1021 IN APO FORM	3.6.1.9
3SZZ	CRYSTAL STRUCTURE OF PHOSPHONOACETATE HYDROLASE FROM SINORHIZOBIUM MELILOTI 1021 IN COMPLEX WITH ACETATE	3.6.1.9
3T00	CRYSTAL STRUCTURE OF PHOSPHONOACETATE HYDROLASE FROM SINORHIZOBIUM MELILOTI 1021 IN COMPLEX WITH VANADATE	3.6.1.9
3T01	CRYSTAL STRUCTURE OF PHOSPHONOACETATE HYDROLASE FROM SINORHIZOBIUM MELILOTI 1021 IN COMPLEX WITH PHOSPHONOFORMATE	3.6.1.9
3T02	CRYSTAL STRUCTURE OF PHOSPHONOACETATE HYDROLASE FROM SINORHIZOBIUM MELILOTI 1021 IN COMPLEX WITH PHOSPHONOACETATE	3.6.1.9
3T0O	CRYSTAL STRUCTURE ANALYSIS OF HUMAN RNASE T2	3.1.27.1 4.6.1.19
3T0R	CRYSTAL STRUCTURE OF MJTX-I, A MYOTOXIC LYS49-PHOSPHOLIPASE A2 FROM BOTHROPS MOOJENI	3.1.1.4
3T11	DIMERIC INHIBITOR OF HIV-1 PROTEASE.	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
3T12	MGLA IN COMPLEX WITH MGLB IN TRANSITION STATE	3.6.5.2
3T13	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS A69G AT CRYOGENIC TEMPERATURE	3.1.31.1
3T16	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT NVIAGA/M98G AT CRYOGENIC TEMPERATURE	3.1.31.1
3T19	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (WILD TYPE) IN COMPLEX WITH INHIBITOR M05	2.7.7.49 2.7.7.7 3.1.26.13 3.4.23.16 3.1.13.2 2.7.7 3.1
3T1A	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (K103N MUTANT) IN COMPLEX WITH INHIBITOR M05	2.7.7.49 2.7.7.7 3.1.26.13 3.4.23.16 3.1.13.2 2.7.7 3.1
3T1E	THE STRUCTURE OF THE NEWCASTLE DISEASE VIRUS HEMAGGLUTININ-NEURAMINIDASE (HN) ECTODOMAIN REVEALS A 4-HELIX BUNDLE STALK	3.2.1.18
3T1G	ENGINEERING OF ORGANOPHOSPHATE HYDROLASE BY COMPUTATIONAL DESIGN AND DIRECTED EVOLUTION	3 3.5.4.4
3T1I	CRYSTAL STRUCTURE OF HUMAN MRE11: UNDERSTANDING TUMORIGENIC MUTATIONS	3.1
3T1O	MGLA BOUND TO GDP	3.6.5.2
3T1Q	MGLA BOUND TO GPPNHP IN COMPLEX WITH MGLB	3.6.5.2
3T1T	MGLA BOUND TO GDP IN P1 TETRAMERIC ARRANGEMENT	3.6.5.2
3T1V	MGLA BOUND TO GDP IN P2(1) TETRAMERIC ARRANGEMENT	3.6.5.2
3T25	TMAO-GROWN ORTHORHOMBIC TRYPSIN (BOVINE)	3.4.21.4
3T26	ORTHORHOMBIC TRYPSIN (BOVINE) IN THE PRESENCE OF SARCOSINE	3.4.21.4
3T27	ORTHORHOMBIC TRYPSIN (BOVINE) IN THE PRESENCE OF BETAINE	3.4.21.4
3T28	TMAO-GROWN TRYPSIN (BOVINE)-PREVIOUSLY UNREPORTED TETRAGONAL CRYSTAL FORM	3.4.21.4
3T29	TMAO-GROWN TRIGONAL TRYPSIN (BOVINE)	3.4.21.4
3T2B	FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE/PHOSPHATASE FROM THERMOPROTEUS NEUTROPHILUS, LIGAND FREE	4.1.2.13 3.1.3.11
3T2C	FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE/PHOSPHATASE FROM THERMOPROTEUS NEUTROPHILUS, DHAP-BOUND FORM	4.1.2.13 3.1.3.11
3T2D	FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE/PHOSPHATASE FROM THERMOPROTEUS NEUTROPHILUS, FBP-BOUND FORM	4.1.2.13 3.1.3.11
3T2E	FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE/PHOSPHATASE FROM THERMOPROTEUS NEUTROPHILUS, F6P-BOUND FORM	4.1.2.13 3.1.3.11
3T2F	FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE/PHOSPHATASE FROM THERMOPROTEUS NEUTROPHILUS, SOAKED WITH EDTA AND DHAP	4.1.2.13 3.1.3.11
3T2G	FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE/PHOSPHATASE FROM THERMOPROTEUS NEUTROPHILUS, Y229F VARIANT WITH DHAP	4.1.2.13 3.1.3.11
3T2H	TETRAGONAL THERMOLYSIN IN THE PRESENCE OF TMAO	3.4.24.27
3T2I	TETRAGONAL THERMOLYSIN IN THE PRESENCE OF SARCOSINE	3.4.24.27
3T2J	TETRAGONAL THERMOLYSIN IN THE PRESENCE OF BETAINE	3.4.24.27
3T2N	HUMAN HEPSIN PROTEASE IN COMPLEX WITH THE FAB FRAGMENT OF AN INHIBITORY ANTIBODY	3.4.21.106
3T2O	E. COLI (LACZ) BETA-GALACTOSIDASE (S796D)	3.2.1.23
3T2P	E. COLI (LACZ) BETA-GALACTOSIDASE (S796D) IN COMPLEX WITH IPTG	3.2.1.23
3T3C	STRUCTURE OF HIV PR RESISTANT PATIENT DERIVED MUTANT (COMPRISING 22 MUTATIONS) IN COMPLEX WITH DRV	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
3T3N	MOLECULAR BASIS FOR THE RECOGNITION AND CLEAVAGE OF RNA (UUCCGU) BY THE BIFUNCTIONAL 5'-3' EXO/ENDORIBONUCLEASE RNASE J	3 3.1
3T3O	MOLECULAR BASIS FOR THE RECOGNITION AND CLEAVAGE OF RNA (CUGG) BY THE BIFUNCTIONAL 5'-3' EXO/ENDORIBONUCLEASE RNASE J	3 3.1
3T41	1.95 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF EPIDERMIN LEADER PEPTIDE PROCESSING SERINE PROTEASE (EPIP) S393A MUTANT FROM STAPHYLOCOCCUS AUREUS	3.4.21
3T4J	ARABIDOPSIS HISTIDINE KINASE 4 SENSOR DOMAIN IN COMPLEX WITH N-ISOPENTENYL ADENINE	2.7.13.3 3.1.3.16
3T4K	ARABIDOPSIS HISTIDINE KINASE 4 SENSOR DOMAIN IN COMPLEX WITH N-BENZYLADENINE	2.7.13.3 3.1.3.16
3T4L	ARABIDOPSIS HISTIDINE KINASE 4 SENSOR DOMAIN IN COMPLEX WITH TRANS-ZEATIN	2.7.13.3 3.1.3.16
3T4O	ARABIDOPSIS HISTIDINE KINASE 4 SENSOR DOMAIN IN COMPLEX WITH DIHYDROZEATIN	2.7.13.3 3.1.3.16
3T4Q	ARABIDOPSIS HISTIDINE KINASE 4 SENSOR DOMAIN IN COMPLEX WITH TRANS-ZEATIN RIBOSIDE (HYDROLYSED)	2.7.13.3 3.1.3.16
3T4S	ARABIDOPSIS HISTIDINE KINASE 4 SENSOR DOMAIN IN COMPLEX WITH KINETIN	2.7.13.3 3.1.3.16
3T4T	ARABIDOPSIS HISTIDINE KINASE 4 SENSOR DOMAIN IN COMPLEX WITH THIADIAZURON	2.7.13.3 3.1.3.16
3T4U	L29I MUTATION IN AN ARYL ESTERASE FROM PSEUDOMONAS FLUORESCENS LEADS TO UNIQUE PEPTIDE FLIP AND INCREASED ACTIVITY	3.1.1.2 1
3T52	L29I MUTATION IN AN ARYL ESTERASE FROM PSEUDOMONAS FLUORESCENS LEADS TO UNIQUE PEPTIDE FLIP AND INCREASED ACTIVITY	3.1.1.2 1
3T5F	HUMAN THROMBIN IN COMPLEX WITH MI340	3.4.21.5
3T5N	1.8A CRYSTAL STRUCTURE OF LASSA VIRUS NUCLEOPROTEIN IN COMPLEX WITH SSRNA	3.1.13
3T5Q	3A STRUCTURE OF LASSA VIRUS NUCLEOPROTEIN IN COMPLEX WITH SSRNA	3.1.13
3T60	5'-DIPHENYL NUCLEOSIDE INHIBITORS OF PLASMODIUM FALCIPARUM DUTPASE	3.6.1.23
3T62	CRYSTAL STRUCTURE OF RECOMBINANT KUNITZ TYPE SERINE PROTEASE INHIBITOR-1 FROM THE CARIBBEAN SEA ANEMONE STICHODACTYLA HELIANTHUS IN COMPLEX WITH BOVINE CHYMOTRYPSIN	3.4.21.1
3T64	5'-DIPHENYL NUCLEOSIDE INHIBITORS OF PLASMODIUM FALCIPARUM DUTPASE	3.6.1.23
3T6B	STRUCTURE OF HUMAN DPPIII IN COMPLEX WITH THE OPIOID PEPTIDE TYNORPHIN, AT 2.4 ANGSTROMS	3.4.14.4
3T6I	ENDOTHIAPEPSIN IN COMPLEX WITH AN AZEPIN DERIVATIVE	3.4.23.22
3T6J	STRUCTURE OF HUMAN DPPIII IN COMPLEX WITH THE OPIOID PEPTIDE TYNORPHIN, AT 3.0 ANGSTROMS	3.4.14.4
3T6U	CRYSTAL STRUCTURE OF LYSOZYME IN 40% SUCROSE	3.2.1.17
3T6Y	5'-DIPHENYL NUCLEOSIDE INHIBITORS OF PLASMODIUM FALCIPARUM DUTPASE	3.6.1.23
3T70	5'-DIPHENYL NUCLEOSIDE INHIBITORS OF PLASMODIUM FALCIPARUM DUTPASE	3.6.1.23
3T73	THERMOLYSIN IN COMPLEX WITH UBTLN22	3.4.24.27
3T74	THERMOLYSIN IN COMPLEX WITH UBTLN27	3.4.24.27
3T7P	ENDOTHIAPEPSIN IN COMPLEX WITH A HYDRAZIDE DERIVATIVE	3.4.23.22
3T7Q	ENDOTHIAPEPSIN IN COMPLEX WITH AN INHIBITOR BASED ON THE GEWALD REACTION	3.4.23.22
3T7X	ENDOTHIAPEPSIN IN COMPLEX WITH AN INHIBITOR BASED ON THE GEWALD REACTION	3.4.23.22
3T81	CRYSTAL STRUCTURE OF DIIRON ADENINE DEAMINASE	3.5.4.2
3T87	THERMOLYSIN IN COMPLEX WITH UBTLN28	3.4.24.27
3T8C	THERMOLYSIN IN COMPLEX WITH UBTLN30	3.4.24.27
3T8D	THERMOLYSIN IN COMPLEX WITH UBTLN31	3.4.24.27
3T8F	THERMOLYSIN IN COMPLEX WITH UBTLN34	3.4.24.27
3T8G	THERMOLYSIN IN COMPLEX WITH UBTLN26	3.4.24.27
3T8H	THERMOLYSIN IN COMPLEX WITH UBTLN29	3.4.24.27
3T8I	STRUCTURAL ANALYSIS OF THERMOSTABLE S. SOLFATARICUS PURINE-SPECIFIC NUCLEOSIDE HYDROLASE	3.2.2.1
3T8J	STRUCTURAL ANALYSIS OF THERMOSTABLE S. SOLFATARICUS PYRIMIDINE-SPECIFIC NUCLEOSIDE HYDROLASE	3.2.2.1
3T8L	CRYSTAL STRUCTURE OF ADENINE DEAMINASE WITH MN/FE	3.5.4.2
3T8V	A BESTATIN-BASED CHEMICAL BIOLOGY STRATEGY REVEALS DISTINCT ROLES FOR MALARIA M1- AND M17-FAMILY AMINOPEPTIDASES	3.4.11
3T8Y	CRYSTAL STRUCTURE OF THE RESPONSE REGULATOR DOMAIN OF THERMOTOGA MARITIMA CHEB	3.1.1.61 3.5.1.44
3T91	STRUCTURE OF THE PHOSPHATASE DOMAIN OF THE CELL FATE DETERMINANT SPOIIE FROM BACILLUS SUBTILIS	3.1.3.16
3T9L	STRUCTURE OF N-TERMINAL DUSP-UBL DOMAINS OF HUMAN USP15	3.4.19.12
3T9M	CRYSTAL STRUCTURE OF MUTANT C221D OF CARBAPENEMASE CPHA FROM AEROMONAS HYDROPHILA	3.5.2.6
3T9Q	STRUCTURE OF THE PHOSPHATASE DOMAIN OF THE CELL FATE DETERMINANT SPOIIE FROM BACILLUS SUBTILIS (MN PRESOAKED)	3.1.3.16
3TA9	BETA-GLUCOSIDASE A FROM THE HALOTHERMOPHILE H. ORENII	3.2.1.21
3TAI	CRYSTAL STRUCTURE OF NURA	3.1
3TAJ	CRYSTAL STRUCTURE OF C-LOBE OF BOVINE LACTOFERRIN COMPLEXED WITH NABUMETONE AT 1.7A RESOLUTION	3.4.21
3TAL	CRYSTAL STRUCTURE OF NURA WITH MANGANESE	3.1
3TAM	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (K103N MUTANT) IN COMPLEX WITH INHIBITOR M06	2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 3.4.23.16 2.7.7 3.1
3TAV	CRYSTAL STRUCTURE OF A METHIONINE AMINOPEPTIDASE FROM MYCOBACTERIUM ABSCESSUS	3.4.11.18
3TAZ	CRYSTAL STRUCTURE OF NURA BOUND TO DAMP AND MANGANESE	3.1
3TB3	CRYSTAL STRUCTURE OF THE UCH DOMAIN OF UCH-L5 WITH 6 RESIDUES DELETED	3.4.19.12
3TB4	CRYSTAL STRUCTURE OF THE ISC DOMAIN OF VIBB	3.3.2.1
3TB5	CRYSTAL STRUCTURE OF THE ENTEROCOCCUS FAECALIS METHIONINE AMINOPEPTIDASE APO FORM	3.4.11.18
3TB7	THE TYPE I CRYSTAL STRUCTURE OF STREPTOCOCCUS AGALACTIAE SORTASE C1	3.4.22
3TBE	THE CRYSTAL STRUCTURE OF THE COMPLEX OF STREPTOCOCCUS AGALACTIAE SORTASE C1 AND MTSET	3.4.22
3TBK	MOUSE RIG-I ATPASE DOMAIN	3.6.4.13
3TC3	CRYSTAL STRUCTURE OF SACUVDE	3
3TCK	CRYSTAL STRUCTURE OF PEPTIDYL-TRNA HYDROLASE FROM MYCOBACTERIUM TUBERCULOSIS - FORM 4	3.1.1.29
3TCN	CRYSTAL STRUCTURES OF PEPTIDYL-TRNA HYDROLASE FROM MYCOBACTERIUM TUBERCULOSIS - FORM 2 GROWN IN PRESENCE OF PENTAGLYCINE	3.1.1.29
3TD2	CRYSTAL STRUCTURES OF PEPTIDYL-TRNA HYDROLASE FROM MYCOBACTERIUM TUBERCULOSIS - FORM 5	3.1.1.29
3TD6	PEPTIDYL-TRNA HYDROLASE FROM MYCOBACTERIUM TUBERCULOSIS FROM TRIGONAL PARTIALLY DEHYDRATED CRYSTAL	3.1.1.29
3TEA	CRYSTAL STRUCTURE OF ARTHROBACTER SP. STRAIN SU 4-HYDROXYBENZOYL COA THIOESTERASE DOUBLE MUTANT Q58E/E73A COMPLEXED WITH 4-HYDROXYPHENACYL COA	3.1.2.23
3TEC	CALCIUM BINDING TO THERMITASE. CRYSTALLOGRAPHIC STUDIES OF THERMITASE AT 0, 5 AND 100 MM CALCIUM	3.4.21.66
3TED	CRYSTAL STRUCTURE OF THE CHD1 DNA-BINDING DOMAIN IN COMPLEX WITH A DNA DUPLEX	3.6.4
3TEN	HOLO FORM OF CARBON DISULFIDE HYDROLASE	3.13.1.5
3TF3	CRYSTAL STRUCTURE OF METAL-FREE HUMAN ARGINASE I	3.5.3.1
3TF4	ENDO/EXOCELLULASE:CELLOTRIOSE FROM THERMOMONOSPORA	3.2.1.4
3TG0	E. COLI ALKALINE PHOSPHATASE WITH BOUND INORGANIC PHOSPHATE	3.1.3.1
3TG2	CRYSTAL STRUCTURE OF THE ISC DOMAIN OF VIBB IN COMPLEX WITH ISOCHORISMATE	3.3.2.1
3TG3	CRYSTAL STRUCTURE OF THE MAPK BINDING DOMAIN OF MKP7	3.1.3.16 3.1.3.48
3TGE	A NOVEL SERIES OF POTENT AND SELECTIVE PDE5 INHIBITOR1	3.1.4.35
3TGG	A NOVEL SERIES OF POTENT AND SELECTIVE PDE5 INHIBITOR2	3.1.4.35
3TGH	GAP50 THE ANCHOR IN THE INNER MEMBRANE COMPLEX OF PLASMODIUM	3.1.3.2
3TGL	STRUCTURE AND MOLECULAR MODEL REFINEMENT OF RHIZOMUCOR MIEHEI TRIACYLGLYCERIDE LIPASE: A CASE STUDY OF THE USE OF SIMULATED ANNEALING IN PARTIAL MODEL REFINEMENT	3.1.1.3
3TGP	ROOM TEMPERATURE H-RAS	3.6.5.2
3TGW	CRYSTAL STRUCTURE OF SUBUNIT B MUTANT H156A OF THE A1AO ATP SYNTHASE	3.6.3.14
3TH0	P22 TAILSPIKE COMPLEXED WITH S.PARATYPHI O ANTIGEN OCTASACCHARIDE	3.2.1
3TH2	MG2+ IS REQUIRED FOR OPTIMAL FOLDING OF THE GAMMA-CARBOXYGLUTAMIC ACID (GLA) DOMAINS OF VITAMIN K-DEPENDENT CLOTTING FACTORS AT PHYSIOLOGICAL CA2+	3.4.21.21
3TH3	MG2+ IS REQUIRED FOR OPTIMAL FOLDING OF THE GAMMA-CARBOXYGLUTAMIC ACID (GLA) DOMAINS OF VITAMIN K-DEPENDENT CLOTTING FACTORS AT PHYSIOLOGICAL CA2+	3.4.21.21
3TH4	MG2+ IS REQUIRED FOR OPTIMAL FOLDING OF THE GAMMA-CARBOXYGLUTAMIC ACID (GLA) DOMAINS OF VITAMIN K-DEPENDENT CLOTTING FACTORS AT PHYSIOLOGICAL CA2+	3.4.21.21
3TH5	CRYSTAL STRUCTURE OF WILD-TYPE RAC1	3.6.5.2
3TH7	CRYSTAL STRUCTURE OF UNLIGANDED CO2+2-HAI (PH 7.0)	3.5.3.1
3TH9	CRYSTAL STRUCTURE OF HIV-1 PROTEASE MUTANT Q7K V32I L63I WITH A CYCLIC SULFONAMIDE INHIBITOR	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
3THC	CRYSTAL STRUCTURE OF HUMAN BETA-GALACTOSIDASE IN COMPLEX WITH GALACTOSE	3.2.1.23
3THD	CRYSTAL STRUCTURE OF HUMAN BETA-GALACTOSIDASE IN COMPLEX WITH 1-DEOXYGALACTONOJIRIMYCIN	3.2.1.23
3THE	CRYSTAL STRUCTURE OF CO2+2-HAI (PH 8.5)	3.5.3.1
3THH	CRYSTAL STRUCTURE OF THE CO2+2-HAI-ABH COMPLEX	3.5.3.1
3THJ	CRYSTAL STRUCTURE OF THE CO2+2-HAI-L-ORN COMPLEX	3.5.3.1
3TI3	CRYSTAL STRUCTURE OF 2009 PANDEMIC H1N1 NEURAMINIDASE COMPLEXED WITH LANINAMIVIR	3.2.1.18
3TI4	CRYSTAL STRUCTURE OF 2009 PANDEMIC H1N1 NEURAMINIDASE COMPLEXED WITH LANINAMIVIR OCTANOATE	3.2.1.18
3TI5	CRYSTAL STRUCTURE OF 2009 PANDEMIC H1N1 NEURAMINIDASE COMPLEXED WITH ZANAMIVIR	3.2.1.18
3TI6	CRYSTAL STRUCTURE OF 2009 PANDEMIC H1N1 NEURAMINIDASE COMPLEXED WITH OSELTAMIVIR	3.2.1.18
3TI7	CRYSTAL STRUCTURE OF THE BASIC PROTEASE BPRV FROM THE OVINE FOOTROT PATHOGEN, DICHELOBACTER NODOSUS	3.4.21
3TI8	CRYSTAL STRUCTURE OF INFLUENZA A VIRUS NEURAMINIDASE N5 COMPLEXED WITH LANINAMIVIR	3.2.1.18
3TIA	CRYSTAL STRUCTURE OF 1957 PANDEMIC H2N2 NEURAMINIDASE COMPLEXED WITH LANINAMIVIR	3.2.1.18
3TIB	CRYSTAL STRUCTURE OF 1957 PANDEMIC H2N2 NEURAMINIDASE COMPLEXED WITH LANINAMIVIR OCTANOATE	3.2.1.18
3TIC	CRYSTAL STRUCTURE OF 1957 PANDEMIC H2N2 NEURAMINIDASE COMPLEXED WITH ZANAMIVIR	3.2.1.18
3TIR	PSEUDO-ATOMIC MODEL OF THE ROUS SARCOMA VIRUS CAPSID HEXAMER	3.4.23 2.7.7.49 2.7.7.7 3.1.26.4 2.7.7 3.1
3TIT	CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PROTEASE COMPLEXED WITH AN ALPHA, BETA-UNSATURATED ETHYL ESTER SG81	3.4.19.12 3.4.22.69 3.4.22 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1
3TIU	CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PROTEASE COMPLEXED WITH AN ALPHA,BETA-UNSATURATED ETHYL ESTER INHIBITOR SG82	3.4.19.12 3.4.22.69 3.4.22 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1
3TIV	CRYSTAL STRUCTURE OF SUBUNIT B MUTANT N157A OF THE A1AO ATP SYNTHASE	3.6.3.14
3TIW	CRYSTAL STRUCTURE OF P97N IN COMPLEX WITH THE C-TERMINUS OF GP78	3.6.4.6
3TJM	CRYSTAL STRUCTURE OF THE HUMAN FATTY ACID SYNTHASE THIOESTERASE DOMAIN WITH AN ACTIVATE SITE-SPECIFIC POLYUNSATURATED FATTY ACYL ADDUCT	2.3.1.85 2.3.1.38 2.3.1.39 2.3.1.41 1.1.1.100 4.2.1.61 1.3.1.10 3.1.2.14 4.2.1.59 1.3.1.39
3TJN	HTRA1 CATALYTIC DOMAIN, APO FORM	3.4.21
3TJO	HTRA1 CATALYTIC DOMAIN, MUTATIONALLY INACTIVATED	3.4.21
3TJQ	N-DOMAIN OF HTRA1	3.4.21
3TJU	CRYSTAL STRUCTURE OF HUMAN GRANZYME H WITH AN INHIBITOR	3.4.21
3TJV	CRYSTAL STRUCTURE OF HUMAN GRANZYME H WITH A PEPTIDYL SUBSTRATE	3.4.21
3TK1	CRYSTAL STRUCTURE OF A MEAB AND RV1496 ORTHOLOG FROM MYCOBACTERIUM THERMORESISTIBLE BOUND TO GDP	3.6
3TK5	FACTOR XA IN COMPLEX WITH D102-4380	3.4.21.6
3TK6	FACTOR XA IN COMPLEX WITH D46-5241	3.4.21.6
3TK9	CRYSTAL STRUCTURE OF HUMAN GRANZYME H	3.4.21
3TKB	CRYSTAL STRUCTURE OF HUMAN URACIL-DNA GLYCOSYLASE D183G/K302R MUTANT	3.2.2.27
3TKG	CRYSTAL STRUCTURE OF HIV MODEL PROTEASE PRECURSOR/SAQUINAVIR COMPLEX	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
3TKJ	CRYSTAL STRUCTURE OF HUMAN ASPARAGINASE-LIKE PROTEIN 1 THR168ALA	3.5.1.1 3.4.19.5
3TKW	CRYSTAL STRUCTURE OF HIV PROTEASE MODEL PRECURSOR/DARUNAVIR COMPLEX	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
3TKZ	STRUCTURE OF THE SHP-2 N-SH2 DOMAIN IN A 1:2 COMPLEX WITH RVIPYFVPLNR PEPTIDE	3.1.3.48
3TL0	STRUCTURE OF SHP2 N-SH2 DOMAIN IN COMPLEX WITH RLNPYAQLWHR PEPTIDE	3.1.3.48
3TL9	CRYSTAL STRUCTURE OF HIV PROTEASE MODEL PRECURSOR/SAQUINAVIR COMPLEX	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
3TLH	STRUCTURAL STUDIES OF HIV AND FIV PROTEASES COMPLEXED WITHAN EFFICIENT INHIBITOR OF FIV PR	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
3TLI	THERMOLYSIN (10% ISOPROPANOL SOAKED CRYSTALS)	3.4.24.27
3TLO	CRYSTAL STRUCTURE OF HCOV-NL63 3C-LIKE PROTEASE	3.4.22 3.4.19.12
3TME	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+NVIAGLA V23E AT CRYOGENIC TEMPERATURE	3.1.31.1
3TMN	THE BINDING OF L-VALYL-L-TRYPTOPHAN TO CRYSTALLINE THERMOLYSIN ILLUSTRATES THE MODE OF INTERACTION OF A PRODUCT OF PEPTIDE HYDROLYSIS	3.4.24.27
3TMO	THE CATALYTIC DOMAIN OF HUMAN DEUBIQUITINASE DUBA	3.4.19.12
3TMP	THE CATALYTIC DOMAIN OF HUMAN DEUBIQUITINASE DUBA IN COMPLEX WITH UBIQUITIN ALDEHYDE	3.4.19.12
3TMU	X-RAY RADIATION DAMAGE TO HEWL CRYSTALS SOAKED IN 100MM SODIUM NITRATE (UNDOSED)	3.2.1.17
3TMV	X-RAY RADIATION DAMAGE TO HEWL CRYSTALS SOAKED IN 100MM SODIUM NITRATE (DOSE=0.12MGY)	3.2.1.17
3TMW	X-RAY RADIATION DAMAGE TO HEWL CRYSTALS SOAKED IN 100MM SODIUM NITRATE (UNDOSED)	3.2.1.17
3TMX	X-RAY RADIATION DAMAGE TO HEWL CRYSTALS SOAKED IN 100MM SODIUM NITRATE (DOSE=1.9MGY)	3.2.1.17
3TN3	CRYSTAL STRUCTURE OF GKAP FROM GEOBACILLUS KAUSTOPHILUS HTA426	3.5
3TN4	CRYSTAL STRUCTURE OF GKAP MUTANT G209D FROM GEOBACILLUS KAUSTOPHILUS HTA426	3.5
3TN5	CRYSTAL STRUCTURE OF GKAP MUTANT Y99L FROM GEOBACILLUS KAUSTOPHILUS HTA426	3.5
3TN6	CRYSTAL STRUCTURE OF GKAP MUTANT R230H FROM GEOBACILLUS KAUSTOPHILUS HTA426	3.5
3TNB	CRYSTAL STRUCTURE OF GKAP MUTANT G209D/R230H FROM GEOBACILLUS KAUSTOPHILUS HTA426	3.5
3TND	CRYSTAL STRUCTURE OF SHIGELLA FLEXNERI VAPBC TOXIN-ANTITOXIN COMPLEX	3.1
3TNE	THE CRYSTAL STRUCTURE OF PROTEASE SAPP1P FROM CANDIDA PARAPSILOSIS IN COMPLEX WITH THE HIV PROTEASE INHIBITOR RITONAVIR	3.4.23.24
3TNS	CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PROTEASE COMPLEXED WITH AN ALPHA, BETA-UNSATURATED ETHYL ESTER INHIBITOR SG83	3.4.19.12 3.4.22.69 3.4.22 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1
3TNT	CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PROTEASE COMPLEXED WITH AN ALPHA, BETA-UNSATURATED ETHYL ESTER INHIBITOR SG85	3.4.19.12 3.4.22.69 3.4.22 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1
3TNV	ACYLPHOSPHATASE WITH THERMOPHILIC SURFACE AND MESOPHILIC CORE	3.6.1.7
3TNX	STRUCTURE OF THE PRECURSOR OF A THERMOSTABLE VARIANT OF PAPAIN AT 2.6 ANGSTROEM RESOLUTION	3.4.22.2
3TOD	CRYSTAL STRUCTURE OF C-LOBE OF BOVINE LACTOFERRIN COMPLEXED WITH 1-BUTYL-1H-PYRAZOLE-5-CARBOXYLIC ACID AT 1.38 A RESOLUTION	3.4.21
3TOF	HIV-1 PROTEASE - EPOXYDIC INHIBITOR COMPLEX (PH 6 - ORTHOROMBIC CRYSTAL FORM P212121)	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
3TOG	HIV-1 PROTEASE - EPOXYDIC INHIBITOR COMPLEX (PH 9 - MONOCLINIC CRYSTAL FORM P21)	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
3TOH	HIV-1 PROTEASE - EPOXYDIC INHIBITOR COMPLEX (PH 9 - ORTHOROMBIC CRYSTAL FORM P212121)	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
3TOI	TAILORING ENZYME STABILITY AND EXPLOITING STABILITY-TRAIT LINKAGE BY ITERATIVE TRUNCATION AND OPTIMIZATION	3.5.2.6
3TON	CRYSTRAL STRUCTURE OF THE C-TERMINAL SUBUNIT OF HUMAN MALTASE-GLUCOAMYLASE	3.2.1.20 3.2.1.3
3TOP	CRYSTRAL STRUCTURE OF THE C-TERMINAL SUBUNIT OF HUMAN MALTASE-GLUCOAMYLASE IN COMPLEX WITH ACARBOSE	3.2.1.20 3.2.1.3
3TOQ	ACYLPHOSPHATASE WITH MESOPHILIC SURFACE AND THERMOPHILIC CORE	3.6.1.7
3TP1	CRYSTAL STRUCTURE OF THE PRECATALYTIC M-PMV DUTPASE - SUBSTRATE (DUPNPP) COMPLEX	3.6.1.23 3.4.23
3TP5	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+NVIAGLA V23E/L36E AT CRYOGENIC TEMPERATURE	3.1.31.1
3TP6	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS L36E/L103K AT CRYOGENIC TEMPERATURE	3.1.31.1
3TP7	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS V99E AT CRYOGENIC TEMPERATURE	3.1.31.1
3TP8	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS L36E AT CRYOGENIC TEMPERATURE	3.1.31.1
3TPJ	APO STRUCTURE OF BACE1	3.4.23.46
3TPL	APO STRUCTURE OF BACE1	3.4.23.46
3TPN	CRYSTAL STRUCTURE OF M-PMV DUTPASE COMPLEXED WITH DUPNPP, SUBSTRATE	3.6.1.23 3.4.23
3TPP	CRYSTAL STRUCTURE OF BACE1 COMPLEXED WITH AN INHIBITOR	3.4.23.46
3TPR	CRYSTAL STRUCTURE OF BACE1 COMPLEXED WITH AN INHIBITOR	3.4.23.46
3TPS	CRYSTAL STRUCTURE OF M-PMV DUTPASE COMPLEXED WITH DUPNPP SUBSTRATE	3.6.1.23 3.4.23
3TPW	CRYSTAL STRUCTURE OF M-PMV DUTPASE - DUPNPP COMPLEX REVEALING DISTORTED LIGAND GEOMETRY (APPROACH INTERMEDIATE)	3.6.1.23 3.4.23
3TPY	CRYSTAL STRUCTURE OF M-PMV DUTPASE WITH A MIXED POPULATION OF SUBSTRATE (DUPNPP) AND POST-INVERSION PRODUCT (DUMP) IN THE ACTIVE SITES	3.6.1.23 3.4.23
3TQ3	CRYSTAL STRUCTURE OF M-PMV DUTPASE WITH A MIXED POPULATION OF SUBSTRATE (DUPNPP) AND POST-INVERSION PRODUCT (DUMP) IN THE ACTIVE SITES	3.6.1.23 3.4.23
3TQ4	CRYSTAL STRUCTURE OF M-PMV DUTPASE WITH A MIXED POPULATION OF SUBSTRATE (DUPNPP) AND POST-INVERSION PRODUCT (DUMP) IN THE ACTIVE SITES	3.6.1.23 3.4.23
3TQ5	CRYSTAL STRUCTURE OF M-PMV DUTPASE POST-INVERSION PRODUCT (DUMP) COMPLEX	3.6.1.23 3.4.23
3TQF	STRUCTURE OF THE HPR(SER) KINASE/PHOSPHATASE FROM COXIELLA BURNETII	2.7.1 3.1.3
3TQU	STRUCTURE OF A HAM1 PROTEIN FROM COXIELLA BURNETII	3.6.1.19 3.6.1.66
3TQZ	STRUCTURE OF A DEOXYURIDINE 5'-TRIPHOSPHATE NUCLEOTIDOHYDROLASE (DUT) FROM COXIELLA BURNETII	3.6.1.23
3TR4	STRUCTURE OF AN INORGANIC PYROPHOSPHATASE (PPA) FROM COXIELLA BURNETII	3.6.1.1
3TR7	STRUCTURE OF A URACIL-DNA GLYCOSYLASE (UNG) FROM COXIELLA BURNETII	3.2.2.27
3TR8	STRUCTURE OF AN OLIGORIBONUCLEASE (ORN) FROM COXIELLA BURNETII	3.1
3TRG	STRUCTURE OF AN ACYLPHOSPHATASE FROM COXIELLA BURNETII	3.6.1.7
3TRK	STRUCTURE OF THE CHIKUNGUNYA VIRUS NSP2 PROTEASE	2.1.1 2.7.7 3.1.3.33 3.4.22 3.6.1.15 3.6.4.13 3.1.3.84 2.7.7.19 2.7.7.48
3TRL	CRYSTAL STRUCTURE OF M-PMV DUTPASE POST-INVERSION PRODUCT (DUMP) COMPLEX	3.6.1.23 3.4.23
3TRN	CRYSTAL STRUCTURE OF M-PMV DUTPASE POST-INVERSION PRODUCT (DUMP) COMPLEX	3.6.1.23 3.4.23
3TRS	THE CRYSTAL STRUCTURE OF ASPERGILLOGLUTAMIC PEPTIDASE FROM ASPERGILLUS NIGER	3.4.23.19
3TS4	HUMAN MMP12 IN COMPLEX WITH L-GLUTAMATE MOTIF INHIBITOR	3.4.24.65
3TS6	CRYSTAL STRUCTURE OF M-PMV DUTPASE RELAXED END-PRODUCT (DUMP) COMPLEX	3.6.1.23 3.4.23
3TS9	CRYSTAL STRUCTURE OF THE MDA5 HELICASE INSERT DOMAIN	3.6.4.13
3TSG	CRYSTAL STRUCTURE OF GES-14	3.5.2.6
3TSI	STRUCTURE OF THE PARAINFLUENZA VIRUS 5 (PIV5) HEMAGGLUTININ-NEURAMINIDASE (HN) STALK DOMAIN	3.2.1.18
3TSK	HUMAN MMP12 IN COMPLEX WITH L-GLUTAMATE MOTIF INHIBITOR	3.4.24.65
3TSL	CRYSTAL STRUCTURE OF M-PMV DUTPASE RELAXED END-PRODUCT (DUMP) COMPLEX	3.6.1.23 3.4.23
3TSR	X-RAY STRUCTURE OF MOUSE RIBONUCLEASE INHIBITOR COMPLEXED WITH MOUSE RIBONUCLEASE 1	3.1.27.5 4.6.1.18
3TT4	HUMAN MMP8 IN COMPLEX WITH L-GLUTAMATE MOTIF INHIBITOR	3.4.24.34
3TT6	STRUCTURE OF CLPP FROM BACILLUS SUBTILIS IN COMPRESSED STATE	3.4.21.92
3TT7	STRUCTURE OF CLPP FROM BACILLUS SUBTILIS IN COMPLEX WITH DFP	3.4.21.92
3TTA	CRYSTAL STRUCTURE OF M-PMV DUTPASE RELAXED END-PRODUCT (DUMP) COMPLEX	3.6.1.23 3.4.23
3TTP	STRUCTURE OF MULTIRESISTANT HIV-1 PROTEASE IN COMPLEX WITH DARUNAVIR	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
3TTR	CRYSTAL STRUCTURE OF C-LOBE OF BOVINE LACTOFERRIN COMPLEXED WITH LIDOCAINE AT 2.27 A RESOLUTION	3.4.21
3TTY	CRYSTAL STRUCTURE OF BETA-GALACTOSIDASE FROM BACILLUS CIRCULANS SP. ALKALOPHILUS IN COMPLEX WITH GALACTOSE	3.2.1.23
3TU7	HUMAN ALPHA-THROMBIN COMPLEXED WITH N-(METHYLSULFONYL)-D-PHENYLALANYL-N-((1-CARBAMIMIDOYL-4-PIPERIDINYL)METHYL)-L-PROLINAMIDE (BMS-189664)	3.4.21.5
3TUS	CRYSTAL STRUCTURE OF C-LOBE OF BOVINE LACTOFERRIN COMPLEXED WITH META-HYDROXY BENZOIC ACID AT 2.5 A RESOLUTION	3.4.21
3TUV	CRYSTAL STRUCTURE OF INSULYSIN WITH BOUND ATP	3.4.24.56
3TV8	PHARMACOLOGICAL CHAPERONING IN HUMAN ALPHA-GALACTOSIDASE	3.2.1.22 3.2.1.47
3TVC	HUMAN MMP13 IN COMPLEX WITH L-GLUTAMATE MOTIF INHIBITOR	3.4.24
3TVD	CRYSTAL STRUCTURE OF MOUSE RHOA-GTP COMPLEX	3.6.5.2
3TVJ	CATALYTIC FRAGMENT OF MASP-2 IN COMPLEX WITH ITS SPECIFIC INHIBITOR DEVELOPED BY DIRECTED EVOLUTION ON SGCI SCAFFOLD	3.4.21.104
3TVL	COMPLEX BETWEEN THE HUMAN THIAMINE TRIPHOSPHATASE AND TRIPHOSPHATE	3.6.1.28
3TVX	THE STRUCTURE OF PDE4A WITH PENTOXIFYLLINE AT 2.84A RESOLUTION	3.1.4.17 3.1.4.53
3TW2	HIGH RESOLUTION STRUCTURE OF HUMAN HISTIDINE TRIAD NUCLEOTIDE-BINDING PROTEIN 1 (HHINT1)/AMP COMPLEX IN A MONOCLINIC SPACE GROUP	3
3TWH	SELENIUM DERIVATIZED RNA/DNA HYBRID IN COMPLEX WITH RNASE H CATALYTIC DOMAIN D132N MUTANT	3.1.26.4
3TWK	CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA FPG	3.2.2.23 4.2.99.18
3TWL	CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA FPG	3.2.2.23 4.2.99.18
3TWM	CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA FPG	3.2.2.23 4.2.99.18
3TX2	STRUCTURE OF A PROBABLE 6-PHOSPHOGLUCONOLACTONASE FROM MYCOBACTERIUM ABSCESSUS	3.1.1.31
3TX8	CRYSTAL STRUCTURE OF A SUCCINYL-DIAMINOPIMELATE DESUCCINYLASE (ARGE) FROM CORYNEBACTERIUM GLUTAMICUM ATCC 13032 AT 2.97 A RESOLUTION	3.5.1.18
3TXB	HEWL CO-CRYSTALLIZATION WITH CISPLATIN IN AQUEOUS MEDIA WITH GLYCEROL AS THE CRYOPROTECTANT	3.2.1.17
3TXD	HEWL CO-CRYSTALLIZATION WITH CARBOPLATIN IN AQUEOUS MEDIA WITH GLYCEROL AS THE CRYOPROTECTANT	3.2.1.17
3TXE	HEWL CO-CRYSTALLIZATION WITH CARBOPLATIN IN AQUEOUS MEDIA WITH PARATONE AS THE CRYOPROTECTANT	3.2.1.17
3TXF	HEWL CO-CRYSTALLIZATION WITH CISPLATIN IN DMSO MEDIA WITH GLYCEROL AS THE CRYOPROTECTANT	3.2.1.17
3TXG	HEWL CO-CRYSTALLIZATION WITH CISPLATIN IN DMSO MEDIA WITH PARATONE AS THE CRYOPROTECTANT	3.2.1.17
3TXH	HEWL CO-CRYSTALLIZATION WITH CARBOPLATIN IN DMSO MEDIA WITH GLYCEROL AS THE CRYOPROTECTANT	3.2.1.17
3TXI	HEWL CO-CRYSTALLIZATION WITH CARBOPLATIN IN DMSO MEDIA WITH PARATONE AS THE CRYOPROTECTANT	3.2.1.17
3TXJ	HEWL CO-CRYSTALLIZATION WITH NAG WITH SILICONE OIL AS THE CRYOPROTECTANT	3.2.1.17
3TXK	HEWL CO-CRYSTALLIZATION WITH CISPLATIN IN DMSO MEDIA WITH PARATONE AS THE CRYOPROTECTANT AT PH 6.5	3.2.1.17
3TXT	CRYSTAL STRUCTURE OF GLPG IN COMPLEX WITH INHIBITOR DFP	3.4.21.105
3TY2	STRUCTURE OF A 5'-NUCLEOTIDASE (SURE) FROM COXIELLA BURNETII	3.1.3.5
3TY6	ATP-DEPENDENT PROTEASE HSLV FROM BACILLUS ANTHRACIS STR. AMES	3.4.25.2
3TYP	THE CRYSTAL STRUCTURE OF THE INORGANIC TRIPHOSPHATASE NE1496	3.6.1.25
3TYQ	SAR DEVELOPMENT AND DISCOVERY OF POTENT INDOLE-BASED INHIBITORS OF THE HEPATITIS C VIRUS NS5B POLYMERASE	2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13
3TYV	SAR DEVELOPMENT AND DISCOVERY OF POTENT INDOLE-BASED INHIBITORS OF THE HEPATITIS C VIRUS NS5B POLYMERASE	2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13
3U00	CRYSTAL STRUCTURE OF WILD-TYPE ONCONASE AT 1.65 A RESOLUTION	3.1.27
3U01	CRYSTAL STRUCTURE OF ONCONASE DOUBLE MUTANT C30A/C75A AT 1.12 A RESOLUTION	3.1.27
3U04	CRYSTAL STRUCTURE OF PEPTIDE DEFORMYLASE FROM EHRLICHIA CHAFFEENSIS IN COMPLEX WITH ACTINONIN	3.5.1.88
3U0S	CRYSTAL STRUCTURE OF AN ENZYME REDESIGNED THROUGH MULTIPLAYER ONLINE GAMING: CE6	3.1.8.2
3U0V	CRYSTAL STRUCTURE ANALYSIS OF HUMAN LYPLAL1	3.1.2
3U12	THE PLECKSTRIN HOMOLOGY (PH) DOMAIN OF USP37	3.4.19.12
3U14	STRUCTURE OF D50A-FRUCTOFURANOSIDASE FROM SCHWANNIOMYCES OCCIDENTALIS COMPLEXED WITH INULIN	3.2.1.26
3U1I	DENGUE VIRUS PROTEASE COVALENTLY BOUND TO A PEPTIDE	3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48
3U1J	APROTININ BOUND TO DENGUE VIRUS PROTEASE	3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48
3U1N	STRUCTURE OF THE CATALYTIC CORE OF HUMAN SAMHD1	3.1.4 3.1.5
3U1T	HALOALKANE DEHALOGENASE, DMMA, OF MARINE MICROBIAL ORIGIN	3.8.1.5
3U1Y	POTENT INHIBITORS OF LPXC FOR THE TREATMENT OF GRAM-NEGATIVE INFECTIONS	3.5.1 3.5.1.108
3U2A	ADAPTOR DEPENDENT DEGRADATION OF A CELL-CYCLE REGULATOR REVEALS DIVERSITY IN SUBSTRATE ARCHITECTURES	3.1.4.52
3U31	PLASMODIUM FALCIPARUM SIR2A PREFERENTIALLY HYDROLYZES MEDIUM AND LONG CHAIN FATTY ACYL LYSINE	3.5.1.17 2.3.1
3U3D	PLASMODIUM FALCIPARUM SIR2A PREFERENTIALLY HYDROLYZES MEDIUM AND LONG CHAIN FATTY ACYL LYSINE	3.5.1.17 2.3.1
3U3G	STRUCTURE OF LC11-RNASE H1 ISOLATED FROM COMPOST BY METAGENOMIC APPROACH: INSIGHT INTO THE STRUCTURAL BASES FOR UNUSUAL ENZYMATIC PROPERTIES OF STO-RNASE H1	3.1.26.4
3U3Y	MOUSE TREX1 D200H MUTANT	3.1.11.2
3U44	CRYSTAL STRUCTURE OF ADDAB-DNA COMPLEX	3.1 3.6.4.12
3U4H	CD38 STRUCTURE-BASED INHIBITOR DESIGN USING THE N1-CYCLIC INOSINE 5'-DIPHOSPHATE RIBOSE TEMPLATE	3.2.2.5 3.2.2.6 2.4.99.20
3U4I	CD38 STRUCTURE-BASED INHIBITOR DESIGN USING THE N1-CYCLIC INOSINE 5'-DIPHOSPHATE RIBOSE TEMPLATE	3.2.2.5 3.2.2.6 2.4.99.20
3U4O	NOVEL HCV NS5B POLYMERASE INHIBITORS: DISCOVERY OF INDOLE C2 ACYL SULFONAMIDES	2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13
3U4R	NOVEL HCV NS5B POLYMERASE INHIBITORS: DISCOVERY OF INDOLE C2 ACYL SULFONAMIDES	2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13
3U53	CRYSTAL STRUCTURE OF HUMAN AP4A HYDROLASE	3.6.1.17
3U57	STRUCTURES OF ALKALOID BIOSYNTHETIC GLUCOSIDASES DECODE SUBSTRATE SPECIFICITY	3.2.1.125 2.4.1.219
3U5U	STRUCTURES OF ALKALOID BIOSYNTHETIC GLUCOSIDASES DECODE SUBSTRATE SPECIFICITY	3.2.1.125 2.4.1.219
3U5Y	STRUCTURES OF ALKALOID BIOSYNTHETIC GLUCOSIDASES DECODE SUBSTRATE SPECIFICITY	3.2.1.125 2.4.1.219
3U69	UNLIGANDED WILD-TYPE HUMAN THROMBIN	3.4.21.5
3U6A	RATIONAL DESIGN AND SYNTHESIS OF AMINOPIPERAZINONES AS BETA SECRETASE (BACE) INHIBITORS	3.4.23.46
3U6C	MUTM SET 1 APGO	3.2.2.23 4.2.99.18
3U6D	MUTM SET 1 GPGO	3.2.2.23 4.2.99.18
3U6E	MUTM SET 1 TPGO	3.2.2.23 4.2.99.18
3U6F	MOUSE TREX1 D200N MUTANT	3.1.11.2
3U6L	MUTM SET 2 CPGO	3.2.2.23 4.2.99.18
3U6M	STRUCTURAL EFFECTS OF SEQUENCE CONTEXT ON LESION RECOGNITION BY MUTM	3.2.2.23 4.2.99.18
3U6O	MUTM SET 1 APG	3.2.2.23 4.2.99.18
3U6P	MUTM SET 1 GPG	3.2.2.23 4.2.99.18
3U6Q	MUTM SET 2 APGO	3.2.2.23 4.2.99.18
3U6S	MUTM SET 1 TPG	3.2.2.23 4.2.99.18
3U6T	CRYSTAL STRUCTURE OF THE COMPLEX OF TYPE I RIBOSOME INACTIVATING PROTEIN IN COMPLEX WITH KANAMYCIN AT 1.85 A	3.2.2.22
3U6Z	CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN TYPE 1 RIBOSOME INACTIVATING PROTEIN AND ADENINE AT 1.7A RESOLUTION	3.2.2.22
3U70	CRYSTAL STRUCTURE OF TYPE 1 RIBOSOME INACTIVATING PROTEIN COMPLEXED WITH ADENINE IN LOW IONIC SOLVENT	3.2.2.22
3U71	CRYSTAL STRUCTURE ANALYSIS OF SOUTH AFRICAN WILD TYPE HIV-1 SUBTYPE C PROTEASE	2.7.7.49 3.1.26.13
3U72	CRYSTAL STRUCTURE OF C-LOBE OF BOVINE LACTOFERRIN COMPLEXED WITH ISONIAZID AT 2.2 A RESOLUTION	3.4.21
3U73	CRYSTAL STRUCTURE OF STABILIZED HUMAN UPAR MUTANT IN COMPLEX WITH ATF	3.4.21.73
3U75	STRUCTURE OF E230A-FRUCTOFURANOSIDASE FROM SCHWANNIOMYCES OCCIDENTALIS COMPLEXED WITH FRUCTOSYLNYSTOSE	3.2.1.26
3U7B	A NEW CRYSTAL STRUCTURE OF A FUSARIUM OXYSPORUM GH10 XYLANASE REVEALS THE PRESENCE OF AN EXTENDED LOOP ON TOP OF THE CATALYTIC CLEFT	3.2.1.8
3U7E	CRYSTAL STRUCTURE OF MPNKP CATALYTIC FRAGMENT (D170A)	3.1.3.32 2.7.1.78
3U7F	CRYSTAL STRUCTURE OF MPNKP CATALYTIC FRAGMENT (D170A) BOUND TO SINGLE-STRANDED DNA (TCCTCP)	3.1.3.32 2.7.1.78
3U7G	CRYSTAL STRUCTURE OF MPNKP CATALYTIC FRAGMENT (D170A) BOUND TO SINGLE-STRANDED DNA (TCCTAP)	3.1.3.32 2.7.1.78
3U7H	CRYSTAL STRUCTURE OF MPNKP CATALYTIC FRAGMENT (D170A) BOUND TO SINGLE-STRANDED DNA (TCCTTP)	3.1.3.32 2.7.1.78
3U7K	CRYSTAL STRUCTURES OF THE STAPHYLOCOCCUS AUREUS PEPTIDE DEFORMYLASE IN COMPLEX WITH TWO CLASSES OF NEW INHIBITORS	3.5.1.88
3U7L	CRYSTAL STRUCTURES OF THE STAPHYLOCOCCUS AUREUS PEPTIDE DEFORMYLASE IN COMPLEX WITH TWO CLASSES OF NEW INHIBITORS	3.5.1.88
3U7M	CRYSTAL STRUCTURES OF THE STAPHYLOCOCCUS AUREUS PEPTIDE DEFORMYLASE IN COMPLEX WITH TWO CLASSES OF NEW INHIBITORS	3.5.1.88
3U7N	CRYSTAL STRUCTURES OF THE STAPHYLOCOCCUS AUREUS PEPTIDE DEFORMYLASE IN COMPLEX WITH TWO CLASSES OF NEW INHIBITORS	3.5.1.88
3U7S	HIV PR DRUG RESISTANT PATIENT'S VARIANT IN COMPLEX WITH DARUNAVIR	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
3U7V	THE STRUCTURE OF A PUTATIVE BETA-GALACTOSIDASE FROM CAULOBACTER CRESCENTUS CB15.	3.2.1.23
3U8B	FUNCTIONALLY SELECTIVE INHIBITION OF GROUP IIA PHOSPHOLIPASE A2 REVEALS A ROLE FOR VIMENTIN IN REGULATING ARACHIDONIC ACID METABOLISM	3.1.1.4
3U8D	FUNCTIONALLY SELECTIVE INHIBITION OF GROUP IIA PHOSPHOLIPASE A2 REVEALS A ROLE FOR VIMENTIN IN REGULATING ARACHIDONIC ACID METABOLISM	3.1.1.4
3U8F	CRYSTAL STRUCTURE OF THE COMPLEX OF TYPE I RIBOSOME INACTIVATING PROTEIN IN COMPLEX WITH MYCOLIC ACID AT 1.8 A RESOLUTION	3.2.2.22
3U8H	FUNCTIONALLY SELECTIVE INHIBITION OF GROUP IIA PHOSPHOLIPASE A2 REVEALS A ROLE FOR VIMENTIN IN REGULATING ARACHIDONIC ACID METABOLISM	3.1.1.4
3U8I	FUNCTIONALLY SELECTIVE INHIBITION OF GROUP IIA PHOSPHOLIPASE A2 REVEALS A ROLE FOR VIMENTIN IN REGULATING ARACHIDONIC ACID METABOLISM	3.1.1.4
3U8O	HUMAN THROMBIN COMPLEXED WITH D-PHE-PRO-D-ARG-D-THR	3.4.21.5
3U8Q	CRYSTAL STRUCTURE OF C-LOBE OF BOVINE LACTOFERRIN COMPLEXED WITH PHENYL-PROPANOLAMINE AT 1.97 A RESOLUTION	3.4.21
3U8R	HUMAN THROMBIN COMPLEXED WITH D-PHE-PRO-D-ARG-ILE	3.4.21.5
3U8T	HUMAN THROMBIN COMPLEXED WITH D-PHE-PRO-D-ARG-CYS	3.4.21.5
3U8U	CRYSTAL STRUCTURE OF HUMAN APURINIC/APYRIDINIMIC ENDONUCLEASE, APE1 IN A NEW CRYSTAL FORM	3.1 4.2.99.18
3U96	CRYSTAL STRUCTURE OF YOPHQ357F(CATALYTIC DOMAIN, RESIDUES 163-468) IN COMPLEX WITH PNCS	3.1.3.48
3U97	1.1 ANGSTROM-RESOLUTION CRYSTAL STRUCTURE OF THE BRUCELLA ABORTUS RIBONUCLEASE TOXIN, BRNT	3.1.27.1
3U98	HUMAN THROMBIN IN COMPLEX WITH MI001	3.4.21.5
3U9A	HUMAN THROMBIN IN COMPLEX WITH MI330	3.4.21.5
3U9O	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT NVIAGA/N100G AT CRYOGENIC TEMPERATURE	3.1.31.1
3U9W	STRUCTURE OF HUMAN LEUKOTRIENE A4 HYDROLASE IN COMPLEX WITH INHIBITOR SC57461A	3.3.2.6 3.4.11.4
3UAJ	CRYSTAL STRUCTURE OF THE ENVELOPE GLYCOPROTEIN ECTODOMAIN FROM DENGUE VIRUS SEROTYPE 4 IN COMPLEX WITH THE FAB FRAGMENT OF THE CHIMPANZEE MONOCLONAL ANTIBODY 5H2	3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48
3UAO	STRUCTURE AND CATALYTIC MECHANISM OF THE VITAMIN B3 DEGRADATIVE ENZYME MALEAMATE AMIDOHYDROLASE FROM BORDETALLA BRONCHISEPTICA RB50	3.5.1.107
3UB0	CRYSTAL STRUCTURE OF THE NONSTRUCTURAL PROTEIN 7 AND 8 COMPLEX OF FELINE CORONAVIRUS	3.4.19.12 3.4.22 2.7.7.48 3.6.4.12 3.6.4.13 3.1.13 3.1 2.1.1
3UBB	THE CRYSTAL STRUCTURE OF GLPG IN COMPLEX WITH A PHOSPHONOFLUORIDATE INHIBITOR	3.4.21.105
3UBP	DIAMIDOPHOSPHATE INHIBITED BACILLUS PASTEURII UREASE	3.5.1.5
3UBY	CRYSTAL STRUCTURE OF HUMAN ALKLYADENINE DNA GLYCOSYLASE IN A LOWER AND HIGHER-AFFINITY COMPLEX WITH DNA	3.2.2.21
3UC0	CRYSTAL STRUCTURE OF DOMAIN I OF THE ENVELOPE GLYCOPROTEIN ECTODOMAIN FROM DENGUE VIRUS SEROTYPE 4 IN COMPLEX WITH THE FAB FRAGMENT OF THE CHIMPANZEE MONOCLONAL ANTIBODY 5H2	3.4.21.91 3.6.1.15 3.6.4.13
3UCB	CRYSTAL STRUCTURE OF MULTIDRUG RESISTANT HIV-1 PROTEASE CLINICAL ISOLATE PR20 IN COMPLEX WITH DARUNAVIR	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
3UCI	CRYSTAL STRUCTURE OF RHODOSTOMIN ARLDDL MUTANT	3.4.24
3UDF	CRYSTAL STRUCTURE OF APO PBP1A FROM ACINETOBACTER BAUMANNII	2.4.1.129 3.4.16.4
3UDH	CRYSTAL STRUCTURE OF BACE WITH COMPOUND 1	3.4.23.46
3UDI	CRYSTAL STRUCTURE OF ACINETOBACTER BAUMANNII PBP1A IN COMPLEX WITH PENICILLIN G	2.4.1.129 3.4.16.4
3UDJ	CRYSTAL STRUCTURE OF BACE WITH COMPOUND 5	3.4.23.46
3UDK	CRYSTAL STRUCTURE OF BACE WITH COMPOUND 6	3.4.23.46
3UDL	3-HETEROCYCLYL QUINOLONE BOUND TO HCV NS5B	3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48
3UDM	CRYSTAL STRUCTURE OF BACE WITH COMPOUND 8	3.4.23.46
3UDN	CRYSTAL STRUCTURE OF BACE WITH COMPOUND 9	3.4.23.46
3UDP	CRYSTAL STRUCTURE OF BACE WITH COMPOUND 12	3.4.23.46
3UDQ	CRYSTAL STRUCTURE OF BACE WITH COMPOUND 13	3.4.23.46
3UDR	CRYSTAL STRUCTURE OF BACE WITH COMPOUND 14	3.4.23.46
3UDX	CRYSTAL STRUCTURE OF ACINETOBACTER BAUMANNII PBP1A IN COMPLEX WITH IMIPENEM	2.4.1.129 3.4.16.4
3UDY	CRYSTAL STRUCTURE OF BACE WITH COMPOUND 11	3.4.23.46
3UE0	CRYSTAL STRUCTURE OF ACINETOBACTER BAUMANNII PBP1A IN COMPLEX WITH AZTREONAM	2.4.1.129 3.4.16.4
3UE3	CRYSTAL STRUCTURE OF ACINETOBACTER BAUMANNI PBP3	2.4.1.129 3.4.16.4
3UEK	CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF RAT POLY (ADP-RIBOSE) GLYCOHYDROLASE	3.2.1.143
3UEL	CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF RAT POLY (ADP-RIBOSE) GLYCOHYDROLASE BOUND TO ADP-HPD	3.2.1.143
3UES	CRYSTAL STRUCTURE OF ALPHA-1,3/4-FUCOSIDASE FROM BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS COMPLEXED WITH DEOXYFUCONOJIRIMYCIN	3.2.1.111
3UET	CRYSTAL STRUCTURE OF ALPHA-1,3/4-FUCOSIDASE FROM BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS D172A/E217A MUTANT COMPLEXED WITH LACTO-N-FUCOPENTAOSE II	3.2.1.111
3UF3	CRYSTAL STRUCTURE OF MULTIDRUG RESISTANT HIV-1 PROTEASE CLINICAL ISOLATE PR20	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
3UF7	CO-CRYSTAL STRUCTURE OF ESCHERICHIA COLI URACIL-DNA GLYCOSYLASE AND A C-TERMINAL FRAGEMENT OF THE SINGLE-STRANDED DNA-BINDING PROTEIN	3.2.2.27
3UFA	CRYSTAL STRUCTURE OF THE STAPHYLOCOCCAL SERINE PROTEASE SPLA IN COMPLEX WITH A SPECIFIC PHOSPHONATE INHIBITOR	3.4.21
3UFJ	HUMAN THYMINE DNA GLYCOSYLASE BOUND TO SUBSTRATE ANALOG 2'-FLUORO-2'-DEOXYURIDINE	3.2.2.29
3UFL	DISCOVERY OF PYRROLIDINE-BASED B-SECRETASE INHIBITORS: LEAD ADVANCEMENT THROUGH CONFORMATIONAL DESIGN FOR MAINTENANCE OF LIGAND BINDING EFFICIENCY	3.4.23.46
3UFM	CO-CRYSTAL STRUCTURE OF DEINOCOCCUS RADIODURANS URACIL-DNA GLYCOSYLASE AND THE C-TERMINUS OF THE SINGLE-STRANDED DNA-BINDING PROTEIN	3.2.2.27
3UFN	CRYSTAL STRUCTURE OF MULTIDRUG RESISTANT HIV-1 PROTEASE CLINICAL ISOLATE PR20 IN COMPLEX WITH SAQUINAVIR	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
3UG3	CRYSTAL STRUCTURE OF ALPHA-L-ARABINOFURANOSIDASE FROM THERMOTOGA MARITIMA LIGAND FREE FORM	3.2.1.55
3UG5	CRYSTAL STRUCTURE OF ALPHA-L-ARABINOFURANOSIDASE FROM THERMOTOGA MARITIMA XYLOSE COMPLEX	3.2.1.55
3UG6	CRYSTAL STRUCTURE OF GET3 FROM METHANOCALDOCOCCUS JANNASCHII	3.6.3.16 7.3.2.7
3UG7	CRYSTAL STRUCTURE OF GET3 FROM METHANOCALDOCOCCUS JANNASCHII	3.6.3.16 7.3.2.7
3UGW	CRYSTAL STRUCTURE OF C-LOBE OF BOVINE LACTOFERRIN COMPLEXED WITH DEOXYCYTIDINE AT 1.87 A RESOLUTION	3.4.21
3UHL	CRYSTAL STRUCTURE OF MULTIDRUG RESISTANT HIV-1 PROTEASE CLINICAL ISOLATE PR20 IN COMPLEX WITH P2-NC SUBSTRATE ANALOG	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
3UHM	UDP-3-O-[3-HYDROXYMYRISTOYL] N-ACETYLGLUCOSAMINE DEACETYLASE IN COMPLEX WITH INHIBITOR	3.5.1 3.5.1.108
3UI3	STRUCTURAL AND BIOCHEMICAL CHARACTERIZATION OF HP0315 FROM HELICOBACTER PYLORI AS A VAPD PROTEIN WITH AN ENDORIBONUCLEASE ACTIVITY	3.1
3UI7	DISCOVERY OF ORALLY ACTIVE PYRAZOLOQUINOLINE AS A POTENT PDE10 INHIBITOR FOR THE MANAGEMENT OF SCHIZOPHRENIA	3.1.4.17 3.1.4.35
3UIQ	RB69 DNA POLYMERASE TERNARY COMPLEX CONTAINING DUPNPP	2.7.7.7 3.1.11
3UIR	CRYSTAL STRUCTURE OF THE PLASMIN-TEXTILININ-1 COMPLEX	3.4.21.7
3UJ3	CRYSTAL STRUCTURE OF THE SYNAPTIC TETRAMER OF THE G-SEGMENT INVERTASE (GIN)	3.1.22 6.5.1
3UJK	CRYSTAL STRUCTURE OF PROTEIN PHOSPHATASE ABI2	3.1.3.16
3UJZ	CRYSTAL STRUCTURE OF ENTEROHEMORRHAGIC E. COLI STCE	3.4.24
3UK4	CRYSTAL STRUCTURE OF C-LOBE OF BOVINE LACTOFERRIN COMPLEXED WITH 1,2,5-PENTANETRIOL AT 1.98 A RESOLUTION	3.4.21
3UL7	CRYSTAL STRUCTURE OF THE TV3 MUTANT F63W	3.2.2.6
3UL8	CRYSTAL STRUCTURE OF THE TV3 MUTANT V134L	3.2.2.6
3UL9	STRUCTURE OF THE TV3 MUTANT M41E	3.2.2.6
3ULA	CRYSTAL STRUCTURE OF THE TV3 MUTANT F63W-MD-2-ERITORAN COMPLEX	3.2.2.6
3ULD	HIGH RESOLUTION STRUCTURE OF DNA/RNA HYBRID IN COMPLEX WITH RNASE H CATALYTIC DOMAIN D132N MUTANT	3.1.26.4
3ULQ	CRYSTAL STRUCTURE OF THE ANTI-ACTIVATOR RAPF COMPLEXED WITH THE RESPONSE REGULATOR COMA DNA BINDING DOMAIN	3.1
3ULR	LYSOZYME CONTAMINATION FACILITATES CRYSTALLIZATION OF A HETERO-TRIMERICCORTACTIN:ARG:LYSOZYME COMPLEX	3.2.1.17
3UM9	CRYSTAL STRUCTURE OF THE DEFLUORINATING L-2-HALOACID DEHALOGENASE BPRO0530	3.8.1.2
3UMB	CRYSTAL STRUCTURE OF THE L-2-HALOACID DEHALOGENASE RSC1362	3.8.1.2
3UMC	CRYSTAL STRUCTURE OF THE L-2-HALOACID DEHALOGENASE PA0810	3.8.1.2
3UMG	CRYSTAL STRUCTURE OF THE DEFLUORINATING L-2-HALOACID DEHALOGENASE RHA0230	3.8.1.2
3UMJ	CRYSTAL STRUCTURE OF D311E LIPASE	3.1.1.3
3UNQ	BOVINE TRYPSIN VARIANT X(TRIPLEPHE227) IN COMPLEX WITH SMALL MOLECULE INHIBITOR	3.4.21.4
3UNR	BOND LENGTH ANALYSIS OF ASP, GLU AND HIS RESIDUES IN TRYPSIN AT 1.2A RESOLUTION	3.4.21.4
3UNS	BOVINE TRYPSIN VARIANT X(TRIPLEPHE227) IN COMPLEX WITH SMALL MOLECULE INHIBITOR	3.4.21.4
3UNW	CRYSTAL STRUCTURE OF HUMAN GAC IN COMPLEX WITH GLUTAMATE	3.5.1.2
3UNX	BOND LENGTH ANALYSIS OF ASP, GLU AND HIS RESIDUES IN SUBTILISIN CARLSBERG AT 1.26A RESOLUTION	3.4.21.62
3UO7	CRYSTAL STRUCTURE OF HUMAN THYMINE DNA GLYCOSYLASE BOUND TO SUBSTRATE 5-CARBOXYLCYTOSINE	3.2.2.29
3UO8	CRYSTAL STRUCTURE OF THE MALT1 PARACASPASE (P1 FORM)	3.4.22
3UO9	CRYSTAL STRUCTURE OF HUMAN GAC IN COMPLEX WITH GLUTAMATE AND BPTES	3.5.1.2
3UOA	CRYSTAL STRUCTURE OF THE MALT1 PARACASPASE (P21 FORM)	3.4.22
3UOB	CRYSTAL STRUCTURE OF HUMAN THYMINE DNA GLYCOSYLASE BOUND TO SUBSTRATE ANALOG 2'-DEOXY-2'-BETA-FLUORO-CYTIDINE	3.2.2.29
3UON	STRUCTURE OF THE HUMAN M2 MUSCARINIC ACETYLCHOLINE RECEPTOR BOUND TO AN ANTAGONIST	3.2.1.17
3UOP	BOVINE TRYPSIN VARIANT X(TRIPLEPHE227) IN COMPLEX WITH SMALL MOLECULE INHIBITOR	3.4.21.4
3UOU	CRYSTAL STRUCTURE OF THE KUNITZ-TYPE PROTEASE INHIBITOR SHPI-1 LYS13LEU MUTANT IN COMPLEX WITH PANCREATIC ELASTASE	3.4.21.36
3UPE	BOVINE TRYPSIN VARIANT X(TRIPLEPHE227) IN COMPLEX WITH SMALL MOLECULE INHIBITOR	3.4.21.4
3UPF	CRYSTAL STRUCTURE OF MURINE NOROVIRUS RNA-DEPENDENT RNA POLYMERASE BOUND TO NF023	2.7.7.48 3.4.22.66 3.6.1.15
3UPH	SYNTHESIS OF NOVEL 4,5-DIHYDROFURANO INDOLES AND THEIR EVALUATION AS HCV NS5B POLYMERASE INHIBITORS	2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13
3UPI	SYNTHESIS OF NOVEL 4,5-DIHYDROFURANO INDOLES AND THEIR EVALUATION AS HCV NS5B POLYMERASE INHIBITORS	2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13
3UPJ	HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 PROTEASE MUTANT WITH LYS 57 REPLACED BY LEU (K57L) COMPLEX WITH U096333 [4-HYDROXY-3-[1-(PHENYL)PROPYL]-7-METHOXYCOUMARIN]	3.4.23.16 3.4.23.47 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
3UPM	CRYSTAL STRUCTURE OF PTE MUTANT H254Q/H257F/K185R/I274N	3.1.8.1
3UPU	CRYSTAL STRUCTURE OF THE T4 PHAGE SF1B HELICASE DDA	3.6.4.12
3UQO	BOVINE TRYPSIN VARIANT X(TRIPLEPHE227) IN COMPLEX WITH SMALL MOLECULE INHIBITOR	3.4.21.4
3UQP	CRYSTAL STRUCTURE OF BACE1 WITH ITS INHIBITOR	3.4.23.46
3UQR	CRYSTAL STRUCTURE OF BACE1 WITH ITS INHIBITOR	3.4.23.46
3UQS	CRYSTAL STRUCTURES OF MURINE NOROVIRUS RNA-DEPENDENT RNA POLYMERASE	2.7.7.48 3.4.22.66 3.6.1.15
3UQU	CRYSTAL STRUCTURE OF BACE1 WITH ITS INHIBITOR	3.4.23.46
3UQV	BOVINE TRYPSIN VARIANT X(TRIPLEPHE227) IN COMPLEX WITH SMALL MOLECULE INHIBITOR	3.4.21.4
3UQW	CRYSTAL STRUCTURE OF BACE1 WITH ITS INHIBITOR	3.4.23.46
3UQX	CRYSTAL STRUCTURE OF BACE1 WITH ITS INHIBITOR	3.4.23.46
3UR0	CRYSTAL STRUCTURES OF MURINE NOROVIRUS RNA-DEPENDENT RNA POLYMERASE IN COMPLEX WITH SURAMIN	2.7.7.48 3.4.22.66 3.6.1.15
3UR2	CRYSTAL STRUCTURE OF PTE MUTANT H254G/H257W/L303T/K185R/I274N/A80V	3.1.8.1
3UR5	CRYSTAL STRUCTURE OF PTE MUTANT K185R/I274N	3.1.8.1
3UR6	1.5A RESOLUTION STRUCTURE OF APO NORWALK VIRUS PROTEASE	3.4.22.66 3.6.1.15 2.7.7.48
3UR7	HIGHER-DENSITY CRYSTAL STRUCTURE OF POTATO ENDO-1,3-BETA-GLUCANASE	3.2.1.39
3UR8	LOWER-DENSITY CRYSTAL STRUCTURE OF POTATO ENDO-1,3-BETA-GLUCANASE	3.2.1.39
3UR9	1.65A RESOLUTION STRUCTURE OF NORWALK VIRUS PROTEASE CONTAINING A COVALENTLY BOUND DIPEPTIDYL INHIBITOR	3.4.22.66 3.6.1.15 2.7.7.48
3URA	CRYSTAL STRUCTURE OF PTE MUTANT H254G/H257W/L303T/K185R/I274N/A80V/S61T	3.1.8.1
3URB	CRYSTAL STRUCTURE OF PTE MUTANT H254G/H257W/L303T/M317L/I106C/F132I/L271I/K185R/I274N/A80V/R67H	3.1.8.1
3URC	T181G MUTANT OF ALPHA-LYTIC PROTEASE	3.4.21.12
3URD	T181A MUTANT OF ALPHA-LYTIC PROTEASE	3.4.21.12
3URE	REPACK MUTANT (T181I, W199L, Q210I) OF ALPHA-LYTIC PROTEASE	3.4.21.12
3URI	ENDOTHIAPEPSIN-DB5 COMPLEX.	3.4.23.22
3URJ	TYPE IV NATIVE ENDOTHIAPEPSIN	3.4.23.22
3URN	CRYSTAL STRUCTURE OF PTE MUTANT H254G/H257W/L303T/K185R/I274N/A80V/S61T WITH CYCLOHEXYL METHYLPHOSPHONATE INHIBITOR	3.1.8.1
3URP	RE-REFINEMENT OF PDB ENTRY 5RNT - RIBONUCLEASE T1 WITH GUANOSINE-3',5'-DIPHOSPHATE AND PHOSPHATE ION BOUND	3.1.27.3 4.6.1.24
3URQ	CRYSTAL STRUCTURE OF PTE MUTANT H254G/H257W/L303T/M317L/I106C/F132I/L271I/K185R/I274N/A80V/R67H WITH CYCLOHEXYL METHYLPHOSPHONATE INHIBITOR	3.1.8.1
3USD	CRYSTAL STRUCTURE OF C-LOBE OF BOVINE LACTOFERRIN COMPLEXED WITH IMIDAZOL (1,2 A) PYRIDINE3-YL-ACITIC ACID AT 2.4 A RESOLUTION	3.4.21
3USN	STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN FIBROBLAST STROMELYSIN-1 INHIBITED WITH THE THIADIAZOLE INHIBITOR IPNU-107859, NMR, 1 STRUCTURE	3.4.24.17
3USV	STRUCTURE OF THE PRECURSOR OF A THERMOSTABLE VARIANT OF PAPAIN AT 3.8 A RESOLUTION FROM A CRYSTAL SOAKED AT PH 4	3.4.22.2
3USZ	CRYSTAL STRUCTURE OF TRUNCATED EXO-1,3/1,4-BETA-GLUCANASE (EXOP) FROM PSEUDOALTEROMONAS SP. BB1	3.2.1
3UTL	HUMAN PEPSIN 3B	3.4.23.1
3UTU	HIGH AFFINITY INHIBITOR OF HUMAN THROMBIN	3.4.21.5
3UUO	THE DISCOVERY OF POTENT, SELECTIVITY, AND ORALLY BIOAVAILABLE PYROZOLOQUINOLINES AS PDE10 INHIBITORS FOR THE TREATMENT OF SCHIZOPHRENIA	3.1.4.17 3.1.4.35
3UUZ	BOVINE TRYPSIN VARIANT X(TRIPLEPHE227) IN COMPLEX WITH SMALL MOLECULE INHIBITOR	3.4.21.4
3UVC	MMP12 IN A COMPLEX WITH THE DIMERIC ADDUCT: 5-(5-PHENYLHYDANTOIN)-5-PHENYLHYDANTOIN	3.4.24.65
3UVD	CRYSTAL STRUCTURE OF THE BROMODOMAIN OF HUMAN TRANSCRIPTION ACTIVATOR BRG1 (SMARCA4) IN COMPLEX WITH N-METHYL-2-PYRROLIDONE	3.6.4
3UW0	PECTIN METHYLESTERASE FROM YERSINIA ENTEROCOLITICA	3.1.1.11
3UWI	BOVINE TRYPSIN VARIANT X(TRIPLEGLU217PHE227) IN COMPLEX WITH SMALL MOLECULE INHIBITOR	3.4.21.4
3UWJ	HUMAN THROMBIN IN COMPLEX WITH MI353	3.4.21.5
3UXU	THE STRUCTURE OF THE CATALYTIC DOMAIN OF THE SULFOLOBUS SPINDLE-SHAPED VIRAL INTEGRASE REVEALS AN EVOLUTIONARILY CONSERVED CATALYTIC CORE AND SUPPORTS A MECHANISM OF DNA CLEAVAGE IN TRANS	2.7.7 3.1
3UYJ	CRYSTAL STRUCTURE OF JMJD5 CATALYTIC CORE DOMAIN IN COMPLEX WITH NICKLE AND ALPHA-KG	1.14.11.27 1.14.11 3.4
3UZV	CRYSTAL STRUCTURE OF THE DENGUE VIRUS SEROTYPE 2 ENVELOPE PROTEIN DOMAIN III IN COMPLEX WITH THE VARIABLE DOMAINS OF MAB 4E11	3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48
3V0A	2.7 ANGSTROM CRYSTAL STRUCTURE OF BONT/AI IN COMPLEX WITH NTNHA	3.4.24.69
3V0B	3.9 ANGSTROM CRYSTAL STRUCTURE OF BONT/AI IN COMPLEX WITH NTNHA	3.4.24.69
3V0C	4.3 ANGSTROM CRYSTAL STRUCTURE OF AN INACTIVE BONT/A (E224Q/R363A/Y366F)	3.4.24.69
3V0X	BOVINE TRYPSIN VARIANT X(TRIPLEGLU217PHE227) IN COMPLEX WITH SMALL MOLECULE INHIBITOR	3.4.21.4
3V11	STRUCTURE OF THE TERNARY INITIATION COMPLEX AIF2:GDPNP:METHIONYLATED INITIATOR TRNA	3.6.5.3
3V12	BOVINE TRYPSIN VARIANT X(TRIPLEGLU217PHE227) IN COMPLEX WITH SMALL MOLECULE INHIBITOR	3.4.21.4
3V13	BOVINE TRYPSIN VARIANT X(TRIPLEGLU217PHE227) IN COMPLEX WITH SMALL MOLECULE INHIBITOR	3.4.21.4
3V14	CRYSTAL STRUCTURE OF THE COMPLEX OF TYPE I RIBOSOME INACTIVATING PROTEIN COMPLEXED WITH TREHALOSE AT 1.70 A RESOLUTION	3.2.2.22
3V1K	CRYSTAL STRUCTURE OF THE H265Q MUTANT OF A C-C HYDROLASE, BPHD FROM BURKHOLDERIA XENOVORANS LB400.	3.7.1.8
3V1L	CRYSTAL STRUCTURE OF THE S112A/H265Q MUTANT OF A C-C HYDROLASE, BPHD FROM BURKHOLDERIA XENOVORANS LB400	3.7.1.8
3V1M	CRYSTAL STRUCTURE OF THE S112A/H265Q MUTANT OF A C-C HYDROLASE, BPHD FROM BURKHOLDERIA XENOVORANS LB400, AFTER EXPOSURE TO ITS SUBSTRATE HOPDA	3.7.1.8
3V1N	CRYSTAL STRUCTURE OF THE H265Q MUTANT OF A C-C HYDROLASE, BPHD FROM BURKHOLDERIA XENOVORANS LB400, AFTER EXPOSURE TO ITS SUBSTRATE HOPDA	3.7.1.8
3V1O	CRYSTAL STRUCTURES OF THE REVERSE TRANSCRIPTASE-ASSOCIATED RIBONUCLEASE H DOMAIN OF XENOTROPIC MURINE LEUKEMIA-VIRUS RELATED VIRUS	3.1.26.4 3.4.23 2.7.7.49 2.7.7.7 2.7.7 3.1
3V1Q	CRYSTAL STRUCTURES OF THE REVERSE TRANSCRIPTASE-ASSOCIATED RIBONUCLEASE H DOMAIN OF XENOTROPIC MURINE LEUKEMIA-VIRUS RELATED VIRUS	3.1.26.4 3.4.23 2.7.7.49 2.7.7.7 2.7.7 3.1
3V1R	CRYSTAL STRUCTURES OF THE REVERSE TRANSCRIPTASE-ASSOCIATED RIBONUCLEASE H DOMAIN OF XMRV WITH INHIBITOR BETA-THUJAPLICINOL	3.1.26.4 3.4.23 2.7.7.49 2.7.7.7 2.7.7 3.1
3V1Z	CRYSTAL STRUCTURE OF TYPE IIF RESTRICTION ENDONUCLEASE BSE634I WITH COGNATE DNA	3.1.21.4
3V20	CRYSTAL STRUCTURE OF TYPE IIF RESTRICTION ENDONUCLEASE BSE634I WITH COGNATE DNA	3.1.21.4
3V21	CRYSTAL STRUCTURE OF TYPE IIF RESTRICTION ENDONUCLEASE BSE634I WITH COGNATE DNA	3.1.21.4
3V2I	STRUCTURE OF A PEPTIDYL-TRNA HYDROLASE (PTH) FROM BURKHOLDERIA THAILANDENSIS	3.1.1.29
3V2K	CRYSTAL STRUCTURE OF RIBOSOME INACTIVATING PROTEIN FROM MOMORDICA BALSAMINA COMPLEXED WITH THE PRODUCT OF RNA SUBSTRATE ADENOSINE TRIPHOSPHATE AT 2.0 A RESOLUTION	3.2.2.22
3V2T	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS I92A/V66A AT CRYOGENIC TEMPERATURE	3.1.31.1
3V2W	CRYSTAL STRUCTURE OF A LIPID G PROTEIN-COUPLED RECEPTOR AT 3.35A	3.2.1.17
3V2Y	CRYSTAL STRUCTURE OF A LIPID G PROTEIN-COUPLED RECEPTOR AT 2.80A	3.2.1.17
3V32	CRYSTAL STRUCTURE OF MCPIP1 N-TERMINAL CONSERVED DOMAIN	3.1
3V33	CRYSTAL STRUCTURE OF MCPIP1 CONSERVED DOMAIN WITH ZINC-FINGER MOTIF	3.1
3V34	CRYSTAL STRUCTURE OF MCPIP1 CONSERVED DOMAIN WITH MAGNESIUM ION IN THE CATALYTIC CENTER	3.1
3V38	CARBOXYPEPTIDASE T MUTANT L254N	3.4.17.18
3V39	BD3459, A PREDATORY PEPTIDOGLYCAN ENDOPEPTIDASE FROM BDELLOVIBRIO BACTERIOVORUS	3.4.16.4
3V3M	SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS (SARS-COV) 3CL PROTEASE IN COMPLEX WITH N-[(1R)-2-(TERT-BUTYLAMINO)-2-OXO-1-(PYRIDIN-3-YL)ETHYL]-N-(4-TERT-BUTYLPHENYL)FURAN-2-CARBOXAMIDE INHIBITOR.	3.4.19.12 3.4.22.69 3.4.22
3V3R	CRYSTAL STRUCTURE OF GES-11	3.5.2.6
3V3S	CRYSTAL STRUCTURE OF GES-18	3.5.2.6
3V3T	CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM PHAGE C-ST TUBZ	3.6.5
3V48	CRYSTAL STRUCTURE OF THE PUTATIVE ALPHA/BETA HYDROLASE RUTD FROM E.COLI	3.5.1
3V4F	H-RAS PEG 400/CACL2, ORDERED OFF	3.6.5.2
3V4I	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) WITH DNA AND AZTTP	2.7.7.49 2.7.7.7 3.4.23.16 3.1.26.13 3.1.13.2 2.7.7 3.1
3V4J	FIRST-IN-CLASS SMALL MOLECULE INHIBITORS OF THE SINGLE-STRAND DNA CYTOSINE DEAMINASE APOBEC3G	3.5.4
3V4K	FIRST-IN-CLASS SMALL MOLECULE INHIBITORS OF THE SINGLE-STRAND DNA CYTOSINE DEAMINASE APOBEC3G	3.5.4
3V4L	MOUSE MALT1(CASPASE-IG3 DOMAINS) IN COMPLEX WITH A IRREVERSIBLE PEPTIDIC INHIBITOR	3.4.22
3V4O	HUMAN MALT1 (CASPASE DOMAIN) IN COMPLEX WITH AN IRREVERSIBLE PEPTIDIC INHIBITOR	3.4.22
3V4Y	CRYSTAL STRUCTURE OF THE FIRST NUCLEAR PP1 HOLOENZYME	3.1.3.16
3V50	COMPLEX OF SHV S130G MUTANT BETA-LACTAMASE COMPLEXED TO SA2-13	3.5.2.6
3V55	HUMAN MALT1 (334-719) IN ITS LIGAND FREE FORM	3.4.22
3V5A	CRYSTAL STRUCTURE OF C-LOBE OF BOVINE LACTOFERRIN COMPLEXED WITH GAMMA AMINO BUTYRIC ACID AT 1.44 A RESOLUTION	3.4.21
3V5M	CRYSTAL STRUCTURE OF M69V MUTANT OF SHV BETA-LACTAMASE	3.5.2.6
3V6C	CRYSTAL STRUCTURE OF USP2 IN COMPLEX WITH MUTATED UBIQUITIN	3.4.19.12
3V6D	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) CROSS-LINKED WITH AZT-TERMINATED DNA	2.7.7.49 2.7.7.7 3.4.23.16 3.1.26.13 3.1.13.2 2.7.7 3.1
3V6E	CRYSTAL STRUCTURE OF USP2 AND A MUTANT FORM OF UBIQUITIN	3.4.19.12
3V6L	CRYSTAL STRUCTURE OF CASPASE-6 INACTIVATION MUTATION	3.4.22.59
3V6M	INHIBITION OF CASPASE-6 ACTIVITY BY SINGLE MUTATION OUTSIDE THE ACTIVE SITE	3.4.22.59
3V7P	CRYSTAL STRUCTURE OF AMIDOHYDROLASE NIS_0429 (TARGET EFI-500396) FROM NITRATIRUPTOR SP. SB155-2	3.5.4.40
3V7T	CRYSTAL STRUCTURE OF HUMAN BETA-TRYPTASE COMPLEXED WITH A SYNTHETIC INHIBITOR WITH A TROPANYLAMIDE SCAFFOLD	3.4.21.59
3V7Z	CARBOXYPEPTIDASE T WITH GEMSA	3.4.17.18
3V81	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) WITH DNA AND THE NONNUCLEOSIDE INHIBITOR NEVIRAPINE	2.7.7.49 2.7.7.7 3.4.23.16 3.1.26.13 3.1.13.2 2.7.7 3.1
3V85	1.9 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE PROTEIN Q9SIY3 FROM ARABIDOPSIS THALIANA	3.6.1 3.6.1.25
3V8E	CRYSTAL STRUCTURE OF THE YEAST NICOTINAMIDASE PNC1P BOUND TO THE INHIBITOR NICOTINALDEHYDE	3.5.1.19
3V93	UNLIGANDED STRUCTURE OF TCRPDEC1 CATALYTIC DOMAIN	3.1.4.17 3.1.4
3V9B	CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF PDE4D2 WITH (S)-N-(3-{1-[1-(3-CYCLOPROPYLMETHOXY-4-DIFLUOROMETHOXYPHENYL)-2-(1-OXYPYRIDIN-4-YL)-ETHYL]-1H-PYRAZL-3-YL}PHENYL)ACETAMIDE	3.1.4.17 3.1.4.53
3V9M	PHOSPHOLIPASE ACII4 FROM AUSTRALIAN KING BROWN SNAKE	3.1.1.4
3V9S	CRYSTAL STRUCTURE OF RNASE T IN COMPLEX WITH A PRODUCT SSDNA (AAC) WITH ONE MG IN THE ACTIVE SITE	3.1.13
3V9U	CRYSTAL STRUCTURE OF RNASE T IN COMPLEX WITH A PREFERRED SSDNA (AAT) WITH TWO MG IN THE ACTIVE SITE	3.1.13
3V9W	CRYSTAL STRUCTURE OF RNASE T IN COMPLEX WITH A PREFERRED SSDNA (TTA) WITH TWO MG IN THE ACTIVE SITE	3.1.13
3V9X	CRYSTAL STRUCTURE OF RNASE T IN COMPLEX WITH A PREFERRED SSDNA (AAA) WITH TWO MG IN THE ACTIVE SITE	3.1.13
3V9Z	CRYSTAL STRUCTURE OF RNASE T IN COMPLEX WITH A PRODUCT SSDNA (ACC) WITH ONE MG IN THE ACTIVE SITE	3.1.13
3VA0	CRYSTAL STRUCTURE OF RNASE T IN COMPLEX WITH A DI-NUCLEOTIDE PRODUCT (GG) WITH ONE MG IN THE ACTIVE SITE	3.1.13
3VA3	CRYSTAL STRUCTURE OF RNASE T IN COMPLEX WITH A DUPLEX DNA PRODUCT (STEM LOOP DNA WITH 2 NUCLEOTIDE 3' OVERHANG)	3.1.13
3VA5	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS I92A/V23A AT CRYOGENIC TEMPERATURE	3.1.31.1
3VAR	CRYSTAL STRUCTURE OF DNPEP, ZNZN FORM	3.4.11.21
3VAT	CRYSTAL STRUCTURE OF DNPEP, ZNMG FORM	3.4.11.21
3VB3	CRYSTAL STRUCTURE OF SARS-COV 3C-LIKE PROTEASE IN APO FORM	3.4.22 3.4.19.12 3.4.22.69
3VB4	CRYSTAL STRUCTURE OF SARS-COV 3C-LIKE PROTEASE WITH B4Z	3.4.22 3.4.19.12 3.4.22.69
3VB5	CRYSTAL STRUCTURE OF SARS-COV 3C-LIKE PROTEASE WITH C4Z	3.4.22 3.4.19.12 3.4.22.69
3VB6	CRYSTAL STRUCTURE OF SARS-COV 3C-LIKE PROTEASE WITH C6Z	3.4.22 3.4.19.12 3.4.22.69
3VB7	CRYSTAL STRUCTURE OF SARS-COV 3C-LIKE PROTEASE WITH M4Z	3.4.22 3.4.19.12 3.4.22.69
3VBF	CRYSTAL STRUCTURE OF FORMALDEHYDE TREATED HUMAN ENTEROVIRUS 71 (SPACE GROUP I23)	3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48
3VBH	CRYSTAL STRUCTURE OF FORMALDEHYDE TREATED HUMAN ENTEROVIRUS 71 (SPACE GROUP R32)	3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48
3VBO	CRYSTAL STRUCTURE OF FORMALDEHYDE TREATED EMPTY HUMAN ENTEROVIRUS 71 PARTICLE (CRYO AT 100K)	3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48
3VBR	CRYSTAL STRUCTURE OF FORMALDEHYDE TREATED EMPTY HUMAN ENTEROVIRUS 71 PARTICLE (ROOM TEMPERATURE)	3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48
3VBS	CRYSTAL STRUCTURE OF HUMAN ENTEROVIRUS 71	3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48
3VBU	CRYSTAL STRUCTURE OF EMPTY HUMAN ENTEROVIRUS 71 PARTICLE	3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48
3VBZ	CRYSTAL STRUCTURE OF TAIPOXIN BETA SUBUNIT ISOFORM 2	3.1.1.4
3VC0	CRYSTAL STRUCTURE OF TAIPOXIN BETA SUBUNIT ISOFORM 1	3.1.1.4
3VC8	CRYSTAL STRUCTURE OF THE C-TERMINAL CYTOPLASMIC DOMAIN OF NON-STRUCTURAL PROTEIN 4 FROM MOUSE HEPATITIS VIRUS A59	3.4.19.12 3.4.22.69 3.4.22 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1
3VCB	C425S MUTANT OF THE C-TERMINAL CYTOPLASMIC DOMAIN OF NON-STRUCTURAL PROTEIN 4 FROM MOUSE HEPATITIS VIRUS A59	3.4.19.12 3.4.22.69 3.4.22 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1
3VCF	SSV1 INTEGRASE C-TERMINAL CATALYTIC DOMAIN (174-335AA)	2.7.7 3.1
3VCM	CRYSTAL STRUCTURE OF HUMAN PRORENIN	3.4.23.15
3VD3	E. COLI (LACZ) BETA-GALACTOSIDASE (N460D)	3.2.1.23
3VD4	E. COLI (LACZ) BETA-GALACTOSIDASE (N460D) IN COMPLEX WITH IPTG	3.2.1.23
3VD9	E. COLI (LACZ) BETA-GALACTOSIDASE (N460S) IN COMPLEX WITH IPTG	3.2.1.23
3VDA	E. COLI (LACZ) BETA-GALACTOSIDASE (N460T)	3.2.1.23
3VDB	E. COLI (LACZ) BETA-GALACTOSIDASE (N460T) IN COMPLEX WITH GALACTONOLACTONE	3.2.1.23
3VDF	CRYSTAL STRUCTURE OF C-LOBE OF BOVINE LACTOFERRIN COMPLEXED WITH DIAMINOPIMELIC ACID AT 1.46 A RESOLUTION	3.4.21
3VEM	STRUCTURAL BASIS OF TRANSCRIPTIONAL GENE SILENCING MEDIATED BY ARABIDOPSIS MOM1	3.6.4
3VEU	CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE IN COMPLEX WITH NVP-AVI326	3.4.23.46
3VF3	CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE IN COMPLEX WITH NVP-BQQ711	3.4.23.46
3VF5	CRYSTAL STRUCTURE OF HIV-1 PROTEASE MUTANT I47V WITH NOVEL P1'-LIGANDS GRL-02031	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
3VF7	CRYSTAL STRUCTURE OF HIV-1 PROTEASE MUTANT L76V WITH NOVEL P1'-LIGANDS GRL-02031	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
3VFA	CRYSTAL STRUCTURE OF HIV-1 PROTEASE MUTANT V82A WITH NOVEL P1'-LIGANDS GRL-02031	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
3VFB	CRYSTAL STRUCTURE OF HIV-1 PROTEASE MUTANT N88D WITH NOVEL P1'-LIGANDS GRL-02031	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
3VFD	HUMAN SPASTIN AAA DOMAIN	3.6.4.3 5.6.1.1
3VFE	VIRTUAL SCREENING AND X-RAY CRYSTALLOGRAPHY FOR HUMAN KALLIKREIN 6 INHIBITORS WITH AN AMIDINOTHIOPHENE P1 GROUP	3.4.21
3VFF	BLAC E166A CDC-OME ACYL-INTERMEDIATE COMPLEX	3.5.2.6
3VFH	BLAC E166A CDC-1 ACYL-INTERMEDIATE	3.5.2.6
3VG1	CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE IN COMPLEX WITH NVP-BUR436, DERIVED FROM A SOAKING EXPERIMENT	3.4.23.46
3VGB	CRYSTAL STRUCTURE OF GLYCOSYLTREHALOSE TREHALOHYDROLASE (GTHASE) FROM SULFOLOBUS SOLFATARICUS KM1	3.2.1.141
3VGC	GAMMA-CHYMOTRYPSIN L-NAPHTHYL-1-ACETAMIDO BORONIC ACID ACID INHIBITOR COMPLEX	3.4.21.1
3VGD	CTYSTAL STRUCTURE OF GLYCOSYLTREHALOSE TREHALOHYDROLASE (D252E)	3.2.1.141
3VGE	CRYSTAL STRUCTURE OF GLYCOSYLTREHALOSE TREHALOHYDROLASE (D252S)	3.2.1.141
3VGF	CRYSTAL STRUCTURE OF GLYCOSYLTREHALOSE TREHALOHYDROLASE (D252S) COMPLEXED WITH MALTOTRIOSYLTREHALOSE	3.2.1.141
3VGG	CRYSTAL STRUCTURE OF GLYCOSYLTREHALOSE TREHALOHYDROLASE (E283Q) COMPLEXED WITH MALTOHEPTAOSE	3.2.1.141
3VGH	CRYSTAL STRUCTURE OF GLYCOSYLTREHALOSE TREHALOHYDROLASE (E283Q) COMPLEXED WITH MALTOTRIOSYLTREHALOSE	3.2.1.141
3VH9	CRYSTAL STRUCTURE OF AEROMONAS PROTEOLYTICA AMINOPEPTIDASE COMPLEXED WITH 8-QUINOLINOL	3.4.11.10
3VHN	Y61G MUTANT OF CELLULASE 12A FROM THERMOTOGA MARITIMA	3.2.1.4
3VHO	Y61-GG INSERTION MUTANT OF TM-CELLULASE 12A	3.2.1.4
3VHP	THE INSERTION MUTANT Y61GG OF TM CEL12A	3.2.1.4
3VHQ	CRYSTAL STRUCTURE OF THE CA6 SITE MUTANT OF PRO-SA-SUBTILISIN	3.4.21.62 3.4.21
3VHS	CRYSTAL STRUCTURE OF UBZ OF HUMAN WRNIP1	3.6.1
3VI1	CRYSTAL STRUCTURE OF PSEUDOMONAS AERGINOSA ALKALINE PROTEASE COMPLEXED WITH SUBSTANCE P(1-6)	3.4.24 3.4.24.40
3VIF	CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE FROM TERMITE NEOTERMES KOSHUNENSIS IN COMPLEX WITH GLUCONOLACTONE	3.2.1.21
3VIG	CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE FROM TERMITE NEOTERMES KOSHUNENSIS IN COMPLEX WITH 1-DEOXYNOJIRIMYCIN	3.2.1.21
3VIH	CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE FROM TERMITE NEOTERMES KOSHUNENSIS IN COMPLEX WITH GLYCEROL	3.2.1.21
3VII	CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE FROM TERMITE NEOTERMES KOSHUNENSIS IN COMPLEX WITH BIS-TRIS	3.2.1.21
3VIJ	CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE FROM TERMITE NEOTERMES KOSHUNENSIS IN COMPLEX WITH GLUCOSE	3.2.1.21
3VIK	CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE FROM TERMITE NEOTERMES KOSHUNENSIS IN COMPLEX WITH CELLOBIOSE	3.2.1.21
3VIL	CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE FROM TERMITE NEOTERMES KOSHUNENSIS IN COMPLEX WITH SALICIN	3.2.1.21
3VIM	CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE FROM TERMITE NEOTERMES KOSHUNENSIS IN COMPLEX WITH A NEW GLUCOPYRANOSIDIC PRODUCT	3.2.1.21
3VIN	CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE FROM TERMITE NEOTERMES KOSHUNENSIS IN COMPLEX WITH A NEW GLUCOPYRANOSIDIC PRODUCT	3.2.1.21
3VIO	CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE FROM TERMITE NEOTERMES KOSHUNENSIS IN COMPLEX WITH A NEW GLUCOPYRANOSIDIC PRODUCT	3.2.1.21
3VIP	CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE FROM TERMITE NEOTERMES KOSHUNENSIS IN COMPLEX WITH A NEW GLUCOPYRANOSIDIC PRODUCT	3.2.1.21
3VIV	1510-N MEMBRANE-BOUND STOMATIN-SPECIFIC PROTEASE K138A MUTANT IN COMPLEX WITH A SUBSTRATE PEPTIDE	3.4.21
3VJ7	CRYSTAL STRUCTURE OF THE CARBOXY-TERMINAL RIBONUCLEASE DOMAIN OF COLICIN E5 R33Q MUTANT	3.1
3VJK	CRYSTAL STRUCTURE OF HUMAN DEPIPTIDYL PEPTIDASE IV (DPP-4) IN COMPLEX WITH MP-513	3.4.14.5
3VJL	CRYSTAL STRUCTURE OF HUMAN DEPIPTIDYL PEPTIDASE IV (DPP-4) IN COMPLEX WITH A PROLYLTHIAZOLIDINE INHIBITOR #2	3.4.14.5
3VJM	CRYSTAL STRUCTURE OF HUMAN DEPIPTIDYL PEPTIDASE IV (DPP-4) IN COMPLEX WITH A PROLYLTHIAZOLIDINE INHIBITOR #1	3.4.14.5
3VJR	CRYSTAL STRUCTURE OF PEPTIDYL-TRNA HYDROLASE FROM ESCHERICHIA COLI IN COMPLEX WITH THE CCA-ACCEPTOR-T[PSI]C DOMAIN OF TRNA	3.1.1.29
3VK7	CRYSTAL STRUCTURE OF DNA-GLYCOSYLASE BOUND TO DNA CONTAINING 5-HYDROXYURACIL	3.2.2.23 4.2.99.18
3VK8	CRYSTAL STRUCTURE OF DNA-GLYCOSYLASE BOUND TO DNA CONTAINING THYMINE GLYCOL	3.2.2.23 4.2.99.18
3VKK	CRYSTAL STRUCTURE OF THE COVALENT INTERMEDIATE OF HUMAN CYTOSOLIC BETA-GLUCOSIDASE-MANNOSE COMPLEX	3.2.1.21
3VKW	CRYSTAL STRUCTURE OF THE SUPERFAMILY 1 HELICASE FROM TOMATO MOSAIC VIRUS	2.1.1 2.7.7 3.6.4.13 2.7.7.48
3VL8	CRYSTAL STRUCTURE OF XEG	3.2.1.151
3VL9	CRYSTAL STRUCTURE OF XEG-XYLOGLUCAN	3.2.1.151
3VLC	CRYSTAL STRUCTURE OF S. CEREVISIAE GET3 IN THE SEMI OPEN CONFORMATION IN COMPLEX WITH GET1 CYTOSOLIC DOMAIN AT 4.5 ANGSTROM RESOLUTION	3.6
3VM5	RECOMBINANT MEDAKA FISH ALPHA-AMYLASE EXPRESSED IN YEAST PICHIA PASTORIS	3.2.1.1
3VM7	STRUCTURE OF AN ALPHA-AMYLASE FROM MALBRANCHEA CINNAMOMEA	3.2.1.1
3VM8	CRYSTAL STRUCTURE OF THE HUMAN APOBEC3C HAVING HIV-1 VIF-BINDING INTERFACE	3.5.4 3.5.4.38
3VMA	CRYSTAL STRUCTURE OF THE FULL-LENGTH TRANSGLYCOSYLASE PBP1B FROM ESCHERICHIA COLI	2.4.1.129 3.4 3.4.16.4
3VMN	CRYSTAL STRUCTURE OF DEXTRANASE FROM STREPTOCOCCUS MUTANS	3.2.1.11
3VMO	CRYSTAL STRUCTURE OF DEXTRANASE FROM STREPTOCOCCUS MUTANS IN COMPLEX WITH ISOMALTOTRIOSE	3.2.1.11
3VMP	CRYSTAL STRUCTURE OF DEXTRANASE FROM STREPTOCOCCUS MUTANS IN COMPLEX WITH 4,5-EPOXYPENTYL ALPHA-D-GLUCOPYRANOSIDE	3.2.1.11
3VN4	CRYSTAL STRUCTURE OF THE EXOSITE-CONTAINING FRAGMENT OF HUMAN ADAMTS13 (P475S MUTANT)	3.4.24.87
3VN5	CRYSTAL STRUCTURE OF AQUIFEX AEOLICUS RNASE H3	3.1.26.4
3VNY	CRYSTAL STRUCTURE OF BETA-GLUCURONIDASE FROM ACIDOBACTERIUM CAPSULATUM	3.2.1.31
3VNZ	CRYSTAL STRUCTURE OF BETA-GLUCURONIDASE FROM ACIDOBACTERIUM CAPSULATUM IN COMPLEX WITH D-GLUCURONIC ACID	3.2.1.31
3VO0	CRYSTAL STRUCTURE OF BETA-GLUCURONIDASE FROM ACIDOBACTERIUM CAPSULATUM COVALENT-BONDED WITH 2-DEOXY-2-FLUORO-D-GLUCURONIC ACID	3.2.1.31
3VOC	CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF BETA-AMYLASE FROM PAENIBACILLUS POLYMYXA	3.2.1.2 3.2.1.1
3VOF	CELLOBIOHYDROLASE MUTANT, CCCEL6C D102A, IN THE CLOSED FORM	3.2.1.91 3.2.1
3VOG	CATALYTIC DOMAIN OF THE CELLOBIOHYDROLASE, CCCEL6A, FROM COPRINOPSIS CINEREA	3.2.1.91 3.2.1
3VOH	CCCEL6A CATALYTIC DOMAIN COMPLEXED WITH CELLOBIOSE	3.2.1.91 3.2.1
3VOI	CCCEL6A CATALYTIC DOMAIN COMPLEXED WITH P-NITROPHENYL BETA-D-CELLOTRIOSIDE	3.2.1.91 3.2.1
3VOJ	CCCEL6A CATALYTIC DOMAIN MUTANT D164A	3.2.1.91 3.2.1
3VOW	CRYSTAL STRUCTURE OF THE HUMAN APOBEC3C HAVING HIV-1 VIF-BINDING INTERFACE	3.5.4 3.5.4.38
3VOY	CRYSTAL STRUCTURE OF HUMAN GLUTAMINASE IN APO FORM	3.5.1.2
3VOZ	CRYSTAL STRUCTURE OF HUMAN GLUTAMINASE IN COMPLEX WITH BPTES	3.5.1.2
3VP0	CRYSTAL STRUCTURE OF HUMAN GLUTAMINASE IN COMPLEX WITH L-GLUTAMINE	3.5.1.2
3VP1	CRYSTAL STRUCTURE OF HUMAN GLUTAMINASE IN COMPLEX WITH L-GLUTAMATE AND BPTES	3.5.1.2
3VP2	CRYSTAL STRUCTURE OF HUMAN GLUTAMINASE IN COMPLEX WITH INHIBITOR 2	3.5.1.2
3VP3	CRYSTAL STRUCTURE OF HUMAN GLUTAMINASE IN COMPLEX WITH INHIBITOR 3	3.5.1.2
3VP4	CRYSTAL STRUCTURE OF HUMAN GLUTAMINASE IN COMPLEX WITH INHIBITOR 4	3.5.1.2
3VPB	ARGX FROM SULFOLOBUS TOKODAII COMPLEXED WITH LYSW/GLU/ADP/MG/ZN/SULFATE	3.5.1.16 6.3.2
3VPC	ARGX FROM SULFOLOBUS TOKODAII COMPLEXED WITH ADP	3.5.1.16 6.3.2
3VPE	CRYSTAL STRUCTURE OF METALLO-BETA-LACTAMASE SMB-1	3.5.2.6
3VPI	CRYSTAL STRUCTURE OF TYPE VI EFFECTOR TSE1 FROM PSEUDOMONAS AERUGINOSA	3.4.19.11
3VPJ	CRYSTAL STRUCTURE OF TYPE VI EFFECTOR TSE1 FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH IMMUNE PROTEIN TSI1	3.4.19.11
3VPK	CRYSTAL STRUCTURE OF 6-GUANIDINOHEXANOYL TRYPSIN	3.4.21.4
3VPL	CRYSTAL STRUCTURE OF A 2-FLUOROXYLOTRIOSYL COMPLEX OF THE VIBRIO SP. AX-4 BETA-1,3-XYLANASE	3.2.1.32
3VQ1	CRYSTAL STRUCTURE OF MOUSE TLR4/MD-2/LIPID IVA COMPLEX	3.2.2.6
3VQ2	CRYSTAL STRUCTURE OF MOUSE TLR4/MD-2/LPS COMPLEX	3.2.2.6
3VQ4	FRAGMENTS BOUND TO HIV-1 INTEGRASE	2.7.7.49 3.1.13.2 3.1.26.13
3VQ5	HIV-1 IN CORE DOMAIN IN COMPLEX WITH N-METHYL-1-(4-METHYL-2-PHENYL-1,3-THIAZOL-5-YL)METHANAMINE	2.7.7.49 3.1.13.2 3.1.26.13
3VQ6	HIV-1 IN CORE DOMAIN IN COMPLEX WITH (1-METHYL-5-PHENYL-1H-PYRAZOL-4-YL)METHANOL	2.7.7.49 3.1.13.2 3.1.26.13
3VQ7	HIV-1 IN CORE DOMAIN IN COMPLEX WITH 4-(1H-PYRROL-1-YL)ANILINE	2.7.7.49 3.1.13.2 3.1.26.13
3VQ8	HIV-1 IN CORE DOMAIN IN COMPLEX WITH (3R)-3,4-DIHYDRO-2H-CHROMEN-3-YLMETHANOL	2.7.7.49 3.1.13.2 3.1.26.13
3VQ9	HIV-1 IN CORE DOMAIN IN COMPLEX WITH 6-FLUORO-1,3-BENZOTHIAZOL-2-AMINE	2.7.7.49 3.1.13.2 3.1.26.13
3VQA	HIV-1 IN CORE DOMAIN IN COMPLEX WITH 1-BENZOTHIOPHEN-6-AMINE 1,1-DIOXIDE	2.7.7.49 3.1.13.2 3.1.26.13
3VQB	HIV-1 IN CORE DOMAIN IN COMPLEX WITH 6-FLUORO-4H-1,3-BENZODIOXINE-8-CARBOXYLIC ACID	2.7.7.49 3.1.13.2 3.1.26.13
3VQC	HIV-1 IN CORE DOMAIN IN COMPLEX WITH (5-METHYL-3-PHENYL-1,2-OXAZOL-4-YL)METHANOL	2.7.7.49 3.1.13.2 3.1.26.13
3VQD	HIV-1 IN CORE DOMAIN IN COMPLEX WITH 5-METHYL-3-PHENYL-1,2-OXAZOLE-4-CARBOXYLIC ACID	2.7.7.49 3.1.13.2 3.1.26.13
3VQE	HIV-1 IN CORE DOMAIN IN COMPLEX WITH [1-(4-FLUOROPHENYL)-5-METHYL-1H-PYRAZOL-4-YL]METHANOL	2.7.7.49 3.1.13.2 3.1.26.13
3VQJ	CRYSTAL STRUCTUTRE OF THIOBACILLUS THIOPARUS THI115 CARBONYL SULFIDE HYDROLASE	3.13.1.7
3VQP	HIV-1 IN CORE DOMAIN IN COMPLEX WITH 2,3-DIHYDRO-1,4-BENZODIOXIN-5-YLMETHANOL	2.7.7.49 3.1.13.2 3.1.26.13
3VQQ	HIV-1 INTEGRASE CORE DOMAIN IN COMPLEX WITH 2,1,3-BENZOTHIADIAZOL-4-AMINE	2.7.7.49 3.1.13.2 3.1.26.13
3VQS	CRYSTAL STRUCTURE OF HCV NS5B RNA POLYMERASE WITH A NOVEL PIPERAZINE INHIBITOR	3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48
3VQZ	CRYSTAL STRUCTURE OF METALLO-BETA-LACTAMASE, SMB-1, IN A COMPLEX WITH MERCAPTOACETIC ACID	3.5.2.6
3VR3	CRYSTAL STRUCTURE OF AMP-PNP BOUND A3B3 COMPLEX FROM ENTEROCOCCUS HIRAE V-ATPASE [BA3B3]	3.6.3.15 7.2.2.1
3VR5	CRYSTAL STRUCTURE OF NUCLEOTIDE-FREE ENTEROCOCCUS HIRAE V1-ATPASE [EV1(L)]	3.6.3.15 7.2.2.1
3VRK	CRYSTAL STRUCTUTRE OF THIOBACILLUS THIOPARUS THI115 CARBONYL SULFIDE HYDROLASE / THIOCYANATE COMPLEX	3.13.1.7
3VSB	SUBTILISIN CARLSBERG D-NAPHTHYL-1-ACETAMIDO BORONIC ACID INHIBITOR COMPLEX	3.4.21.62
3VSR	MICROBACTERIUM SACCHAROPHILUM K-1 BETA-FRUCTOFURANOSIDASE CATALYTIC DOMAIN	3.2.1.26
3VSS	MICROBACTERIUM SACCHAROPHILUM K-1 BETA-FRUCTOFURANOSIDASE CATALYTIC DOMAIN COMPLEXED WITH FRUCTOSE	3.2.1.26
3VSU	THE COMPLEX STRUCTURE OF XYLC WITH XYLOBIOSE	3.2.1.37
3VSW	HUMAN RENIN IN COMPLEX WITH COMPOUND 8	3.4.23.15
3VTA	CRYSTAL STRUCTURE OF CUCUMISIN, A SUBTILISIN-LIKE ENDOPROTEASE FROM CUCUMIS MELO L	3.4.21.25
3VTG	HIGH CHORIOLYTIC ENZYME 1 (HCE-1), A HATCHING ENZYME ZINC-PROTEASE FROM ORYZIAS LATIPES (MEDAKA FISH)	3.4.24.67
3VTR	CRYSTAL STRUCTURE OF INSECT BETA-N-ACETYL-D-HEXOSAMINIDASE OFHEX1 E328A COMPLEXED WITH TMG-CHITOTRIOMYCIN	3.2.1.52
3VTT	HIGH RESOLUTION CRYSTAL STRUCTURE OF DENGUE 3 ENVELOPE PROTEIN DOMAIN III (ED3)	3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48
3VUC	HUMAN RENIN IN COMPLEX WITH COMPOUND 5	3.4.23.15
3VUS	ESCHERICHIA COLI PGAB N-TERMINAL DOMAIN	3.5.1
3VV2	CRYSTAL STRUCTURE OF COMPLEX FORM BETWEEN S324A-SUBTILISIN AND MUTANT TKPRO	3.4.21
3VV6	CRYSTAL STRUCTURE OF BETA SECETASE IN COMPLEX WITH 2-AMINO-3-METHYL-6-((1S, 2R)-2-PHENYLCYCLOPROPYL)PYRIMIDIN-4(3H)-ONE	3.4.23.46
3VV7	CRYSTAL STRUCTURE OF BETA SECETASE IN COMPLEX WITH 2-AMINO-6-((1S,2R)-2-(3'-METHOXYBIPHENYL-3-YL)CYCLOPROPYL)-3-METHYLPYRIMIDIN-4(3H)-ONE	3.4.23.46
3VV8	CRYSTAL STRUCTURE OF BETA SECETASE IN COMPLEX WITH 2-AMINO-3-METHYL-6-((1S,2R)-2-(3'-METHYLBIPHENYL-4-YL)CYCLOPROPYL)PYRIMIDIN-4(3H)-ONE	3.4.23.46
3VW7	CRYSTAL STRUCTURE OF HUMAN PROTEASE-ACTIVATED RECEPTOR 1 (PAR1) BOUND WITH ANTAGONIST VORAPAXAR AT 2.2 ANGSTROM	3.2.1.17
3VWL	CRYSTAL STRUCTURE OF 6-AMINOHEXANOATE-DIMER HYDROLASE G181D/R187S/H266N/D370Y MUTANT	3.5.1.46
3VWM	CRYSTAL STRUCTURE OF 6-AMINOHEXANOATE-DIMER HYDROLASE G181D/R187A/H266N/D370Y MUTANT	3.5.1.46
3VWN	CRYSTAL STRUCTURE OF 6-AMINOHEXANOATE-DIMER HYDROLASE G181D/R187G/H266N/D370Y MUTANT	3.5.1.46
3VWP	CRYSTAL STRUCTURE OF 6-AMINOHEXANOATE-DIMER HYDROLASE S112A/G181D/R187S/H266N/D370Y MUTANT COMPLEXD WITH 6-AMINOHEXANOATE	3.5.1.46
3VWQ	6-AMINOHEXANOATE-DIMER HYDROLASE S112A/G181D/R187A/H266N/D370Y MUTANT COMPLEXD WITH 6-AMINOHEXANOATE	3.5.1.46
3VWR	CRYSTAL STRUCTURE OF 6-AMINOHEXANOATE-DIMER HYDROLASE S112A/G181D/R187G/H266N/D370Y MUTANT COMPLEXD WITH 6-AMINOHEXANOATE	3.5.1.46
3VWS	DENGUE SEROTYPE 3 RNA-DEPENDENT RNA POLYMERASE BOUND TO NITD-107	2.7.7.48 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57
3VX0	CRYSTAL STRUCTURE OF ALPHA-AMYLASE FROM ASPERGILLUS ORYZAE	3.2.1.1
3VX1	CRYSTAL STRUCTURE OF ALPHA-AMYLASE FROM ASPERGILLUS ORYZAE	3.2.1.1
3VXD	CRYSTAL STRUCTURE OF UNSATURATED GLUCURONYL HYDROLASE MUTANT D115N FROM STREPTCOCCUS AGALACTIAE	3.2.1 3.2.1.180
3VXE	HUMAN ALPHA-THROMBIN-BIVALIRUDIN COMPLEX AT PD5.0	3.4.21.5
3VXF	X/N JOINT REFINEMENT OF HUMAN ALPHA-THROMBIN-BIVALIRUDIN COMPLEX PD5	3.4.21.5
3VXK	CRYSTAL STRUCTURE OF OSD14	3.1
3VXV	CRYSTAL STRUCTURE OF METHYL CPG BINDING DOMAIN OF MBD4 IN COMPLEX WITH THE 5MCG/TG SEQUENCE	3.2.2
3VXX	CRYSTAL STRUCTURE OF METHYL CPG BINDING DOMAIN OF MBD4 IN COMPLEX WITH THE 5MCG/5MCG SEQUENCE	3.2.2
3VYB	CRYSTAL STRUCTURE OF METHYL CPG BINDING DOMAIN OF MBD4 IN COMPLEX WITH THE 5MCG/HMCG SEQUENCE	3.2.2
3VYD	HUMAN RENIN IN COMPLEX WITH INHIBITOR 6	3.4.23.15
3VYE	HUMAN RENIN IN COMPLEX WITH INHIBITOR 7	3.4.23.15
3VYF	HUMAN RENIN IN COMPLEX WITH INHIBITOR 9	3.4.23.15
3VYG	CRYSTAL STRUCTURE OF THIOCYANATE HYDROLASE MUTANT R136W	3.5.5.8
3VYQ	CRYSTAL STRUCTURE OF THE METHYL CPG BINDING DOMAIN OF MBD4 IN COMPLEX WITH THE 5MCG/TG SEQUENCE IN SPACE GROUP P1	3.2.2
3VYV	CRYSTAL STRUCTURE OF SUBTILISIN NAT AT 1.36	3.4.21.62
3VYX	STRUCTURAL INSIGHTS INTO RISC ASSEMBLY FACILITATED BY DSRNA BINDING DOMAINS OF HUMAN RNA HELICASE (DHX9)	3.6.4.13
3VYY	STRUCTURAL INSIGHTS INTO RISC ASSEMBLY FACILITATED BY DSRNA BINDING DOMAINS OF HUMAN RNA HELICASE A (DHX9)	3.6.4.13
3VZJ	CRYSTAL STRUCTURE OF THE BACILLUS CIRCULANS ENDO-BETA-(1,4)-XYLANASE (BCX) E172H MUTANT	3.2.1.8
3VZK	CRYSTAL STRUCTURE OF THE BACILLUS CIRCULANS ENDO-BETA-(1,4)-XYLANASE (BCX) N35E MUTANT	3.2.1.8
3VZL	CRYSTAL STRUCTURE OF THE BACILLUS CIRCULANS ENDO-BETA-(1,4)-XYLANASE (BCX) N35H MUTANT	3.2.1.8
3VZM	CRYSTAL STRUCTURE OF THE BACILLUS CIRCULANS ENDO-BETA-(1,4)-XYLANASE (BCX) E172H MUTANT WITH GLU78 COVALENTLY BONDED TO 2-DEOXY-2-FLUORO-XYLOBIOSE	3.2.1.8
3VZN	CRYSTAL STRUCTURE OF THE BACILLUS CIRCULANS ENDO-BETA-(1,4)-XYLANASE (BCX) N35E MUTANT WITH GLU78 COVALENTLY BONDED TO 2-DEOXY-2-FLUORO-XYLOBIOSE	3.2.1.8
3VZO	CRYSTAL STRUCTURE OF THE BACILLUS CIRCULANS ENDO-BETA-(1,4)-XYLANASE (BCX) N35H MUTANT WITH GLU78 COVALENTLY BONDED TO 2-DEOXY-2-FLUORO-XYLOBIOSE	3.2.1.8
3W04	CRYSTAL STRUCTURE OF ORYZA SATIVA DWARF14 (D14)	3.1
3W05	CRYSTAL STRUCTURE OF ORYZA SATIVA DWARF14 (D14) IN COMPLEX WITH PMSF	3.1
3W09	INFLUENZA VIRUS NEURAMINIDASE SUBTYPE N9 (TERN) COMPLEXED WITH 2,3-DIF GUANIDINO-NEU5AC2EN INHIBITOR	3.2.1.18
3W0F	CRYSTAL STRUCTURE OF MOUSE ENDONUCLEASE VIII-LIKE 3 (MNEIL3)	3.2.2 4.2.99.18
3W24	THE HIGH-RESOLUTION CRYSTAL STRUCTURE OF TSXYLA, INTRACELLULAR XYLANASE FROM THERMOANAEROBACTERIUM SACCHAROLYTICUM JW/SL-YS485	3.2.1.8
3W25	THE HIGH-RESOLUTION CRYSTAL STRUCTURE OF TSXYLA, INTRACELLULAR XYLANASE FROM /THERMOANAEROBACTERIUM SACCHAROLYTICUM JW/SL-YS485/: THE COMPLEX OF THE E146A MUTANT WITH XYLOBIOSE	3.2.1.8
3W26	THE HIGH-RESOLUTION CRYSTAL STRUCTURE OF TSXYLA, INTRACELLULAR XYLANASE FROM /THERMOANAEROBACTERIUM SACCHAROLYTICUM JW/SL-YS485/: THE COMPLEX OF THE E146A MUTANT WITH XYLOTRIOSE	3.2.1.8
3W27	THE HIGH-RESOLUTION CRYSTAL STRUCTURE OF TSXYLA, INTRACELLULAR XYLANASE FROM /THERMOANAEROBACTERIUM SACCHAROLYTICUM JW/SL-YS485/: THE COMPLEX OF THE E251A MUTANT WITH XYLOBIOSE	3.2.1.8
3W28	THE HIGH-RESOLUTION CRYSTAL STRUCTURE OF TSXYLA, INTRACELLULAR XYLANASE FROM /THERMOANAEROBACTERIUM SACCHAROLYTICUM JW/SL-YS485/: THE COMPLEX OF THE E251A MUTANT WITH XYLOTRIOSE	3.2.1.8
3W29	THE HIGH-RESOLUTION CRYSTAL STRUCTURE OF TSXYLA, INTRACELLULAR XYLANASE FROM /THERMOANAEROBACTERIUM SACCHAROLYTICUM JW/SL-YS485/: THE COMPLEX OF THE E251A MUTANT WITH XYLOTETRAOSE	3.2.1.8
3W2T	CRYSTAL STRUCTURE OF HUMAN DEPIPTIDYL PEPTIDASE IV (DPP-4) IN COMPLEX WITH VILDAGLIPTIN	3.4.14.5
3W2X	CRYSTAL STRUCTURE OF DNA URIDINE ENDONUCLEASE MTH212	3.1.11.2 4.2.99.18
3W2Y	CRYSTAL STRUCTURE OF DNA URIDINE ENDONUCLEASE MTH212 MUTANT W205S	3.1.11.2 4.2.99.18
3W37	SUGAR BEET ALPHA-GLUCOSIDASE WITH ACARBOSE	3.2.1.20
3W38	SUGAR BEET ALPHA-GLUCOSIDASE	3.2.1.20
3W40	CRYSTAL STRUCTURE OF RSBX IN COMPLEX WITH MAGNESIUM IN SPACE GROUP P1	3.1.3.3
3W41	CRYSTAL STRUCTURE OF RSBX IN COMPLEX WITH MAGNESIUM IN SPACE GROUP P21	3.1.3.3
3W42	CRYSTAL STRUCTURE OF RSBX IN COMPLEX WITH MANGANESE IN SPACE GROUP P1	3.1.3.3
3W43	CRYSTAL STRUCTURE OF RSBX IN COMPLEX WITH MANGANESE IN SPACE GROUP P21	3.1.3.3
3W44	CRYSTAL STRUCTURE OF RSBX, SELENOMETHIONINE DERIVATIVE	3.1.3.3
3W45	CRYSTAL STRUCTURE OF RSBX IN COMPLEX WITH COBALT IN SPACE GROUP P1	3.1.3.3
3W4O	CRYSTAL STRUCTURE OF PENI BETA-LACTAMASE FROM BURKHOLDERIA PSEUDOMALLEI AT PH9.5	3.5.2.6
3W4P	CRYSTAL STRUCTURE OF PENI BETA-LACTAMASE FROM BURKHOLDERIA PSEUDOMALLEI AT PH7.5	3.5.2.6
3W4Q	CRYSTAL STRUCTURE OF PENA BETA-LACTAMASE FROM BURKHOLDERIA MULTIVORANS AT PH4.2	3.5.2.6
3W4R	CRYSTAL STRUCTURE OF AN INSECT CHITINASE FROM THE ASIAN CORN BORER, OSTRINIA FURNACALIS	3.2.1.14
3W52	ZINC-DEPENDENT BIFUNCTIONAL NUCLEASE	3.1.30.1
3W53	CRYSTAL STRUCTURE OF PSYCHROPHILIC BETA-GLUCOSIDASE BGLU FROM MICROCOCCUS ANTARCTICUS	3.2.1.21
3W5E	CRYSTAL STRUCTURE OF PHOSPHODIESTERASE 4B IN COMPLEX WITH COMPOUND 31E	3.1.4.17 3.1.4.53
3W5F	CRYSTAL STRUCTURE OF TOMATO BETA-GALACTOSIDASE 4	3.2.1.23
3W5G	CRYSTAL STRUCTURE OF TOMATO BETA-GALACTOSIDASE 4 IN COMPLEX WITH GALACTOSE	3.2.1.23
3W5M	CRYSTAL STRUCTURE OF STREPTOMYCES AVERMITILIS ALPHA-L-RHAMNOSIDASE	3.2.1.40
3W5N	CRYSTAL STRUCTURE OF STREPTOMYCES AVERMITILIS ALPHA-L-RHAMNOSIDASE COMPLEXED WITH L-RHAMNOSE	3.2.1.40
3W6A	CRYSTAL STRUCTURE OF CROSS-LINKED TETRAGONAL HEN EGG WHITE LYSOZYME SOAKED WIHT 5MM [RU(BENZENE)CL2]2	3.2.1.17
3W6B	CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF CHITINASE FROM RALSTONIA SP. A-471	3.2.1.14
3W6C	CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF CHITINASE FROM RALSTONIA SP. A-471 IN COMPLEX WITH DISACCHARIDE	3.2.1.14
3W6D	CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF CHITINASE FROM RALSTONIA SP. A-471 (E141Q) IN COMPLEX WITH TETRASACCHARIDE	3.2.1.14
3W6E	CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF CHITINASE FROM RALSTONIA SP. A-471 (E162Q)	3.2.1.14
3W6F	CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF CHITINASE FROM RALSTONIA SP. A-471 (E162Q) IN COMPLEX WITH DISACCHARIDE	3.2.1.14
3W6L	CONTRIBUTION OF DISULFIDE BOND TOWARD THERMOSTABILITY IN HYPERTHERMOSTABLE ENDOCELLULASE	3.2.1.4
3W6M	CONTRIBUTION OF DISULFIDE BOND TOWARD THERMOSTABILITY IN HYPERTHERMOSTABLE ENDOCELLULASE	3.2.1.4
3W6N	CRYSTAL STRUCTURE OF HUMAN DLP1 IN COMPLEX WITH GMP-PN.PI	3.6.5.5
3W6O	CRYSTAL STRUCTURE OF HUMAN DLP1 IN COMPLEX WITH GMP-PCP	3.6.5.5
3W6P	CRYSTAL STRUCTURE OF HUMAN DLP1 IN COMPLEX WITH GDP.ALF4	3.6.5.5
3W7B	CRYSTAL STRUCTURE OF FORMYLTETRAHYDROFOLATE DEFORMYLASE FROM THERMUS THERMOPHILUS HB8	3.5.1.10
3W7S	ESCHERICHIA COLI K12 YGJK COMPLEXED WITH GLUCOSE	3.2.1
3W7T	ESCHERICHIA COLI K12 YGJK COMPLEXED WITH MANNOSE	3.2.1
3W7U	ESCHERICHIA COLI K12 YGJK COMPLEXED WITH GALACTOSE	3.2.1
3W7V	CRYSTAL STRUCTURE OF AXE2, AN ACETYLXYLAN ESTERASE FROM GEOBACILLUS STEAROTHERMOPHILUS	3.1.1.72
3W7W	CRYSTAL STRUCTURE OF E. COLI YGJK E727A COMPLEXED WITH 2-O-ALPHA-D-GLUCOPYRANOSYL-ALPHA-D-GALACTOPYRANOSE	3.2.1
3W7X	CRYSTAL STRUCTURE OF E. COLI YGJK D324N COMPLEXED WITH MELIBIOSE	3.2.1
3W81	HUMAN ALPHA-L-IDURONIDASE	3.2.1.76
3W82	HUMAN ALPHA-L-IDURONIDASE IN COMPLEX WITH IDURONIC ACID	3.2.1.76
3W8K	CRYSTAL STRUCTURE OF CLASS C BETA-LACTAMASE MOX-1	3.5.2.6
3W95	CRYSTAL STRUCTURE OF 2A PROTEINASE (C110A) FROM ENTEROVIRUS 71	3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48
3W9B	CRYSTAL STRUCTURE OF CANDIDA ANTARCTICA LIPASE B WITH ANION-TAG	3.1.1.3
3W9U	CRYSTAL STRUCTURE OF LIPK107	3.1.1.3
3WA5	CRYSTAL STRUCTURE OF TYPE VI PEPTIDOGLYCAN MURAMIDASE EFFECTOR TSE3 IN COMPLEX WITH ITS COGNATE IMMUNITY PROTEIN TSI3	3.2.1.17
3WA6	CRYSTAL STRUCTURE OF TANNASE FROM LACTOBACILLUS PLANTARUM IN THE ORTHORHOMBIC CRYSTAL	3.1.1.20
3WA7	CRYSTAL STRUCTURE OF SELENOMETHIONINE-LABELED TANNASE FROM LACTOBACILLUS PLANTARUM IN THE ORTHORHOMBIC CRYSTAL	3.1.1.20
3WAB	CARBOXYPEPTIDASE B IN COMPLEX WITH DD2	3.4.17.2
3WAV	CRYSTAL STRUCTURE OF AUTOTAXIN IN COMPLEX WITH COMPOUND 10	3.1.4.39
3WAW	CRYSTAL STRUCTURE OF AUTOTAXIN IN COMPLEX WITH 2BOA	3.1.4.39
3WAX	CRYSTAL STRUCTURE OF AUTOTAXIN IN COMPLEX WITH 3BOA	3.1.4.39
3WAY	CRYSTAL STRUCTURE OF AUTOTAXIN IN COMPLEX WITH 4BOA	3.1.4.39
3WB4	CRYSTAL STRUCTURE OF BETA SECETASE IN COMPLEX WITH 2-AMINO-3,6-DIMETHYL-6-(2-PHENYLETHYL)-3,4,5,6-TETRAHYDROPYRIMIDIN-4-ONE	3.4.23.46
3WB5	CRYSTAL STRUCTURE OF BETA SECETASE IN COMPLEX WITH (6S)-2-AMINO-3,6-DIMETHYL-6-[(1R,2R)-2-PHENYLCYCLOPROPYL]-3,4,5,6-TETRAHYDROPYRIMIDIN-4-ONE	3.4.23.46
3WBA	RICE OS3BGLU6 E178Q WITH COVALENT GLUCOSYL MOIETY FROM P-NITROPHENYL GLUCOPYRANOSIDE.	3.2.1.21
3WBE	RICE OS3BGLU6 BETA-GLUCOSIDASE E178Q MUTANT IN A COVALENT COMPLEX WITH GLC FROM GA4GE.	3.2.1.21
3WBH	STRUCTURAL CHARACTERISTICS OF ALKALINE PHOSPHATASE FROM A MODERATELY HALOPHILIC BACTERIA HALOMONAS SP.593	3.1.3.1
3WBI	CRYSTAL STRUCTURE ANALYSIS OF EUKARYOTIC TRANSLATION INITIATION FACTOR 5B STRUCTURE I	3.6.5.3
3WBJ	CRYSTAL STRUCTURE ANALYSIS OF EUKARYOTIC TRANSLATION INITIATION FACTOR 5B STRUCTURE II	3.6.5.3
3WBK	CRYSTAL STRUCTURE ANALYSIS OF EUKARYOTIC TRANSLATION INITIATION FACTOR 5B AND 1A COMPLEX	3.6.5.3
3WC3	CRYSTAL STRUCTURE OF ENDO-1,4-BETA-GLUCANASE FROM EISENIA FETIDA	3.2.1.4
3WC5	CARBOXYPEPTIDASE B IN COMPLEX WITH DD9	3.4.17.2
3WC6	CARBOXYPEPTIDASE B IN COMPLEX WITH 2ND ZINC	3.4.17.2
3WC7	CARBOXYPEPTIDASE B IN COMPLEX WITH EF6265	3.4.17.2
3WD0	SERRATIA MARCESCENS CHITINASE B, TETRAGONAL FORM	3.2.1.14
3WD1	SERRATIA MARCESCENS CHITINASE B COMPLEXED WITH SYN-TRIAZOLE INHIBITOR	3.2.1.14
3WD2	SERRATIA MARCESCENS CHITINASE B COMPLEXED WITH AZIDE INHIBITOR	3.2.1.14
3WD3	SERRATIA MARCESCENS CHITINASE B COMPLEXED WITH AZIDE INHIBITOR	3.2.1.14
3WD4	SERRATIA MARCESCENS CHITINASE B COMPLEXED WITH AZIDE INHIBITOR AND QUINOLINE COMPOUND	3.2.1.14
3WD9	CRYSTAL STRUCTURE OF PHOSPHODIESTERASE 4B IN COMPLEX WITH COMPOUND 10F	3.1.4.17 3.1.4.53
3WDF	STAPHYLOCOCCUS AUREUS UDG	3.2.2.27
3WDG	STAPHYLOCOCCUS AUREUS UDG / UGI COMPLEX	3.2.2.27
3WDH	CRYSTAL STRUCTURE OF PULLULANASE FROM ANOXYBACILLUS SP. LM18-11	3.2.1.41
3WDI	CRYSTAL STRUCTURE OF PULLULANASE COMPLEXED WITH MALTOTRIOSE FROM ANOXYBACILLUS SP. LM18-11	3.2.1.41
3WDJ	CRYSTAL STRUCTURE OF PULLULANASE COMPLEXED WITH MALTOTETRAOSE FROM ANOXYBACILLUS SP. LM18-11	3.2.1.41
3WDP	STRUCTURAL ANALYSIS OF A BETA-GLUCOSIDASE MUTANT DERIVED FROM A HYPERTHERMOPHILIC TETRAMERIC STRUCTURE	3.2.1.21
3WDQ	CRYSTAL STRUCTURE OF BETA-MANNANASE FROM A SYMBIOTIC PROTIST OF THE TERMITE RETICULITERMES SPERATUS	3.2.1.78
3WDR	CRYSTAL STRUCTURE OF BETA-MANNANASE FROM A SYMBIOTIC PROTIST OF THE TERMITE RETICULITERMES SPERATUS COMPLEXED WITH GLUCO-MANNO-OLIGOSACCHARIDE	3.2.1.78
3WDT	THE APO-FORM STRUCTURE OF PTLIC16A FROM PAECILOMYCES THERMOPHILA	3.2.1.73
3WDU	THE COMPLEX STRUCTURE OF PTLIC16A WITH CELLOBIOSE	3.2.1.73
3WDV	THE COMPLEX STRUCTURE OF PTLIC16A WITH CELLOTETRAOSE	3.2.1.73
3WDW	THE APO-FORM STRUCTURE OF E113A FROM PAECILOMYCES THERMOPHILA	3.2.1.73
3WDX	THE COMPLEX STRUCTURE OF E113A WITH GLUCOTRIOSE	3.2.1.73
3WDY	THE COMPLEX STRUCTURE OF E113A WITH CELLOTETRAOSE	3.2.1.73
3WE1	CRYSTAL STRUCTURE OF DENGUE 4 ENVELOPE PROTEIN DOMAIN III (ED3)	3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48
3WE2	STRUCTURE OF BLM RQC DOMAIN BOUND TO A PHOSPHATE ION	3.6.4.12
3WE3	STRUCTURE OF BLM RQC DOMAIN BOUND TO AN ARSENATE ION	3.6.4.12
3WEL	SUGAR BEET ALPHA-GLUCOSIDASE WITH ACARVIOSYL-MALTOTRIOSE	3.2.1.20
3WEM	SUGAR BEET ALPHA-GLUCOSIDASE WITH ACARVIOSYL-MALTOTETRAOSE	3.2.1.20
3WEN	SUGAR BEET ALPHA-GLUCOSIDASE WITH ACARVIOSYL-MALTOPENTAOSE	3.2.1.20
3WEO	SUGAR BEET ALPHA-GLUCOSIDASE WITH ACARVIOSYL-MALTOHEXAOSE	3.2.1.20
3WEZ	CRYSTAL STRUCTURE OF HUMAN BETA-GALACTOSIDASE IN COMPLEX WITH NOEV	3.2.1.23
3WF0	CRYSTAL STRUCTURE OF HUMAN BETA-GALACTOSIDASE IN COMPLEX WITH 6S-NBI-DGJ	3.2.1.23
3WF1	CRYSTAL STRUCTURE OF HUMAN BETA-GALACTOSIDASE IN COMPLEX WITH 6S-NBI-GJ	3.2.1.23
3WF2	CRYSTAL STRUCTURE OF HUMAN BETA-GALACTOSIDASE IN COMPLEX WITH NBT-DGJ	3.2.1.23
3WF3	CRYSTAL STRUCTURE OF HUMAN BETA-GALACTOSIDASE MUTANT I51T IN COMPLEX WITH GALACTOSE	3.2.1.23
3WF4	CRYSTAL STRUCTURE OF HUMAN BETA-GALACTOSIDASE MUTANT I51T IN COMPLEX WITH 6S-NBI-DGJ	3.2.1.23
3WFA	CATALYTIC ROLE OF THE CALCIUM ION IN GH97 INVERTING GLYCOSIDE HYDROLASE	3.2.1.3
3WFL	CRTSTAL STRUCTURE OF GLYCOSIDE HYDROLASE FAMILY 5 BETA-MANNANASE FROM TALAROMYCES TRACHYSPERMUS	3.2.1.78
3WG1	CRYSTAL STRUCTURE OF AGROCYBE CYLINDRACEA GALECTIN WITH LACTOSE	3.1.21
3WG2	CRYSTAL STRUCTURE OF AGROCYBE CYLINDRACEA GALECTIN MUTANT (N46A)	3.1.21
3WG3	CRYSTAL STRUCTURE OF AGROCYBE CYLINDRACEA GALECTIN WITH BLOOD TYPE A ANTIGEN TETRAOSE	3.1.21
3WG4	CRYSTAL STRUCTURE OF AGROCYBE CYLINDRACEA GALECTIN MUTANT (N46A) WITH BLOOD TYPE A ANTIGEN TETRAOSE	3.1.21
3WG5	1510-N MEMBRANE-BOUND STOMATIN-SPECIFIC PROTEASE K138A MUTANT IN COMPLEX WITH A SUBSTRATE PEPTIDE UNDER HEAT TREATMENT	3.4.21
3WGU	CRYSTAL STRUCTURE OF A NA+-BOUND NA+,K+-ATPASE PRECEDING THE E1P STATE WITHOUT OLIGOMYCIN	3.6.3.9 7.2.2.13
3WH1	CRYSTAL STRUCTURE OF A FAMILY GH19 CHITINASE FROM BRYUM CORONATUM IN COMPLEX WITH (GLCNAC)4 AT 1.0 A RESOLUTION	3.2.1.14
3WH5	CRYSTAL STRUCTURE OF GH1 BETA-GLUCOSIDASE TD2F2	3.2.1.21
3WH6	CRYSTAL STRUCTURE OF GH1 BETA-GLUCOSIDASE TD2F2 GLUCOSE COMPLEX	3.2.1.21
3WH7	CRYSTAL STRUCTURE OF GH1 BETA-GLUCOSIDASE TD2F2 L-FUCOSE COMPLEX	3.2.1.21
3WH8	CRYSTAL STRUCTURE OF GH1 BETA-GLUCOSIDASE TD2F2 ISOFAGOMINE COMPLEX	3.2.1.21
3WH9	THE LIGAND-FREE STRUCTURE OF MANBK FROM ASPERGILLUS NIGER BK01	3.2.1.78
3WHI	CRYSTAL STRUCTURE OF UNAUTOPROCESSED FORM OF IS1-INSERTED PRO-SUBTILISIN E	3.4.21.62
3WHO	X-RAY-CRYSTALLOGRAPHIC STRUCTURE OF AN RNASE PO1 EXHIBITING ANTI-TUMOR ACTIVITY	3.1.27.3 4.6.1.24
3WHQ	CRYSTAL STRUCTURE OF GAMMA-GLUTAMYLTRANSPEPTIDASE FROM BACILLUS SUBTILIS (CRYSTAL SOAKED FOR 0 MIN. IN ACIVICIN SOLN. )	2.3.2.2 3.4.19.13
3WHR	CRYSTAL STRUCTURE OF GAMMA-GLUTAMYLTRANSPEPTIDASE FROM BACILLUS SUBTILIS (CRYSTAL SOAKED FOR 3MIN. IN ACIVICIN SOLN. )	2.3.2.2 3.4.19.13
3WHS	CRYSTAL STRUCTURE OF BACILLUS SUBTILIS GAMMA-GLUTAMYLTRANSPEPTIDASE IN COMPLEX WITH ACIVICIN	2.3.2.2 3.4.19.13
3WHW	MTH1 IN COMPLEX WITH RUTHENIUM-BASED INHIBITOR	3.6.1.55 3.6.1.56
3WI2	CRYSTAL STRUCTURE OF PDE10A IN COMPLEX WITH INHIBITOR	3.1.4.17 3.1.4.35
3WI7	CRYSTAL STRUCTURE OF THE NOVEL HALOALKANE DEHALOGENASE DATA FROM AGROBACTERIUM TUMEFACIENS C58	3.8.1.5
3WIB	CRYSTAL STRUCTURE OF Y109W MUTANT HALOALKANE DEHALOGENASE DATA FROM AGROBACTERIUM TUMEFACIENS C58	3.8.1.5
3WIJ	CRYSTAL STRUCTURE OF A PLANT CLASS V CHITINASE MUTANT FROM CYCAS REVOLUTA IN COMPLEX WITH (GLCNAC)3	3.2.1.14
3WIO	CRYSTAL STRUCTURE OF OSD14 IN COMPLEX WITH HYDROXY D-RING	3.1
3WIU	CRYSTAL STRUCTURE OF PRO-S324A/L349A	3.4.21
3WIV	CRYSTAL STRUCTURE OF PRO-S324A/D356A	3.4.21
3WJ1	CRYSTAL STRUCTURE OF SSHESTI	3.1.1.1
3WJ2	CRYSTAL STRUCTURE OF ESTFA (FE-LACKING APO FORM)	3.1.1.1
3WJ8	CRYSTAL STRUCTURE OF DL-2-HALOACID DEHALOGENASE MUTANT WITH 2-BROMO-2-METHYLPROPIONATE	3.8.1.10
3WK4	CRYSTAL STRUCTURE OF SOLUBLE EPOXIDE HYDROLASE IN COMPLEX WITH FRAGMENT INHIBITOR	3.3.2.10 3.1.3.76
3WK5	CRYSTAL STRUCTURE OF SOLUBLE EPOXIDE HYDROLASE IN COMPLEX WITH FRAGMENT INHIBITOR	3.3.2.10 3.1.3.76
3WK6	CRYSTAL STRUCTURE OF SOLUBLE EPOXIDE HYDROLASE IN COMPLEX WITH FRAGMENT INHIBITOR	3.3.2.10 3.1.3.76
3WK7	CRYSTAL STRUCTURE OF SOLUBLE EPOXIDE HYDROLASE IN COMPLEX WITH FRAGMENT INHIBITOR	3.3.2.10 3.1.3.76
3WK8	CRYSTAL STRUCTURE OF SOLUBLE EPOXIDE HYDROLASE IN COMPLEX WITH FRAGMENT INHIBITOR	3.3.2.10 3.1.3.76
3WK9	CRYSTAL STRUCTURE OF SOLUBLE EPOXIDE HYDROLASE IN COMPLEX WITH FRAGMENT INHIBITOR	3.3.2.10 3.1.3.76
3WKA	CRYSTAL STRUCTURE OF SOLUBLE EPOXIDE HYDROLASE IN COMPLEX WITH FRAGMENT INHIBITOR	3.3.2.10 3.1.3.76
3WKB	CRYSTAL STRUCTURE OF SOLUBLE EPOXIDE HYDROLASE IN COMPLEX WITH FRAGMENT INHIBITOR	3.3.2.10 3.1.3.76
3WKC	CRYSTAL STRUCTURE OF SOLUBLE EPOXIDE HYDROLASE IN COMPLEX WITH FRAGMENT INHIBITOR	3.3.2.10 3.1.3.76
3WKD	CRYSTAL STRUCTURE OF SOLUBLE EPOXIDE HYDROLASE IN COMPLEX WITH FRAGMENT INHIBITOR	3.3.2.10 3.1.3.76
3WKE	CRYSTAL STRUCTURE OF SOLUBLE EPOXIDE HYDROLASE IN COMPLEX WITH T-AUCB	3.3.2.10 3.1.3.76
3WKL	THE PERIPLASMIC PDZ TANDEM FRAGMENT OF THE RSEP HOMOLOGUE FROM AQUIFEX AEOLICUS	3.4.24
3WKM	THE PERIPLASMIC PDZ TANDEM FRAGMENT OF THE RSEP HOMOLOGUE FROM AQUIFEX AEOLICUS IN COMPLEX WITH THE FAB FRAGMENT	3.4.24
3WKW	CRYSTAL STRUCTURE OF GH127 BETA-L-ARABINOFURANOSIDASE HYPBA1 FROM BIFIDOBACTERIUM LONGUM LIGAND FREE FORM	3.2.1.185
3WKX	CRYSTAL STRUCTURE OF GH127 BETA-L-ARABINOFURANOSIDASE HYPBA1 FROM BIFIDOBACTERIUM LONGUM ARABINOSE COMPLEX FORM	3.2.1.185
3WKZ	CRYSTAL STRUCTURE OF THE OSTRINIA FURNACALIS GROUP I CHITINASE CATALYTIC DOMAIN E148Q MUTANT	3.2.1.14
3WL0	CRYSTAL STRUCTURE OF OSTRINIA FURNACALIS GROUP I CHITINASE CATALYTIC DOMAIN E148A MUTANT IN COMPLEX WITH A(GLCNAC)2	3.2.1.14
3WL1	CRYSTAL STRUCTURE OF OSTRINIA FURNACALIS GROUP I CHITINASE CATALYTIC DOMAIN IN COMPLEX WITH REACTION PRODUCTS (GLCNAC)2,3	3.2.1.14
3WL2	MONOCLINIC LYSOZYME AT 0.96 A RESOLUTION	3.2.1.17
3WL5	CRYSTAL STRUCTURE OF POPH S172C	3.7.1.7
3WL6	CRYSTAL STRUCTURE OF POPH NATIVE	3.7.1.7
3WL7	THE COMPLEX STRUCTURE OF POPH S172C WITH LIGAND, ACA	3.7.1.7
3WL8	CRYSTAL STRUCTURE OF POPH S172A WITH OCTANOIC ACID	3.7.1.7
3WLA	CRYSTAL STRUCTURE OF SOPH NATIVE	3.7.1.7
3WLI	CRYSTAL STRUCTURE ANALYSIS OF PLANT EXOHYDROLASE	3.2.1
3WLJ	CRYSTAL STRUCTURE OF BARLEY BETA-D-GLUCAN GLUCOHYDROLASE ISOENZYME EXO1 IN COMPLEX WITH 3-DEOXY-GLUCOSE	3.2.1
3WLK	CRYSTAL STRUCTURE OF BARLEY BETA-D-GLUCAN GLUCOHYDROLASE ISOENZYME EXO1 IN COMPLEX WITH 4-DEOXY-GLUCOSE	3.2.1
3WLL	CRYSTAL STRUCTURE OF BARLEY BETA-D-GLUCAN GLUCOHYDROLASE ISOENZYME EXO1 IN COMPLEX WITH PEG400	3.2.1
3WLM	CRYSTAL STRUCTURE OF BARLEY BETA-D-GLUCAN GLUCOHYDROLASE ISOENZYME EXO1 IN COMPLEX WITH OCTYL-O-GLUCOSIDE	3.2.1
3WLN	CRYSTAL STRUCTURE OF BARLEY BETA-D-GLUCAN GLUCOHYDROLASE ISOENZYME EXO1 IN COMPLEX WITH OCTYL-S-GLUCOSIDE	3.2.1
3WLO	CRYSTAL STRUCTURE ANALYSIS OF PLANT EXOHYDROLASE	3.2.1
3WLP	CRYSTAL STRUCTURE ANALYSIS OF PLANT EXOHYDROLASE	3.2.1
3WLQ	CRYSTAL STRUCTURE ANALYSIS OF PLANT EXOHYDROLASE	3.2.1
3WLR	CRYSTAL STRUCTURE ANALYSIS OF PLANT EXOHYDROLASE	3.2.1
3WMB	CRYSTAL STRUCTURE OF INSECT BETA-N-ACETYL-D-HEXOSAMINIDASE OFHEX1 COMPLEXED WITH NAPHTHALIMIDE DERIVATIVE Q1	3.2.1.52
3WMC	CRYSTAL STRUCTURE OF INSECT BETA-N-ACETYL-D-HEXOSAMINIDASE OFHEX1 COMPLEXED WITH NAPHTHALIMIDE DERIVATIVE Q2	3.2.1.52
3WMK	CRYSTAL STRUCTURE OF HEN EGG-WHITE LYSOZYME IN PH 4.5 SODIUM ACETATEWITH 1M NACL AT 277K	3.2.1.17
3WML	STRUCTURE OF PHOSPHOTRIESTERASE MUTANT (S308L/Y309A) FROM AGROBACTERIUM RADIOBACTER	3.1.8.1
3WMT	CRYSTAL STRUCTURE OF FERULOYL ESTERASE B FROM ASPERGILLUS ORYZAE	3.1.1.73
3WMY	CRYSTAL STRUCTURE OF STREPTOMYCES COELICOLOR ALPHA-L-ARABINOFURANOSIDASE	3.2.1.55
3WMZ	CRYSTAL STRUCTURE OF STREPTOMYCES COELICOLOR ALPHA-L-ARABINOFURANOSIDASE ETHYLMERCURY DERIVATIVE	3.2.1.55
3WN0	CRYSTAL STRUCTURE OF STREPTOMYCES COELICOLOR ALPHA-L-ARABINOFURANOSIDASE IN COMPLEX WITH L-ARABINOSE	3.2.1.55
3WN1	CRYSTAL STRUCTURE OF STREPTOMYCES COELICOLOR ALPHA-L-ARABINOFURANOSIDASE IN COMPLEX WITH XYLOTRIOSE	3.2.1.55
3WN2	CRYSTAL STRUCTURE OF STREPTOMYCES COELICOLOR ALPHA-L-ARABINOFURANOSIDASE IN COMPLEX WITH XYLOHEXAOSE	3.2.1.55
3WN6	CRYSTAL STRUCTURE OF ALPHA-AMYLASE AMYI-1 FROM ORYZA SATIVA	3.2.1.1
3WNE	CYCLIC HEXAPEPTIDE PKIDNG IN COMPLEX WITH HIV-1 INTEGRASE	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
3WNF	CYCLIC HEXAPEPTIDE CKIDNC IN COMPLEX WITH HIV-1 INTEGRASE	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
3WNG	CYCLIC HEXAPEPTIDE PKIDNP IN COMPLEX WITH HIV-1 INTEGRASE	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
3WNH	CYCLIC HEXAPEPTIDE PKZDNV IN COMPLEX WITH HIV-1 INTEGRASE	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
3WO8	CRYSTAL STRUCTURE OF THE BETA-N-ACETYLGLUCOSAMINIDASE FROM THERMOTOGA MARITIMA	3.2.1.52
3WOI	CRYSTAL STRUCTURE OF THE DAP BII (S657A)	3.4.14
3WOJ	CRYSTAL STRUCTURE OF THE DAP BII	3.4.14
3WOK	CRYSTAL STRUCTURE OF THE DAP BII (SPACE)	3.4.14
3WOL	CRYSTAL STRUCTURE OF THE DAP BII DIPEPTIDE COMPLEX I	3.4.14
3WOM	CRYSTAL STRUCTURE OF THE DAP BII DIPEPTIDE COMPLEX II	3.4.14
3WON	CRYSTAL STRUCTURE OF THE DAP BII DIPEPTIDE COMPLEX III	3.4.14
3WOO	CRYSTAL STRUCTURE OF THE DAP BII HEXAPEPTIDE COMPLEX I	3.4.14
3WOP	CRYSTAL STRUCTURE OF THE DAP BII HEXAPEPTIDE COMPLEX II	3.4.14
3WOQ	CRYSTAL STRUCTURE OF THE DAP BII HEXAPEPTIDE COMPLEX III	3.4.14
3WOR	CRYSTAL STRUCTURE OF THE DAP BII OCTAPEPTIDE COMPLEX	3.4.14
3WP3	XYLANASE 11C FROM TALAROMYCES CELLULOLYTICUS (FORMERLY KNOWN AS ACREMONIUM CELLULOLYTICUS)	3.2.1.8
3WP4	THE CRYSTAL STRUCTURE OF NATIVE CDBFV FROM NEOCALLIMASTIX PATRICIARUM	3.2.1.8
3WP5	THE CRYSTAL STRUCTURE OF MUTANT CDBFV E109A FROM NEOCALLIMASTIX PATRICIARUM	3.2.1.8
3WP6	THE COMPLEX STRUCTURE OF CDBFV E109A WITH XYLOTRIOSE	3.2.1.8
3WPJ	SPATIOTEMPORAL DEVELOPMENT OF SOAKED PROTEIN CRYSTAL; NATIVE	3.2.1.17
3WPK	SPATIOTEMPORAL DEVELOPMENT OF SOAKED PROTEIN CRYSTAL; 750 SEC	3.2.1.17
3WPL	SPATIOTEMPORAL DEVELOPMENT OF SOAKED PROTEIN CRYSTAL; 2510 SEC	3.2.1.17
3WPU	FULL-LENGTH BETA-FRUCTOFURANOSIDASE FROM MICROBACTERIUM SACCHAROPHILUM K-1	3.2.1.26
3WPV	MICROBACTERIUM SACCHAROPHILUM K-1 BETA-FRUCTOFURANOSIDASE MUTANT T47S/F447V/F470Y/P500S	3.2.1.26
3WQ0	STRUCTURE OF HYPERTHERMOPHILIC FAMILY 12 ENDOCELLULASE FROM PYROCOCCUS FURIOSUS IN COMPLEX WITH GLUCO-OLIGOSACCHARIDE	3.2.1.4
3WQ1	STRUCTURE OF HYPERTHERMOPHILIC FAMILY 12 ENDOCELLULASE FROM PYROCOCCUS FURIOSUS IN COMPLEX WITH CELLO-OLIGOSACCHARIDE	3.2.1.4
3WQ4	CRYSTAL STRUCTURE OF BETA-PRIMEVEROSIDASE	3.2.1.149
3WQ5	BETA-PRIMEVEROSIDASE IN COMPLEX WITH DISACCHARIDE SUBSTRATE-ANALOG N-BETA-PRIMEVEROSYLAMIDINE, NATURAL AGLYCONE DERIVATIVE	3.2.1.149
3WQ6	BETA-PRIMEVEROSIDASE IN COMPLEX WITH DISACCHARIDE SUBSTRATE-ANALOG N-BETA-PRIMEVEROSYLAMIDINE, ARTIFICIAL AGLYCONE DERIVATIVE	3.2.1.149
3WQ7	NEW CRYSTAL FORM OF THE HYPERTHERMOPHILIC FAMILY 12 ENDO-CELLULASE FROM PYROCOCCUS FURIOSUS	3.2.1.4
3WQH	CRYSTAL STRUCTURE OF HUMAN DPP-IV IN COMPLEX WITH ANAGLIPTIN	3.4.14.5
3WQK	CRYSTAL STRUCTURE OF RV3378C WITH PO4	3.1.7.9 3.1.7.8 2.5.1
3WQL	CRYSTAL STRUCTURE OF RV3378C WITH MG2+ AND PPI	3.1.7.9 3.1.7.8 2.5.1
3WQM	CRYSTAL STRUCTURE OF RV3378C WITH INHIBITOR BPH-629	3.1.7.9 3.1.7.8 2.5.1
3WQN	CRYSTAL STRUCTURE OF RV3378C_Y51F WITH TPP	3.1.7.9 3.1.7.8 2.5.1
3WQV	CRYSTAL STRUCTURE OF OSTRINIA FURNACALIS GROUP I CHITINASE CATALYTIC DOMAIN IN COMPLEX WITH A(GLCN)5	3.2.1.14
3WQW	CRYSTAL STRUCTURE OF OSTRINIA FURNACALIS GROUP I CHITINASE CATALYTIC DOMAIN IN COMPLEX WITH A(GLCN)6	3.2.1.14
3WR0	STRUCTURE OF HYPERTHERMOPHILIC FAMILY 12 ENDOCELLULASE MUTANT FROM PYROCOCCUS FURIOSUS	3.2.1.4
3WR2	RNASE PO1 COMPLEXED WITH 3'GMP	3.1.27.3 4.6.1.24
3WRE	THE CRYSTAL STRUCTURE OF NATIVE HYPBA1 FROM BIFIDOBACTERIUM LONGUM JCM 1217	3.2.1.185
3WRF	THE CRYSTAL STRUCTURE OF NATIVE HYPBA1 FROM BIFIDOBACTERIUM LONGUM JCM 1217	3.2.1.185
3WRG	THE COMPLEX STRUCTURE OF HYPBA1 WITH L-ARABINOSE	3.2.1.185
3WRN	MINUTE VIRUS OF MICE NON-STRUCTURAL PROTEIN-1N-TERMINAL NUCLEASE DOMAIN REVEALS A UNIQUE ZN2+ COORDINATION IN THE ACTIVE SITE POCKET AND SHOWS A NOVEL MODE OF DNA RECOGNITION AT THE ORIGIN OF REPLICATION	3.1.21 3.6.4.12
3WRO	MINUTE VIRUS OF MICE NON-STRUCTURAL PROTEIN-1N-TERMINAL NUCLEASE DOMAIN REVEALS A UNIQUE ZN2+ COORDINATION IN THE ACTIVE SITE POCKET AND SHOWS A NOVEL MODE OF DNA RECOGNITION AT THE ORIGIN OF REPLICATION	3.1.21 3.6.4.12
3WRQ	MINUTE VIRUS OF MICE NON-STRUCTURAL PROTEIN-1N-TERMINAL NUCLEASE DOMAIN REVEALS A UNIQUE ZN2+ COORDINATION IN THE ACTIVE SITE POCKET AND SHOWS A NOVEL MODE OF DNA RECOGNITION AT THE ORIGIN OF REPLICATION	3.1.21 3.6.4.12
3WRR	MINUTE VIRUS OF MICE NON-STRUCTURAL PROTEIN-1N-TERMINAL NUCLEASE DOMAIN REVEALS A UNIQUE ZN2+ COORDINATION IN THE ACTIVE SITE POCKET AND SHOWS A NOVEL MODE OF DNA RECOGNITION AT THE ORIGIN OF REPLICATION	3.1.21 3.6.4.12
3WRS	MINUTE VIRUS OF MICE NON-STRUCTURAL PROTEIN-1N-TERMINAL NUCLEASE DOMAIN REVEALS A UNIQUE ZN2+ COORDINATION IN THE ACTIVE SITE POCKET AND SHOWS A NOVEL MODE OF DNA RECOGNITION AT THE ORIGIN OF REPLICATION	3.1.21 3.6.4.12
3WRT	WILD TYPE BETA-LACTAMASE DERIVED FROM CHROMOHALOBACTER SP.560	3.5.2.6
3WRZ	N288Q-N321Q MUTANT BETA-LACTAMASE DERIVED FROM CHROMOHALOBACTER SP.560 (WITHOUT SOAKING)	3.5.2.6
3WS0	N288Q-N321Q MUTANT BETA-LACTAMASE DERIVED FROM CHROMOHALOBACTER SP.560 (CONDITION-1A)	3.5.2.6
3WS1	N288Q-N321Q MUTANT BETA-LACTAMASE DERIVED FROM CHROMOHALOBACTER SP.560 (CONDITION-1B)	3.5.2.6
3WS2	N288Q-N321Q MUTANT BETA-LACTAMASE DERIVED FROM CHROMOHALOBACTER SP.560 (CONDITION-1C)	3.5.2.6
3WS4	N288Q-N321Q MUTANT BETA-LACTAMASE DERIVED FROM CHROMOHALOBACTER SP.560 (CONDITION-2A)	3.5.2.6
3WS5	N288Q-N321Q MUTANT BETA-LACTAMASE DERIVED FROM CHROMOHALOBACTER SP.560 (CONDITION-2B)	3.5.2.6
3WS8	CRYSTAL STRUCTURE OF PDE10A IN COMPLEX WITH A BENZIMIDAZOLE INHIBITOR	3.1.4.17 3.1.4.35
3WS9	CRYSTAL STRUCTURE OF PDE10A IN COMPLEX WITH A BENZIMDAZOLE INHIBITOR	3.1.4.17 3.1.4.35
3WSU	CRYSTAL STRUCTURE OF BETA-MANNANASE FROM STREPTOMYCES THERMOLILACINUS	3.2.1.4
3WT3	NEW CRYSTAL FORM OF A HYPERTHERMOPHILIC ENDOCELLULASE	3.2.1.4
3WT4	STRUCTURAL AND KINETIC BASES FOR THE METAL PREFERENCE OF THE M18 AMINOPEPTIDASE FROM PSEUDOMONAS AERUGINOSA	3.4.11
3WU3	REDUCED-FORM STRUCTURE OF E.COLI LON PROTEOLYTIC DOMAIN	3.4.21.53
3WU4	OXIDIZED-FORM STRUCTURE OF E.COLI LON PROTEOLYTIC DOMAIN	3.4.21.53
3WU6	OXIDIZED E.COLI LON PROTEOLYTIC DOMAIN	3.4.21.53
3WU7	SPATIOTEMPORAL DEVELOPMENT OF SOAKED PROTEIN CRYSTAL; DERIVATIVE 250 SEC	3.2.1.17
3WU8	SPATIOTEMPORAL DEVELOPMENT OF SOAKED PROTEIN CRYSTAL; DERIVATIVE 1080 SEC	3.2.1.17
3WU9	SPATIOTEMPORAL DEVELOPMENT OF SOAKED PROTEIN CRYSTAL; DERIVATIVE 1580 SEC	3.2.1.17
3WUA	SPATIOTEMPORAL DEVELOPMENT OF SOAKED PROTEIN CRYSTAL; DERIVATIVE 3610 SEC	3.2.1.17
3WUB	THE WILD TYPE CRYSTAL STRUCTURE OF B-1,4-XYLANASE (XYNAS9) FROM STREPTOMYCES SP. 9	3.2.1.8
3WUE	THE WILD TYPE CRYSTAL STRUCTURE OF B-1,4-XYLANASE (XYNAS9) WITH XYLOBIOSE FROM STREPTOMYCES SP. 9	3.2.1.8
3WUF	THE MUTANT CRYSTAL STRUCTURE OF B-1,4-XYLANASE (XYNAS9_V43P/G44E) FROM STREPTOMYCES SP. 9	3.2.1.8
3WUG	THE MUTANT CRYSTAL STRUCTURE OF B-1,4-XYLANASE (XYNAS9_V43P/G44E) WITH XYLOBIOSE FROM STREPTOMYCES SP. 9	3.2.1.8
3WUL	CRYSTAL STRUCTURE OF HEN EGG-WHITE LYSOZYME	3.2.1.17
3WUM	CRYSTAL STRUCTURE OF HEN EGG-WHITE LYSOZYME	3.2.1.17
3WUN	CRYSTAL STRUCTURE OF HEN EGG-WHITE LYSOZYME	3.2.1.17
3WUS	CRYSTAL STRUCTURE OF THE VIF-BINDING DOMAIN OF HUMAN APOBEC3F	3.5.4 3.5.4.38
3WUX	CRYSTAL STRUCTURE OF UNSATURATED GLUCURONYL HYDROLASE MUTANT D115N/K370S FROM STREPTOCOCCUS AGALACTIAE	3.2.1.180
3WV1	CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-13 COMPLEXED WITH 4-(2-((6-FLUORO-2-((3-METHOXYBENZYL)CARBAMOYL)-4-OXO-3,4-DIHYDROQUINAZOLIN-5-YL)OXY)ETHYL)BENZOIC ACID	3.4.24
3WV2	CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-13 COMPLEXED WITH N-(3-METHOXYBENZYL)-4-OXO-3,4-DIHYDROQUINAZOLINE-2-CARBOXAMIDE	3.4.24
3WV3	CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-13 COMPLEXED WITH N-(3-METHOXYBENZYL)-4-OXO-3,4-DIHYDROTHIENO[2,3-D]PYRIMIDINE-2-CARBOXAMIDE	3.4.24
3WVA	SEMET-LABELLED HCGF FROM METHANOCALDOCOCCUS JANNASCHII	3.1.2
3WVB	HCGF FROM METHANOCALDOCOCCUS JANNASCHII	3.1.2
3WVC	GUANYLYLPYRIDINOL (GP)-BOUND HCGF FROM METHANOCALDOCOCCUS JANNASCHII	3.1.2
3WVG	TIME-RESOLVED CRYSTAL STRUCTURE OF HINDIII WITH 0SEC SOAKING	3.1.21.4
3WVH	TIME-RESOLVED CRYSTAL STRUCTURE OF HINDIII WITH 25SEC SOAKING	3.1.21.4
3WVI	TIME-RESOLVED CRYSTAL STRUCTURE OF HINDIII WITH 40 SEC SOAKING	3.1.21.4
3WVJ	THE CRYSTAL STRUCTURE OF NATIVE GLYCOSIDIC HYDROLASE	3.2.1.73
3WVK	TIME-RESOLVED CRYSTAL STRUCTURE OF HINDIII WITH 230SEC SOAKING	3.1.21.4
3WVP	TIME-RESOLVED CRYSTAL STRUCTURE OF HINDIII WITH 60SEC SOAKING	3.1.21.4
3WVX	STRUCTURE OF D48A HEN EGG WHITE LYSOZYME	3.2.1.17
3WVY	STRUCTURE OF D48A HEN EGG WHITE LYSOZYME IN COMPLEX WITH (GLCNAC)4	3.2.1.17
3WW5	CRYSTAL STRUCTURE OF HEN EGG WHITE LYSOZYME MUTANT N46E/D52S	3.2.1.17
3WW6	CRYSTAL STRUCTURE OF HEN EGG WHITE LYSOZYME MUTANT N46D/D52S	3.2.1.17
3WWC	THE COMPLEX OF POPH_S172A OF PNPB	3.7.1.7
3WWD	THE COMPLEX OF POPH_S172C WITH DMSO	3.7.1.7
3WWE	THE COMPLEX OF POPH WITH PEG	3.7.1.7
3WWG	CRYSTAL STRUCTURE OF THE N-GLYCAN-DEFICIENT VARIANT N448A OF ISOPULLULANASE COMPLEXED WITH ISOPANOSE	3.2.1.57
3WWV	C-TERMINAL DOMAIN OF STOMATIN OPERON PARTNER PROTEIN 1510-C FROM PYROCOCCUS HORIKOSHII	3.4.21
3WX5	CRYSTAL STRUCTURE OF METAGENOME-DERIVED GLYCOSIDE HYDROLASE FAMILY 12 ENDOGLUCANASE	3.2.1.4
3WXC	CRYSTAL STRUCTURE OF IMP-1 METALLO-BETA-LACTAMASE COMPLEXED WITH A 3-AMINOPHTALIC ACID INHIBITOR	3.5.2.6
3WXP	STRUCTURE OF HYPERTHERMOPHILIC FAMILY 12 ENDOCELLULASE (E197A) FROM PYROCOCCUS FURIOSUS IN COMPLEX WITH CELLOBIOSE	3.2.1.4
3WXT	CRYSTAL STRUCTURE OF HEN EGG-WHITE LYSOZYME	3.2.1.17
3WXU	CRYSTAL STRUCTURE OF HEN EGG-WHITE LYSOZYME	3.2.1.17
3WY1	CRYSTAL STRUCTURE OF ALPHA-GLUCOSIDASE	3.2.1.20
3WY2	CRYSTAL STRUCTURE OF ALPHA-GLUCOSIDASE IN COMPLEX WITH GLUCOSE	3.2.1.20
3WY3	CRYSTAL STRUCTURE OF ALPHA-GLUCOSIDASE MUTANT D202N IN COMPLEX WITH GLUCOSE AND GLYCEROL	3.2.1.20
3WY4	CRYSTAL STRUCTURE OF ALPHA-GLUCOSIDASE MUTANT E271Q IN COMPLEX WITH MALTOSE	3.2.1.20
3WY6	STRUCTURE OF HYPERTHERMOPHILIC FAMILY 12 ENDOCELLULASE (E197A) FROM PYROCOCCUS FURIOSUS IN COMPLEX WITH LAMINARIBIOSE	3.2.1.4
3WY8	CRYSTAL STRUCTURE OF PROTEASE ANISEP FROM ARTHROBACTER NICOTINOVORANS	3.4.21.1
3WYD	C-TERMINAL ESTERASE DOMAIN OF LC-EST1	3.1.1.1
3WYH	STRUCTURE OF DISULFIDE BOND DELETION MUTANT OF OSTRICH EGG WHITE LYSOZYME	3.2.1.17
3WYK	CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF PDE10A COMPLEXED WITH 3-(1-PHENYL-1H-PYRAZOL-5-YL)-1-(3-(TRIFLUOROMETHYL)PHENYL)PYRIDAZIN-4(1H)-ONE	3.1.4.17 3.1.4.35
3WYL	CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF PDE10A COMPLEXED WITH 5-METHOXY-3-(1-PHENYL-1H-PYRAZOL-5-YL)-1-(3-(TRIFLUOROMETHYL)PHENYL)PYRIDAZIN-4(1H)-ONE	3.1.4.17 3.1.4.35
3WYM	CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF PDE10A COMPLEXED WITH 1-(2-FLUORO-4-(1H-PYRAZOL-1-YL)PHENYL)-5-METHOXY-3-(1-PHENYL-1H-PYRAZOL-5-YL)PYRIDAZIN-4(1H)-ONE	3.1.4.17 3.1.4.35
3WYZ	ON ARCHAEAL HOMOLOGS OF THE HUMAN RNASE P PROTEIN RPP30 IN THE HYPERTHERMOPHILIC ARCHAEON THERMOCOCCUS KODAKARENSIS	3.1.26.5
3WZ0	ON ARCHAEAL HOMOLOGS OF THE HUMAN RNASE P PROTEINS POP5 AND RPP30 IN THE HYPERTHERMOPHILIC ARCHAEON THERMOCOCCUS KODAKARENSIS	3.1.26.5
3WZ1	CATALYTIC DOMAIN OF BETA-AGARASE FROM MICROBULBIFER THERMOTOLERANS JAMB-A94	3.2.1.81
3WZ6	ENDOTHIAPEPSIN IN COMPLEX WITH GEWALD REACTION-DERIVED INHIBITOR (5)	3.4.23.22
3WZ7	ENDOTHIAPEPSIN IN COMPLEX WITH GEWALD REACTION-DERIVED INHIBITOR (6)	3.4.23.22
3WZ8	ENDOTHIAPEPSIN IN COMPLEX WITH GEWALD REACTION-DERIVED INHIBITOR (8)	3.4.23.22
3X17	CRYSTAL STRUCTURE OF METAGENOME-DERIVED GLYCOSIDE HYDROLASE FAMILY 9 ENDOGLUCANASE	3.2.1.4
3X1D	CRYSTAL STRUCTURE OF ATLASTIN FROM DROSOPHILA MELANOGASTER	3.6.5
3X1W	RAS-RELATED PROTEIN RAP1B WITH GDP	3.6.5.2
3X1X	RAS-RELATED PROTEIN RAP1B WITH GPPNHP	3.6.5.2
3X1Y	RAS-RELATED PROTEIN RAP1B(L9V) WITH GPPNHP	3.6.5.2
3X1Z	RAS-RELATED PROTEIN RAP1B(T65A) WITH GPPNHP	3.6.5.2
3X2E	A THERMOPHILIC HYDROLASE	3.3.1.1
3X2F	A THERMOPHILIC S-ADENOSYLHOMOCYSTEINE HYDROLASE	3.3.1.1
3X3M	CRYSTAL STRUCTURE OF ECCB1 OF MYCOBACTERIUM TUBERCULOSIS IN SPACEGROUP P212121	3.6
3X3N	CRYSTAL STRUCTURE OF ECCB1 OF MYCOBACTERIUM TUBERCULOSIS IN SPACEGROUP P21	3.6
3ZBD	STRUCTURE OF TGEV NSP1	3.4.19.12 3.4.22
3ZBP	MONOMERIC SUBUNIT OF TUBZ FROM BACTERIOPHAGE PHIKZ	3.6.5
3ZBQ	PROTOFILAMENT OF TUBZ FROM BACTERIOPHAGE PHIKZ	3.6.5
3ZBR	CATALYTIC DOMAIN OF MOUSE 2',3'-CYCLIC NUCLEOTIDE 3'- PHOSPHODIESTERASE, WITH MUTATION H230S, CRYSTALLIZED WITH NADP	3.1.4.37
3ZBS	CATALYTIC DOMAIN OF MOUSE 2',3'-CYCLIC NUCLEOTIDE 3'- PHOSPHODIESTERASE, WITH MUTATION V321A, CRYSTALLIZED WITH 2'-AMPS	3.1.4.37
3ZBW	CRYSTAL STRUCTURE OF MURINE ANGIOGENIN-3	3.1.27
3ZBZ	CATALYTIC DOMAIN OF MOUSE 2',3'-CYCLIC NUCLEOTIDE 3'- PHOSPHODIESTERASE, WITH MUTATION V321A, CRYSTALLIZED WITH 2'-AMPS	3.1.4.37
3ZCM	SMALL MOLECULE INHIBITORS OF THE LEDGF SITE OF HIV INTEGRASE IDENTIFIED BY FRAGMENT SCREENING AND STRUCTURE BASED DESIGN.	2.7.7 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 3.1
3ZCZ	CRYSTAL STRUCTURE OF A COMPLEX BETWEEN ACTINOMADURA R39 DD-PEPTIDASE AND A TRIFLUOROKETONE INHIBITOR	3.4.16.4
3ZD0	THE SOLUTION STRUCTURE OF MONOMERIC HEPATITIS C VIRUS P7 YIELDS POTENT INHIBITORS OF VIRION RELEASE	2.7.7.48 3.4.21.98 3.6.1.15 3.6.4.13
3ZD6	SNAPSHOT 1 OF RIG-I SCANNING ON RNA DUPLEX	3.6.4.13
3ZD7	SNAPSHOT 3 OF RIG-I SCANNING ON RNA DUPLEX	3.6.4.13
3ZD8	POTASSIUM BOUND STRUCTURE OF E. COLI EXOIX IN P1	3.1
3ZD9	POTASSIUM BOUND STRUCTURE OF E. COLI EXOIX IN P21	3.1
3ZDA	STRUCTURE OF E. COLI EXOIX IN COMPLEX WITH A FRAGMENT OF THE FLAP1 DNA OLIGONUCLEOTIDE, POTASSIUM AND MAGNESIUM	3.1
3ZDB	STRUCTURE OF E. COLI EXOIX IN COMPLEX WITH THE PALINDROMIC 5OV4 DNA OLIGONUCLEOTIDE, DI-MAGNESIUM AND POTASSIUM	3.1
3ZDC	STRUCTURE OF E. COLI EXOIX IN COMPLEX WITH THE PALINDROMIC 5OV4 DNA OLIGONUCLEOTIDE, POTASSIUM AND CALCIUM	3.1
3ZDD	STRUCTURE OF E. COLI EXOIX IN COMPLEX WITH THE PALINDROMIC 5OV6 OLIGONUCLEOTIDE AND POTASSIUM	3.1
3ZDE	POTASSIUM FREE STRUCTURE OF E. COLI EXOIX	3.1
3ZDQ	STRUCTURE OF THE HUMAN MITOCHONDRIAL ABC TRANSPORTER, ABCB10 (NUCLEOTIDE-FREE FORM)	3.6.3.43
3ZEB	A COMPLEX OF GLPG WITH ISOCOUMARIN INHIBITOR COVALENTLY BONDED TO SERINE 201 AND HISTIDINE 150	3.4.21.105
3ZEK	HEN EGG-WHITE LYSOZYME STRUCTURE DETERMINED AT ROOM TEMPERATURE BY IN- SITU DIFFRACTION IN CHIPX	3.2.1.17
3ZEZ	PHAGE DUTPASES CONTROL TRANSFER OF VIRULENCE GENES BY A PROTO- ONCOGENIC G PROTEIN-LIKE MECHANISM.(STAPHYLOCOCCUS BACTERIOPHAGE 80ALPHA DUTPASE WITH DUPNHPP).	3.6.1.23
3ZF0	PHAGE DUTPASES CONTROL TRANSFER OF VIRULENCE GENES BY A PROTO-ONCOGENIC G PROTEIN-LIKE MECHANISM. (STAPHYLOCOCCUS BACTERIOPHAGE 80ALPHA DUTPASE D81A MUTANT WITH DUPNHPP).	3.6.1.23
3ZF1	PHAGE DUTPASES CONTROL TRANSFER OF VIRULENCE GENES BY A PROTO- ONCOGENIC G PROTEIN-LIKE MECHANISM. (STAPHYLOCOCCUS BACTERIOPHAGE 80ALPHA DUTPASE D81N MUTANT WITH DUPNHPP).	3.6.1.23
3ZF2	PHAGE DUTPASES CONTROL TRANSFER OF VIRULENCE GENES BY A PROTO- ONCOGENIC G PROTEIN-LIKE MECHANISM. (STAPHYLOCOCCUS BACTERIOPHAGE 80ALPHA DUTPASE).	3.6.1.23
3ZF3	PHAGE DUTPASES CONTROL TRANSFER OF VIRULENCE GENES BY A PROTO-ONCOGENIC G PROTEIN-LIKE MECHANISM. (STAPHYLOCOCCUS BACTERIOPHAGE 80ALPHA DUTPASE Y84I MUTANT).	3.6.1.23
3ZF4	PHAGE DUTPASES CONTROL TRANSFER OF VIRULENCE GENES BY A PROTO- ONCOGENIC G PROTEIN-LIKE MECHANISM. (STAPHYLOCOCCUS BACTERIOPHAGE 80ALPHA DUTPASE Y81A MUTANT WITH DUPNHPP).	3.6.1.23
3ZF5	PHAGE DUTPASES CONTROL TRANSFER OF VIRULENCE GENES BY A PROTO-ONCOGENIC G PROTEIN-LIKE MECHANISM. (STAPHYLOCOCCUS BACTERIOPHAGE 80ALPHA DUTPASE Y84F MUTANT WITH DUPNHPP).	3.6.1.23
3ZF6	PHAGE DUTPASES CONTROL TRANSFER OF VIRULENCE GENES BY A PROTO-ONCOGENIC G PROTEIN-LIKE MECHANISM. (STAPHYLOCOCCUS BACTERIOPHAGE 80ALPHA DUTPASE D81A D110C S168C MUTANT WITH DUPNHPP).	3.6.1.23
3ZFC	CRYSTAL STRUCTURE OF THE KIF4 MOTOR DOMAIN COMPLEXED WITH MG-AMPPNP	3.6.4.4
3ZFD	CRYSTAL STRUCTURE OF THE KIF4 MOTOR DOMAIN COMPLEXED WITH MG-AMPPNP	3.6.4.4
3ZFE	HUMAN ENTEROVIRUS 71 IN COMPLEX WITH CAPSID BINDING INHIBITOR WIN51711	3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48
3ZFF	HUMAN ENTEROVIRUS 71 IN COMPLEX WITH CAPSID BINDING INHIBITOR WIN51711	3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48
3ZFG	HUMAN ENTEROVIRUS 71 IN COMPLEX WITH CAPSID BINDING INHIBITOR WIN51711	3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48
3ZFK	N-TERMINAL TRUNCATED NUCLEASE DOMAIN OF COLICIN E7	3.1
3ZFN	CRYSTAL STRUCTURE OF PRODUCT-LIKE, PROCESSED N-TERMINAL PROTEASE NPRO	3.4.22
3ZFO	CRYSTAL STRUCTURE OF SUBSTRATE-LIKE, UNPROCESSED N-TERMINAL PROTEASE NPRO MUTANT S169P	3.4.22
3ZFP	CRYSTAL STRUCTURE OF PRODUCT-LIKE, PROCESSED N-TERMINAL PROTEASE NPRO WITH INTERNAL HIS-TAG	3.4.22
3ZFQ	CRYSTAL STRUCTURE OF PRODUCT-LIKE, PROCESSED N-TERMINAL PROTEASE NPRO WITH MERCURY	3.4.22
3ZFR	CRYSTAL STRUCTURE OF PRODUCT-LIKE, PROCESSED N-TERMINAL PROTEASE NPRO WITH IRIDIUM	3.4.22
3ZFT	CRYSTAL STRUCTURE OF PRODUCT-LIKE, PROCESSED N-TERMINAL PROTEASE NPRO AT PH 3	3.4.22
3ZFU	CRYSTAL STRUCTURE OF SUBSTRATE-LIKE, UNPROCESSED N-TERMINAL PROTEASE NPRO MUTANT S169P WITH SULPHATE	3.4.22
3ZFV	CRYSTAL STRUCTURE OF AN ARCHAEAL CRISPR-ASSOCIATED CAS6 NUCLEASE	3.1
3ZFZ	CRYSTAL STRUCTURE OF CEFTAROLINE ACYL-PBP2A FROM MRSA WITH NON- COVALENTLY BOUND CEFTAROLINE AND MURAMIC ACID AT ALLOSTERIC SITE OBTAINED BY SOAKING	3.4.16.4
3ZG0	CRYSTAL STRUCTURE OF CEFTAROLINE ACYL-PBP2A FROM MRSA WITH NON- COVALENTLY BOUND CEFTAROLINE AND MURAMIC ACID AT ALLOSTERIC SITE OBTAINED BY COCRYSTALLIZATION	3.4.16.4
3ZG5	CRYSTAL STRUCTURE OF PBP2A FROM MRSA IN COMPLEX WITH PEPTIDOGLYCAN ANALOGUE AT ALLOSTERIC	3.4.16.4
3ZG6	THE NOVEL DE-LONG CHAIN FATTY ACID FUNCTION OF HUMAN SIRT6	3.5.1 2.4.2.31 2.3.1.286
3ZG7	CRYSTAL STRUCTURE OF PENICILLIN-BINDING PROTEIN 4 FROM LISTERIA MONOCYTOGENES IN THE APO FORM	2.4.1.129 3.4.16.4
3ZG8	CRYSTAL STRUCTURE OF PENICILLIN BINDING PROTEIN 4 FROM LISTERIA MONOCYTOGENES IN THE AMPICILLIN BOUND FORM	2.4.1.129 3.4.16.4
3ZG9	CRYSTAL STRUCTURE OF PENICILLIN-BINDING PROTEIN 4 FROM LISTERIA MONOCYTOGENES IN THE CEFUROXIME BOUND FORM	2.4.1.129 3.4.16.4
3ZGA	CRYSTAL STRUCTURE OF PENICILLIN-BINDING PROTEIN 4 FROM LISTERIA MONOCYTOGENES IN THE CARBENICILLIN BOUND FORM	2.4.1.129 3.4.16.4
3ZGO	RE-REFINED STRUCTURE OF THE HUMAN SIRT2 APOFORM	3.5.1 2.3.1.286
3ZGV	STRUCTURE OF HUMAN SIRT2 IN COMPLEX WITH ADP-RIBOSE	3.5.1 2.3.1.286
3ZHH	X-RAY STRUCTURE OF THE FULL-LENGTH BETA-LACTAMASE FROM M.TUBERCULOSIS	3.5.2.6
3ZI5	CRYSTAL STRUCTURE OF RESTRICTION ENDONUCLEASE BFII C-TERMINAL RECOGNITION DOMAIN IN COMPLEX WITH COGNATE DNA	3.1.21.4
3ZI6	STRUCTURE OF THERMOLYSIN SOLVED BY SAD FROM DATA COLLECTED BY DIRECT DATA COLLECTION (DDC) USING THE GROB ROBOT GONIOMETER	3.4.24.27
3ZI7	STRUCTURE OF FAE SOLVED BY SAD FROM DATA COLLECTED BY DIRECT DATA COLLECTION (DDC) USING THE GROB ROBOT GONIOMETER	3.2.1.8
3ZIZ	CRYSTAL STRUCTURE OF PODOSPORA ANSERINA GH5 BETA-(1,4)-MANNANASE	3.2.1.78
3ZJ6	CRYSTAL OF RAUCAFFRICINE GLUCOSIDASE IN COMPLEX WITH INHIBITOR	3.2.1.125 2.4.1.219
3ZJ7	CRYSTAL STRUCTURE OF STRICTOSIDINE GLUCOSIDASE IN COMPLEX WITH INHIBITOR-1	3.2.1.105
3ZJ8	CRYSTAL STRUCTURE OF STRICTOSIDINE GLUCOSIDASE IN COMPLEX WITH INHIBITOR-2	3.2.1.105
3ZJD	A20 OTU DOMAIN IN REDUCED, ACTIVE STATE AT 1.87 A RESOLUTION	3.4.19.12 6.3.2 2.3.2
3ZJE	A20 OTU DOMAIN IN REVERSIBLY OXIDISED (SOH) STATE	3.4.19.12 6.3.2 2.3.2
3ZJF	A20 OTU DOMAIN WITH IRREVERSIBLY OXIDISED CYS103 FROM 270 MIN H2O2 SOAK.	3.4.19.12 6.3.2 2.3.2
3ZJG	A20 OTU DOMAIN WITH IRREVERSIBLY OXIDISED CYS103 FROM 60 MIN H2O2 SOAK.	3.4.19.12 6.3.2 2.3.2
3ZJK	CRYSTAL STRUCTURE OF TTB-GLY F401S MUTANT	3.2.1.21
3ZK4	STRUCTURE OF PURPLE ACID PHOSPHATASE PPD1 ISOLATED FROM YELLOW LUPIN (LUPINUS LUTEUS) SEEDS	3.1.3.2
3ZKG	BACE2 MUTANT APO STRUCTURE	3.4.23.45
3ZKI	BACE2 MUTANT STRUCTURE WITH LIGAND	3.4.23.45
3ZKM	BACE2 FAB COMPLEX	3.4.23.45
3ZKN	BACE2 FAB INHIBITOR COMPLEX	3.4.23.45
3ZKO	THE STRUCTURE OF ''BREATHING'' DENGUE VIRUS.	3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48
3ZKQ	BACE2 XAPERONE COMPLEX	3.4.23.45
3ZKS	BACE2 XAPERONE COMPLEX WITH INHIBITOR	3.4.23.45
3ZKX	TERNARY BACE2 XAPERONE COMPLEX	3.4.23.45
3ZL7	BACE2 FYNOMER COMPLEX	3.4.23.45
3ZLQ	BACE2 XAPERONE COMPLEX	3.4.23.45
3ZLT	CRYSTAL STRUCTURE OF ACETYLCHOLINESTERASE IN COMPLEX WITH RVX	3.1.1.7
3ZLU	CRYSTAL STRUCTURE OF MOUSE ACETYLCHOLINESTERASE IN COMPLEX WITH CYCLOSARIN	3.1.1.7
3ZLV	CRYSTAL STRUCTURE OF MOUSE ACETYLCHOLINESTERASE IN COMPLEX WITH TABUN AND HI-6	3.1.1.7
3ZM0	CATALYTIC DOMAIN OF HUMAN SHP2	3.1.3.48
3ZM1	CATALYTIC DOMAIN OF HUMAN SHP2	3.1.3.48
3ZM2	CATALYTIC DOMAIN OF HUMAN SHP2	3.1.3.48
3ZM3	CATALYTIC DOMAIN OF HUMAN SHP2	3.1.3.48
3ZM8	CRYSTAL STRUCTURE OF PODOSPORA ANSERINA GH26-CBM35 BETA-(1,4)- MANNANASE	3.2.1.78
3ZMG	CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH CHEMICAL LIGAND	3.4.23.46
3ZMH	STRUCTURE OF E.COLI RHOMBOID PROTEASE GLPG IN COMPLEX WITH MONOBACTAM L62	3.4.21.105
3ZMI	STRUCTURE OF E.COLI RHOMBOID PROTEASE GLPG IN COMPLEX WITH MONOBACTAM L29	3.4.21.105
3ZMJ	STRUCTURE OF E.COLI RHOMBOID PROTEASE GLPG IN COMPLEX WITH MONOBACTAM L61	3.4.21.105
3ZMP	SRC-DERIVED PEPTIDE INHIBITOR COMPLEX OF PTP1B	3.1.3.48
3ZMQ	SRC-DERIVED MUTANT PEPTIDE INHIBITOR COMPLEX OF PTP1B	3.1.3.48
3ZMR	BACTEROIDES OVATUS GH5 XYLOGLUCANASE IN COMPLEX WITH A XXXG HEPTASACCHARIDE	3.2.1.151
3ZN8	STRUCTURAL BASIS OF SIGNAL SEQUENCE SURVEILLANCE AND SELECTION BY THE SRP-SR COMPLEX	3.6.5.4
3ZNB	METALLO-BETA-LACTAMASE (ZN, HG-BOUND FORM)	3.5.2.6
3ZNH	CRIMEAN CONGO HEMORRHAGIC FEVER VIRUS OTU DOMAIN IN COMPLEX WITH UBIQUITIN-PROPARGYL.	3.4.19.12 2.7.7.48
3ZNR	HDAC7 BOUND WITH INHIBITOR TMP269	3.5.1.98
3ZNS	HDAC7 BOUND WITH TFMO INHIBITOR TMP942	3.5.1.98
3ZNT	CRYSTAL STRUCTURE OF OXA-24 CLASS D BETA-LACTAMASE WITH TAZOBACTAM	3.5.2.6
3ZNV	CRYSTAL STRUCTURE OF THE OTU DOMAIN OF OTULIN AT 1.3 ANGSTROMS.	3.4.19.12
3ZNX	CRYSTAL STRUCTURE OF THE OTU DOMAIN OF OTULIN D336A MUTANT	3.4.19.12
3ZNY	CRYSTAL STRUCTURE OF THE CLASS A EXTENDED-SPECTRUM BETA-LACTAMASE CTX- M-96, A NATURAL D240G MUTANT DERIVED FROM CTX-M-12	3.5.2.6
3ZNZ	CRYSTAL STRUCTURE OF OTULIN OTU DOMAIN (C129A) IN COMPLEX WITH MET1- DI UBIQUITIN	3.4.19.12
3ZO5	STRUCTURE OF SENP2-LOOP1 IN COMPLEX WITH PRESUMO-2	3.4.22.68 3.4.22
3ZO9	THE STRUCTURE OF TREHALOSE SYNTHASE (TRES) OF MYCOBACTERIUM SMEGMATIS	3.2.1.1 5.4.99.16
3ZOA	THE STRUCTURE OF TREHALOSE SYNTHASE (TRES) OF MYCOBACTERIUM SMEGMATIS IN COMPLEX WITH ACARBOSE	3.2.1.1 5.4.99.16
3ZOQ	STRUCTURE OF BSUDG-P56 COMPLEX	3.2.2.27
3ZOR	STRUCTURE OF BSUDG	3.2.2.27
3ZOT	STRUCTURE OF E.COLI RHOMBOID PROTEASE GLPG IN COMPLEX WITH MONOBACTAM L29 (DATA SET 2)	3.4.21.105
3ZOV	CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH CHEMICAL LIGAND	3.4.23.46
3ZPC	ACINETOBACTER BAUMANNII RIBD, FORM 1	3.5.4.26 1.1.1.193
3ZPG	ACINETOBACTER BAUMANNII RIBD, FORM 2	3.5.4.26 1.1.1.193
3ZPS	DESIGN AND SYNTHESIS OF P1-P3 MACROCYCLIC TERTIARY ALCOHOL COMPRISING HIV-1 PROTEASE INHIBITORS	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
3ZPT	DESIGN AND SYNTHESIS OF P1-P3 MACROCYCLIC TERTIARY ALCOHOL COMPRISING HIV-1 PROTEASE INHIBITORS	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
3ZPU	DESIGN AND SYNTHESIS OF P1-P3 MACROCYCLIC TERTIARY ALCOHOL COMPRISING HIV-1 PROTEASE INHIBITORS	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
3ZPX	USTILAGO MAYDIS LIPASE UM03410, SHORT FORM WITHOUT FLAP	3.1.1.3
3ZQ4	UNUSUAL, DUAL ENDO- AND EXO-NUCLEASE ACTIVITY IN THE DEGRADOSOME EXPLAINED BY CRYSTAL STRUCTURE ANALYSIS OF RNASE J1	3.1
3ZQ6	ADP-ALF4 COMPLEX OF M. THERM. TRC40	3.6.3.16 7.3.2.7
3ZQ9	STRUCTURE OF A PAENIBACILLUS POLYMYXA XYLOGLUCANASE FROM GLYCOSIDE HYDROLASE FAMILY 44	3.2.1.4 3.2.1.151
3ZQW	STRUCTURE OF CBM3B OF MAJOR SCAFFOLDIN SUBUNIT SCAA FROM ACETIVIBRIO CELLULOLYTICUS	3.2.1.4
3ZQX	CARBOHYDRATE-BINDING MODULE CBM3B FROM THE CELLULOSOMAL CELLOBIOHYDROLASE 9A FROM CLOSTRIDIUM THERMOCELLUM	3.2.1.91 3.2.1
3ZQZ	CRYSTAL STRUCTURE OF ANCE IN COMPLEX WITH A SELENIUM ANALOGUE OF CAPTOPRIL	3.4.15.1
3ZR0	CRYSTAL STRUCTURE OF HUMAN MTH1 IN COMPLEX WITH 8-OXO-DGMP	3.6.1 3.6.1.55 3.6.1.56
3ZR1	CRYSTAL STRUCTURE OF HUMAN MTH1	3.6.1 3.6.1.55 3.6.1.56
3ZR5	STRUCTURE OF GALACTOCEREBROSIDASE FROM MOUSE	3.2.1.46
3ZR6	STRUCTURE OF GALACTOCEREBROSIDASE FROM MOUSE IN COMPLEX WITH GALACTOSE	3.2.1.46
3ZR9	STRUCTURE OF NEW DELHI METALLO-BETA-LACTAMASE 1 (NDM-1)	3.5.2.6
3ZRH	CRYSTAL STRUCTURE OF THE LYS29, LYS33-LINKAGE-SPECIFIC TRABID OTU DEUBIQUITINASE DOMAIN REVEALS AN ANKYRIN-REPEAT UBIQUITIN BINDING DOMAIN (ANKUBD)	3.4.19.12
3ZS8	S. CEREVISIAE GET3 COMPLEXED WITH A CYTOSOLIC GET1 FRAGMENT	3.6.3.16 3.6
3ZS9	S. CEREVISIAE GET3-ADP-ALF4- COMPLEX WITH A CYTOSOLIC GET2 FRAGMENT	3.6.3.16 3.6
3ZSE	3D STRUCTURE OF A THERMOPHILIC FAMILY GH11 XYLANASE FROM THERMOBIFIDA FUSCA	3.2.1.8
3ZSO	SMALL MOLECULE INHIBITORS OF THE LEDGF SITE OF HIV TYPE 1 INTEGRASE IDENTIFIED BY FRAGMENT SCREENING AND STRUCTURE BASED DESIGN	2.7.7 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 3.1
3ZSQ	SMALL MOLECULE INHIBITORS OF THE LEDGF SITE OF HIV TYPE 1 INTEGRASE IDENTIFIED BY FRAGMENT SCREENING AND STRUCTURE BASED DRUG DESIGN	2.7.7 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 3.1
3ZSR	SMALL MOLECULE INHIBITORS OF THE LEDGF SITE OF HIV TYPE 1 INTEGRASE IDENTIFIED BY FRAGMENT SCREENING AND STRUCTURE BASED DRUG DESIGN	2.7.7 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 3.1
3ZST	GLGE ISOFORM 1 FROM STREPTOMYCES COELICOLOR WITH ALPHA-CYCLODEXTRIN BOUND	3.2.1 2.4.1 2.4.99.16
3ZSV	SMALL MOLECULE INHIBITORS OF THE LEDGF SITE OF HIV TYPE 1 INTEGRASE IDENTIFIED BY FRAGMENT SCREENING AND STRUCTURE BASED DRUG DESIGN	2.7.7 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 3.1
3ZSW	SMALL MOLECULE INHIBITORS OF THE LEDGF SITE OF HIV TYPE 1 INTEGRASE IDENTIFIED BY FRAGMENT SCREENING AND STRUCTURE BASED DRUG DESIGN	2.7.7 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 3.1
3ZSX	SMALL MOLECULE INHIBITORS OF THE LEDGF SITE OF HIV TYPE 1 INTEGRASE IDENTIFIED BY FRAGMENT SCREENING AND STRUCTURE BASED DRUG DESIGN	2.7.7 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 3.1
3ZSY	SMALL MOLECULE INHIBITORS OF THE LEDGF SITE OF HIV TYPE 1 INTEGRASE IDENTIFIED BY FRAGMENT SCREENING AND STRUCTURE BASED DRUG DESIGN	2.7.7 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 3.1
3ZSZ	SMALL MOLECULE INHIBITORS OF THE LEDGF SITE OF HIV TYPE 1 INTEGRASE IDENTIFIED BY FRAGMENT SCREENING AND STRUCTURE BASED DRUG DESIGN	2.7.7 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 3.1
3ZT0	SMALL MOLECULE INHIBITORS OF THE LEDGF SITE OF HIV TYPE 1 INTEGRASE IDENTIFIED BY FRAGMENT SCREENING AND STRUCTURE BASED DRUG DESIGN	2.7.7 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 3.1
3ZT1	SMALL MOLECULE INHIBITORS OF THE LEDGF SITE OF HIV TYPE 1 INTEGRASE IDENTIFIED BY FRAGMENT SCREENING AND STRUCTURE BASED DRUG DESIGN	2.7.7 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 3.1
3ZT2	SMALL MOLECULE INHIBITORS OF THE LEDGF SITE OF HIV TYPE 1 INTEGRASE IDENTIFIED BY FRAGMENT SCREENING AND STRUCTURE BASED DRUG DESIGN	2.7.7 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 3.1
3ZT3	SMALL MOLECULE INHIBITORS OF THE LEDGF SITE OF HIV TYPE 1 INTEGRASE IDENTIFIED BY FRAGMENT SCREENING AND STRUCTURE BASED DRUG DESIGN	2.7.7 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 3.1
3ZT4	SMALL MOLECULE INHIBITORS OF THE LEDGF SITE OF HIV TYPE 1 INTEGRASE IDENTIFIED BY FRAGMENT SCREENING AND STRUCTURE BASED DRUG DESIGN	2.7.7 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 3.1
3ZT9	THE BACTERIAL STRESSOSOME: A MODULAR SYSTEM THAT HAS BEEN ADAPTED TO CONTROL SECONDARY MESSENGER SIGNALING	3.1.3.16
3ZTV	STRUCTURE OF HAEMOPHILUS INFLUENZAE NAD NUCLEOTIDASE (NADN)	3.1.3.5
3ZTW	THE 3-DIMENSIONAL STRUCTURE OF APO-MPGP, THE MANNOSYL-3- PHOSPHOGLYCERATE PHOSPHATASE FROM THERMUS THERMOPHILUS HB27 IN ITS APO-FORM	3.1.3.70
3ZTY	THE 3-DIMENSIONAL STRUCTURE OF THE GADOLINIUM DERIVATIVE OF MPGP, THE MANNOSYL-3-PHOSPHOGLYCERATE PHOSPHATASE FROM THERMUS THERMOPHILUS HB27	3.1.3.70
3ZU0	STRUCTURE OF HAEMOPHILUS INFLUENZAE NAD NUCLEOTIDASE (NADN)	3.1.3.5
3ZU6	THE 3-DIMENSIONAL STRUCTURE OF MPGP FROM THERMUS THERMOPHILUS HB27, IN COMPLEX WITH THE ALPHA-MANNOSYLGLYCERATE AND ORTHOPHOSPHATE REACTION PRODUCTS.	3.1.3.70
3ZU8	STRUCTURE OF CBM3B OF MAJOR SCAFFOLDIN SUBUNIT SCAA FROM ACETIVIBRIO CELLULOLYTICUS DETERMINED ON THE NIKEL ABSORPTION EDGE	3.2.1.4
3ZUA	A C39-LIKE DOMAIN	3.4.22.2
3ZUC	STRUCTURE OF CBM3B OF MAJOR SCAFFOLDIN SUBUNIT SCAA FROM ACETIVIBRIO CELLULOLYTICUS DETERMINED FROM THE CRYSTALS GROWN IN THE PRESENCE OF NICKEL	3.2.1.4
3ZUD	THERMOASCUS GH61 ISOZYME A	3.2.1.4
3ZUE	RABBIT HEMORRHAGIC DISEASE VIRUS (RHDV)CAPSID PROTEIN	3.6.1.15 3.4.22.66 2.7.7.48
3ZUK	CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS ZINC METALLOPROTEASE ZMP1 IN COMPLEX WITH INHIBITOR	3.4.24
3ZUP	THE 3-DIMENSIONAL STRUCTURE OF MPGP FROM THERMUS THERMOPHILUS HB27, IN COMPLEX WITH THE ALPHA-MANNOSYLGLYCERATE AND ORTHOPHOSPHATE REACTION PRODUCTS.	3.1.3.70
3ZUQ	CRYSTAL STRUCTURE OF AN ENGINEERED BOTULINUM NEUROTOXIN TYPE B - DERIVATIVE, LC-B-GS-HN-B	3.4.24.69
3ZUR	CRYSTAL STRUCTURE OF AN ENGINEERED BOTULINUM NEUROTOXIN TYPE A- SNARE23 DERIVATIVE, LC0-A-SNAP25-HN-A	3.4.24.69
3ZUS	CRYSTAL STRUCTURE OF AN ENGINEERED BOTULINUM NEUROTOXIN TYPE A- SNARE23 DERIVATIVE, LC-A-SNAP23-HN-A	3.4.24.69
3ZV2	HUMAN PROTEIN-TYROSINE PHOSPHATASE 1B C215A, S216A MUTANT	3.1.3.48
3ZV7	TORPEDO CALIFORNICA ACETYLCHOLINESTERASE INHIBITION BY BISNORCYMSERINE	3.1.1.7
3ZV8	CRYSTAL STRUCTURE OF 3C PROTEASE OF ENTEROVIRUS 68	3.4.22.28 3.4.22.29 3.6.1.15 2.7.7.48
3ZV9	3C PROTEASE OF ENTEROVIRUS 68 COMPLEXED WITH MICHAEL RECEPTOR INHIBITOR 74	3.4.22.28 3.4.22.29 3.6.1.15 2.7.7.48
3ZVA	3C PROTEASE OF ENTEROVIRUS 68 COMPLEXED WITH MICHAEL RECEPTOR INHIBITOR 75	3.4.22.28 3.4.22.29 3.6.1.15 2.7.7.48
3ZVB	3C PROTEASE OF ENTEROVIRUS 68 COMPLEXED WITH MICHAEL RECEPTOR INHIBITOR 81	3.4.22.28 3.4.22.29 3.6.1.15 2.7.7.48
3ZVC	3C PROTEASE OF ENTEROVIRUS 68 COMPLEXED WITH MICHAEL RECEPTOR INHIBITOR 82	3.4.22.28 3.4.22.29 3.6.1.15 2.7.7.48
3ZVD	3C PROTEASE OF ENTEROVIRUS 68 COMPLEXED WITH MICHAEL RECEPTOR INHIBITOR 83	3.4.22.28 3.4.22.29 3.6.1.15 2.7.7.48
3ZVE	3C PROTEASE OF ENTEROVIRUS 68 COMPLEXED WITH MICHAEL RECEPTOR INHIBITOR 84	3.4.22.28 3.4.22.29 3.6.1.15 2.7.7.48
3ZVF	3C PROTEASE OF ENTEROVIRUS 68 COMPLEXED WITH MICHAEL RECEPTOR INHIBITOR 85	3.4.22.28 3.4.22.29 3.6.1.15 2.7.7.48
3ZVG	3C PROTEASE OF ENTEROVIRUS 68 COMPLEXED WITH MICHAEL RECEPTOR INHIBITOR 98	3.4.22.28 3.4.22.29 3.6.1.15 2.7.7.48
3ZVK	CRYSTAL STRUCTURE OF VAPBC2 FROM RICKETTSIA FELIS BOUND TO A DNA FRAGMENT FROM THEIR PROMOTER	3.1
3ZVL	THE STRUCTURAL BASIS FOR SUBSTRATE RECOGNITION BY MAMMALIAN POLYNUCLEOTIDE KINASE 3' PHOSPHATASE	3.1.3.32 2.7.1.78
3ZVM	THE STRUCTURAL BASIS FOR SUBSTRATE RECOGNITION BY MAMMALIAN POLYNUCLEOTIDE KINASE 3' PHOSPHATASE	3.1.3.32 2.7.1.78
3ZVN	THE STRUCTURAL BASIS FOR SUBSTRATE RECOGNITION BY MAMMALIAN POLYNUCLEOTIDE KINASE 3' PHOSPHATASE	3.1.3.32 2.7.1.78
3ZVQ	CRYSTAL STRUCTURE OF PROTEOLYZED LYSOZYME	3.2.1.17
3ZVS	CRYSTAL STRUCTURE OF ARCHAEMETZINCIN (AMZA) FROM ARCHAEOGLOBUS FULGIDUS AT 1.4 A RESOLUTION COMPLEXED WITH MALONATE	3 3.4
3ZVT	UNEXPECTED TRICOVALENT BINDING MODE OF BORONIC ACIDS WITHIN THE ACTIVE SITE OF A PENICILLIN BINDING PROTEIN	3.4.16.4
3ZVW	UNEXPECTED TRICOVALENT BINDING MODE OF BORONIC ACIDS WITHIN THE ACTIVE SITE OF A PENICILLIN BINDING PROTEIN	3.4.16.4
3ZW7	THE 3-DIMENSIONAL STRUCTURE OF MPGP FROM THERMUS THERMOPHILUS HB27, IN COMPLEX WITH THE ALPHA-MANNOSYLGLYCERATE AND METAPHOSPHATE.	3.1.3.70
3ZWD	THE 3-DIMENSIONAL STRUCTURE OF MPGP FROM THERMUS THERMOPHILUS HB27, IN COMPLEX WITH THE ALPHA-MANNOSYLGLYCERATE.	3.1.3.70
3ZWF	CRYSTAL STRUCTURE OF HUMAN TRNASE Z, SHORT FORM (ELAC1).	3.1.26.11
3ZWK	THE 3-DIMENSIONAL STRUCTURE OF MPGP FROM THERMUS THERMOPHILUS HB27, IN COMPLEX WITH THE METAVANADATE	3.1.3.70
3ZWN	CRYSTAL STRUCTURE OF APLYSIA CYCLASE COMPLEXED WITH SUBSTRATE NGD AND PRODUCT CGDPR	3.2.2.5 3.2.2.6 2.4.99.20
3ZWO	CRYSTAL STRUCTURE OF ADP RIBOSYL CYCLASE COMPLEXED WITH REACTION INTERMEDIATE	3.2.2.5 3.2.2.6 2.4.99.20
3ZWQ	HYPERTHERMOPHILIC ESTERASE FROM THE ARCHEON PYROBACULUM CALIDIFONTIS	3.1.1.1
3ZWU	PSEUDOMONAS FLUORESCENS PHOX IN COMPLEX WITH VANADATE, A TRANSITION STATE ANALOGUE	3.1.3.1
3ZWX	CRYSTAL STRUCTURE OF ADP-RIBOSYL CYCLASE COMPLEXED WITH 8-BROMO-ADP- RIBOSE	3.2.2.5 3.2.2.6 2.4.99.20
3ZX0	NTPDASE1 IN COMPLEX WITH HEPTAMOLYBDATE	3.6.1.5
3ZX2	NTPDASE1 IN COMPLEX WITH DECAVANADATE	3.6.1.5
3ZX3	CRYSTAL STRUCTURE AND DOMAIN ROTATION OF NTPDASE1 CD39	3.6.1.5
3ZX4	THE 3-DIMENSIONAL STRUCTURE OF MPGP FROM THERMUS THERMOPHILUS HB27, IN COMPLEX WITH THE ALPHA-MANNOSYLGLYCERATE,ORTHOPHOSPHATE AND MAGNESIUM	3.1.3.70
3ZX5	THE 3-DIMENSIONAL STRUCTURE OF MPGP FROM THERMUS THERMOPHILUS HB27, COVALENTLY BOUND TO VANADATE AND IN COMPLEX WITH ALPHA- MANNOSYLGLYCERATE AND MAGNESIUM	3.1.3.70
3ZXH	MMP-13 COMPLEXED WITH 2-NAPTHYLSULFONAMIDE HYDROXAMIC ACID INHIBITOR	3.4.24
3ZXJ	ENGINEERING THE ACTIVE SITE OF A GH43 GLYCOSIDE HYDROLASE GENERATES A BIOTECHNOLOGICALLY SIGNIFICANT ENZYME THAT DISPLAYS BOTH ENDO- XYLANASE AND EXO-ARABINOFURANOSIDASE ACTIVITY	3.2.1.55
3ZXK	ENGINEERING THE ACTIVE SITE OF A GH43 GLYCOSIDE HYDROLASE GENERATES A BIOTECHNOLOGICALLY SIGNIFICANT ENZYME THAT DISPLAYS BOTH ENDO- XYLANASE AND EXO-ARABINOFURANOSIDASE ACTIVITY	3.2.1.55
3ZXL	ENGINEERING THE ACTIVE SITE OF A GH43 GLYCOSIDE HYDROLASE GENERATES A BIOTECHNOLOGICALLY SIGNIFICANT ENZYME THAT DISPLAYS BOTH ENDO- XYLANASE AND EXO-ARABINOFURANOSIDASE ACTIVITY	3.2.1.55
3ZYC	DYNAMIN 1 GTPASE GED FUSION DIMER COMPLEXED WITH GMPPCP	3.6.5.5
3ZYD	CRYSTAL STRUCTURE OF 3C PROTEASE OF COXSACKIEVIRUS B3	3.4.22.28 3.4.22.29 3.6.1.15 2.7.7.48
3ZYE	CRYSTAL STRUCTURE OF 3C PROTEASE MUTANT (T68A) OF COXSACKIEVIRUS B3	3.4.22.28 3.4.22.29 3.6.1.15 2.7.7.48
3ZYZ	CRYSTAL STRUCTURE OF A GLYCOSIDE HYDROLASE FAMILY 3 BETA-GLUCOSIDASE, BGL1 FROM HYPOCREA JECORINA AT 2.1A RESOLUTION.	3.2.1.21
3ZZ1	CRYSTAL STRUCTURE OF A GLYCOSIDE HYDROLASE FAMILY 3 BETA-GLUCOSIDASE, BGL1 FROM HYPOCREA JECORINA AT 2.1A RESOLUTION.	3.2.1.21
3ZZ3	CRYSTAL STRUCTURE OF 3C PROTEASE MUTANT (N126Y) OF COXSACKIEVIRUS B3	3.4.22.28 3.4.22.29 3.6.1.15 2.7.7.48
3ZZ4	CRYSTAL STRUCTURE OF 3C PROTEASE MUTANT (T68A AND N126Y) OF COXSACKIEVIRUS B3	3.4.22.28 3.4.22.29 3.6.1.15 2.7.7.48
3ZZ5	CRYSTAL STRUCTURE OF 3C PROTEASE OF COXSACKIEVIRUS B3 COMPLEXED WITH ALPHA, BETA-UNSATURATED ETHYL ESTER INHIBITOR 74	3.4.22.28 3.4.22.29 3.6.1.15 2.7.7.48
3ZZ6	CRYSTAL STRUCTURE OF 3C PROTEASE OF COXSACKIEVIRUS B3 COMPLEXED WITH MICHAEL RECEPTOR INHIBITOR 75	3.4.22.28 3.4.22.29 3.6.1.15 2.7.7.48
3ZZ7	CRYSTAL STRUCTURE OF 3C PROTEASE OF COXSACKIEVIRUS B3 COMPLEXED WITH ALPHA, BETA-UNSATURATED ETHYL ESTER INHIBITOR 81	3.4.22.28 3.4.22.29 3.6.1.15 2.7.7.48
3ZZ8	CRYSTAL STRUCTURE OF 3C PROTEASE OF COXSACKIEVIRUS B3 COMPLEXED WITH ALPHA, BETA-UNSATURATED ETHYL ESTER INHIBITOR 82	3.4.22.28 3.4.22.29 3.6.1.15 2.7.7.48
3ZZ9	CRYSTAL STRUCTURE OF 3C PROTEASE OF COXSACKIEVIRUS B3 COMPLEXED WITH ALPHA, BETA-UNSATURATED ETHYL ESTER INHIBITOR 83	3.4.22.28 3.4.22.29 3.6.1.15 2.7.7.48
3ZZA	CRYSTAL STRUCTURE OF 3C PROTEASE OF COXSACKIEVIRUS B3 COMPLEXED WITH ALPHA, BETA-UNSATURATED ETHYL ESTER INHIBITOR 84	3.4.22.28 3.4.22.29 3.6.1.15 2.7.7.48
3ZZB	CRYSTAL STRUCTURE OF 3C PROTEASE OF COXSACKIEVIRUS B3 COMPLEXED WITH ALPHA, BETA-UNSATURATED ETHYL ESTER INHIBITOR 85	3.4.22.28 3.4.22.29 3.6.1.15 2.7.7.48
3ZZC	CRYSTAL STRUCTURE OF 3C PROTEASE MUTANT (T68A AND N126Y) OF COXSACKIEVIRUS B3 COMPLEXED WITH ALPHA, BETA-UNSATURATED ETHYL ESTER INHIBITOR 83	3.4.22.28 3.4.22.29 3.6.1.15 2.7.7.48
3ZZD	CRYSTAL STRUCTURE OF 3C PROTEASE MUTANT (T68A AND N126Y) OF COXSACKIEVIRUS B3 COMPLEXED WITH ALPHA, BETA-UNSATURATED ETHYL ESTER INHIBITOR 85	3.4.22.28 3.4.22.29 3.6.1.15 2.7.7.48
3ZZM	CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PURH WITH A NOVEL BOUND NUCLEOTIDE CFAIR, AT 2.2 A RESOLUTION.	2.1.2.3 3.5.4.10
421P	THREE-DIMENSIONAL STRUCTURES OF H-RAS P21 MUTANTS: MOLECULAR BASIS FOR THEIR INABILITY TO FUNCTION AS SIGNAL SWITCH MOLECULES	3.6.5.2
456C	CRYSTAL STRUCTURE OF COLLAGENASE-3 (MMP-13) COMPLEXED TO A DIPHENYL-ETHER SULPHONE BASED HYDROXAMIC ACID	3.4.24
4A01	CRYSTAL STRUCTURE OF THE H-TRANSLOCATING PYROPHOSPHATASE	3.6.1.1 7.1.3.1
4A05	STRUCTURE OF THE CATALYTIC CORE DOMAIN OF THE CELLOBIOHYDROLASE, CEL6A, FROM CHAETOMIUM THERMOPHILUM	3.2.1.91 3.2.1
4A0D	STRUCTURE OF UNLIGANDED HUMAN PARG CATALYTIC DOMAIN	3.2.1.143
4A15	CRYSTAL STRUCTURE OF AN XPD DNA COMPLEX	3.6.4.12
4A16	STRUCTURE OF MOUSE ACETYLCHOLINESTERASE COMPLEX WITH HUPRINE DERIVATIVE	3.1.1.7
4A1F	CRYSTAL STRUCTURE OF C-TERMINAL DOMAIN OF HELICOBACTER PYLORI DNAB HELICASE	3.6.4.12
4A1N	HUMAN MITOCHONDRIAL ENDO-EXONUCLEASE	3.1.30
4A1O	CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PURH COMPLEXED WITH AICAR AND A NOVEL NUCLEOTIDE CFAIR, AT 2.48 A RESOLUTION.	2.1.2.3 3.5.4.10
4A1T	CO-COMPLEX OF THE OF NS3-4A PROTEASE WITH THE INHIBITORY PEPTIDE CP5- 46-A (IN-HOUSE DATA)	3.4.21.98 3.6.1.15 3.6.4.13 3.4.22 2.7.7.48
4A1V	CO-COMPLEX STRUCTURE OF NS3-4A PROTEASE WITH THE OPTIMIZED INHIBITORY PEPTIDE CP5-46A-4D5E	3.4.21.98 3.6.1.15 3.6.4.13 3.4.22 2.7.7.48
4A1X	CO-COMPLEX STRUCTURE OF NS3-4A PROTEASE WITH THE INHIBITORY PEPTIDE CP5-46-A (SYNCHROTRON DATA)	3.4.21.98 3.6.1.15 3.6.4.13 3.4.22 2.7.7.48
4A23	MUS MUSCULUS ACETYLCHOLINESTERASE IN COMPLEX WITH RACEMIC C5685	3.1.1.7
4A26	THE CRYSTAL STRUCTURE OF LEISHMANIA MAJOR N5,N10- METHYLENETETRAHYDROFOLATE DEHYDROGENASE/CYCLOHYDROLASE	1.5.1.5 3.5.4.9
4A2O	STRUCTURE OF THE HUMAN EOSINOPHIL CATIONIC PROTEIN IN COMPLEX WITH SULFATE ANIONS	3.1.27
4A2P	STRUCTURE OF DUCK RIG-I HELICASE DOMAIN	3.6.4.13
4A2Q	STRUCTURE OF DUCK RIG-I TANDEM CARDS AND HELICASE DOMAIN	3.6.4.13
4A2V	STRUCTURE OF DUCK RIG-I C-TERMINAL DOMAIN (CTD)	3.6.4.13
4A2Y	STRUCTURE OF THE HUMAN EOSINOPHIL CATIONIC PROTEIN IN COMPLEX WITH CITRATE ANIONS	3.1.27
4A36	STRUCTURE OF DUCK RIG-I HELICASE DOMAIN BOUND TO 19-MER DSRNA AND ATP TRANSITION STATE ANALOGUE	3.6.4.13
4A3H	2',4' DINITROPHENYL-2-DEOXY-2-FLURO-B-D-CELLOBIOSIDE COMPLEX OF THE ENDOGLUCANASE CEL5A FROM BACILLUS AGARADHAERENS AT 1.6 A RESOLUTION	3.2.1.4
4A3O	CRYSTAL STRUCTURE OF THE USP15 DUSP-UBL MONOMER	3.4.19.12
4A3P	STRUCTURE OF USP15 DUSP-UBL DELETION MUTANT	3.4.19.12
4A3W	CRYSTAL STRUCTURE OF ARCHAEMETZINCIN (AMZA) FROM ARCHAEOGLOBUS FULGIDUS AT 2.16 A RESOLUTION COMPLEXED WITH CITRATE	3 3.4
4A3Y	CRYSTAL STRUCTURE OF RAUCAFFRICINE GLUCOSIDASE FROM AJMALINE BIOSYNTHESIS PATHWAY	3.2.1.125 2.4.1.219
4A3Z	CPGH89CBM32-4 (SELENO-METHIONINE LABELED) PRODUCED BY CLOSTRIDIUM PERFRINGENS	3.2.1.50
4A41	CPGH89CBM32-5, FROM CLOSTRIDIUM PERFRINGENS, IN COMPLEX WITH GALACTOSE	3.2.1.50
4A42	CPGH89CBM32-6 PRODUCED BY CLOSTRIDIUM PERFRINGENS	3.2.1.50
4A45	CPGH89CBM32-5, FROM CLOSTRIDIUM PERFRINGENS, IN COMPLEX WITH GALNAC- BETA-1,3-GALACTOSE	3.2.1.50
4A48	CROSSTALK BETWEEN CU(I) AND ZN(II) HOMEOSTASIS	3.6.3.54 7.2.2.8
4A4A	CPGH89 (E483Q, E601Q), FROM CLOSTRIDIUM PERFRINGENS, IN COMPLEX WITH ITS SUBSTRATE GLCNAC-ALPHA-1,4-GALACTOSE	3.2.1.50
4A4D	CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAIN OF THE HUMAN DEAD-BOX RNA HELICASE DDX5 (P68)	3.6.4.13
4A4J	CROSSTALK BETWEEN CU(I) AND ZN(II) HOMEOSTASIS	3.6.3.54 7.2.2.8
4A4K	CRYSTAL STRUCTURE OF THE S. CEREVISIAE SKI2 INSERTION DOMAIN	3.6.4.13
4A4Q	STEREOSELECTIVE SYNTHESIS, X-RAY ANALYSIS, AND BIOLOGICAL EVALUATION OF A NEW CLASS OF LACTAM BASED HIV-1 PROTEASE INHIBITORS	3.4.23.16
4A4Z	CRYSTAL STRUCTURE OF THE S. CEREVISIAE DEXH HELICASE SKI2 BOUND TO AMPPNP	3.6.4.13
4A57	CRYSTAL STRUCTURE OF TOXOPLASMA GONDII NUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE 3 (NTPDASE3)	3.6.1.15
4A59	CRYSTAL STRUCTURE OF TOXOPLASMA GONDII NUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE 3 (NTPDASE3) IN COMPLEX WITH AMP	3.6.1.5 3.6.1.15
4A5O	CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA N5, N10- METHYLENETETRAHYDROFOLATE DEHYDROGENASE-CYCLOHYDROLASE (FOLD)	1.5.1.5 3.5.4.9
4A5R	CRYSTAL STRUCTURE OF CLASS A BETA-LACTAMASE FROM BACILLUS LICHENIFORMIS BS3 WITH TAZOBACTAM	3.5.2.6
4A5S	CRYSTAL STRUCTURE OF HUMAN DPP4 IN COMPLEX WITH A NOVAL HETEROCYCLIC DPP4 INHIBITOR	3.4.14.5
4A5T	STRUCTURAL BASIS FOR THE CONFORMATIONAL MODULATION	3.4.21.7
4A5U	TURNIP YELLOW MOSAIC VIRUS PROTEINASE AND ESCHERICHIA COLI 30S RIBOSOMAL S15	2.7.7.48 2.1.1 3.4.22 3.6.4
4A69	STRUCTURE OF HDAC3 BOUND TO COREPRESSOR AND INOSITOL TETRAPHOSPHATE	3.5.1.98
4A6A	A115V VARIANT OF DCTP DEAMINASE-DUTPASE FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH DTTP	3.5.4.13 3.5.4.30
4A6B	STEREOSELECTIVE SYNTHESIS, X-RAY ANALYSIS, AND BIOLOGICAL EVALUATION OF A NEW CLASS OF LACTAM BASED HIV-1 PROTEASE INHIBITORS	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
4A6C	STEREOSELECTIVE SYNTHESIS, X-RAY ANALYSIS, AND BIOLOGICAL EVALUATION OF A NEW CLASS OF LACTAM BASED HIV-1 PROTEASE INHIBITORS	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
4A6L	BETA-TRYPTASE INHIBITOR	3.4.21.59
4A6O	CPGH89CBM32-4, PRODUCED BY CLOSTRIDIUM PERFRINGENS, IN COMPLEX WITH GLCNAC-ALPHA-1,4-GALACTOSE	3.2.1.50
4A6V	X-RAY STRUCTURES OF OXAZOLE HYDROXAMATE ECMETAP-MN COMPLEXES	3.4.11.18
4A6W	X-RAY STRUCTURES OF OXAZOLE HYDROXAMATE ECMETAP-MN COMPLEXES	3.4.11.18
4A7B	MMP13 IN COMPLEX WITH A NOVEL SELECTIVE NON ZINC BINDING INHIBITOR CMPD22	3.4.24
4A7D	X-RAY CRYSTAL STRUCTURE OF HEWL FLASH-COOLED AT HIGH PRESSURE	3.2.1.17
4A7I	FACTOR XA IN COMPLEX WITH A POTENT 2-AMINO-ETHANE SULFONAMIDE INHIBITOR	3.4.21.6
4A8A	ASYMMETRIC CRYO-EM RECONSTRUCTION OF E. COLI DEGQ 12-MER IN COMPLEX WITH LYSOZYME	3.4.21.107
4A8B	SYMMETRIZED CRYO-EM RECONSTRUCTION OF E. COLI DEGQ 12-MER IN COMPLEX WITH LYSOZYMES	3.4.21.107
4A8C	SYMMETRIZED CRYO-EM RECONSTRUCTION OF E. COLI DEGQ 12-MER IN COMPLEX WITH A BINDING PEPTIDE	3.4.21.107
4A8D	DEGP DODECAMER WITH BOUND OMP	3.4.21.107
4A92	FULL-LENGTH HCV NS3-4A PROTEASE-HELICASE IN COMPLEX WITH A MACROCYCLIC PROTEASE INHIBITOR.	3.4.21.98 3.6.1.15 3.6.4.13 3.4.22 2.7.7.48
4A94	STRUCTURE OF THE CARBOXYPEPTIDASE INHIBITOR FROM NERITA VERSICOLOR IN COMPLEX WITH HUMAN CPA4	3.4.17
4A9C	CRYSTAL STRUCTURE OF HUMAN SHIP2 IN COMPLEX WITH BIPHENYL 2,3',4,5',6- PENTAKISPHOSPHATE	3.1.3.86
4A9V	PSEUDOMONAS FLUORESCENS PHOX	3.1.3.1
4A9X	PSEUDOMONAS FLUORESCENS PHOX IN COMPLEX WITH THE SUBSTRATE ANALOGUE APPCP	3.1.3.1
4AA1	CRYSTAL STRUCTURE OF ANCE IN COMPLEX WITH ANGIOTENSIN-II	3.4.15.1
4AA2	CRYSTAL STRUCTURE OF ANCE IN COMPLEX WITH BRADYKININ POTENTIATING PEPTIDE B	3.4.15.1
4AA8	BOVINE CHYMOSIN AT 1.8A RESOLUTION	3.4.23.4
4AA9	CAMEL CHYMOSIN AT 1.6A RESOLUTION	3.4.23.4
4AAB	CRYSTAL STRUCTURE OF THE MUTANT D75N I-CREI IN COMPLEX WITH ITS WILD- TYPE TARGET (THE FOUR CENTRAL BASES, 2NN REGION, ARE COMPOSED BY GTAC FROM 5' TO 3')	3.1
4AAD	CRYSTAL STRUCTURE OF THE MUTANT D75N I-CREI IN COMPLEX WITH ITS WILD- TYPE TARGET IN ABSENCE OF METAL IONS AT THE ACTIVE SITE (THE FOUR CENTRAL BASES, 2NN REGION, ARE COMPOSED BY GTAC FROM 5' TO 3')	3.1
4AAE	CRYSTAL STRUCTURE OF THE MUTANT D75N I-CREI IN COMPLEX WITH AN ALTERED TARGET (THE FOUR CENTRAL BASES, 2NN REGION, ARE COMPOSED BY AGCG FROM 5' TO 3')	3.1
4AAF	CRYSTAL STRUCTURE OF THE MUTANT D75N I-CREI IN COMPLEX WITH AN ALTERED TARGET (THE FOUR CENTRAL BASES, 2NN REGION, ARE COMPOSED BY TGCA FROM 5' TO 3')	3.1
4AAG	CRYSTAL STRUCTURE OF THE MUTANT D75N I-CREI IN COMPLEX WITH ITS WILD- TYPE TARGET IN PRESENCE OF CA AT THE ACTIVE SITE (THE FOUR CENTRAL BASES, 2NN REGION, ARE COMPOSED BY GTAC FROM 5' TO 3')	3.1
4AAP	CRYSTAL STRUCTURE OF JMJD5 DOMAIN OF HUMAN LYSINE-SPECIFIC DEMETHYLASE 8 (KDM8) IN COMPLEX WITH N-OXALYLGLYCINE (NOG)	1.14.11.27 1.14.11 3.4
4AAX	CPGH89CBM32-5, FROM CLOSTRIDIUM PERFRINGENS, IN COMPLEX WITH N- ACETYLGALACTOSAMINE	3.2.1.50
4AB1	RECOMBINANT HUMAN CARBOXYLESTERASE 1 FROM WHOLE CABBAGE LOOPERS	3.1.1.1 3.1.1.56 3.1.1.13
4AB8	FRAGMENTS BOUND TO BOVINE TRYPSIN FOR THE SAMPL CHALLENGE	3.4.21.4
4AB9	FRAGMENTS BOUND TO BOVINE TRYPSIN FOR THE SAMPL CHALLENGE	3.4.21.4
4ABA	FRAGMENTS BOUND TO BOVINE TRYPSIN FOR THE SAMPL CHALLENGE	3.4.21.4
4ABB	FRAGMENTS BOUND TO BOVINE TRYPSIN FOR THE SAMPL CHALLENGE	3.4.21.4
4ABD	FRAGMENTS BOUND TO BOVINE TRYPSIN FOR THE SAMPL CHALLENGE	3.4.21.4
4ABE	FRAGMENTS BOUND TO BOVINE TRYPSIN FOR THE SAMPL CHALLENGE	3.4.21.4
4ABF	FRAGMENTS BOUND TO BOVINE TRYPSIN FOR THE SAMPL CHALLENGE	3.4.21.4
4ABG	FRAGMENTS BOUND TO BOVINE TRYPSIN FOR THE SAMPL CHALLENGE	3.4.21.4
4ABH	FRAGMENTS BOUND TO BOVINE TRYPSIN FOR THE SAMPL CHALLENGE	3.4.21.4
4ABI	CO-COMPLEX STRUCTURE OF BOVINE TRYPSIN WITH A MODIFIED BOWMAN-BIRK INHIBITOR (PTA)SFTI-1(1,14), THAT WAS 1,4-DISUBSTITUTED WITH A 1,2,3- TRIZOL TO MIMIC A TRANS AMIDE BOND	3.4.21.4
4ABJ	CO-COMPLEX STRUCTURE OF BOVINE TRYPSIN WITH A MODIFIED BOWMAN-BIRK INHIBITOR (ICA)SFTI-1(1,14), THAT WAS 1,5-DISUBSTITUTED WITH 1,2,3- TRIZOL TO MIMIC A CIS AMIDE BOND	3.4.21.4
4ABT	CRYSTAL STRUCTURE OF TYPE IIF RESTRICTION ENDONUCLEASE NGOMIV WITH COGNATE UNCLEAVED DNA	3.1.21.4
4ABY	CRYSTAL STRUCTURE OF DEINOCOCCUS RADIODURANS RECN HEAD DOMAIN	3.6.1.3
4AC1	THE STRUCTURE OF A FUNGAL ENDO-BETA-N-ACETYLGLUCOSAMINIDASE FROM GLYCOSYL HYDROLASE FAMILY 18, AT 1.3A RESOLUTION	3.2.1.96
4AC7	THE CRYSTAL STRUCTURE OF SPOROSARCINA PASTEURII UREASE IN COMPLEX WITH CITRATE	3.5.1.5
4ACU	AMINOIMIDAZOLES AS BACE-1 INHIBITORS. X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH COMPOUND 14	3.4.23.46
4ACX	AMINOIMIDAZOLES AS BACE-1 INHIBITORS. X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH COMPOUND 23	3.4.23.46
4ACY	SELENOMETHIONINE DERIVATIVE OF THE GH99 ENDO-ALPHA-MANNOSIDASE FROM BACTEROIDES THETAIOTAOMICRON	3.2.1.130
4ACZ	STRUCTURE OF THE GH99 ENDO-ALPHA-MANNOSIDASE FROM BACTEROIDES THETAIOTAOMICRON	3.2.1.130
4AD0	STRUCTURE OF THE GH99 ENDO-ALPHA-MANNOSIDASE FROM BACTERIODES THETAIOTAOMICRON IN COMPLEX WITH BIS-TRIS-PROPANE	3.2.1.130
4AD1	STRUCTURE OF THE GH99 ENDO-ALPHA-MANNOSIDASE FROM BACTEROIDES XYLANISOLVENS	3.2.1.130
4AD2	STRUCTURE OF THE GH99 ENDO-ALPHA-MANNOSIDASE FROM BACTEROIDES XYLANISOLVENS IN COMPLEX WITH GLUCOSE-1,3-ISOFAGOMINE	3.2.1.130
4AD3	STRUCTURE OF THE GH99 ENDO-ALPHA-MANNOSIDASE FROM BACTEROIDES XYLANISOLVENS IN COMPLEX WITH GLUCOSE-1,3-DEOXYMANNOJIRIMYCIN	3.2.1.130
4AD4	STRUCTURE OF THE GH99 ENDO-ALPHA-MANNOSIDASE FROM BACTEROIDES XYLANISOLVENS IN COMPLEX WITH GLUCOSE-1,3-ISOFAGOMINE AND ALPHA-1,2- MANNOBIOSE	3.2.1.130
4AD5	STRUCTURE OF THE GH99 ENDO-ALPHA-MANNOSIDASE FROM BACTEROIDES XYLANISOLVENS IN COMPLEX WITH GLUCOSE-1,3-DEOXYMANNOJIRIMYCIN AND ALPHA-1,2-MANNOBIOSE	3.2.1.130
4AD8	CRYSTAL STRUCTURE OF A DELETION MUTANT OF DEINOCOCCUS RADIODURANS RECN	3.6.1.3
4AD9	CRYSTAL STRUCTURE OF HUMAN LACTB2.	3 3.1.27
4ADP	HCV-J6 NS5B POLYMERASE V405I MUTANT	2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13
4AE3	CRYSTAL STRUCTURE OF AMMOSAMIDE 272:MYOSIN-2 MOTOR DOMAIN COMPLEX	3.6.4.1
4AE7	CRYSTAL STRUCTURE OF HUMAN THEM5	3.1.2.2
4AE8	CRYSTAL STRUCTURE OF HUMAN THEM4	3.1.2.2
4AED	CRYSTAL STRUCTURE OF HUMAN ENTEROVIRUS 71	3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48
4AEE	CRYSTAL STRUCTURE OF MALTOGENIC AMYLASE FROM S.MARINUS	3.2.1.133
4AEF	THE CRYSTAL STRUCTURE OF THERMOSTABLE AMYLASE FROM THE PYROCOCCUS	3.2.1.135
4AEL	PDE10A IN COMPLEX WITH THE INHIBITOR AZ5	3.1.4.17 3.1.4.35
4AEP	HCV-JFH1 NS5B POLYMERASE STRUCTURE AT 1.8 ANGSTROM	2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13
4AEX	HCV-JFH1 NS5B POLYMERASE STRUCTURE AT 2.4 ANGSTROM IN A PRIMITIVE ORTHORHOMBIC SPACE GROUP	2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13
4AF1	ARCHEAL RELEASE FACTOR ARF1	3.6.5.3
4AF8	THE STRUCTURAL BASIS FOR METACASPASE SUBSTRATE SPECIFICITY AND ACTIVATION	3.4.22
4AFP	THE STRUCTURE OF METACASPASE 2 FROM T. BRUCEI DETERMINED IN THE PRESENCE OF SAMARIUM	3.4.22
4AFQ	HUMAN CHYMASE - FYNOMER COMPLEX	3.4.21.39
4AFR	THE STRUCTURE OF METACASPASE 2 (C213A MUTANT) FROM T. BRUCEI	3.4.22
4AFS	HUMAN CHYMASE - FYNOMER COMPLEX	3.4.21.39
4AFU	HUMAN CHYMASE - FYNOMER COMPLEX	3.4.21.39
4AFV	THE STRUCTURE OF METACASPASE 2 FROM T. BRUCEI DETERMINED IN THE PRESENCE OF CALCIUM CHLORIDE	3.4.22
4AFY	CRYSTAL STRUCTURE OF THE FIMX EAL DOMAIN IN COMPLEX WITH REACTION PRODUCT PGPG	3.1.4.52
4AFZ	HUMAN CHYMASE - FYNOMER COMPLEX	3.4.21.39
4AG0	CRYSTAL STRUCTURE OF FIMX EAL DOMAIN	3.1.4.52
4AG1	HUMAN CHYMASE - FYNOMER COMPLEX	3.4.21.39
4AG2	HUMAN CHYMASE - FYNOMER COMPLEX	3.4.21.39
4AGA	HOFMEISTER EFFECTS OF IONIC LIQUIDS IN PROTEIN CRYSTALLIZATION: DIRECT AND WATER-MEDIATED INTERACTIONS	3.2.1.17
4AGJ	CRYSTAL STRUCTURE OF THE CAPSID PROTEIN (110-267) FROM AURA VIRUS IN COMPLEX WITH DIOXANE	3.4.21.90
4AGK	CRYSTAL STRUCTURE OF CAPSID PROTEIN (110-267) FROM AURA VIRUS	3.4.21.90
4AH9	PARALLEL SCREENING OF A LOW MOLECULAR WEIGHT COMPOUND LIBRARY: DO DIFFERENCES IN METHODOLOGY AFFECT HIT IDENTIFICATION	2.7.7.1 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
4AHD	Q12L - ANGIOGENIN MUTANTS AND AMYOTROPHIC LATERAL SCLEROSIS - A BIOCHEMICAL AND BIOLOGICAL ANALYSIS	3.1.27
4AHE	K17I - ANGIOGENIN MUTANTS AND AMYOTROPHIC LATERAL SCLEROSIS - A BIOCHEMICAL AND BIOLOGICAL ANALYSIS	3.1.27
4AHF	K17E - ANGIOGENIN MUTANTS AND AMYOTROPHIC LATERAL SCLEROSIS - A BIOCHEMICAL AND BIOLOGICAL ANALYSIS	3.1.27
4AHG	S28N - ANGIOGENIN MUTANTS AND AMYOTROPHIC LATERAL SCLEROSIS - A BIOCHEMICAL AND BIOLOGICAL ANALYSIS	3.1.27
4AHH	R31K - ANGIOGENIN MUTANTS AND AMYOTROPHIC LATERAL SCLEROSIS - A BIOCHEMICAL AND BIOLOGICAL ANALYSIS	3.1.27
4AHI	K40I - ANGIOGENIN MUTANTS AND AMYOTROPHIC LATERAL SCLEROSIS - A BIOCHEMICAL AND BIOLOGICAL ANALYSIS	3.1.27
4AHJ	I46V - ANGIOGENIN MUTANTS AND AMYOTROPHIC LATERAL SCLEROSIS - A BIOCHEMICAL AND BIOLOGICAL ANALYSIS	3.1.27
4AHK	K54E - ANGIOGENIN MUTANTS AND AMYOTROPHIC LATERAL SCLEROSIS - A BIOCHEMICAL AND BIOLOGICAL ANALYSIS	3.1.27
4AHL	P112L - ANGIOGENIN MUTANTS AND AMYOTROPHIC LATERAL SCLEROSIS - A BIOCHEMICAL AND BIOLOGICAL ANALYSIS	3.1.27
4AHM	V113I - ANGIOGENIN MUTANTS AND AMYOTROPHIC LATERAL SCLEROSIS - A BIOCHEMICAL AND BIOLOGICAL ANALYSIS	3.1.27
4AHN	R121H - ANGIOGENIN MUTANTS AND AMYOTROPHIC LATERAL SCLEROSIS - A BIOCHEMICAL AND BIOLOGICAL ANALYSIS	3.1.27
4AHR	PARALLEL SCREENING OF A LOW MOLECULAR WEIGHT COMPOUND LIBRARY: DO DIFFERENCES IN METHODOLOGY AFFECT HIT IDENTIFICATION	2.7.7.1 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
4AHS	PARALLEL SCREENING OF A LOW MOLECULAR WEIGHT COMPOUND LIBRARY: DO DIFFERENCES IN METHODOLOGY AFFECT HIT IDENTIFICATION	2.7.7.1 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
4AHT	PARALLEL SCREENING OF A LOW MOLECULAR WEIGHT COMPOUND LIBRARY: DO DIFFERENCES IN METHODOLOGY AFFECT HIT IDENTIFICATION	2.7.7.1 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
4AHU	PARALLEL SCREENING OF A LOW MOLECULAR WEIGHT COMPOUND LIBRARY: DO DIFFERENCES IN METHODOLOGY AFFECT HIT IDENTIFICATION	2.7.7.1 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
4AHV	PARALLEL SCREENING OF A LOW MOLECULAR WEIGHT COMPOUND LIBRARY: DO DIFFERENCES IN METHODOLOGY AFFECT HIT IDENTIFICATION	2.7.7.1 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
4AI4	CRYSTAL STRUCTURE OF E38Q MUTANT OF 3-METHYLADENINE DNA GLYCOSYLASE I FROM STAPHYLOCOCCUS AUREUS	3.2.2.20
4AI5	CRYSTAL STRUCTURE OF Y16F OF 3-METHYLADENINE DNA GLYCOSYLASE I (TAG) IN COMPLEX WITH 3-METHYLADENINE	3.2.2.20
4AIA	THE STRUCTURAL BASIS OF 3-METHYLADENINE RECOGNITION BY 3- METHYLADENINE DNA GLYCOSYLASE I (TAG) FROM STAPHYLOCOCCUS AUREUS	3.2.2.20
4AIE	STRUCTURE OF GLUCAN-1,6-ALPHA-GLUCOSIDASE FROM LACTOBACILLUS ACIDOPHILUS NCFM	3.2.1.70 3.2.1.10
4AIG	ADAMALYSIN II WITH PHOSPHONATE INHIBITOR	3.4.24.46
4AIO	CRYSTAL STRUCTURE OF THE STARCH DEBRANCHING ENZYME BARLEY LIMIT DEXTRINASE	3.2.1.41
4AIS	A COMPLEX STRUCTURE OF BTGH84	3.2.1.52 3.2.1.169
4AIU	A COMPLEX STRUCTURE OF BTGH84	3.2.1.52 3.2.1.169
4AJD	IDENTIFICATION AND STRUCTURAL CHARACTERIZATION OF PDE10 FRAGMENT INHIBITORS	3.1.4.17 3.1.4.35
4AJF	IDENTIFICATION AND STRUCTURAL CHARACTERIZATION OF PDE10 FRAGMENT INHIBITORS	3.1.4.17 3.1.4.35
4AJG	IDENTIFICATION AND STRUCTURAL CHARACTERIZATION OF PDE10 FRAGMENT INHIBITORS	3.1.4.17 3.1.4.35
4AJM	DEVELOPMENT OF A PLATE-BASED OPTICAL BIOSENSOR METHODOLOGY TO IDENTIFY PDE10 FRAGMENT INHIBITORS	3.1.4.17 3.1.4.35
4AL2	PEPTIDE DEFORMYLASE (NI-FORM) WITH HYDROSULFIDE	3.5.1.88
4AL3	PEPTIDE DEFORMYLASE (CO-FORM) WITH MERCAPTOETHANOL	3.5.1.88
4AL5	CRYSTAL STRUCTURE OF THE CSY4-CRRNA PRODUCT COMPLEX	3.1
4AL6	CRYSTAL STRUCTURE OF THE S148ACSY4-CRRNA COMPLEX	3.1
4AL7	CRYSTAL STRUCTURE OF THE CSY4-MINIMAL CRRNA COMPLEX	3.1
4AL8	STRUCTURE OF DENGUE VIRUS DIII IN COMPLEX WITH FAB 2H12	3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48
4ALF	PSEUDOMONAS FLUORESCENS PHOX IN COMPLEX WITH PHOSPHATE	3.1.3.1
4AMF	PSEUDOMONAS FLUORESCENS PHOX IN COMPLEX WITH THE SUBSTRATE ANALOGUE APPCP	3.1.3.1
4AMT	CRYSTAL STRUCTURE AT 2.6A OF HUMAN PRORENIN	3.4.23.15
4AMY	PROLYL OLIGOPEPTIDASE FROM PORCINE BRAIN WITH A COVALENTLY BOUND INHIBITOR IC-1	3.4.21.26
4AMZ	PROLYL OLIGOPEPTIDASE FROM PORCINE BRAIN WITH A COVALENTLY BOUND INHIBITOR IC-2	3.4.21.26
4AN0	PROLYL OLIGOPEPTIDASE FROM PORCINE BRAIN WITH A COVALENTLY BOUND INHIBITOR IC-3	3.4.21.26
4AN1	PROLYL OLIGOPEPTIDASE FROM PORCINE BRAIN WITH A COVALENTLY BOUND INHIBITOR IC-4	3.4.21.26
4AN7	KUNITZ TYPE TRYPSIN INHIBITOR COMPLEX WITH PORCINE TRYPSIN	3.4.21.4
4AO1	HIGH RESOLUTION CRYSTAL STRUCTURE OF BOVINE PANCREATIC RIBONUCLEASE CRYSTALLIZED USING IONIC LIQUID	3.1.27.5 4.6.1.18
4AO5	B. SUBTILIS PROPHAGE DUTPASE YOSS IN COMPLEX WITH DUMP	3.6.1.23
4AOH	STRUCTURAL SNAPSHOTS AND FUNCTIONAL ANALYSIS OF HUMAN ANGIOGENIN VARIANTS ASSOCIATED WITH AMYOTROPHIC LATERAL SCLEROSIS (ALS)	3.1.27
4AOO	B. SUBTILIS DUTPASE YNCF IN COMPLEX WITH DU PPI AND MG IN H32	3.6.1.23
4AOQ	CATIONIC TRYPSIN IN COMPLEX WITH MUTATED SPINACIA OLERACEA TRYPSIN INHIBITOR III (SOTI-III) (F14A)	3.4.21.4
4AOR	CATIONIC TRYPSIN IN COMPLEX WITH THE SPINACIA OLERACEA TRYPSIN INHIBITOR III (SOTI-III)	3.4.21.4
4AOZ	B. SUBTILIS DUTPASE YNCF IN COMPLEX WITH DU, PPI AND MG (P212121)	3.6.1.23
4AP9	CRYSTAL STRUCTURE OF PHOSPHOSERINE PHOSPHATASE FROM T. ONNURINEUS IN COMPLEX WITH NDSB-201	3.1.3.3
4APE	THE ACTIVE SITE OF ASPARTIC PROTEINASES	3.4.23.10 3.4.23.22
4APH	HUMAN ANGIOTENSIN-CONVERTING ENZYME IN COMPLEX WITH ANGIOTENSIN-II	3.2.1 3.4.15.1
4APJ	HUMAN ANGIOTENSIN-CONVERTING ENZYME IN COMPLEX WITH BPPB	3.2.1 3.4.15.1
4APR	STRUCTURES OF COMPLEXES OF RHIZOPUSPEPSIN WITH PEPSTATIN AND OTHER STATINE-CONTAINING INHIBITORS	3.4.23.6 3.4.23.21
4AQ0	STRUCTURE OF THE GH92 FAMILY GLYCOSYL HYDROLASE CCMAN5 IN COMPLEX WITH DEOXYMANNOJIRIMYCIN	3.2.1.24
4AQB	MBL-FICOLIN ASSOCIATED PROTEIN-1, MAP-1 AKA MAP44	3.4.21
4AQD	CRYSTAL STRUCTURE OF FULLY GLYCOSYLATED HUMAN BUTYRYLCHOLINESTERASE	3.1.1.8
4AQL	HUMAN GUANINE DEAMINASE IN COMPLEX WITH VALACYCLOVIR	3.5.4.3
4AQO	CRYSTAL STRUCTURE OF THE CALCIUM BOUND PKD-LIKE DOMAIN OF COLLAGENASE G FROM CLOSTRIDIUM HISTOLYTICUM AT 0.99 ANGSTROM RESOLUTION.	3.4.24.3
4AQU	CRYSTAL STRUCTURE OF I-CREI COMPLEXED WITH ITS TARGET METHYLATED AT POSITION PLUS 2 (IN THE B STRAND) IN THE PRESENCE OF CALCIUM	3.1
4AQX	CRYSTAL STRUCTURE OF I-CREI COMPLEXED WITH ITS TARGET METHYLATED AT POSITION PLUS 2 (IN THE B STRAND) IN THE PRESENCE OF MAGNESIUM	3.1
4AR1	CRYSTAL STRUCTURE OF THE PEPTIDASE DOMAIN OF COLLAGENASE H FROM CLOSTRIDIUM HISTOLYTICUM AT 2.01 ANGSTROM RESOLUTION.	3.4.24.3
4AR8	CRYSTAL STRUCTURE OF THE PEPTIDASE DOMAIN OF COLLAGENASE T FROM CLOSTRIDIUM TETANI COMPLEXED WITH THE PEPTIDIC INHIBITOR ISOAMYL- PHOSPHONYL-GLY-PRO-ALA AT 2.05 ANGSTROM RESOLUTION.	3.4.24.3
4AR9	CRYSTAL STRUCTURE OF THE PEPTIDASE DOMAIN OF COLLAGENASE T FROM CLOSTRIDIUM TETANI AT 1.69 ANGSTROM RESOLUTION.	3.4.24.3
4ARA	MUS MUSCULUS ACETYLCHOLINESTERASE IN COMPLEX WITH (R)-C5685 AT 2.5 A RESOLUTION.	3.1.1.7
4ARB	MUS MUSCULUS ACETYLCHOLINESTERASE IN COMPLEX WITH (S)-C5685 AT 2.25 A RESOLUTION.	3.1.1.7
4ARE	CRYSTAL STRUCTURE OF THE COLLAGENASE UNIT OF COLLAGENASE G FROM CLOSTRIDIUM HISTOLYTICUM AT 2.19 ANGSTROM RESOLUTION.	3.4.24.3
4ARF	CRYSTAL STRUCTURE OF THE PEPTIDASE DOMAIN OF COLLAGENASE H FROM CLOSTRIDIUM HISTOLYTICUM IN COMPLEX WITH THE PEPTIDIC INHIBITOR ISOAMYLPHOSPHONYL-GLY-PRO-ALA AT 1.77 ANGSTROM RESOLUTION.	3.4.24.3
4ARJ	CRYSTAL STRUCTURE OF A PESTICIN (TRANSLOCATION AND RECEPTOR BINDING DOMAIN) FROM Y. PESTIS AND T4-LYSOZYME CHIMERA	3.2.1.17
4ARN	CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAIN OF DROSOPHILA TOLL RECEPTOR	3.2.2.6
4ARO	HAFNIA ALVEI PHYTASE IN COMPLEX WITH MYO-INOSITOL HEXAKIS SULPHATE	3.1.3.26
4ARR	CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAIN OF DROSOPHILA TOLL RECEPTOR WITH THE MAGIC TRIANGLE I3C	3.2.2.6
4ARS	HAFNIA ALVEI PHYTASE APO FORM	3.1.3.26
4ARU	HAFNIA ALVEI PHYTASE IN COMPLEX WITH TARTRATE	3.1.3.26
4ARV	YERSINIA KRISTENSENII PHYTASE APO FORM	3.1.3.26
4AS2	PSEUDOMONAS AERUGINOSA PHOSPHORYLCHOLINE PHOSPHATASE. MONOCLINIC FORM	3.1.3.75
4AS3	PSEUDOMONAS AERUGINOSA PHOSPHORYLCHOLINE PHOSPHATASE. ORTHORHOMBIC FORM	3.1.3.75
4AS4	STRUCTURE OF HUMAN INOSITOL MONOPHOSPHATASE 1	3.1.3.25 3.1.3.94
4AS5	STRUCTURE OF MOUSE INOSITOL MONOPHOSPHATASE 1	3.1.3.25 3.1.3.94
4ASH	CRYSTAL STRUCTURE OF THE NS6 PROTEASE FROM MURINE NOROVIRUS 1	3.4.22.66 2.7.7.48 3.6.1.15
4ASM	CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF BETA-AGARASE D FROM ZOBELLIA GALACTANIVORANS	3.2.1.81
4ASQ	CRYSTAL STRUCTURE OF ANCE IN COMPLEX WITH BRADYKININ	3.4.15.1
4ASR	CRYSTAL STRUCTURE OF ANCE IN COMPLEX WITH THR6-BRADYKININ	3.4.15.1
4ATD	CRYSTAL STRUCTURE OF NATIVE RAUCAFFRICINE GLUCOSIDASE	3.2.1.125 2.4.1.219
4ATE	HIGH RESOLUTION CRYSTAL STRUCTURE OF BETA-PORPHYRANASE A FROM ZOBELLIA GALACTANIVORANS	3.2.1.178
4ATF	CRYSTAL STRUCTURE OF INACTIVATED MUTANT BETA-AGARASE B IN COMPLEX WITH AGARO-OCTAOSE	3.2.1.81
4ATL	CRYSTAL STRUCTURE OF RAUCAFFRICINE GLUCOSIDASE IN COMPLEX WITH GLUCOSE	3.2.1.125 2.4.1.219
4ATO	NEW INSIGHTS INTO THE MECHANISM OF BACTERIAL TYPE III TOXIN-ANTITOXIN SYSTEMS: SELECTIVE TOXIN INHIBITION BY A NON-CODING RNA PSEUDOKNOT	3.1
4ATU	HUMAN DOUBLECORTIN N-DC REPEAT PLUS LINKER, AND TUBULIN (2XRP) DOCKED INTO AN 8A CRYO-EM MAP OF DOUBLECORTIN-STABILISED MICROTUBULES RECONSTRUCTED IN ABSENCE OF KINESIN	3.6.5.6
4ATW	THE CRYSTAL STRUCTURE OF ARABINOFURANOSIDASE	3.2.1.55
4ATX	RIGOR KINESIN MOTOR DOMAIN WITH AN ORDERED NECK-LINKER, DOCKED ON TUBULIN DIMER, MODELLED INTO THE 8A CRYO-EM MAP OF DOUBLECORTIN- MICROTUBULES DECORATED WITH KINESIN	3.6.5.6
4AU0	HYPOCREA JECORINA CEL6A D221A MUTANT SOAKED WITH 6-CHLORO-4- METHYLUMBELLIFERYL-BETA-CELLOBIOSIDE	3.2.1.91
4AUC	BOVINE CHYMOSIN IN COMPLEX WITH PEPSTATIN A	3.4.23.4
4AUO	CRYSTAL STRUCTURE OF MMP-1(E200A) IN COMPLEX WITH A TRIPLE-HELICAL COLLAGEN PEPTIDE	3.4.24.7
4AV3	CRYSTAL STRUCTURE OF THERMOTOGA MARITIMA SODIUM PUMPING MEMBRANE INTEGRAL PYROPHOSPHATASE WITH METAL IONS IN ACTIVE SITE	3.6.1.1
4AV6	CRYSTAL STRUCTURE OF THERMOTOGA MARITIMA SODIUM PUMPING MEMBRANE INTEGRAL PYROPHOSPHATASE AT 4 A IN COMPLEX WITH PHOSPHATE AND MAGNESIUM	3.6.1.1
4AVG	INFLUENZA STRAIN PH1N1 2009 POLYMERASE SUBUNIT PA ENDONUCLEASE IN COMPLEX WITH DIKETO COMPOUND 2	3.1
4AVL	INFLUENZA STRAIN PH1N1 2009 POLYMERASE SUBUNIT PA ENDONUCLEASE IN COMPLEX WITH DTMP	3.1
4AVN	THERMOBIFIDA FUSCA CELLOBIOHYDROLASE CEL6B CATALYTIC MUTANT D226A- S232A COCRYSTALLIZED WITH CELLOBIOSE	3.2.1.91 3.2.1
4AVO	THERMOBIFIDA FUSCA CELLOBIOHYDROLASE CEL6B CATALYTIC MUTANT D274A COCRYSTALLIZED WITH CELLOBIOSE	3.2.1.91 3.2.1
4AVQ	INFLUENZA STRAIN PH1N1 2009 POLYMERASE SUBUNIT PA ENDONUCLEASE	3.1
4AW6	CRYSTAL STRUCTURE OF THE HUMAN NUCLEAR MEMBRANE ZINC METALLOPROTEASE ZMPSTE24 (FACE1)	3.4.24.84
4AW7	BPGH86A: A BETA-PORPHYRANASE OF GLYCOSIDE HYDROLASE FAMILY 86 FROM THE HUMAN GUT BACTERIUM BACTEROIDES PLEBEIUS	3.2.1.178
4AW9	CRYSTAL STRUCTURE OF ACTIVE LEGUMAIN IN COMPLEX WITH YVAD-CMK	3.4.22.34
4AWA	CRYSTAL STRUCTURE OF ACTIVE LEGUMAIN IN COMPLEX WITH YVAD-CMK AT PH 5.0	3.4.22.34
4AWB	CRYSTAL STRUCTURE OF ACTIVE LEGUMAIN IN COMPLEX WITH AAN-CMK	3.4.22.34
4AWD	CRYSTAL STRUCTURE OF THE BETA-PORPHYRANASE BPGH16B (BACPLE_01689) FROM THE HUMAN GUT BACTERIUM BACTEROIDES PLEBEIUS	3.2.1.178
4AWE	THE CRYSTAL STRUCTURE OF CHRYSONILIA SITOPHILA ENDO-BETA-D-1,4- MANNANASE	3.2.1.78
4AWF	INFLUENZA STRAIN PH1N1 2009 POLYMERASE SUBUNIT PA ENDONUCLEASE IN COMPLEX WITH 2 4-DIOXO-4-PHENYLBUTANOIC ACID DPBA	3.1
4AWG	INFLUENZA STRAIN PH1N1 2009 POLYMERASE SUBUNIT PA ENDONUCLEASE IN COMPLEX WITH DIKETO COMPOUND 3	3.1
4AWH	INFLUENZA STRAIN PH1N1 2009 POLYMERASE SUBUNIT PA ENDONUCLEASE IN COMPLEX WITH RUMP	3.1
4AWK	INFLUENZA STRAIN PH1N1 2009 POLYMERASE SUBUNIT PA ENDONUCLEASE IN COMPLEX WITH DIKETO COMPOUND 1	3.1
4AWM	INFLUENZA STRAIN PH1N1 2009 POLYMERASE SUBUNIT PA ENDONUCLEASE IN COMPLEX WITH (-)-EPIGALLOCATECHIN GALLATE FROM GREEN TEA	3.1
4AWN	STRUCTURE OF RECOMBINANT HUMAN DNASE I (RHDNASEI) IN COMPLEX WITH MAGNESIUM AND PHOSPHATE.	3.1.21.1
4AWO	COMPLEX OF HSP90 ATPASE DOMAIN WITH TROPANE DERIVED INHIBITORS	3.6.4.10
4AWP	COMPLEX OF HSP90 ATPASE DOMAIN WITH TROPANE DERIVED INHIBITORS	3.6.4.10
4AWQ	COMPLEX OF HSP90 ATPASE DOMAIN WITH TROPANE DERIVED INHIBITORS	3.6.4.10
4AX4	PROLYL OLIGOPEPTIDASE FROM PORCINE BRAIN, H680A MUTANT	3.4.21.26
4AX6	HYPOCREA JECORINA CEL6A D221A MUTANT SOAKED WITH 6-CHLORO-4- PHENYLUMBELLIFERYL-BETA-CELLOBIOSIDE	3.2.1.91
4AX9	HUMAN THROMBIN COMPLEXED WITH NAPSAGATRAN, RO0466240	3.4.21.5
4AXB	CRYSTAL STRUCTURE OF SOMAN-AGED HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH 2-PAM	3.1.1.8
4AXL	HUMAN CATHEPSIN L APO FORM WITH ZN	3.4.22.15
4AXM	TRIAZINE CATHEPSIN INHIBITOR COMPLEX	3.4.22.15
4AXN	HALLMARKS OF PROCESSIVE AND NON-PROCESSIVE GLYCOSIDE HYDROLASES REVEALED FROM COMPUTATIONAL AND CRYSTALLOGRAPHIC STUDIES OF THE SERRATIA MARCESCENS CHITINASES	3.2.1.14
4AXQ	CRYSTAL STRUCTURE OF ARCHAEMETZINCIN (AMZA) FROM ARCHAEOGLOBUS FULGIDUS AT 1.4 A RESOLUTION	3 3.4
4AXT	CRYSTAL STRUCTURE OF HEN EGG WHITE LYSOZYME FROM AN AUTO HARVESTED CRYSTAL, CONTROL EXPERIMENT	3.2.1.17
4AXV	BIOCHEMICAL AND STRUCTURAL CHARACTERIZATION OF THE MPAA AMIDASE AS PART OF A CONSERVED SCAVENGING PATHWAY FOR PEPTIDOGLYCAN DERIVED PEPTIDES IN GAMMA-PROTEOBACTERIA	3.4.17
4AY2	CAPTURING 5' TRI-PHOSPHORYLATED RNA DUPLEX BY RIG-I	3.6.4.13
4AYK	CATALYTIC FRAGMENT OF HUMAN FIBROBLAST COLLAGENASE COMPLEXED WITH CGS-27023A, NMR, 30 STRUCTURES	3.4.24.7
4AYO	STRUCTURE OF THE GH47 PROCESSING ALPHA-1,2-MANNOSIDASE FROM CAULOBACTER STRAIN K31	3.2.1.113
4AYP	STRUCTURE OF THE GH47 PROCESSING ALPHA-1,2-MANNOSIDASE FROM CAULOBACTER STRAIN K31 IN COMPLEX WITH THIOMANNOBIOSIDE	3.2.1.113
4AYQ	STRUCTURE OF THE GH47 PROCESSING ALPHA-1,2-MANNOSIDASE FROM CAULOBACTER STRAIN K31 IN COMPLEX WITH MANNOIMIDAZOLE	3.2.1.113
4AYR	STRUCTURE OF THE GH47 PROCESSING ALPHA-1,2-MANNOSIDASE FROM CAULOBACTER STRAIN K31 IN COMPLEX WITH NOEUROMYCIN	3.2.1.113
4AYV	HUMAN THROMBIN - INHIBITOR COMPLEX	3.4.21.5
4AYY	HUMAN THROMBIN - INHIBITOR COMPLEX	3.4.21.5
4AZ0	CRYSTAL STRUCTURE OF CATHEPSIN A, COMPLEXED WITH 8A.	3.4.16.5
4AZ2	HUMAN THROMBIN - INHIBITOR COMPLEX	3.4.21.5
4AZ3	CRYSTAL STRUCTURE OF CATHEPSIN A, COMPLEXED WITH 15A	3.4.16.5
4AZ4	E.COLI DEFORMYLASE WITH CO(II) AND HYDROSULFIDE	3.5.1.88
4AZ5	DIFFERENTIAL INHIBITION OF THE TANDEM GH20 CATALYTIC MODULES IN THE PNEUMOCOCCAL EXO-BETA-D-N-ACETYLGLUCOSAMINIDASE, STRH	3.2.1.52
4AZ6	DIFFERENTIAL INHIBITION OF THE TANDEM GH20 CATALYTIC MODULES IN THE PNEUMOCOCCAL EXO-BETA-D-N-ACETYLGLUCOSAMINIDASE, STRH	3.2.1.52
4AZ7	DIFFERENTIAL INHIBITION OF THE TANDEM GH20 CATALYTIC MODULES IN THE PNEUMOCOCCAL EXO-BETA-D-N-ACETYLGLUCOSAMINIDASE, STRH	3.2.1.52
4AZB	DIFFERENTIAL INHIBITION OF THE TANDEM GH20 CATALYTIC MODULES IN THE PNEUMOCOCCAL EXO-BETA-D-N-ACETYLGLUCOSAMINIDASE, STRH	3.2.1.52
4AZG	DIFFERENTIAL INHIBITION OF THE TANDEM GH20 CATALYTIC MODULES IN THE PNEUMOCOCCAL EXO-BETA-D-N-ACETYLGLUCOSAMINIDASE, STRH	3.2.1.52
4AZI	DIFFERENTIAL INHIBITION OF THE TANDEM GH20 CATALYTIC MODULES IN THE PNEUMOCOCCAL EXO-BETA-D-N-ACETYLGLUCOSAMINIDASE, STRH	3.2.1.52
4AZY	DESIGN AND SYNTHESIS OF BACE1 INHIBITORS WITH IN VIVO BRAIN REDUCTION OF BETA-AMYLOID PEPTIDES (COMPOUND 10)	3.4.23.46
4AZZ	CARBOHYDRATE BINDING MODULE CBM66 FROM BACILLUS SUBTILIS	3.2.1.80
4B00	DESIGN AND SYNTHESIS OF BACE1 INHIBITORS WITH IN VIVO BRAIN REDUCTION OF BETA-AMYLOID PEPTIDES (COMPOUND (R)-41)	3.4.23.46
4B03	6A ELECTRON CRYOMICROSCOPY STRUCTURE OF IMMATURE DENGUE VIRUS SEROTYPE 1	3.4.21.91 3.6.1.15 3.6.4.13
4B04	CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN DUSP26 (C152S)	3.1.3.16 3.1.3.48
4B05	PRECLINICAL CHARACTERIZATION OF AZD3839, A NOVEL CLINICAL CANDIDATE BACE1 INHIBITOR FOR THE TREATMENT OF ALZHEIMER DISEASE	3.4.23.46
4B0D	CRYSTAL STRUCTURE OF HEN EGG WHITE LYSOZYME FROM AN AUTO HARVESTED CRYSTAL	3.2.1.17
4B0H	B. SUBTILIS DUTPASE YNCF IN COMPLEX WITH DU, PPI AND MG B (P212121)	3.6.1.23
4B0O	CRYSTAL STRUCTURE OF SOMAN-AGED HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH BENZYL PYRIDINIUM-4-METHYLTRICHLOROACETIMIDATE	3.1.1.8
4B0P	CRYSTAL STRUCTURE OF SOMAN-AGED HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH METHYL 2-(PENTAFLUOROBENZYLOXYIMINO)PYRIDINIUM	3.1.1.8
4B0Q	LEAD GENERATION OF BACE1 INHIBITORS BY COUPLING NON-AMIDINE NEW WARHEADS TO A KNOWN BINDING SCAFFOLD	3.4.23.46
4B0R	STRUCTURE OF THE DEAMIDASE-DEPUPYLASE DOP OF THE PROKARYOTIC UBIQUITIN-LIKE MODIFICATION PATHWAY	3.4 3.5.1
4B0S	STRUCTURE OF THE DEAMIDASE-DEPUPYLASE DOP OF THE PROKARYOTIC UBIQUITIN-LIKE MODIFICATION PATHWAY IN COMPLEX WITH ATP	3.4 3.5.1
4B1A	CRYSTAL STRUCTURE OF LYSOZYME WITH KEGGIN MOLECULE	3.2.1.17
4B1C	NEW AMINOIMIDAZOLES AS BACE-1 INHIBITORS: FROM RATIONAL DESIGN TO AB- LOWERING IN BRAIN	3.4.23.46
4B1D	NEW AMINOIMIDAZOLES AS BACE-1 INHIBITORS: FROM RATIONAL DESIGN TO AB- LOWERING IN BRAIN	3.4.23.46
4B1E	NEW AMINOIMIDAZOLES AS BACE-1 INHIBITORS: FROM RATIONAL DESIGN TO AB- LOWERING IN BRAIN	3.4.23.46
4B1G	STRUCTURE OF UNLIGANDED HUMAN PARG CATALYTIC DOMAIN	3.2.1.143
4B1H	STRUCTURE OF HUMAN PARG CATALYTIC DOMAIN IN COMPLEX WITH ADP-RIBOSE	3.2.1.143
4B1I	STRUCTURE OF HUMAN PARG CATALYTIC DOMAIN IN COMPLEX WITH OA-ADP-HPD	3.2.1.143
4B1J	STRUCTURE OF HUMAN PARG CATALYTIC DOMAIN IN COMPLEX WITH ADP-HPD	3.2.1.143
4B1L	CARBOHYDRATE BINDING MODULE CBM66 FROM BACILLUS SUBTILIS	3.2.1.80
4B1M	CARBOHYDRATE BINDING MODULE CBM66 FROM BACILLUS SUBTILIS	3.2.1.80
4B1T	STRUCTURE OF THE FACTOR XA-LIKE TRYPSIN VARIANT TRIPLE-ALA (TA) IN COMPLEX WITH EGLIN C	3.4.21.4
4B20	STRUCTURAL BASIS OF DNA LOOP RECOGNITION BY ENDONUCLEASE V	3.1.21.7
4B21	UNPRECEDENTED SCULPTING OF DNA AT ABASIC SITES BY DNA GLYCOSYLASE HOMOLOG MAG2	3.2.2.21
4B22	UNPRECEDENTED SCULPTING OF DNA AT ABASIC SITES BY DNA GLYCOSYLASE HOMOLOG MAG2	3.2.2.21
4B23	UNPRECEDENTED SCULPTING OF DNA AT ABASIC SITES BY DNA GLYCOSYLASE HOMOLOG MAG2	3.2.2.21
4B24	UNPRECEDENTED SCULPTING OF DNA AT ABASIC SITES BY DNA GLYCOSYLASE HOMOLOG MAG2	3.2.2.21
4B2A	STRUCTURE OF THE FACTOR XA-LIKE TRYPSIN VARIANT TRIPLE-ALA (TGA) IN COMPLEX WITH EGLIN C	3.4.21.4
4B2B	STRUCTURE OF THE FACTOR XA-LIKE TRYPSIN VARIANT TRIPLE-ALA (TGPA) IN COMPLEX WITH EGLIN C	3.4.21.4
4B2C	STRUCTURE OF THE FACTOR XA-LIKE TRYPSIN VARIANT TRIPLE-ALA (TPA) IN COMPLEX WITH EGLIN C	3.4.21.4
4B2O	CRYSTAL STRUCTURE OF BACILLUS SUBTILIS YMDB, A GLOBAL REGULATOR OF LATE ADAPTIVE RESPONSES.	3.1.4.16
4B36	CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN WITH AN ENGINEERED LOOP EXHIBITS CONFORMATIONAL FLEXIBILITY AT THE FUNCTIONAL REGIONS OF THE MOLECULE	3.1.27
4B3F	CRYSTAL STRUCTURE OF IGHMBP2 HELICASE	3.6.4.12 3.6.4.13
4B3G	CRYSTAL STRUCTURE OF IGHMBP2 HELICASE IN COMPLEX WITH RNA	3.6.4.12 3.6.4.13
4B3L	FAMILY 1 6-PHOSPHO-BETA-D GLYCOSIDASE FROM STREPTOCOCCUS PYOGENES	3.2.1.21 3.2.1.86
4B3O	STRUCTURES OF HIV-1 RT AND RNA-DNA COMPLEX REVEAL A UNIQUE RT CONFORMATION AND SUBSTRATE INTERFACE	2.7.7.49 2.7.7.7 3.1.26.13 3.4.23.16 3.1.13.2 2.7.7 3.1
4B3Q	STRUCTURES OF HIV-1 RT AND RNA-DNA COMPLEX REVEAL A UNIQUE RT CONFORMATION AND SUBSTRATE INTERFACE	2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 3.4.23.16 2.7.7 3.1
4B49	1.15 A STRUCTURE OF LYSOZYME CRYSTALLIZED WITHOUT 2-METHYL-2,4- PENTANEDIOL	3.2.1.17
4B4C	CRYSTAL STRUCTURE OF THE DNA-BINDING DOMAIN OF HUMAN CHD1.	3.6.4.12
4B4E	1.00 A STRUCTURE OF LYSOZYME CRYSTALLIZED WITH (R)-2-METHYL-2,4- PENTANEDIOL	3.2.1.17
4B4F	THERMOBIFIDA FUSCA CEL6B(E3) CO-CRYSTALLIZED WITH CELLOBIOSE	3.2.1.91 3.2.1
4B4H	THERMOBIFIDA FUSCA CELLOBIOHYDROLASE CEL6B(E3) CATALYTIC DOMAIN	3.2.1.91 3.2.1
4B4I	1.20 A STRUCTURE OF LYSOZYME CRYSTALLIZED WITH (S)-2-METHYL-2,4- PENTANEDIOL	3.2.1.17
4B4J	1.25 A STRUCTURE OF LYSOZYME CRYSTALLIZED WITH (RS)-2-METHYL-2,4- PENTANEDIOL	3.2.1.17
4B4U	CRYSTAL STRUCTURE OF ACINETOBACTER BAUMANNII N5, N10- METHYLENETETRAHYDROFOLATE DEHYDROGENASE-CYCLOHYDROLASE (FOLD) COMPLEXED WITH NADP COFACTOR	1.5.1.5 3.5.4.9
4B4V	CRYSTAL STRUCTURE OF ACINETOBACTER BAUMANNII N5, N10- METHYLENETETRAHYDROFOLATE DEHYDROGENASE-CYCLOHYDROLASE (FOLD) COMPLEXED WITH NADP COFACTOR AND INHIBITOR LY354899	1.5.1.5 3.5.4.9
4B4W	CRYSTAL STRUCTURE OF ACINETOBACTER BAUMANNII N5, N10- METHYLENETETRAHYDROFOLATE DEHYDROGENASE-CYCLOHYDROLASE (FOLD) COMPLEXED WITH NADP COFACTOR AND AN INHIBITOR	1.5.1.5 3.5.4.9
4B4X	CRYSTAL STRUCTURE OF A COMPLEX BETWEEN ACTINOMADURA R39 DD-PEPTIDASE AND A SULFONAMIDE BORONATE INHIBITOR	3.4.16.4
4B4Z	CRYSTAL STRUCTURE OF A COMPLEX BETWEEN ACTINOMADURA R39 DD-PEPTIDASE AND A SULFONAMIDE BORONATE INHIBITOR	3.4.16.4
4B52	CRYSTAL STRUCTURE OF GENTLYASE, THE NEUTRAL METALLOPROTEASE OF PAENIBACILLUS POLYMYXA	3.4.24.4 3.4.24
4B56	STRUCTURE OF ECTONUCLEOTIDE PYROPHOSPHATASE-PHOSPHODIESTERASE-1 (NPP1)	3.1.4.1 3.6.1.9
4B5F	SUBSTRATE BOUND NEISSERIA AP ENDONUCLEASE IN ABSENCE OF METAL IONS (CRYSTAL FORM 1)	3.1.11.2
4B5G	SUBSTRATE BOUND NEISSERIA AP ENDONUCLEASE IN ABSENCE OF METAL IONS (CRYSTAL FORM 2)	3.1.11.2
4B5H	SUBSTATE BOUND INACTIVE MUTANT OF NEISSERIA AP ENDONUCLEASE IN PRESENCE OF METAL IONS	3.1.11.2
4B5I	PRODUCT COMPLEX OF NEISSERIA AP ENDONUCLEASE IN PRESENCE OF METAL IONS	3.1.11.2
4B5J	NEISSERIA AP ENDONUCLEASE BOUND TO THE SUBSTRATE WITH AN ORPHAN ADENINE BASE	3.1.11.2
4B5L	THE 1.6 A HIGH ENERGY ROOM TEMPERATURE STRUCTURE OF PROTEINASE K AT 38.4 KEV AND 0.04 MGY	3.4.21.64
4B5M	NEISSERIA AP ENDONUCLEASE BOUND TO THE SUBSTRATE WITH A CYTOSINE ORPHAN BASE	3.1.11.2
4B6E	DISCOVERY OF AN ALLOSTERIC MECHANISM FOR THE REGULATION OF HCV NS3 PROTEIN FUNCTION	3.4.21.98 3.6.1.15 3.6.4.13 3.4.22 2.7.7.48
4B6F	DISCOVERY OF AN ALLOSTERIC MECHANISM FOR THE REGULATION OF HCV NS3 PROTEIN FUNCTION	3.4.21.98 3.6.1.15 3.6.4.13 3.4.22 2.7.7.48
4B6G	THE CRYSTAL STRUCTURE OF THE NEISSERIAL ESTERASE D.	3.1.2.12
4B6H	STRUCTURE OF HDCP1A IN COMPLEX WITH PROLINE RICH SEQUENCE OF PNRC2	3
4B6J	CRYSTAL STRUCTURE OF PHOSPHOSERINE PHOSPHATASE FROM T. ONNURINEUS	3.1.3.3
4B70	AMINOIMIDAZOLES AS BACE-1 INHIBITORS: FROM DE NOVO DESIGN TO AB- LOWERING IN BRAIN	3.4.23.46
4B71	DISCOVERY OF AN ALLOSTERIC MECHANISM FOR THE REGULATION OF HCV NS3 PROTEIN FUNCTION	3.4.21.98 3.6.1.15 3.6.4.13 3.4.22 2.7.7.48
4B72	AMINOIMIDAZOLES AS BACE-1 INHIBITORS: FROM DE NOVO DESIGN TO AB- LOWERING IN BRAIN	3.4.23.46
4B73	DISCOVERY OF AN ALLOSTERIC MECHANISM FOR THE REGULATION OF HCV NS3 PROTEIN FUNCTION	3.4.21.98 3.6.1.15 3.6.4.13 3.4.22 2.7.7.48
4B74	DISCOVERY OF AN ALLOSTERIC MECHANISM FOR THE REGULATION OF HCV NS3 PROTEIN FUNCTION	3.4.21.98 3.6.1.15 3.6.4.13 3.4.22 2.7.7.48
4B75	DISCOVERY OF AN ALLOSTERIC MECHANISM FOR THE REGULATION OF HCV NS3 PROTEIN FUNCTION	3.4.21.98 3.6.1.15 3.6.4.13 3.4.22 2.7.7.48
4B76	DISCOVERY OF AN ALLOSTERIC MECHANISM FOR THE REGULATION OF HCV NS3 PROTEIN FUNCTION	3.4.21.98 3.6.1.15 3.6.4.13 3.4.22 2.7.7.48
4B77	AMINOIMIDAZOLES AS BACE-1 INHIBITORS: FROM DE NOVO DESIGN TO AB- LOWERING IN BRAIN	3.4.23.46
4B78	AMINOIMIDAZOLES AS BACE-1 INHIBITORS: FROM DE NOVO DESIGN TO AB- LOWERING IN BRAIN	3.4.23.46
4B7J	H1N1 2009 PANDEMIC INFLUENZA VIRUS: RESISTANCE OF THE I223R NEURAMINIDASE MUTANT EXPLAINED BY KINETIC AND STRUCTURAL ANALYSIS	3.2.1.18
4B7M	H1N1 2009 PANDEMIC INFLUENZA VIRUS: RESISTANCE OF THE I223R NEURAMINIDASE MUTANT EXPLAINED BY KINETIC AND STRUCTURAL ANALYSIS	3.2.1.18
4B7N	H1N1 2009 PANDEMIC INFLUENZA VIRUS: RESISTANCE OF THE I223R NEURAMINIDASE MUTANT EXPLAINED BY KINETIC AND STRUCTURAL ANALYSIS	3.2.1.18
4B7Q	H1N1 2009 PANDEMIC INFLUENZA VIRUS: RESISTANCE OF THE I223R NEURAMINIDASE MUTANT EXPLAINED BY KINETIC AND STRUCTURAL ANALYSIS	3.2.1.18
4B7R	H1N1 2009 PANDEMIC INFLUENZA VIRUS: RESISTANCE OF THE I223R NEURAMINIDASE MUTANT EXPLAINED BY KINETIC AND STRUCTURAL ANALYSIS	3.2.1.18
4B7Z	MUS MUSCULUS ACETYLCHOLINESTERASE IN COMPLEX WITH N-(2-DIETHYLAMINO-ETHYL)-1-(4-METHYLPHENYL)-METHANESULFONAMIDE	3.1.1.7
4B80	MUS MUSCULUS ACETYLCHOLINESTERASE IN COMPLEX WITH N-(2-DIETHYLAMINO-ETHYL)-1-(4-FLUORO-PHENYL)-METHANESULFONAMIDE	3.1.1.7
4B81	MUS MUSCULUS ACETYLCHOLINESTERASE IN COMPLEX WITH 1-(4-CHLORO-PHENYL)- N-(2-DIETHYLAMINO-ETHYL)-METHANESULFONAMIDE	3.1.1.7
4B82	MUS MUSCULUS ACETYLCHOLINESTERASE IN COMPLEX WITH N-(2-DIETHYLAMINO- ETHYL)-2-FLUORANYL-BENZENESULFONAMIDE	3.1.1.7
4B83	MUS MUSCULUS ACETYLCHOLINESTERASE IN COMPLEX WITH N-(2-DIETHYLAMINO- ETHYL)-3-METHOXY-BENZENESULFONAMIDE	3.1.1.7
4B84	MUS MUSCULUS ACETYLCHOLINESTERASE IN COMPLEX WITH N-(2-DIETHYLAMINO- ETHYL)-3-TRIFLUOROMETHYL-BENZENESULFONAMIDE	3.1.1.7
4B85	MUS MUSCULUS ACETYLCHOLINESTERASE IN COMPLEX WITH 4-CHLORANYL-N-(2- DIETHYLAMINO-ETHYL)-BENZENESULFONAMIDE	3.1.1.7
4B88	ANCESTRAL (GNCA) BETA-LACTAMASE CLASS A	3.5.2.6
4B9Y	CRYSTAL STRUCTURE OF APO AGD31B, ALPHA-TRANSGLUCOSYLASE IN GLYCOSIDE HYDROLASE FAMILY 31	3.2.1.20 2.4.1.161
4B9Z	CRYSTAL STRUCTURE OF AGD31B, ALPHA-TRANSGLUCOSYLASE, COMPLEXED WITH ACARBOSE	3.2.1.20 2.4.1.161
4BA0	CRYSTAL STRUCTURE OF AGD31B, ALPHA-TRANSGLUCOSYLASE, COMPLEXED WITH 5F-ALPHA-GLCF	3.2.1.20 2.4.1.161
4BA1	ARCHAEAL EXOSOME (RRP4-RRP41(D182A)-RRP42) BOUND TO INORGANIC PHOSPHATE	3.1.13
4BAC	PROTOTYPE FOAMY VIRUS STRAND TRANSFER COMPLEXES ON PRODUCT DNA	2.7.7.49 2.7.7.7 3.1.26.13 3.1.26.4 3.4.23 2.7.7 3.1
4BAD	HEN EGG-WHITE LYSOZYME STRUCTURE IN COMPLEX WITH THE EUROPIUM TRIS- HYDROXYMETHYLTRIAZOLEDIPICOLINATE COMPLEX AT 1.35 A RESOLUTION.	3.2.1.17
4BAF	HEN EGG-WHITE LYSOZYME STRUCTURE IN COMPLEX WITH THE EUROPIUM TRIS- HYDROXYETHYLTRIAZOLEDIPICOLINATE COMPLEX AT 1.51 A RESOLUTION.	3.2.1.17
4BAG	FERULOYL ESTERASE DOMAIN OF XYNY FROM CLOSTRIDIUM THERMOCELLUM AFTER EXPOSURE TO 266NM UV LASER	3.2.1.8
4BAH	THROMBIN IN COMPLEX WITH INHIBITOR	3.4.21.5
4BAK	THROMBIN IN COMPLEX WITH INHIBITOR	3.4.21.5
4BAM	THROMBIN IN COMPLEX WITH INHIBITOR	3.4.21.5
4BAN	THROMBIN IN COMPLEX WITH INHIBITOR	3.4.21.5
4BAO	THROMBIN IN COMPLEX WITH INHIBITOR	3.4.21.5
4BAP	HEN EGG-WHITE LYSOZYME STRUCTURE IN COMPLEX WITH THE EUROPIUM TRIS- HYDROXYETHYLCHOLINETRIAZOLEDIPICOLINATE COMPLEX AT 1.21 A RESOLUTION.	3.2.1.17
4BAQ	THROMBIN IN COMPLEX WITH INHIBITOR	3.4.21.5
4BAS	STRUCTURE OF THE ARL6 BBS3 SMALL GTPASE FROM TRYPANOSOMA BRUCEI WITH BOUND NUCLEOTIDE ANALOGUE GPPNP	3.6.5.2
4BBJ	COPPER-TRANSPORTING PIB-ATPASE IN COMPLEX WITH BERYLLIUM FLUORIDE REPRESENTING THE E2P STATE	3.6.3 7.2.2.8
4BBW	THE CRYSTAL STRUCTURE OF SIALIDASE VPI 5482 (BTSA) FROM BACTEROIDES THETAIOTAOMICRON	3.2.1.18
4BBX	DISCOVERY OF A POTENT, SELECTIVE AND ORALLY ACTIVE PDE10A INHIBITOR FOR THE TREATMENT OF SCHIZOPHRENIA	3.1.4.17 3.1.4.35
4BBZ	STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY CBDP (2-MIN SOAK): CRESYL-PHOSPHOSERINE ADDUCT	3.1.1.8
4BC0	STRUCTURE OF MOUSE ACETYLCHOLINESTERASE INHIBITED BY CBDP (12-H SOAK) : CRESYL-PHOSPHOSERINE ADDUCT	3.1.1.7
4BC1	STRUCTURE OF MOUSE ACETYLCHOLINESTERASE INHIBITED BY CBDP (30-MIN SOAK): CRESYL-SALIGENIN-PHOSPHOSERINE ADDUCT	3.1.1.7
4BCB	PROLYL OLIGOPEPTIDASE FROM PORCINE BRAIN WITH A COVALENTLY BOUND P2- SUBSTITUTED N-ACYL-PROLYLPYRROLIDINE INHIBITOR	3.4.21.26
4BCC	PROLYL OLIGOPEPTIDASE FROM PORCINE BRAIN WITH A COVALENTLY BOUND P2- SUBSTITUTED N-ACYL-PROLYLPYRROLIDINE INHIBITOR	3.4.21.26
4BCD	PROLYL OLIGOPEPTIDASE FROM PORCINE BRAIN WITH A NON-COVALENTLY BOUND P2-SUBSTITUTED N-ACYL-PROLYLPYRROLIDINE INHIBITOR	3.4.21.26
4BCE	CRYSTAL STRUCTURE OF TTB-GLY N282T MUTANT	3.2.1 3.2.1.21
4BD0	X-RAY STRUCTURE OF A PERDEUTERATED TOHO-1 R274N R276N DOUBLE MUTANT BETA-LACTAMASE IN COMPLEX WITH A FULLY DEUTERATED BORONIC ACID (BZB)	3.5.2.6
4BD1	NEUTRON STRUCTURE OF A PERDEUTERATED TOHO-1 R274N R276N DOUBLE MUTANT BETA-LACTAMASE IN COMPLEX WITH A FULLY DEUTERATED BORONIC ACID (BZB)	3.5.2.6
4BD9	STRUCTURE OF THE COMPLEX BETWEEN SMCI AND HUMAN CARBOXYPEPTIDASE A4	3.4.17
4BDS	HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH TACRINE	3.1.1.8
4BDT	HUMAN ACETYLCHOLINESTERASE IN COMPLEX WITH HUPRINE W AND FASCICULIN 2	3.1.1.7
4BDW	THE STRUCTURE OF THE FNI-EGF TANDEM DOMAIN OF COAGULATION FACTOR XII IN COMPLEX WITH HOLMIUM	3.4.21.38
4BDX	THE STRUCTURE OF THE FNI-EGF TANDEM DOMAIN OF COAGULATION FACTOR XII	3.4.21.38
4BDY	PFV INTASOME WITH INHIBITOR XZ-89	2.7.7 2.7.7.49 2.7.7.7 3.1.26.4 3.4.23 3.1
4BDZ	PFV INTASOME WITH INHIBITOR XZ-90	2.7.7 2.7.7.49 2.7.7.7 3.1.26.4 3.4.23 3.1
4BE0	PFV INTASOME WITH INHIBITOR XZ-115	2.7.7 2.7.7.49 2.7.7.7 3.1.26.4 3.4.23 3.1
4BE1	PFV INTASOME WITH INHIBITOR XZ-116	2.7.7 2.7.7.49 2.7.7.7 3.1.26.4 3.4.23 3.1
4BE2	PFV INTASOME WITH INHIBITOR XZ-259	2.7.7 2.7.7.49 2.7.7.7 3.1.26.4 3.4.23 3.1
4BE4	CLOSED CONFORMATION OF O. PICEAE STEROL ESTERASE	3.1.1.13 3.1.1
4BE7	MUTANT (K220R) OF THE HSDR SUBUNIT OF THE ECOR124I RESTRICTION ENZYME IN COMPLEX WITH ATP	3.1.21.3
4BE9	OPEN CONFORMATION OF O. PICEAE STEROL ESTERASE	3.1.1.13 3.1.1
4BEC	MUTANT (K220A) OF THE HSDR SUBUNIT OF THE ECOR124I RESTRICTION ENZYME IN COMPLEX WITH ATP	3.1.21.3
4BEK	CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH CHEMICAL LIGAND	3.4.23.46
4BEL	BACE2 XAPERONE COMPLEX	3.4.23.45
4BEN	R39-IMIPENEM ACYL-ENZYME CRYSTAL STRUCTURE	3.4.16.4
4BEW	SERCA BOUND TO PHOSPHATE ANALOGUE	3.6.3.8 7.2.2.10
4BF7	EMERICILLA NIDULANS ENDO-BETA-1,4-GALACTANASE	3.2.1.89
4BFB	BACE2 XAPERONE COMPLEX	3.4.23.45
4BFD	CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH CHEMICAL LIGAND	3.4.23.46
4BFN	CRYSTAL STRUCTURE OF THE STARCH-BINDING DOMAIN FROM RHIZOPUS ORYZAE GLUCOAMYLASE IN COMPLEX WITH ISOMALTOTETRAOSE	3.2.1.3
4BFO	CRYSTAL STRUCTURE OF THE STARCH-BINDING DOMAIN FROM RHIZOPUS ORYZAE GLUCOAMYLASE IN COMPLEX WITH ISOMALTOTRIOSE	3.2.1.3
4BGD	CRYSTAL STRUCTURE OF BRR2 IN COMPLEX WITH THE JAB1/MPN DOMAIN OF PRP8	3.6.4.13
4BIJ	THREADING MODEL OF T7 LARGE TERMINASE	3.6.4 3.1.21
4BIN	CRYSTAL STRUCTURE OF THE E. COLI N-ACETYLMURAMOYL-L-ALANINE AMIDASE AMIC	3.5.1.28
4BIR	RIBONUCLEASE T1: FREE HIS92GLN MUTANT	3.1.27.3 4.6.1.24
4BJ0	XYLOGLUCAN BINDING MODULE (CBM4-2 X2-L110F) IN COMPLEX WITH BRANCHED XYLOSES	3.2.1.8
4BJ4	STRUCTURE OF PSEUDOMONAS AERUGINOSA AMIDASE AMPDH2	3.5.1.28
4BJH	CRYSTAL STRUCTURE OF THE AQUIFEX REACTOR COMPLEX FORMED BY DIHYDROOROTASE (H180A, H232A) WITH DIHYDROOROTATE AND ASPARTATE TRANSCARBAMOYLASE WITH N-(PHOSPHONACETYL)-L-ASPARTATE (PALA)	3.5.2.3
4BJO	NITRATE IN THE ACTIVE SITE OF PTP1B IS A PUTATIVE MIMETIC OF THE TRANSITION STATE	3.1.3.48
4BK0	CRYSTAL STRUCTURE OF THE KIX DOMAIN OF HUMAN RECQL5 (DOMAIN-SWAPPED DIMER)	3.6.4.12
4BKM	CRYSTAL STRUCTURE OF THE MURINE AUM (PHOSPHOGLYCOLATE PHOSPHATASE) CAPPING DOMAIN AS A FUSION PROTEIN WITH THE CATALYTIC CORE DOMAIN OF MURINE CHRONOPHIN (PYRIDOXAL PHOSPHATE PHOSPHATASE)	3.1.3.3 3.1.3.74 3.1.3.18 3.1.3.21 3.1.3.48
4BL2	CRYSTAL STRUCTURE OF PBP2A CLINICAL MUTANT E150K FROM MRSA	3.4.16.4
4BL3	CRYSTAL STRUCTURE OF PBP2A CLINICAL MUTANT N146K FROM MRSA	3.4.16.4
4BLM	BETA-LACTAMASE OF BACILLUS LICHENIFORMIS 749(SLASH)C. REFINEMENT AT 2 ANGSTROMS RESOLUTION AND ANALYSIS OF HYDRATION	3.5.2.6
4BLQ	P4 PROTEIN FROM BACTERIOPHAGE PHI8	3.6.1.15
4BMF	SOLUTION STRUCTURE OF THE CELLULOSE-BINDING DOMAIN OF ENDOGLUCANASE I FROM TRICHODERMA REESEI AND ITS INTERACTION WITH CELLO- OLIGOSACCHARIDES	3.2.1.4
4BMX	NATIVE STRUCTURE OF FUTALOSINE HYDROLASE OF HELICOBACTER PYLORI STRAIN 26695	3.2.2.9 3.2.2.30
4BMY	STRUCTURE OF FUTALOSINE HYDROLASE MUTANT OF HELICOBACTER PYLORI STRAIN 26695	3.2.2.9 3.2.2.30
4BMZ	STRUCTURE OF FUTALOSINE HYDROLASE MUTANT OF HELICOBACTER PYLORI STRAIN 26695	3.2.2.9 3.2.2.30
4BN0	STRUCTURE OF FUTALOSINE HYDROLASE MUTANT OF HELICOBACTER PYLORI STRAIN 26695	3.2.2.9 3.2.2.30
4BN4	STRUCTURE OF HUMAN SIRT3 IN COMPLEX WITH ADP-RIBOSE	3.5.1 2.3.1.286
4BNQ	THE STRUCTURE OF THE STAPHYLOCOCCUS AUREUS HAM1 PROTEIN	3.6.1.19 3.6.1.66
4BNR	EXTREMELY STABLE COMPLEX OF CRAYFISH TRYPSIN WITH BOVINE TRYPSIN INHIBITOR	3.4.21.4
4BOH	MADANINS (MEROPS I53) ARE CLEAVED BY THROMBIN AND FACTOR XA	3.4.21.5
4BOP	STRUCTURE OF OTUD1 OTU DOMAIN	3.4.19.12
4BOQ	STRUCTURE OF OTUD2 OTU DOMAIN	3.4.19.12
4BOS	STRUCTURE OF OTUD2 OTU DOMAIN IN COMPLEX WITH UBIQUITIN K11-LINKED PEPTIDE	3.4.19.12
4BOU	STRUCTURE OF OTUD3 OTU DOMAIN	3.4.19.12
4BOW	CRYSTAL STRUCTURE OF LAMA_E269S FROM Z. GALACTANIVORANS IN COMPLEX WITH LAMINARITRIOSE AND LAMINARITETRAOSE	3.2.1.39
4BOZ	STRUCTURE OF OTUD2 OTU DOMAIN IN COMPLEX WITH K11-LINKED DI UBIQUITIN	3.4.19.12
4BP0	CRYSTAL STRUCTURE OF THE CLOSED FORM OF PSEUDOMONAS AERUGINOSA SPM-1	3.5.2.6
4BP2	CRYSTALLOGRAPHIC REFINEMENT OF BOVINE PRO-PHOSPHOLIPASE A2 AT 1.6 ANGSTROMS RESOLUTION	3.1.1.4
4BP8	OLIGOPEPTIDASE B FROM TRYPANOSOMA BRUCEI - OPEN FORM	3.4.21.83
4BP9	OLIGOPEPTIDASE B FROM TRYPANOSOMA BRUCEI WITH COVALENTLY BOUND ANTIPAIN - CLOSED FORM	3.4.21.83
4BPB	STRUCTURAL INSIGHTS INTO RNA RECOGNITION BY RIG-I	3.6.4.13
4BPC	STRUCTURE OF THE CATALYTIC DOMAIN OF PROTEIN TYROSINE PHOSPHATASE SIGMA IN THE SULFENIC ACID FORM	3.1.3.48
4BPS	CRYSTAL STRUCTURE OF CHORISMATASE AT 1.08 ANGSTROM RESOLUTION.	3.3.2.13
4BPV	MOUSE CATHEPSIN S WITH COVALENT LIGAND	3.4.22.27
4BPZ	CRYSTAL STRUCTURE OF LAMA_E269S FROM ZOBELLIA GALACTANIVORANS IN COMPLEX WITH A TRISACCHARIDE OF 1,3-1,4-BETA-D-GLUCAN.	3.2.1.39
4BQ1	CRYSTAL STRUCTURE OF OF LAMACAT FROM ZOBELLIA GALACTANIVORANS	3.2.1.39
4BQ4	STRUCTURAL ANALYSIS OF AN EXO-BETA-AGARASE	3.2.1.81
4BQ5	STRUCTURAL ANALYSIS OF AN EXO-BETA-AGARASE	3.2.1.81
4BQM	CRYSTAL STRUCTURE OF HUMAN LIVER-TYPE GLUTAMINASE, CATALYTIC DOMAIN	3.5.1.2
4BQV	MOUSE CATHEPSIN S WITH COVALENT LIGAND	3.4.22.27
4BQZ	RAT NTPDASE2 IN COMPLEX WITH MG GMPPNP	3.6.1.5 3.6.1
4BR0	RAT NTPDASE2 IN COMPLEX WITH CA AMPNP	3.6.1 3.6.1.5
4BR2	RAT NTPDASE2 IN COMPLEX WITH CA UMPPNP	3.6.1 3.6.1.5
4BR4	LEGIONELLA PNEUMOPHILA NTPDASE1 CRYSTAL FORM I, OPEN, APO	3.6.1.5
4BR5	RAT NTPDASE2 IN COMPLEX WITH ZN AMPPNP	3.6.1.5
4BR7	LEGIONELLA PNEUMOPHILA NTPDASE1 CRYSTAL FORM I, OPEN, AMPNP COMPLEX	3.6.1.5
4BR9	LEGIONELLA PNEUMOPHILA NTPDASE1 CRYSTAL FORM II, CLOSED, APO	3.6.1.5
4BRA	LEGIONELLA PNEUMOPHILA NTPDASE1 CRYSTAL FORM II, CLOSED, MG AMPPNP COMPLEX	3.6.1.5
4BRC	LEGIONELLA PNEUMOPHILA NTPDASE1 CRYSTAL FORM II, CLOSED, MG AMPNP COMPLEX	3.6.1.5
4BRD	LEGIONELLA PNEUMOPHILA NTPDASE1 Q193E CRYSTAL FORM II, CLOSED, MG AMPPNP COMPLEX	3.6.1.5
4BRF	LEGIONELLA PNEUMOPHILA NTPDASE1 CRYSTAL FORM II (CLOSED) IN COMPLEX WITH A DISTORTED ORTHOMOLYBDATE ION AND AMP	3.6.1.5
4BRG	LEGIONELLA PNEUMOPHILA NTPDASE1 CRYSTAL FORM II (CLOSED) IN COMPLEX WITH MG GMPPNP	3.6.1.5
4BRH	LEGIONELLA PNEUMOPHILA NTPDASE1 CRYSTAL FORM II (CLOSED) IN COMPLEX WITH MG AND THIAMINE PHOSPHOVANADATE	3.6.1.5
4BRI	LEGIONELLA PNEUMOPHILA NTPDASE1 CRYSTAL FORM II (CLOSED) IN COMPLEX WITH MG UMPPNP	3.6.1.5
4BRK	LEGIONELLA PNEUMOPHILA NTPDASE1 N302Y VARIANT CRYSTAL FORM III (CLOSED) IN COMPLEX WITH MG UMPPNP	3.6.1.5
4BRL	LEGIONELLA PNEUMOPHILA NTPDASE1 CRYSTAL FORM III (CLOSED) IN COMPLEX WITH TRANSITION STATE MIMIC GUANOSINE 5'-PHOSPHOVANADATE	3.6.1.5
4BRM	SULFUR SAD PHASING OF THE LEGIONELLA PNEUMOPHILA NTPDASE1 - CRYSTAL FORM III (CLOSED) IN COMPLEX WITH SULFATE	3.6.1.5
4BRO	LEGIONELLA PNEUMOPHILA NTPDASE1 CRYSTAL FORM IV (PART-OPEN)	3.6.1.5
4BRP	LEGIONELLA PNEUMOPHILA NTPDASE1 CRYSTAL FORM V (PART-OPEN)	3.6.1.5
4BRQ	LEGIONELLA PNEUMOPHILA NTPDASE1 CRYSTAL FORM II, CLOSED, IN COMPLEX WITH TWO PHOSPHATES BOUND TO ACTIVE SITE MG AND PRODUCT AMP	3.6.1.5
4BRS	STRUCTURE OF WILD TYPE PHAZ7 PHB DEPOLYMERASE	3.1.1.75
4BRU	CRYSTAL STRUCTURE OF THE YEAST DHH1-EDC3 COMPLEX	3.6.4.13
4BRW	CRYSTAL STRUCTURE OF THE YEAST DHH1-PAT1 COMPLEX	3.6.4.13
4BS0	CRYSTAL STRUCTURE OF KEMP ELIMINASE HG3.17 E47N,N300D COMPLEXED WITH TRANSITION STATE ANALOG 6-NITROBENZOTRIAZOLE	4 3.2.1.8
4BS5	MOUSE CATHEPSIN S WITH COVALENT LIGAND	3.4.22.27
4BS6	MOUSE CATHEPSIN S WITH COVALENT LIGAND	3.4.22.27
4BS7	HEN EGG-WHITE LYSOZYME STRUCTURE DETERMINED AT ROOM TEMPERATURE BY IN- SITU DIFFRACTION AND SAD PHASING IN CHIPX	3.2.1.17
4BSQ	MOUSE CATHEPSIN S WITH COVALENT LIGAND	3.4.22.27
4BTE	DJ-1 CU(I) COMPLEX	3.4 3.1.2 3.5.1 3.5.1.124
4BTH	THE LEUA146TRP,PHEB24TYR DOUBLE MUTANT OF THE QUORUM QUENCHING N-ACYL HOMOSERINE LACTONE ACYLASE PVDQ HAS AN ALTERED SUBSTRATE SPECIFICITY TOWARDS SMALL ACYL CHAINS	3.5.1.97
4BTI	FACTOR XA IN COMPLEX WITH THE DUAL THROMBIN-FXA INHIBITOR 58.	3.4.21.6
4BTL	AROMATIC INTERACTIONS IN ACETYLCHOLINESTERASE-INHIBITOR COMPLEXES	3.1.1.7
4BTT	FACTOR XA IN COMPLEX WITH THE DUAL THROMBIN-FXA INHIBITOR 31.	3.4.21.6
4BTU	FACTOR XA IN COMPLEX WITH THE DUAL THROMBIN-FXA INHIBITOR 57.	3.4.21.6
4BTV	STRUCTURE OF PHAZ7 PHB DEPOLYMERASE IN COMPLEX WITH 3HB TRIMER	3.1.1.75
4BU4	RIBONUCLEASE T1 COMPLEX WITH 2'GMP	3.1.27.3 4.6.1.24
4BUZ	SIR2 COMPLEX STRUCTURE MIXTURE OF EX-527 INHIBITOR AND REACTION PRODUCTS OR OF REACTION SUBSTRATES P53 PEPTIDE AND NAD	3.5.1 2.3.1.286
4BV2	CRYSTAL STRUCTURE OF SIR2 IN COMPLEX WITH THE INHIBITOR EX-527, 2'-O-ACETYL-ADP-RIBOSE AND DEACETYLATED P53-PEPTIDE	3.5.1 2.3.1.286
4BV3	CRYSTAL STRUCTURE OF SIRT3 IN COMPLEX WITH THE INHIBITOR EX-527 AND NAD	3.5.1 2.3.1.286
4BV5	IDENTIFICATION OF SMALL MOLECULE INHIBITORS SELECTIVE FOR APO(A) KRINGLES KIV-7, KIV-10 AND KV.	3.4.21
4BV7	IDENTIFICATION OF SMALL MOLECULE INHIBITORS SELECTIVE FOR APO(A) KRINGLES KIV-7, KIV-10 AND KV.	3.4.21
4BVB	CRYSTAL STRUCTURE OF HUMAN SIRT3 IN COMPLEX WITH THE INHIBITOR EX-527 AND ADP-RIBOSE	3.5.1 2.3.1.286
4BVC	IDENTIFICATION OF SMALL MOLECULE INHIBITORS SELECTIVE FOR APO(A) KRINGLES KIV-7, KIV-10 AND KV.	3.4.21
4BVD	IDENTIFICATION OF SMALL MOLECULE INHIBITORS SELECTIVE FOR APO(A) KRINGLES KIV-7, KIV-10 AND KV.	3.4.21
4BVE	CRYSTAL STRUCTURE OF HUMAN SIRT3 IN COMPLEX WITH THIOALKYLIMIDATE FORMED FROM THIO-ACETYL-LYSINE ACS2-PEPTIDE	3.5.1 2.3.1.286
4BVF	CRYSTAL STRUCTURE OF HUMAN SIRT3 IN COMPLEX WITH THIOALKYLIMIDATE FORMED FROM THIO-ACETYL-LYSINE ACS2-PEPTIDE CRYSTALLIZED IN PRESENCE OF THE INHIBITOR EX-527	3.5.1 2.3.1.286
4BVG	CRYSTAL STRUCTURE OF HUMAN SIRT3 IN COMPLEX WITH NATIVE ALKYLIMIDATE FORMED FROM ACETYL-LYSINE ACS2-PEPTIDE CRYSTALLIZED IN PRESENCE OF THE INHIBITOR EX-527	3.5.1 2.3.1.286
4BVH	CRYSTAL STRUCTURE OF HUMAN SIRT3 IN COMPLEX WITH THE INHIBITOR EX-527 AND 2'-O-ACETYL-ADP-RIBOSE	3.5.1 2.3.1.286
4BVJ	STRUCTURE OF Y105A MUTANT OF PHAZ7 PHB DEPOLYMERASE	3.1.1.75
4BVK	STRUCTURE OF Y190E MUTANT OF PHAZ7 PHB DEPOLYMERASE	3.1.1.75
4BVL	STRUCTURE OF 202-208 DELETION MUTANT OF PHAZ7 PHB DEPOLYMERASE	3.1.1.75
4BVO	LEGIONELLA PNEUMOPHILA NTPDASE1 CRYSTAL FORM VI (PART-OPEN) IN COMPLEX WITH POLYTUNGSTATE POM-1	3.6.1.5
4BVQ	CYANURIC ACID HYDROLASE: EVOLUTIONARY INNOVATION BY STRUCTURAL CONCATENATION.	3.5.2.15
4BVR	CYANURIC ACID HYDROLASE: EVOLUTIONARY INNOVATION BY STRUCTURAL CONCATENATION.	3.5.2.15
4BVS	CYANURIC ACID HYDROLASE: EVOLUTIONARY INNOVATION BY STRUCTURAL CONCATENATION.	3.5.2.15
4BVT	CYANURIC ACID HYDROLASE: EVOLUTIONARY INNOVATION BY STRUCTURAL CONCATENATION	3.5.2.15
4BVV	IDENTIFICATION OF SMALL MOLECULE INHIBITORS SELECTIVE FOR APO(A) KRINGLES KIV-7, KIV-10 AND KV.	3.4.21
4BVW	IDENTIFICATION OF SMALL MOLECULE INHIBITORS SELECTIVE FOR APO(A) KRINGLES KIV-7, KIV-10 AND KV.	3.4.21
4BWC	X-RAY STRUCTURE OF A PHOSPHOLIAPSE B LIKE PROTEIN 1 FROM BOVINE KIDNEYS	3.1.1
4BWG	STRUCTURAL BASIS OF SUBTILASE CYTOTOXIN SUBAB ASSEMBLY	3.4.21
4BX0	CRYSTAL STRUCTURE OF A MONOMERIC VARIANT OF MURINE CHRONOPHIN (PYRIDOXAL PHOSPHATE PHOSPHATASE)	3.1.3.74 3.1.3.3
4BX2	CRYSTAL STRUCTURE OF MURINE CHRONOPHIN (PYRIDOXAL PHOSPHATE PHOSPHATASE) IN COMPLEX WITH BERYLLIUM TRIFLUORIDE	3.1.3.74 3.1.3.3
4BX3	CRYSTAL STRUCTURE OF MURINE CHRONOPHIN (PYRIDOXAL PHOSPHATE PHOSPHATASE)	3.1.3.74 3.1.3.3
4BXJ	CRYSTAL STRUCTURE OF AMPDH3 FROM PSEUDOMONAS AERUGINOSA	3.5.1.28
4BXK	CRYSTAL STRUCTURE OF THE ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH A DOMAIN-SPECIFIC INHIBITOR	3.2.1 3.4.15.1
4BXO	ARCHITECTURE AND DNA RECOGNITION ELEMENTS OF THE FANCONI ANEMIA FANCM- FAAP24 COMPLEX	3.6.4.13
4BXS	CRYSTAL STRUCTURE OF THE PROTHROMBINASE COMPLEX FROM THE VENOM OF PSEUDONAJA TEXTILIS	3.4.21.6
4BXW	CRYSTAL STRUCTURE OF THE PROTHROMBINASE COMPLEX FROM THE VENOM OF PSEUDONAJA TEXTILIS	3.4.21.6
4BY3	CRYSTAL STRUCTURE OF THE DIHYDROOROTASE DOMAIN OF HUMAN CAD IN APO- FORM OBTAINED RECOMBINANTLY FROM E. COLI.	6.3.5.5 2.1.3.2 3.5.2.3
4BYF	CRYSTAL STRUCTURE OF HUMAN MYOSIN 1C IN COMPLEX WITH CALMODULIN IN THE PRE-POWER STROKE STATE	3.6.4.1
4BYM	STRUCTURE OF PHAZ7 PHB DEPOLYMERASE Y105E MUTANT	3.1.1.75
4BZ3	CRYSTAL STRUCTURE OF THE METALLO-BETA-LACTAMASE VIM-2	3.5.2.6
4BZB	CRYSTAL STRUCTURE OF THE TETRAMERIC DGTP-BOUND SAMHD1 MUTANT CATALYTIC CORE	3.1.5
4BZC	CRYSTAL STRUCTURE OF THE TETRAMERIC DGTP-BOUND WILD TYPE SAMHD1 CATALYTIC CORE	3.1.5
4BZR	HUMAN TESTIS ANGIOTENSIN CONVERTING ENZYME IN COMPLEX WITH K-26	3.2.1 3.4.15.1
4BZS	HUMAN ANGIOTENISN CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH K-26	3.2.1 3.4.15.1
4BZW	COMPLETE CRYSTAL STRUCTURE OF THE CARBOXYLESTERASE CEST-2923 (LP_2923) FROM LACTOBACILLUS PLANTARUM WCFS1	3.1.1.1
4BZZ	COMPLETE CRYSTAL STRUCTURE OF CARBOXYLESTERASE CEST-2923 FROM LACTOBACILLUS PLANTARUM WCFS1	3.1.1.1
4C09	CRYSTAL STRUCTURE OF THE METALLO-BETA-LACTAMASE BCII	3.5.2.6
4C0J	CRYSTAL STRUCTURE OF DROSOPHILA MIRO EF HAND AND CGTPASE DOMAINS IN THE APO STATE (APO-MIROS)	3.6.5
4C0K	CRYSTAL STRUCTURE OF DROSOPHILA MIRO EF HAND AND CGTPASE DOMAINS BOUND TO ONE CALCIUM ION (CA-MIROS)	3.6.5
4C0L	CRYSTAL STRUCTURE OF DROSOPHILA MIRO EF HAND AND CGTPASE DOMAINS BOUND TO ONE MAGNESIUM ION AND MG:GDP (MGGDP-MIROS)	3.6.5
4C0U	CRYO-EM RECONSTRUCTION OF ENTEROVIRUS 71 IN COMPLEX WITH A NEUTRALIZING ANTIBODY E18	3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48
4C0Y	CRYO-EM RECONSTRUCTION OF EMPTY ENTEROVIRUS 71 IN COMPLEX WITH A NEUTRALIZING ANTIBODY E18	3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48
4C11	DENGUE VIRUS RNA DEPENDENT RNA POLYMERASE WITH RESIDUES FROM THE NS5 LINKER REGION	3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48
4C1B	ESTERASE DOMAIN OF THE ZFL2-1 ORF1 PROTEIN FROM THE ZEBRAFISH ZFL2-1 RETROTRANSPOSON	3.1
4C1C	CRYSTAL STRUCTURE OF THE METALLO-BETA-LACTAMASE BCII WITH D-CAPTOPRIL	3.5.2.6
4C1D	CRYSTAL STRUCTURE OF THE METALLO-BETA-LACTAMASE VIM-2 WITH L-CAPTOPRIL	3.5.2.6
4C1E	CRYSTAL STRUCTURE OF THE METALLO-BETA-LACTAMASE VIM-2 WITH D-CAPTOPRIL	3.5.2.6
4C1F	CRYSTAL STRUCTURE OF THE METALLO-BETA-LACTAMASE IMP-1 WITH L-CAPTOPRIL	3.5.2.6
4C1G	CRYSTAL STRUCTURE OF THE METALLO-BETA-LACTAMASE IMP-1 WITH D-CAPTOPRIL	3.5.2.6
4C1H	CRYSTAL STRUCTURE OF THE METALLO-BETA-LACTAMASE BCII WITH L-CAPTOPRIL	3.5.2.6
4C1O	GEOBACILLUS THERMOGLUCOSIDASIUS GH FAMILY 52 XYLOSIDASE	3.2.1.37
4C1P	GEOBACILLUS THERMOGLUCOSIDASIUS GH FAMILY 52 XYLOSIDASE	3.2.1.37
4C1S	GLYCOSIDE HYDROLASE FAMILY 76 (MANNOSIDASE) BT3792 FROM BACTEROIDES THETAIOTAOMICRON VPI-5482	3.2.1.101
4C1X	CARBOHYDRATE BINDING DOMAIN FROM STREPTOCOCCUS PNEUMONIAE NANA SIALIDASE COMPLEXED WITH 6'-SIALYLLACTOSE	3.2.1.18
4C2C	CRYSTAL STRUCTURE OF THE PROTEASE CTPB IN AN ACTIVE STATE	3.4.21.102
4C2D	CRYSTAL STRUCTURE OF THE PROTEASE CTPB IN AN ACTIVE STATE	3.4.21.102
4C2E	CRYSTAL STRUCTURE OF THE PROTEASE CTPB(S309A) PRESENT IN A RESTING STATE	3.4.21.102
4C2F	CRYSTAL STRUCTURE OF THE CTPB R168A MUTANT PRESENT IN AN ACTIVE CONFORMATION	3.4.21.102
4C2G	CRYSTAL STRUCTURE OF CTPB(S309A) IN COMPLEX WITH A PEPTIDE HAVING A VAL-PRO-ALA C-TERMINUS	3.4.21.102
4C2H	CRYSTAL STRUCTURE OF THE CTPB(V118Y) MUTANT	3.4.21.102
4C2J	CRYSTAL STRUCTURE OF HUMAN MITOCHONDRIAL 3-KETOACYL-COA THIOLASE IN COMPLEX WITH COA	2.3.1.16 2.3.1.9 3.1.2 3.1.2.1 3.1.2.2
4C2K	CRYSTAL STRUCTURE OF HUMAN MITOCHONDRIAL 3-KETOACYL-COA THIOLASE	2.3.1.16 2.3.1.9 3.1.2 3.1.2.1 3.1.2.2
4C2L	CRYSTAL STRUCTURE OF ENDO-XYLOGALACTURONAN HYDROLASE FROM ASPERGILLUS TUBINGENSIS	3.2.1
4C2N	CRYSTAL STRUCTURE OF HUMAN TESTIS ANGIOTENSIN-I CONVERTING ENZYME MUTANT E403R	3.2.1 3.4.15.1
4C2O	CRYSTAL STRUCTURE OF HUMAN TESTIS ANGIOTENSIN-I CONVERTING ENZYME MUTANT D465T	3.2.1 3.4.15.1
4C2P	CRYSTAL STRUCTURE OF HUMAN TESTIS ANGIOTENSIN-I CONVERTING ENZYME MUTANT R522K IN COMPLEX WITH CAPTOPRIL	3.2.1 3.4.15.1
4C2Q	CRYSTAL STRUCTURE OF HUMAN TESTIS ANGIOTENSIN-I CONVERTING ENZYME MUTANT R522K	3.2.1 3.4.15.1
4C2R	CRYSTAL STRUCTURE OF HUMAN TESTIS ANGIOTENSIN-I CONVERTING ENZYME MUTANT R522Q	3.2.1 3.4.15.1
4C3Q	NEUTRON STRUCTURE OF A PERDEUTERATED TOHO-1 R274N R276N DOUBLE MUTANT BETA-LACTAMASE IN COMPLEX WITH A FULLY DEUTERATED BORONIC ACID (BZB) AT 100K	3.5.2.6
4C3U	EXTENSIVE COUNTER-ION INTERACTIONS WITH SUBTILISIN IN AQUEOUS MEDIUM, CS DERIVATIVE	3.4.21.62
4C3V	EXTENSIVE COUNTER-ION INTERACTIONS WITH SUBTILISIN IN AQUEOUS MEDIUM, NO CS SOAK	3.4.21.62
4C3W	VANADIUM(IV)-PICOLINATE COMPLEXED WITH LYSOZYME	3.2.1.17
4C4C	MICHAELIS COMPLEX OF HYPOCREA JECORINA CEL7A E217Q MUTANT WITH CELLONONAOSE SPANNING THE ACTIVE SITE	3.2.1.91
4C4D	COVALENT GLYCOSYL-ENZYME INTERMEDIATE OF HYPOCREA JECORINA CEL7A E217Q MUTANT TRAPPED USING DNP-2-DEOXY-2-FLUORO-CELLOTRIOSIDE	3.2.1.91
4C4X	CRYSTAL STRUCTURE OF HUMAN BIFUNCTIONAL EPOXIDE HYDROXYLASE 2 COMPLEXED WITH C9	3.3.2.10 3.1.3.76
4C4Y	CRYSTAL STRUCTURE OF HUMAN BIFUNCTIONAL EPOXIDE HYDROXYLASE 2 COMPLEXED WITH A4	3.3.2.10 3.1.3.76
4C4Z	CRYSTAL STRUCTURE OF HUMAN BIFUNCTIONAL EPOXIDE HYDROXYLASE 2 COMPLEXED WITH A8	3.3.2.10 3.1.3.76
4C5Y	CRYSTAL STRUCTURE OF A. NIGER OCHRATOXINASE	3.4.13.9 3.5.1
4C5Z	CRYSTAL STRUCTURE OF A. NIGER OCHRATOXINASE	3.4.13.9 3.5.1
4C6B	CRYSTAL STRUCTURE OF THE DIHYDROOROTASE DOMAIN OF HUMAN CAD WITH INCOMPLETE ACTIVE SITE, OBTAINED RECOMBINANTLY FROM E. COLI.	3.5.2.3 6.3.5.5 2.1.3.2
4C6C	CRYSTAL STRUCTURE OF THE DIHYDROOROTASE DOMAIN OF HUMAN CAD IN APO- FORM OBTAINED RECOMBINANTLY FROM HEK293 CELLS.	6.3.5.5 2.1.3.2 3.5.2.3
4C6D	CRYSTAL STRUCTURE OF THE DIHYDROOROTASE DOMAIN OF HUMAN CAD BOUND TO SUBSTRATE AT PH 6.0	6.3.5.5 2.1.3.2 3.5.2.3
4C6E	CRYSTAL STRUCTURE OF THE DIHYDROOROTASE DOMAIN OF HUMAN CAD BOUND TO SUBSTRATE AT PH 5.5	3.5.2.3 6.3.5.5 2.1.3.2
4C6F	CRYSTAL STRUCTURE OF THE DIHYDROOROTASE DOMAIN OF HUMAN CAD BOUND TO SUBSTRATE AT PH 6.5	3.5.2.3 6.3.5.5 2.1.3.2
4C6H	HALOALKANE DEHALOGENASE WITH 1-HEXANOL	3.8.1.5
4C6I	CRYSTAL STRUCTURE OF THE DIHYDROOROTASE DOMAIN OF HUMAN CAD BOUND TO SUBSTRATE AT PH 7.0	3.5.2.3 6.3.5.5 2.1.3.2
4C6J	CRYSTAL STRUCTURE OF THE DIHYDROOROTASE DOMAIN OF HUMAN CAD BOUND TO SUBSTRATE AT PH 7.5	3.5.2.3 6.3.5.5 2.1.3.2
4C6K	CRYSTAL STRUCTURE OF THE DIHYDROOROTASE DOMAIN OF HUMAN CAD BOUND TO SUBSTRATE AT PH 8.0	3.5.2.3 6.3.5.5 2.1.3.2
4C6L	CRYSTAL STRUCTURE OF THE DIHYDROOROTASE DOMAIN OF HUMAN CAD BOUND TO THE INHIBITOR FLUOROOROTATE AT PH 6.0	3.5.2.3 6.3.5.5 2.1.3.2
4C6M	CRYSTAL STRUCTURE OF THE DIHYDROOROTASE DOMAIN OF HUMAN CAD BOUND TO THE INHIBITOR FLUOROOROTATE AT PH 7.0	3.5.2.3 6.3.5.5 2.1.3.2
4C6N	CRYSTAL STRUCTURE OF THE DIHYDROOROTASE DOMAIN OF HUMAN CAD E1637T MUTANT BOUND TO SUBSTRATE AT PH 6.0	3.5.2.3 6.3.5.5 2.1.3.2
4C6O	CRYSTAL STRUCTURE OF THE DIHYDROOROTASE DOMAIN OF HUMAN CAD C1613S MUTANT IN APO-FORM AT PH 6.0	3.5.2.3 6.3.5.5 2.1.3.2
4C6P	CRYSTAL STRUCTURE OF THE DIHYDROOROTASE DOMAIN OF HUMAN CAD C1613S MUTANT IN APO-FORM AT PH 7.0	3.5.2.3 6.3.5.5 2.1.3.2
4C6Q	CRYSTAL STRUCTURE OF THE DIHYDROOROTASE DOMAIN OF HUMAN CAD C1613S MUTANT BOUND TO SUBSTRATE AT PH 7.0	3.5.2.3 6.3.5.5 2.1.3.2
4C6R	CRYSTAL STRUCTURE OF THE TIR DOMAIN FROM THE ARABIDOPSIS THALIANA DISEASE RESISTANCE PROTEIN RPS4	3.2.2.6
4C6Y	ANCESTRAL PNCA (LAST COMMON ANCESTORS OF GRAM-POSITIVE AND GRAM- NEGATIVE BACTERIA) BETA-LACTAMASE CLASS A	3.5.2.6
4C75	CONSENSUS (ALL-CON) BETA-LACTAMASE CLASS A	3.5.2.6
4C78	COMPLEX OF HUMAN SIRT3 WITH BROMO-RESVERATROL AND ACS2 PEPTIDE	3.5.1 2.3.1.286
4C7B	COMPLEX OF HUMAN SIRT3 WITH BROMO-RESVERATROL AND FLUOR-DE-LYS PEPTIDE	3.5.1 2.3.1.286
4C7D	STRUCTURE AND ACTIVITY OF THE GH20 BETA-N-ACETYLHEXOSAMINIDASE FROM STREPTOMYCES COELICOLOR A3(2)	3.2.1.52
4C7F	STRUCTURE AND ACTIVITY OF THE GH20 BETA-N-ACETYLHEXOSAMINIDASE FROM STREPTOMYCES COELICOLOR A3(2)	3.2.1.52
4C7G	STRUCTURE AND ACTIVITY OF THE GH20 BETA-N-ACETYLHEXOSAMINIDASE FROM STREPTOMYCES COELICOLOR A3(2)	3.2.1.52
4C7L	CRYSTAL STRUCTURE OF MOUSE HEPATITIS VIRUS STRAIN S HEMAGGLUTININ- ESTERASE	3.1.1.53
4C7W	CRYSTAL STRUCTURE OF MOUSE HEPATITIS VIRUS STRAIN S HEMAGGLUTININ- ESTERASE IN COMPLEX WITH 4-O-ACETYLATED SIALIC ACID	3.1.1.53
4C88	ESTERASE LPEST1 FROM LACTOBACILLUS PLANTARUM: NATIVE STRUCTURE	3.1.1.1
4C8X	CRYSTAL STRUCTURE OF CARBOHYDRATE-BINDING MODULE CBM3B MUTANT (Y56S) FROM THE CELLULOSOMAL CELLOBIOHYDROLASE 9A FROM CLOSTRIDIUM THERMOCELLUM	3.2.1.91 3.2.1
4C9B	CRYSTAL STRUCTURE OF EIF4AIII-CWC22 COMPLEX	3.6.4.13
4C9W	CRYSTAL STRUCTURE OF NUDT1 (MTH1) WITH R-CRIZOTINIB	3.6.1.55 3.6.1.56
4C9X	CRYSTAL STRUCTURE OF NUDT1 (MTH1) WITH S-CRIZOTINIB	3.6.1.55 3.6.1.56
4CA5	HUMAN ANGIOTENSIN CONVERTING ENZYME IN COMPLEX WITH A PHOSPHINIC TRIPEPTIDE FI	3.2.1 3.4.15.1
4CA6	HUMAN ANGIOTENSIN CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH A PHOSPHINIC TRIPEPTIDE FI	3.4.15.1 3.2.1
4CA7	DROSOPHILA ANGIOTENSIN CONVERTING ENZYME (ANCE) IN COMPLEX WITH A PHOSPHINIC TRIPEPTIDE FI	3.4.15.1
4CA8	DROSOPHILA ANGIOTENSIN CONVERTING ENZYME (ANCE) IN COMPLEX WITH A PHOSPHINIC TRIPEPTIDE FII	3.4.15.1
4CAU	THREE-DIMENSIONAL STRUCTURE OF DENGUE VIRUS SEROTYPE 1 COMPLEXED WITH 2 HMAB 14C10 FAB	3.4.21.91 3.6.1.15 3.6.4.13
4CBG	PESTIVIRUS NS3 HELICASE	3.4.21.113 3.6.1.15 3.6.4.13 3.4.22 2.7.7.48
4CBH	PESTIVIRUS NS3 HELICASE	3.4.21.113 3.6.1.15 3.6.4.13 3.4.22 2.7.7.48
4CBI	PESTIVIRUS NS3 HELICASE	3.4.21.113 3.6.1.15 3.6.4.13 3.4.22 2.7.7.48
4CBL	PESTIVIRUS NS3 HELICASE	3.4.21.113 3.6.1.15 3.6.4.13 3.4.22 2.7.7.48
4CBN	CRYSTAL STRUCTURE OF COMPLEMENT FACTOR D MUTANT R202A AFTER CONVENTIONAL REFINEMENT	3.4.21.46
4CBO	CRYSTAL STRUCTURE OF COMPLEMENT FACTOR D MUTANT R202A AFTER ENSEMBLE REFINEMENT	3.4.21.46
4CBT	DESIGN, SYNTHESIS, AND BIOLOGICAL EVALUATION OF POTENT AND SELECTIVE CLASS IIA HDAC INHIBITORS AS A POTENTIAL THERAPY FOR HUNTINGTON'S DISEASE	3.5.1.98
4CBY	DESIGN, SYNTHESIS, AND BIOLOGICAL EVALUATION OF POTENT AND SELECTIVE CLASS IIA HDAC INHIBITORS AS A POTENTIAL THERAPY FOR HUNTINGTON'S DISEASE	3.5.1.98
4CCC	STRUCTURE OF MOUSE GALACTOCEREBROSIDASE WITH 4NBDG: ENZYME-SUBSTRATE COMPLEX	3.2.1.46
4CCD	STRUCTURE OF MOUSE GALACTOCEREBROSIDASE WITH D-GALACTAL: ENZYME- INTERMEDIATE COMPLEX	3.2.1.46
4CCE	STRUCTURE OF MOUSE GALACTOCEREBROSIDASE WITH GALACTOSE: ENZYME- PRODUCT COMPLEX	3.2.1.46
4CCW	CRYSTAL STRUCTURE OF NAPROXEN ESTERASE (CARBOXYLESTERASE NP) FROM BACILLUS SUBTILIS	3.1.1.1
4CCY	CRYSTAL STRUCTURE OF CARBOXYLESTERASE CESB (YBFK) FROM BACILLUS SUBTILIS	3.1.1.1
4CD1	RNNTPDASE2 IN COMPLEX WITH PSB-071	3.6.1 3.6.1.5
4CD3	RNNTPDASE2 X4 VARIANT IN COMPLEX WITH PSB-071	3.6.1 3.6.1.5
4CD4	THE STRUCTURE OF GH26 BETA-MANNANASE CJMAN26C FROM CELLVIBRIO JAPONICUS IN COMPLEX WITH MANIFG	3.2.1.78
4CD5	THE STRUCTURE OF GH26 BETA-MANNANASE CJMAN26C FROM CELLVIBRIO JAPONICUS IN COMPLEX WITH MANMIM	3.2.1.78
4CD6	THE STRUCTURE OF GH113 BETA-MANNANASE AAMANA FROM ALICYCLOBACILLUS ACIDOCALDARIUS IN COMPLEX WITH MANIFG	3.2.1.78
4CD7	THE STRUCTURE OF GH113 BETA-MANNANASE AAMANA FROM ALICYCLOBACILLUS ACIDOCALDARIUS IN COMPLEX WITH MANIFG AND BETA-1,4-MANNOBIOSE	3.2.1.78
4CD8	THE STRUCTURE OF GH113 BETA-MANNANASE AAMANA FROM ALICYCLOBACILLUS ACIDOCALDARIUS IN COMPLEX WITH MANMIM	3.2.1.78
4CDC	HUMAN DPP1 IN COMPLEX WITH (2S)-2-AMINO-N-((1S)-1-CYANO-2-(4- PHENYLPHENYL)ETHYL)BUTANAMIDE	3.4.14.1
4CDD	HUMAN DPP1 IN COMPLEX WITH (2S)-N-((1S)-1-CYANO-2-(4-(4-CYANOPHENYL) PHENYL)ETHYL)PIPERIDINE-2-CARBOXAMIDE	3.4.14.1
4CDE	HUMAN DPP1 IN COMPLEX WITH 4-AMINO-N-((1S)-1-CYANO-2-(4-(4- CYANOPHENYL)PHENYL)ETHYL)TETRAHYDROPYRAN-4-CARBOXAMIDE	3.4.14.1
4CDF	HUMAN DPP1 IN COMPLEX WITH (2S,4S)-N-((1S)-1-CYANO-2-(4-(4- CYANOPHENYL)PHENYL)ETHYL)-4-HYDROXY-PIPERIDINE-2-CARBOXAMIDE	3.4.14.1
4CDG	CRYSTAL STRUCTURE OF THE BLOOM'S SYNDROME HELICASE BLM IN COMPLEX WITH NANOBODY	3.6.4.12
4CDQ	CRYSTAL STRUCTURE OF HUMAN ENTEROVIRUS 71 IN COMPLEX WITH THE UNCOATING INHIBITOR GPP2	3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48
4CDU	CRYSTAL STRUCTURE OF HUMAN ENTEROVIRUS 71 IN COMPLEX WITH THE UNCOATING INHIBITOR GPP3	3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48
4CDW	CRYSTAL STRUCTURE OF HUMAN ENTEROVIRUS 71 IN COMPLEX WITH THE UNCOATING INHIBITOR GPP4	3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48
4CDX	CRYSTAL STRUCTURE OF HUMAN ENTEROVIRUS 71 IN COMPLEX WITH THE UNCOATING INHIBITOR GPP12	3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48
4CE6	MUTAGENESIS OF A RHODOBACTERACEAE L-HALOACID DEHALOGENASE	3.8.1.2
4CE7	CRYSTAL STRUCTURE OF A NOVEL UNSATURATED BETA-GLUCURONYL HYDROLASE ENZYME, BELONGING TO FAMILY GH105, INVOLVED IN ULVAN DEGRADATION	3.2.1.172 3.2.1
4CE9	INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL CHALLENGE	2.7.7.7 3.4.23.16 2.7.7.49 3.1.26.13 3.1.13.2 2.7.7 3.1
4CEA	INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL CHALLENGE	2.7.7.7 3.4.23.16 2.7.7.49 3.1.26.13 3.1.13.2 2.7.7 3.1
4CEB	INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL CHALLENGE	2.7.7.7 3.4.23.16 2.7.7.49 3.1.26.13 3.1.13.2 2.7.7 3.1
4CEC	INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL CHALLENGE	2.7.7.7 3.4.23.16 2.7.7.49 3.1.26.13 3.1.13.2 2.7.7 3.1
4CED	INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL CHALLENGE	2.7.7.7 3.4.23.16 2.7.7.49 3.1.26.13 3.1.13.2 2.7.7 3.1
4CEE	INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL CHALLENGE	2.7.7.7 3.4.23.16 2.7.7.49 3.1.26.13 3.1.13.2 2.7.7 3.1
4CEF	INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL CHALLENGE	2.7.7.7 3.4.23.16 2.7.7.49 3.1.26.13 3.1.13.2 2.7.7 3.1
4CEH	CRYSTAL STRUCTURE OF ADDAB WITH A FORKED DNA SUBSTRATE	3.1 3.6.4.12
4CEJ	CRYSTAL STRUCTURE OF ADDAB-DNA-ADPNP COMPLEX AT 3 ANGSTROM RESOLUTION	3.1 3.6.4.12
4CEL	ACTIVE-SITE MUTANT D214N DETERMINED AT PH 6.0 WITH NO LIGAND BOUND IN THE ACTIVE SITE	3.2.1.91
4CEO	INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL CHALLENGE	2.7.7.7 3.4.23.16 2.7.7.49 3.1.26.13 3.1.13.2 2.7.7 3.1
4CEQ	INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL CHALLENGE	2.7.7.7 3.4.23.16 2.7.7.49 3.1.26.13 3.1.13.2 2.7.7 3.1
4CER	INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL CHALLENGE	2.7.7.7 3.4.23.16 2.7.7.49 3.1.26.13 3.1.13.2 2.7.7 3.1
4CES	INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL CHALLENGE	2.7.7.7 3.4.23.16 2.7.7.49 3.1.26.13 3.1.13.2 2.7.7 3.1
4CEU	1.58 A RESOLUTION NATIVE SPOROSARCINA PASTEURII UREASE	3.5.1.5
4CEV	ARGINASE FROM BACILLUS CALDEVELOX, L-ORNITHINE COMPLEX	3.5.3.1
4CEW	CRYSTAL STRUCTURE OF HUMAN ENTEROVIRUS 71 IN COMPLEX WITH THE UNCOATING INHIBITOR ALD	3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48
4CEX	1.59 A RESOLUTION FLUORIDE INHIBITED SPOROSARCINA PASTEURII UREASE	3.5.1.5
4CEY	CRYSTAL STRUCTURE OF HUMAN ENTEROVIRUS 71 IN COMPLEX WITH THE UNCOATING INHIBITOR NLD	3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48
4CEZ	INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL CHALLENGE	2.7.7.7 3.4.23.16 2.7.7.49 3.1.26.13 3.1.13.2 2.7.7 3.1
4CF0	INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL CHALLENGE	2.7.7.7 3.4.23.16 2.7.7.49 3.1.26.13 3.1.13.2 2.7.7 3.1
4CF1	INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL CHALLENGE	2.7.7.7 3.4.23.16 2.7.7.49 3.1.26.13 3.1.13.2 2.7.7 3.1
4CF2	INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL CHALLENGE	2.7.7.7 3.4.23.16 2.7.7.49 3.1.26.13 3.1.13.2 2.7.7 3.1
4CF3	MUTAGENESIS OF A RHODOBACTERACEAE L-HALOACID DEHALOGENASE	3.8.1.2
4CF4	MUTAGENESIS OF A RHODOBACTERACEAE L-HALOACID DEHALOGENASE	3.8.1.2
4CF8	INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL CHALLENGE	2.7.7.7 3.4.23.16 2.7.7.49 3.1.26.13 3.1.13.2 2.7.7 3.1
4CF9	INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL CHALLENGE	2.7.7.7 3.4.23.16 2.7.7.49 3.1.26.13 3.1.13.2 2.7.7 3.1
4CFA	INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL CHALLENGE	2.7.7.7 3.4.23.16 2.7.7.49 3.1.26.13 3.1.13.2 2.7.7 3.1
4CFB	INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL CHALLENGE	2.7.7.7 3.4.23.16 2.7.7.49 3.1.26.13 3.1.13.2 2.7.7 3.1
4CFC	INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL CHALLENGE	2.7.7.7 3.4.23.16 2.7.7.49 3.1.26.13 3.1.13.2 2.7.7 3.1
4CFD	INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL CHALLENGE	2.7.7.7 3.4.23.16 2.7.7.49 3.1.26.13 3.1.13.2 2.7.7 3.1
4CFY	SAVINASE CRYSTAL STRUCTURES FOR COMBINED SINGLE CRYSTAL DIFFRACTION AND POWDER DIFFRACTION ANALYSIS	3.4.21.62
4CFZ	SAVINASE CRYSTAL STRUCTURES FOR COMBINED SINGLE CRYSTAL DIFFRACTION AND POWDER DIFFRACTION ANALYSIS	3.4.21.62
4CG0	SAVINASE CRYSTAL STRUCTURES FOR COMBINED SINGLE CRYSTAL DIFFRACTION AND POWDER DIFFRACTION ANALYSIS	3.4.21.62
4CG1	STRUCTURAL AND FUNCTIONAL STUDIES ON A THERMOSTABLE POLYETHYLENE TEREPHTHALATE DEGRADING HYDROLASE FROM THERMOBIFIDA FUSCA	3.1.1.74
4CG2	STRUCTURAL AND FUNCTIONAL STUDIES ON A THERMOSTABLE POLYETHYLENE TEREPHTHALATE DEGRADING HYDROLASE FROM THERMOBIFIDA FUSCA	3.1.1.74
4CG3	STRUCTURAL AND FUNCTIONAL STUDIES ON A THERMOSTABLE POLYETHYLENE THEREPHTALATE DEGRADING HYDROLASE FROM THERMOBIFIDA FUSCA	3.1.1.74
4CGD	INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL CHALLENGE	2.7.7.7 3.4.23.16 2.7.7.49 3.1.26.13 3.1.13.2 2.7.7 3.1
4CGE	CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS RESUSCITATION PROMOTING FACTOR E	3
4CGF	INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL CHALLENGE	2.7.7.7 3.4.23.16 2.7.7.49 3.1.26.13 3.1.13.2 2.7.7 3.1
4CGG	INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL CHALLENGE	2.7.7.7 3.4.23.16 2.7.7.49 3.1.26.13 3.1.13.2 2.7.7 3.1
4CGH	INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL CHALLENGE	2.7.7.7 3.4.23.16 2.7.7.49 3.1.26.13 3.1.13.2 2.7.7 3.1
4CGI	INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL CHALLENGE	2.7.7.7 3.4.23.16 2.7.7.49 3.1.26.13 3.1.13.2 2.7.7 3.1
4CGJ	INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL CHALLENGE	2.7.7.7 3.4.23.16 2.7.7.49 3.1.26.13 3.1.13.2 2.7.7 3.1
4CGZ	CRYSTAL STRUCTURE OF THE BLOOM'S SYNDROME HELICASE BLM IN COMPLEX WITH DNA	3.6.4.12
4CH2	LOW-SALT CRYSTAL STRUCTURE OF A THROMBIN-GPIBALPHA PEPTIDE COMPLEX	3.4.21.5
4CH8	HIGH-SALT CRYSTAL STRUCTURE OF A THROMBIN-GPIBALPHA PEPTIDE COMPLEX	3.4.21.5
4CHA	STRUCTURE OF ALPHA-*CHYMOTRYPSIN REFINED AT 1.68 ANGSTROMS RESOLUTION	3.4.21.1
4CHG	CRYSTAL STRUCTURE OF VAPBC15 COMPLEX FROM MYCOBACTERIUM TUBERCULOSIS	3.1
4CHN	INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL CHALLENGE	2.7.7.7 3.4.23.16 2.7.7.49 3.1.26.13 3.1.13.2 2.7.7 3.1
4CHO	INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL CHALLENGE	2.7.7.7 3.4.23.16 2.7.7.49 3.1.26.13 3.1.13.2 2.7.7 3.1
4CHP	INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL CHALLENGE	2.7.7.7 3.4.23.16 2.7.7.49 3.1.26.13 3.1.13.2 2.7.7 3.1
4CHQ	INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL CHALLENGE	2.7.7.7 3.4.23.16 2.7.7.49 3.1.26.13 3.1.13.2 2.7.7 3.1
4CHY	INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL CHALLENGE	2.7.7.7 3.4.23.16 2.7.7.49 3.1.26.13 3.1.13.2 2.7.7 3.1
4CHZ	INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL CHALLENGE	2.7.7.7 3.4.23.16 2.7.7.49 3.1.26.13 3.1.13.2 2.7.7 3.1
4CI7	THE CRYSTAL STRUCTURE OF THE CYSTEINE PROTEASE AND LECTIN-LIKE DOMAINS OF CWP84, A SURFACE LAYER ASSOCIATED PROTEIN OF CLOSTRIDIUM DIFFICILE	3.4.22.15
4CI9	CRYSTAL STRUCTURE OF CATHEPSIN A, APO-STRUCTURE	3.4.16.5
4CIA	CRYSTAL STRUCTURE OF CATHEPSIN A, COMPLEXED WITH COMPOUND 1	3.4.16.5
4CIB	CRYSTAL STRUCTURE OF CATHEPSIN A, COMPLEXED WITH COMPOUND 2	3.4.16.5
4CID	STRUCTURAL INSIGHTS INTO THE N-TERMINUS OF THE EHD2 ATPASE	3.6.5.5
4CIE	INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL CHALLENGE	2.7.7.7 3.4.23.16 2.7.7.49 3.1.26.13 3.1.13.2 2.7.7 3.1
4CIF	INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL CHALLENGE	2.7.7.7 3.4.23.16 2.7.7.49 3.1.26.13 3.1.13.2 2.7.7 3.1
4CIG	INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL CHALLENGE	2.7.7.7 3.4.23.16 2.7.7.49 3.1.26.13 3.1.13.2 2.7.7 3.1
4CIK	PLASMINOGEN KRINGLE 1 IN COMPLEX WITH INHIBITOR	3.4.21.7
4CIS	STRUCTURE OF MUTM IN COMPLEX WITH CARBOCYCLIC 8-OXO-G CONTAINING DNA	3.2.2.23 4.2.99.18
4CJ0	CRYSTAL STRUCTURE OF CELD IN COMPLEX WITH AFFITIN E12	3.2.1.4
4CJ1	CRYSTAL STRUCTURE OF CELD IN COMPLEX WITH AFFITIN H3	3.2.1.4
4CJ2	CRYSTAL STRUCTURE OF HEWL IN COMPLEX WITH AFFITIN H4	3.2.1.17
4CJ3	INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL CHALLENGE	2.7.7.7 3.4.23.16 2.7.7.49 3.1.26.13 3.1.13.2 2.7.7 3.1
4CJ4	INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL CHALLENGE	2.7.7.7 3.4.23.16 2.7.7.49 3.1.26.13 3.1.13.2 2.7.7 3.1
4CJ5	INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL CHALLENGE	2.7.7.7 3.4.23.16 2.7.7.49 3.1.26.13 3.1.13.2 2.7.7 3.1
4CJE	INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL CHALLENGE	2.7.7.7 3.4.23.16 2.7.7.49 3.1.26.13 3.1.13.2 2.7.7 3.1
4CJF	INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL CHALLENGE	2.7.7.7 3.4.23.16 2.7.7.49 3.1.26.13 3.1.13.2 2.7.7 3.1
4CJK	INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL CHALLENGE	2.7.7.7 3.4.23.16 2.7.7.49 3.1.26.13 3.1.13.2 2.7.7 3.1
4CJL	INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL CHALLENGE	2.7.7.7 3.4.23.16 2.7.7.49 3.1.26.13 3.1.13.2 2.7.7 3.1
4CJP	INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL CHALLENGE	2.7.7.7 3.4.23.16 2.7.7.49 3.1.26.13 3.1.13.2 2.7.7 3.1
4CJQ	INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL CHALLENGE	2.7.7.7 3.4.23.16 2.7.7.49 3.1.26.13 3.1.13.2 2.7.7 3.1
4CJR	INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL CHALLENGE	2.7.7.7 3.4.23.16 2.7.7.49 3.1.26.13 3.1.13.2 2.7.7 3.1
4CJS	INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL CHALLENGE	2.7.7.7 3.4.23.16 2.7.7.49 3.1.26.13 3.1.13.2 2.7.7 3.1
4CJT	INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL CHALLENGE	2.7.7.7 3.4.23.16 2.7.7.49 3.1.26.13 3.1.13.2 2.7.7 3.1
4CJU	INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL CHALLENGE	2.7.7.7 3.4.23.16 2.7.7.49 3.1.26.13 3.1.13.2 2.7.7 3.1
4CJV	INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL CHALLENGE	2.7.7.7 3.4.23.16 2.7.7.49 3.1.26.13 3.1.13.2 2.7.7 3.1
4CJW	INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL CHALLENGE	2.7.7.7 3.4.23.16 2.7.7.49 3.1.26.13 3.1.13.2 2.7.7 3.1
4CK1	INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL CHALLENGE	2.7.7.7 3.4.23.16 2.7.7.49 3.1.26.13 3.1.13.2 2.7.7 3.1
4CK2	INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL CHALLENGE	2.7.7.7 3.4.23.16 2.7.7.49 3.1.26.13 3.1.13.2 2.7.7 3.1
4CK3	INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL CHALLENGE	2.7.7.7 3.4.23.16 2.7.7.49 3.1.26.13 3.1.13.2 2.7.7 3.1
4CKD	MODEL OF COMPLEX BETWEEN THE E.COLI ENZYME BETA-GALACTOSIDASE AND FOUR SINGLE CHAIN FV ANTIBODY DOMAINS SCFV13R4.	3.2.1.23
4CKQ	X-RAY STRUCTURE OF GLUCURONOXYLAN-XYLANOHYDROLASE (XYN30A) FROM CLOSTRIDIUM THERMOCELLUM	3.2.1.8
4CKU	THREE DIMENSIONAL STRUCTURE OF PLASMEPSIN II IN COMPLEX WITH HYDROXYETHYLAMINE-BASED INHIBITOR	3.4.23.39
4CL1	THE CRYSTAL STRUCTURE OF NS5A DOMAIN 1 FROM GENOTYPE 1A REVEALS NEW CLUES TO THE MECHANISM OF ACTION FOR DIMERIC HCV INHIBITORS	2.7.7.48 3.4.21.98 3.6.1.15 3.6.4.13
4CMH	CRYSTAL STRUCTURE OF CD38 WITH A NOVEL CD38-TARGETING ANTIBODY SAR650984	3.2.2.5 3.2.2.6 2.4.99.20
4CML	CRYSTAL STRUCTURE OF INPP5B IN COMPLEX WITH PHOSPHATIDYLINOSITOL 3,4- BISPHOSPHATE	3.1.3.36
4CMN	CRYSTAL STRUCTURE OF OCRL IN COMPLEX WITH A PHOSPHATE ION	3.1.3.36 3.1.3.56 3.1.3.86
4CMS	X-RAY ANALYSES OF ASPARTIC PROTEINASES IV. STRUCTURE AND REFINEMENT AT 2.2 ANGSTROMS RESOLUTION OF BOVINE CHYMOSIN	3.4.23.4
4CMV	CRYSTAL STRUCTURE OF RV3378C	3.1.7.9 3.1.7.8 2.5.1
4CMW	CRYSTAL STRUCTURE OF RV3378C	3.1.7.9 3.1.7.8 2.5.1
4CMX	CRYSTAL STRUCTURE OF RV3378C	2.5.1 3.1.7.9 3.1.7.8
4CNQ	MUTAGENESIS OF A RHODOBACTERACEAE L-HALOACID DEHALOGENASE	3.8.1.2
4CO9	CRYSTAL STRUCTURE OF KYNURENINE FORMAMIDASE FROM BACILLUS ANTHRACIS	3.5.1.9
4COB	CRYSTAL STRUCTURE KYNURENINE FORMAMIDASE FROM PSEUDOMONAS AERUGINOSA	3.5.1.9
4COC	HIV-1 CAPSID C-TERMINAL DOMAIN MUTANT (Y169L)	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
4COE	MACROCYCLIC TRANSITION-STATE MIMICKING HIV-1 PROTEASE INHIBITORS ENCOMPASSING A TERTIARY ALCOHOL	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
4COG	CRYSTAL STRUCTURE OF KYNURENINE FORMAMIDASE FROM BURKHOLDERIA CENOCEPACIA	3.5.1.9
4COP	HIV-1 CAPSID C-TERMINAL DOMAIN MUTANT (Y169S)	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
4COT	THE IMPORTANCE OF THE ABN2 CALCIUM CLUSTER IN THE ENDO-1,5- ARABINANASE ACTIVITY FROM BACILLUS SUBTILIS	3.2.1.99
4CP7	MACROCYCLIC TRANSITION-STATE MIMICKING HIV-1 PROTEASE INHIBITORS ENCOMPASSING A TERTIARY ALCOHOL	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
4CP8	STRUCTURE OF THE AMIDASE DOMAIN OF ALLOPHANATE HYDROLASE FROM PSEUDOMONAS SP STRAIN ADP	3.5.1.54
4CPA	REFINED CRYSTAL STRUCTURE OF THE POTATO INHIBITOR COMPLEX OF CARBOXYPEPTIDASE A AT 2.5 ANGSTROMS RESOLUTION	3.4.17.1
4CPK	CRYSTAL STRUCTURE OF PBP2A DOUBLE CLINICAL MUTANT N146K-E150K FROM MRSA	3.4.16.4
4CPN	STRUCTURE OF THE NEURAMINIDASE FROM THE B/BRISBANE/60/2008 VIRUS IN COMPLEX WITH ZANAMIVIR	3.2.1.18
4CPO	STRUCTURE OF THE NEURAMINIDASE FROM THE B/LYON/CHU/15.216/2011 VIRUS	3.2.1.18
4CPQ	MACROCYCLIC TRANSITION-STATE MIMICKING HIV-1 PROTEASE INHIBITORS ENCOMPASSING A TERTIARY ALCOHOL	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
4CPR	MACROCYCLIC TRANSITION-STATE MIMICKING HIV-1 PROTEASE INHIBITORS ENCOMPASSING A TERTIARY ALCOHOL	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
4CPS	MACROCYCLIC TRANSITION-STATE MIMICKING HIV-1 PROTEASE INHIBITORS ENCOMPASSING A TERTIARY ALCOHOL	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
4CPT	MACROCYCLIC TRANSITION-STATE MIMICKING HIV-1 PROTEASE INHIBITORS ENCOMPASSING A TERTIARY ALCOHOL	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
4CPU	MACROCYCLIC TRANSITION-STATE MIMICKING HIV-1 PROTEASE INHIBITORS ENCOMPASSING A TERTIARY ALCOHOL	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
4CPW	MACROCYCLIC TRANSITION-STATE MIMICKING HIV-1 PROTEASE INHIBITORS ENCOMPASSING A TERTIARY ALCOHOL	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
4CPX	MACROCYCLIC TRANSITION-STATE MIMICKING HIV-1 PROTEASE INHIBITORS ENCOMPASSING A TERTIARY ALCOHOL	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
4CPY	STRUCTURE OF THE NEURAMINIDASE FROM THE B/LYON/CHU/15.216/2011 VIRUS IN COMPLEX WITH OSELTAMIVIR	3.2.1.18
4CQB	THE REACTION MECHANISM OF THE N-ISOPROPYLAMMELIDE ISOPROPYLAMINOHYDROLASE ATZC: INSIGHTS FROM STRUCTURAL AND MUTAGENESIS STUDIES	3.5.99.4 3.5.4.42
4CQC	THE REACTION MECHANISM OF THE N-ISOPROPYLAMMELIDE ISOPROPYLAMINOHYDROLASE ATZC: INSIGHTS FROM STRUCTURAL AND MUTAGENESIS STUDIES	3.5.99.4 3.5.4.42
4CQD	THE REACTION MECHANISM OF THE N-ISOPROPYLAMMELIDE ISOPROPYLAMINOHYDROLASE ATZC: INSIGHTS FROM STRUCTURAL AND MUTAGENESIS STUDIES	3.5.99.4 3.5.4.42
4CR5	CREATING NOVEL F1 INHIBITORS THROUGH FRAGMENT BASED LEAD GENERATION AND STRUCTURE AIDED DRUG DESIGN	3.4.21.27
4CR9	CREATING NOVEL F1 INHIBITORS THROUGH FRAGMENT BASED LEAD GENERATION AND STRUCTURE AIDED DRUG DESIGN	3.4.21.27
4CRA	CREATING NOVEL F1 INHIBITORS THROUGH FRAGMENT BASED LEAD GENERATION AND STRUCTURE AIDED DRUG DESIGN	3.4.21.27
4CRB	CREATING NOVEL F1 INHIBITORS THROUGH FRAGMENT BASED LEAD GENERATION AND STRUCTURE AIDED DRUG DESIGN	3.4.21.27
4CRC	CREATING NOVEL F1 INHIBITORS THROUGH FRAGMENT BASED LEAD GENERATION AND STRUCTURE AIDED DRUG DESIGN	3.4.21.27
4CRD	CREATING NOVEL F1 INHIBITORS THROUGH FRAGMENT BASED LEAD GENERATION AND STRUCTURE AIDED DRUG DESIGN	3.4.21.27
4CRE	CREATING NOVEL F1 INHIBITORS THROUGH FRAGMENT BASED LEAD GENERATION AND STRUCTURE AIDED DRUG DESIGN	3.4.21.27
4CRF	CREATING NOVEL F1 INHIBITORS THROUGH FRAGMENT BASED LEAD GENERATION AND STRUCTURE AIDED DRUG DESIGN	3.4.21.27
4CRG	CREATING NOVEL F1 INHIBITORS THROUGH FRAGMENT BASED LEAD GENERATION AND STRUCTURE AIDED DRUG DESIGN	3.4.21.27
4CRQ	CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF THE MODULAR LAMINARINASE ZGLAMC MUTANT E142S	3.2.1.39
4CSI	CRYSTAL STRUCTURE OF THE THERMOSTABLE CELLOBIOHYDROLASE CEL7A FROM THE FUNGUS HUMICOLA GRISEA VAR. THERMOIDEA.	3.2.1.176 3.2.1.91
4CT5	DDX6	3.6.4.13
4CTE	CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF THE MODULAR LAMINARINASE ZGLAMC MUTANT E142S IN COMPLEX WITH A THIO-OLIGOSACCHARIDE	3.2.1.39
4CTH	NEPRILYSIN VARIANT G399V,G714K IN COMPLEX WITH PHOSPHORAMIDON	3.4.24.11
4CTJ	DENGUE 3 NS5 METHYLTRANSFERASE BOUND TO S-ADENOSYL METHIONINE AND FRAGMENT 3A9	2.1.1.56 2.1.1.57 3.4.21.91 3.6.1.15 3.6.4.13
4CTK	DENGUE 3 NS5 METHYLTRANSFERASE BOUND TO S-ADENOSYL METHIONINE AND FRAGMENT 2A4	2.1.1.56 2.1.1.57 3.4.21.91 3.6.1.15 3.6.4.13
4CU2	C-TERMINAL DOMAIN OF CTP1L ENDOLYSIN MUTANT V195P THAT REDUCES AUTOPROTEOLYSIS	3.2.1.17
4CU6	UNRAVELLING THE MULTIPLE FUNCTIONS OF THE ARCHITECTURALLY INTRICATE STREPTOCOCCUS PNEUMONIAE BETA-GALACTOSIDASE, BGAA	3.2.1.23
4CU7	UNRAVELLING THE MULTIPLE FUNCTIONS OF THE ARCHITECTURALLY INTRICATE STREPTOCOCCUS PNEUMONIAE BETA-GALACTOSIDASE, BGAA	3.2.1.23
4CU8	UNRAVELLING THE MULTIPLE FUNCTIONS OF THE ARCHITECTURALLY INTRICATE STREPTOCOCCUS PNEUMONIAE BETA-GALACTOSIDASE, BGAA	3.2.1.23
4CU9	UNRAVELLING THE MULTIPLE FUNCTIONS OF THE ARCHITECTURALLY INTRICATE STREPTOCOCCUS PNEUMONIAE BETA-GALACTOSIDASE, BGAA	3.2.1.23
4CUA	UNRAVELLING THE MULTIPLE FUNCTIONS OF THE ARCHITECTURALLY INTRICATE STREPTOCOCCUS PNEUMONIAE BETA-GALACTOSIDASE, BGAA	3.2.1.23
4CUB	UNRAVELLING THE MULTIPLE FUNCTIONS OF THE ARCHITECTURALLY INTRICATE STREPTOCOCCUS PNEUMONIAE BETA-GALACTOSIDASE, BGAA	3.2.1.23
4CUC	UNRAVELLING THE MULTIPLE FUNCTIONS OF THE ARCHITECTURALLY INTRICATE STREPTOCOCCUS PNEUMONIAE BETA-GALACTOSIDASE, BGAA.	3.2.1.23
4CVD	CRYSTAL STRUCTURE OF THE CENTRAL REPEAT OF CELL WALL BINDING MODULE OF CPL7	3.2.1.17
4CVO	CRYSTAL STRUCTURE OF THE N-TERMINAL COLIED-COIL DOMAIN OF HUMAN DNA EXCISION REPAIR PROTEIN ERCC-6	3.6.4
4CVU	STRUCTURE OF FUNGAL BETA-MANNOSIDASE FROM GLYCOSIDE HYDROLASE FAMILY 2 OF TRICHODERMA HARZIANUM	3.2.1.25
4CWM	HIGH-GLYCOSYLATION CRYSTAL STRUCTURE OF THE BIFUNCTIONAL ENDONUCLEASE (ATBFN2) FROM ARABIDOPSIS THALIANA	3.1.30.1
4CX8	MONOMERIC PSEUDORABIES VIRUS PROTEASE PUL26N AT 2.5 A RESOLUTION	3.4.21.97
4CXK	G9 MUTANT OF PAS, ARYLSULFATASE FROM PSEUDOMONAS AERUGINOSA	3.1.6.1
4CXO	BIFUNCTIONAL ENDONUCLEASE IN COMPLEX WITH SSDNA	3.1.30.1
4CXP	STRUCTURE OF BIFUNCTIONAL ENDONUCLEASE (ATBFN2) FROM ARABIDOPSIS THALIANA IN COMPLEX WITH SULFATE	3.1.30.1
4CXS	G4 MUTANT OF PAS, ARYLSULFATASE FROM PSEUDOMONAS AERUGINOSA, IN COMPLEX WITH PHENYLPHOSPHONIC ACID	3.1.6.1
4CXU	G4 MUTANT OF PAS, ARYLSULFATASE FROM PSEUDOMONAS AERUGINOSA, IN COMPLEX WITH 3-BR-PHENOLPHENYLPHOSPHONATE	3.1.6.1
4CXV	STRUCTURE OF BIFUNCTIONAL ENDONUCLEASE (ATBFN2) IN COMPLEX WITH PHOSPHATE.	3.1.30.1
4CYF	THE STRUCTURE OF VANIN-1: DEFINING THE LINK BETWEEN METABOLIC DISEASE, OXIDATIVE STRESS AND INFLAMMATION	3.5.1.92
4CYG	THE STRUCTURE OF VANIN-1: DEFINING THE LINK BETWEEN METABOLIC DISEASE, OXIDATIVE STRESS AND INFLAMMATION	3.5.1.92
4CYM	COMPLEX OF HUMAN VARP-ANKRD1 WITH RAB32-GPPCP	3.6.5.2
4CYR	G4 MUTANT OF PAS, ARYLSULFATASE FROM PSEUDOMONAS AERUGINOSA	3.1.6.1
4CYS	G6 MUTANT OF PAS, ARYLSULFATASE FROM PSEUDOMONAS AERUGINOSA, IN COMPLEX WITH PHENYLPHOSPHONIC ACID	3.1.6.1
4CYY	THE STRUCTURE OF VANIN-1: DEFINING THE LINK BETWEEN METABOLIC DISEASE, OXIDATIVE STRESS AND INFLAMMATION	3.5.1.92
4CZ1	CRYSTAL STRUCTURE OF KYNURENINE FORMAMIDASE FROM BACILLUS ANTHRACIS COMPLEXED WITH 2-AMINOACETOPHENONE.	3.5.1.9
4CZV	STRUCTURE OF THE NEUROSPORA CRASSA PAN2 WD40 DOMAIN	3.1.13.4
4CZW	STRUCTURE OF THE NEUROSPORA CRASSA PAN2 CATALYTIC UNIT (PROTEASE AND NUCLEASE DOMAIN)	3.1.13.4
4CZX	COMPLEX OF NEUROSPORA CRASSA PAN2 (WD40) WITH PAN3 (C-TERM)	3.1.13.4
4CZY	COMPLEX OF NEUROSPORA CRASSA PAN2 (WD40-CS1) WITH PAN3 (PSEUDOKINASE AND C-TERM)	3.1.13.4
4D08	PDE2A CATALYTIC DOMAIN IN COMPLEX WITH A BRAIN PENETRANT INHIBITOR	3.1.4.17
4D09	PDE2A CATALYTIC DOMAIN IN COMPLEX WITH A BRAIN PENETRANT INHIBITOR	3.1.4.17
4D0K	COMPLEX OF CHAETOMIUM THERMOPHILUM PAN2 (WD40-CS1) WITH PAN3 (C-TERM)	3.1.13.4
4D0N	AKAP13 (AKAP-LBC) RHOGEF DOMAIN IN COMPLEX WITH RHOA	3.6.5.2
4D0Y	CRYSTAL STRUCTURE OF DACB FROM STREPTOCOCCUS PNEUMONIAE D39	3.4.17.13
4D25	CRYSTAL STRUCTURE OF THE BOMBYX MORI VASA HELICASE (E339Q) IN COMPLEX WITH RNA AND AMPPNP	3.6.4.13
4D26	CRYSTAL STRUCTURE OF THE BOMBYX MORI VASA HELICASE (E339Q) IN COMPLEX WITH RNA,ADP AND PI	3.6.4.13
4D2H	CRYSTAL STRUCTURE OF THE TETRAMERISATION DOMAIN OF HUMAN CTIP	3.1
4D2I	CRYSTAL STRUCTURE OF THE HERA HEXAMERIC DNA TRANSLOCASE FROM SULFOLOBUS SOLFATARICUS BOUND TO AMP-PNP	3.6.4.12
4D2O	CRYSTAL STRUCTURE OF THE CLASS A EXTENDED-SPECTRUM BETA-LACTAMASE PER- 2	3.5.2.6
4D3P	CRYSTAL STRUCTURE OF POINT MUTATED DUSP19 (C150A)	3.1.3.16 3.1.3.48
4D3Q	CRYSTAL STRUCTURE OF POINT MUTATED DUSP19 (R156A)	3.1.3.16 3.1.3.48
4D3R	CRYSTAL STRUCTURE OF POINT MUTATED DUSP19 (I187A)	3.1.3.16 3.1.3.48
4D3X	THE STRUCTURE OF MATURE LEGUMAIN FROM CHINESE HAMSTER.	3.4.22.34
4D3Y	THE STRUCTURE OF INACTIVE PROLEGUMAIN FROM CHINESE HAMSTER.	3.4.22.34
4D3Z	THE STRUCTURE OF INACTIVE PROLEGUMAIN FROM CHINESE HAMSTER, TRIGONAL SPACE GROUP.	3.4.22.34
4D4A	STRUCTURE OF THE CATALYTIC DOMAIN (BCGH76) OF THE BACILLUS CIRCULANS GH76 ALPHA MANNANASE, AMAN6.	3.2.1.101
4D4B	THE CATALYTIC DOMAIN, BCGH76, OF BACILLUS CIRCULANS AMAN6 IN COMPLEX WITH MSMSME	3.2.1.101
4D4C	THE CATALYTIC DOMAIN, BCGH76, OF BACILLUS CIRCULANS AMAN6 IN COMPLEX WITH 1,6-MANDMJ	3.2.1.101
4D4D	THE CATALYTIC DOMAIN, BCGH76, OF BACILLUS CIRCULANS AMAN6 IN COMPLEX WITH 1,6-MANIFG	3.2.1.101
4D4J	HUMAN PFKFB3 IN COMPLEX WITH A PYRROLOPYRIMIDONE COMPOUND	2.7.1.105 3.1.3.46
4D4K	HUMAN PFKFB3 IN COMPLEX WITH A PYRROLOPYRIMIDONE COMPOUND	2.7.1.105 3.1.3.46
4D4L	HUMAN PFKFB3 IN COMPLEX WITH A PYRROLOPYRIMIDONE COMPOUND	2.7.1.105 3.1.3.46
4D4M	HUMAN PFKFB3 IN COMPLEX WITH A PYRROLOPYRIMIDONE COMPOUND	2.7.1.105 3.1.3.46
4D59	CLOSTRIDIAL CYSTEINE PROTEASE CWP84 C116A AFTER PROPEPTIDE CLEAVAGE	3.4.22.15
4D5A	CLOSTRIDIAL CYSTEINE PROTEASE CWP84 C116A AFTER PROPEPTIDE CLEAVAGE	3.4.22.15
4D5E	CRYSTAL STRUCTURE OF RECOMBINANT WILDTYPE CDH	3.7.1.11
4D5G	STRUCTURE OF RECOMBINANT CDH-H28AN484A	3.7.1.11
4D5I	HYPOCREA JECORINA CELLOBIOHYDROLASE CEL7A E212Q SOAKED WITH XYLOTRIOSE.	3.2.1.176 3.2.1.91
4D5J	HYPOCREA JECORINA CELLOBIOHYDROLASE CEL7A E217Q SOAKED WITH XYLOTRIOSE.	3.2.1.176 3.2.1.91
4D5O	HYPOCREA JECORINA CELLOBIOHYDROLASE CEL7A E212Q SOAKED WITH XYLOPENTAOSE.	3.2.1.176 3.2.1.91
4D5P	HYPOCREA JECORINA CELLOBIOHYDROLASE CEL7A E217Q SOAKED WITH XYLOPENTAOSE.	3.2.1.176 3.2.1.91
4D5Q	HYPOCREA JECORINA CEL7A (WILD TYPE) SOAKED WITH XYLOPENTAOSE.	3.2.1.176 3.2.1.91
4D5V	HYPOCREA JECORINA CELLOBIOHYDROLASE CEL7A E217Q SOAKED WITH XYLOTETRAOSE.	3.2.1.176 3.2.1.91
4D6C	CRYSTAL STRUCTURE OF A FAMILY 98 GLYCOSIDE HYDROLASE CATALYTIC MODULE (SP3GH98)(L19 MUTANT)	3.2.1.102
4D6D	CRYSTAL STRUCTURE OF A FAMILY 98 GLYCOSIDE HYDROLASE CATALYTIC MODULE (SP3GH98) IN COMPLEX WITH THE BLOOD GROUP A-TRISACCHARIDE (X02 MUTANT)	3.2.1.102
4D6E	CRYSTAL STRUCTURE OF A FAMILY 98 GLYCOSIDE HYDROLASE CATALYTIC MODULE (SP3GH98) IN COMPLEX WITH THE BLOOD GROUP A-TRISACCHARIDE (X01 MUTANT)	3.2.1.102
4D6F	CRYSTAL STRUCTURE OF A FAMILY 98 GLYCOSIDE HYDROLASE CATALYTIC MODULE (SP3GH98) IN COMPLEX WITH THE TYPE 1 BLOOD GROUP A-TETRASACCHARIDE (E558A, X01 MUTANT)	3.2.1.102
4D6G	CRYSTAL STRUCTURE OF A FAMILY 98 GLYCOSIDE HYDROLASE CATALYTIC MODULE (SP3GH98) IN COMPLEX WITH THE BLOOD GROUP A-TRISACCHARIDE (L19 MUTANT)	3.2.1.102
4D6H	CRYSTAL STRUCTURE OF A FAMILY 98 GLYCOSIDE HYDROLASE CATALYTIC MODULE (SP3GH98) IN COMPLEX WITH THE TYPE 1 BLOOD GROUP A-TETRASACCHARIDE (E558A X02 MUTANT)	3.2.1.102
4D6I	CRYSTAL STRUCTURE OF A FAMILY 98 GLYCOSIDE HYDROLASE CATALYTIC MODULE (SP3GH98) IN COMPLEX WITH THE TYPE 1 BLOOD GROUP A-TETRASACCHARIDE (E558A L19 MUTANT)	3.2.1.102
4D6J	CRYSTAL STRUCTURE OF A FAMILY 98 GLYCOSIDE HYDROLASE CATALYTIC MODULE (SP3GH98) IN COMPLEX WITH THE TYPE 2 BLOOD GROUP A-TETRASACCHARIDE (E558A X01 MUTANT)	3.2.1.102
4D6N	THE CRYSTAL STRUCTURE OF I-DMOI IN COMPLEX WITH ITS TARGET DNA AT 10 DAYS INCUBATION IN 5MM MG (STATE 7)	3.1
4D6O	THE CRYSTAL STRUCTURE OF I-DMOI IN COMPLEX WITH ITS TARGET DNA AT 1H INCUBATION IN 5MM MG (STATE 2)	3.1
4D70	STRUCTURAL, BIOPHYSICAL AND BIOCHEMICAL ANALYSES OF A CLOSTRIDIUM PERFRINGENS SORTASE D5 TRANSPEPTIDASE	3.4.22.70
4D71	CRYSTAL STRUCTURE OF A FAMILY 98 GLYCOSIDE HYDROLASE CATALYTIC MODULE (SP3GH98) IN COMPLEX WITH THE TYPE 2 BLOOD GROUP A-TETRASACCHARIDE (E558A X02 MUTANT)	3.2.1.102
4D72	CRYSTAL STRUCTURE OF A FAMILY 98 GLYCOSIDE HYDROLASE CATALYTIC MODULE (SP3GH98) IN COMPLEX WITH THE TYPE 2 BLOOD GROUP A-TETRASACCHARIDE (E558A L19 MUTANT)	3.2.1.102
4D74	1.57 A CRYSTAL STRUCTURE OF ERWINIA AMYLOVORA TYROSINE PHOSPHATASE AMSI	3.1.3.48
4D76	HUMAN FXIA IN COMPLEX WITH SMALL MOLECULE INHIBITORS.	3.4.21.27
4D7F	HUMAN FXIA IN COMPLEX WITH SMALL MOLECULE INHIBITORS.	3.4.21.27
4D7G	HUMAN FXIA IN COMPLEX WITH SMALL MOLECULE INHIBITORS.	3.4.21.27
4D80	METALLOSPHERA SEDULA VPS4 CRYSTAL STRUCTURE	3.6.4.6
4D81	METALLOSPHERA SEDULA VPS4 CRYSTAL STRUCTURE	3.6.4.6
4D82	METALLOSPHERA SEDULA VPS4 CRYSTAL STRUCTURE	3.6.4.6
4D83	CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE IN COMPLEX WITH NVP-BUR436, DERIVED FROM A CO-CRYSTALLIZATION EXPERIMENT	3.4.23.46
4D85	CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE IN COMPLEX WITH NVP-BVI151	3.4.23.46
4D88	CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE IN COMPLEX WITH NVP-BXQ490	3.4.23.46
4D89	CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE IN COMPLEX WITH NVP-BXD552, DERIVED FROM A SOAKING EXPERIMENT	3.4.23.46
4D8B	HIGH RESOLUTION STRUCTURE OF MONOMERIC S. PROGENIES SPEB REVEALS ROLE OF GLYCINE-RICH ACTIVE SITE LOOP	3.4.22.10
4D8C	CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE IN COMPLEX WITH NVP-BXD552, DERIVED FROM A CO-CRYSTALLIZATION EXPERIMENT	3.4.23.46
4D8E	HIGH RESOLUTION STRUCTURES OF MONOMERIC S. PYOGENES SPEB REVEALS ROLE OF GLYCINE-RICH ACTIVE SITE LOOP	3.4.22.10
4D8I	HIGH RESOLUTION STRUCTURES OF MONOMERIC S. PYOGENES SPEB REVEALS ROLE OF GLYCINE-RICH ACTIVE SITE LOOP	3.4.22.10
4D8L	CRYSTAL STRUCTURE OF THE 2-PYRONE-4,6-DICARBOXYLIC ACID HYDROLASE FROM SPHINGOMONAS PAUCIMOBILIS	3.1.1.57
4D8N	HUMAN KALLIKREIN 6 INHIBITORS WITH A PARA-AMIDOBENZYLANMINE P1 GROUP CARRY A HIGH BINDING EFFICIENCY	3.4.21
4D8S	INFLUENZA NA IN COMPLEX WITH ANTIVIRAL COMPOUND	3.2.1.18
4D91	THERMOLYSIN IN COMPLEX WITH DMSO AND ACETATE	3.4.24.27
4D9R	INHIBITING ALTERNATIVE PATHWAY COMPLEMENT ACTIVATION BY TARGETING THE EXOSITE ON FACTOR D	3.4.21.46
4D9W	THERMOLYSIN IN COMPLEX WITH UBTLN32	3.4.24.27
4D9Z	LYSOZYME AT 318K	3.2.1.17
4DB2	MSS116P DEAD-BOX HELICASE DOMAIN 2 BOUND TO AN RNA DUPLEX	3.6.4.13
4DB4	MSS116P DEAD-BOX HELICASE DOMAIN 2 BOUND TO A CHIMAERIC RNA-DNA DUPLEX	3.6.4.13
4DBK	CRYSTAL STRUCTURE OF PORCINE PANCREATIC PHOSPHOLIPASE A2 COMPLEXED WITH BERBERINE	3.1.1.4
4DC4	LYSOZYME TRIMER	3.2.1.17
4DCB	Y. PESTIS PLASMINOGEN ACTIVATOR PLA IN COMPLEX WITH HUMAN PLASMINOGEN ACTIVATION LOOP PEPTIDE ALP11	3.4.23.48
4DCD	1.6A RESOLUTION STRUCTURE OF POLIOVIRUS 3C PROTEASE CONTAINING A COVALENTLY BOUND DIPEPTIDYL INHIBITOR	3.4.22.28 3.4.22.29 3.6.1.15 2.7.7.48
4DCJ	CRYSTAL STRUCTURE OF CASPASE 3, L168D MUTANT	3.4.22.56
4DCO	CRYSTAL STRUCTURE OF CASPASE 3, L168Y MUTANT	3.4.22.56
4DCP	CRYSTAL STRUCTURE OF CASPASE 3, L168F MUTANT	3.4.22.56
4DD0	EVAL PROCESSED HEWL, CISPLATIN AQUEOUS GLYCEROL	3.2.1.17
4DD1	EVAL PROCESSED HEWL, CISPLATIN AQUEOUS PARATONE	3.2.1.17
4DD2	EVAL PROCESSED HEWL, CARBOPLATIN AQUEOUS GLYCEROL	3.2.1.17
4DD3	EVAL PROCESSED HEWL, CARBOPLATIN AQUEOUS PARATONE	3.2.1.17
4DD7	EVAL PROCESSED HEWL, CARBOPLATIN DMSO GLYCEROL	3.2.1.17
4DD8	ADAM-8 METALLOPROTEINASE DOMAIN WITH BOUND BATIMASTAT	3.4.24
4DD9	EVAL PROCESSED HEWL, CARBOPLATIN DMSO PARATONE	3.2.1.17
4DDA	EVAL PROCESSED HEWL, NAG	3.2.1.17
4DDB	EVAL PROCESSED HEWL, CISPLATIN DMSO PARATONE PH 6.5	3.2.1.17
4DDC	EVAL PROCESSED HEWL, CISPLATIN DMSO NAG SILICONE OIL	3.2.1.17
4DDI	CRYSTAL STRUCTURE OF HUMAN OTUB1/UBCH5B~UB/UB	6.3.2.19 3.4.19.12 2.3.2.23 2.3.2.24
4DDL	PDE10A CRYSTAL STRUCTURE COMPLEXED WITH NOVEL INHIBITOR	3.1.4.17 3.1.4.35
4DDS	CTX-M-9 CLASS A BETA-LACTAMASE COMPLEXED WITH COMPOUND 11	3.5.2.6
4DDT	THERMOTOGA MARITIMA REVERSE GYRASE, C2 FORM 2	3.6.4.12 5.99.1.3 5.6.2.2
4DDU	THERMOTOGA MARITIMA REVERSE GYRASE, C2 FORM 1	3.6.4.12 5.99.1.3 5.6.2.2
4DDW	THERMOTOGA MARITIMA REVERSE GYRASE, C-CENTERED ORTHORHOMBIC FORM	3.6.4.12 5.99.1.3 5.6.2.2
4DDX	THERMOTOGA MARITIMA REVERSE GYRASE, PRIMITIVE MONOCLINIC FORM	3.6.4.12 5.99.1.3 5.6.2.2
4DDY	CTX-M-9 CLASS A BETA-LACTAMASE COMPLEXED WITH COMPOUND 10	3.5.2.6
4DE0	CTX-M-9 CLASS A BETA-LACTAMASE COMPLEXED WITH COMPOUND 16	3.5.2.6
4DE1	CTX-M-9 CLASS A BETA-LACTAMASE COMPLEXED WITH COMPOUND 18	3.5.2.6
4DE2	CTX-M-9 CLASS A BETA-LACTAMASE COMPLEXED WITH COMPOUND 12	3.5.2.6
4DE3	CTX-M-9 CLASS A BETA-LACTAMASE COMPLEXED WITH COMPOUND 4	3.5.2.6
4DF6	CRYSTAL STRUCTURE OF THE INHIBITOR NXL104 COVALENT ADDUCT WITH TB B-LACTAMASE	3.5.2.6
4DF7	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS V23L/V99I AT CRYOGENIC TEMPERATURE	3.1.31.1
4DFA	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS I92A/L36A AT CRYOGENIC TEMPERATURE	3.1.31.1
4DFC	CORE UVRA/TRCF COMPLEX	3.6.4
4DFF	THE SAR DEVELOPMENT OF DIHYDROIMIDAZOISOQUINOLINE DERIVATIVES AS PHOSPHODIESTERASE 10A INHIBITORS FOR THE TREATMENT OF SCHIZOPHRENIA	3.1.4.17 3.1.4.35
4DFG	CRYSTAL STRUCTURE OF WILD-TYPE HIV-1 PROTEASE WITH CYCLOPENTYLTETRAHYDRO- FURANYL URETHANES AS P2-LIGAND, GRL-0249A	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
4DG1	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) WITH POLYMORPHISM MUTATION K172A AND K173A	2.7.7.49 2.7.7.7 3.4.23.16 3.1.26.13 3.1.13.2 2.7.7 3.1
4DG4	HUMAN MESOTRYPSIN-S39Y COMPLEXED WITH BOVINE PANCREATIC TRYPSIN INHIBITOR (BPTI)	3.4.21.4
4DGJ	STRUCTURE OF A HUMAN ENTEROPEPTIDASE LIGHT CHAIN VARIANT	3.4.21.9
4DGP	THE WILD-TYPE SRC HOMOLOGY 2 (SH2)-DOMAIN CONTAINING PROTEIN TYROSINE PHOSPHATASE-2 (SHP2)	3.1.3.48
4DGR	INFLUENZA SUBTYPE 9 NEURAMINIDASE BENZOIC ACID INHIBITOR COMPLEX	3.2.1.18
4DGV	STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY HCV1, P2(1) FORM	3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48
4DGX	LEOPARD SYNDROME-ASSOCIATED SHP2/Y279C MUTANT	3.1.3.48
4DGY	STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY HCV1, C2 FORM	3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48
4DGZ	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS I92A/L125A AT CRYOGENIC TEMPERATURE	3.1.31.1
4DH6	STRUCTURE OF BACE-1 (BETA-SECRETASE) IN COMPLEX WITH (2R)-N-((2S,3R)-1-(BENZO[D][1,3]DIOXOL-5-YL)-3-HYDROXY-4-((S)-6'-NEOPENTYL-3',4'-DIHYDROSPIRO[CYCLOBUTANE-1,2'-PYRANO[2,3-B]PYRIDINE]-4'-YLAMINO)BUTAN-2-YL)-2-METHOXYPROPANAMIDE	3.4.23.46
4DHI	STRUCTURE OF C. ELEGANS OTUB1 BOUND TO HUMAN UBC13	3.4.19.12
4DHK	CRYSTAL STRUCTURE OF A DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE (DCTP DEAMINASE) FROM BURKHOLDERIA THAILANDENSIS	3.5.4.13
4DHL	CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH MAYBRIDGE FRAGMENT MO07123	3.1.3.2
4DHW	CRYSTAL STRUCTURE OF PEPTIDYL-TRNA HYDROLASE FROM PSEUDOMONAS AERUGINOSA WITH ADIPIC ACID AT 2.4 ANGSTROM RESOLUTION	3.1.1.29
4DHZ	THE STRUCTURE OF H/CEOTUB1-UBIQUITIN ALDEHYDE-UBC13~UB	3.4.19.12
4DI2	CRYSTAL STRUCTURE OF BACE1 IN COMPLEX WITH HYDROXYETHYLAMINE INHIBITOR 37	3.4.23.46
4DI8	CRYSTAL STRUCTURE OF THE D248A MUTANT OF 2-PYRONE-4,6-DICARBOXYLIC ACID HYDROLASE FROM SPHINGOMONAS PAUCIMOBILIS COMPLEXED WITH SUBSTRATE AT PH 8.5	3.1.1.57
4DI9	CRYSTAL STRUCTURE OF THE D248A MUTANT OF 2-PYRONE-4,6-DICARBOXYLIC ACID HYDROLASE FROM SPHINGOMONAS PAUCIMOBILIS COMPLEXED WITH SUBSTRATE AT PH 6.5	3.1.1.57
4DIA	CRYSTAL STRUCTURE OF THE D248N MUTANT OF 2-PYRONE-4,6-DICARBOXYLIC ACID HYDROLASE FROM SPHINGOMONAS PAUCIMOBILIS COMPLEXED WITH SUBSTRATE AT PH 4.6	3.1.1.57
4DID	CRYSTAL STRUCTURE OF SALMONELLA EFFECTOR N-TERMINAL DOMAIN SOPB IN COMPLEX WITH CDC42	3.6.5.2
4DIG	CRYSTAL STRUCTURE OF C-LOBE OF BOVINE LACTOFERRIN COMPLEXED WITH N-ACETYLMURAMYL L-ALANYL D-ISOGLUTAMINE AT 1.8 A RESOLUTION	3.4.21
4DJ4	X-RAY STRUCTURE OF MUTANT N211D OF BIFUNCTIONAL NUCLEASE TBN1 FROM SOLANUM LYCOPERSICUM (TOMATO)	3.1.30.1
4DJ5	PROTEINASE K BY LANGMUIR-BLODGETT HANGING DROP METHOD AT 1.8A RESOLUTION FOR UNIQUE WATER DISTRIBUTION	3.4.21.64
4DJH	STRUCTURE OF THE HUMAN KAPPA OPIOID RECEPTOR IN COMPLEX WITH JDTIC	3.2.1.17
4DJJ	CRYSTAL STRUCTURE OF THE COMPLEX OF PEPTIDYL-TRNA HYDROLASE FROM PSEUDOMONAS AERUGINOSA WITH PIMELIC ACID AT 2.9 ANGSTROM RESOLUTION	3.1.1.29
4DJL	CARBOXYPEPTIDASE T WITH N-SULFAMOYL-L-PHENYLALANINE	3.4.17.18
4DJO	CRYSTAL STRUCTURE OF WILD-TYPE HIV-1 PROTEASE IN COMPLEX WITH MKP56	2.7.7.49 3.1.26.13
4DJP	CRYSTAL STRUCTURE OF WILD-TYPE HIV-1 PROTEASE IN COMPLEX WITH MKP73	2.7.7.49 3.1.26.13
4DJQ	CRYSTAL STRUCTURE OF WILD-TYPE HIV-1 PROTEASE IN COMPLEX WITH MKP86	2.7.7.49 3.1.26.13
4DJR	CRYSTAL STRUCTURE OF WILD-TYPE HIV-1 PROTEASE IN COMPLEX WITH MKP97	2.7.7.49 3.1.26.13
4DJU	STRUCTURE OF BACE BOUND TO 2-IMINO-3-METHYL-5,5-DIPHENYLIMIDAZOLIDIN-4-ONE	3.4.23.46
4DJV	STRUCTURE OF BACE BOUND TO 2-IMINO-5-(3'-METHOXY-[1,1'-BIPHENYL]-3-YL)-3-METHYL-5-PHENYLIMIDAZOLIDIN-4-ONE	3.4.23.46
4DJW	STRUCTURE OF BACE BOUND TO 2-IMINO-3-METHYL-5-PHENYL-5-(3-(PYRIDIN-3-YL)PHENYL)IMIDAZOLIDIN-4-ONE	3.4.23.46
4DJX	STRUCTURE OF BACE BOUND TO 5-(3-(5-CHLOROPYRIDIN-3-YL)PHENYL)-5-CYCLOPROPYL-2-IMINO-3-METHYLIMIDAZOLIDIN-4-ONE	3.4.23.46
4DJY	STRUCTURE OF BACE BOUND TO (R)-5-CYCLOPROPYL-2-IMINO-3-METHYL-5-(3-(5-(PROP-1-YN-1-YL)PYRIDIN-3-YL)PHENYL)IMIDAZOLIDIN-4-ONE	3.4.23.46
4DJZ	CATALYTIC FRAGMENT OF MASP-1 IN COMPLEX WITH ITS SPECIFIC INHIBITOR DEVELOPED BY DIRECTED EVOLUTION ON SGCI SCAFFOLD	3.4.21
4DK2	CRYSTAL STRUCTURE OF OPEN TRYPANOSOMA BRUCEI DUTPASE	3.6.1.23
4DK4	CRYSTAL STRUCTURE OF TRYPANOSOMA BRUCEI DUTPASE WITH DUPNP, CA2+ AND NA+	3.6.1.23
4DK9	CRYSTAL STRUCTURE OF MBD4 CATALYTIC DOMAIN BOUND TO ABASIC DNA	3.2.2
4DKB	CRYSTAL STRUCTURE OF TRYPANOSOMA BRUCEI DUTPASE WITH DUPNP AND CA2+	3.6.1.23
4DKI	STRUCTURAL INSIGHTS INTO THE ANTI- METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) ACTIVITY OF CEFTOBIPROLE	3.4.16.4
4DKL	CRYSTAL STRUCTURE OF THE MU-OPIOID RECEPTOR BOUND TO A MORPHINAN ANTAGONIST	3.2.1.17
4DKS	A SPINDLE-SHAPED VIRUS PROTEIN (CHYMOTRYPSIN TREATED)	2.7.7 3.1
4DKT	CRYSTAL STRUCTURE OF HUMAN PEPTIDYLARGININE DEIMINASE 4 IN COMPLEX WITH N-ACETYL-L-THREONYL-L-ALPHA-ASPARTYL-N5-[(1E)-2-FLUOROETHANIMIDOYL]-L-ORNITHINAMIDE	3.5.3.15
4DKW	STRUCTURE OF P22 LARGE TERMINASE NUCLEASE DOMAIN	3.1.21 3.6.4
4DL0	CRYSTAL STRUCTURE OF THE HETEROTRIMERIC EGCHEAD PERIPHERAL STALK COMPLEX OF THE YEAST VACUOLAR ATPASE	3.6.3.14
4DL8	CRYSTAL STRUCTURE OF TRYPANOSOMA BRUCEI DUTPASE WITH DUMP, PLANAR [ALF3-OPO3] TRANSITION STATE ANALOGUE, MG2+, AND NA+	3.6.1.23
4DLC	CRYSTAL STRUCTURE OF TRYPANOSOMA BRUCEI DUTPASE WITH DUMP, MGF3- TRANSITION STATE ANALOGUE, AND MG2+	3.6.1.23
4DLR	H-RAS PEG 400/CA(OAC)2, ORDERED OFF	3.6.5.2
4DLT	H-RAS SET 2 CA(OAC)2, ON	3.6.5.2
4DLU	H-RAS SET 1 CA(OAC)2, ON	3.6.5.2
4DLV	H-RAS SET 2 CACL2/DTT, ORDERED OFF	3.6.5.2
4DLW	H-RAS SET 2 CA(OAC)2/DTT, ON	3.6.5.2
4DLX	H-RAS SET 1 CACL2/DTE, ORDERED OFF	3.6.5.2
4DLY	SET 1 CACL2/DTT, ORDERED OFF	3.6.5.2
4DLZ	H-RAS SET 2 CA(OAC)2/DTE, ORDERED OFF	3.6.5.2
4DM0	TN5 TRANSPOSASE: 20MER OUTSIDE END 2 MN COMPLEX	3.1
4DM1	CONTRIBUTION OF DISULFIDE BOND TOWARD THERMOSTABILITY IN HYPERTHERMOSTABLE ENDOCELLULASE	3.2.1.4
4DM2	CONTRIBUTION OF DISULFIDE BOND TOWARD THERMOSTABILITY IN HYPERTHERMOSTABLE ENDOCELLULASE	3.2.1.4
4DM9	THE CRYSTAL STRUCTURE OF UBIQUITIN CARBOXY-TERMINAL HYDROLASE L1 (UCHL1) BOUND TO A TRIPEPTIDE FLUOROMETHYL KETONE Z-VAE(OME)-FMK	3.4.19.12 6
4DMB	X-RAY STRUCTURE OF HUMAN HEPATITUS C VIRUS NS5A-TRANSACTIVATED PROTEIN 2 AT THE RESOLUTION 1.9A, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET HR6723	3.1.3.89
4DMN	HIV-1 INTEGRASE CATALYTICAL CORE DOMAIN	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
4DMV	CRYSTAL STRUCTURE OF THE GT DOMAIN OF CLOSTRIDIUM DIFFICILE TOXIN A	2.4.1 3.4.22
4DMW	CRYSTAL STRUCTURE OF THE GT DOMAIN OF CLOSTRIDIUM DIFFICILE TOXIN A (TCDA) IN COMPLEX WITH UDP AND MANGANESE	2.4.1 3.4.22
4DMX	CATHEPSIN K INHIBITOR	3.4.22.38
4DMY	CATHEPSIN K INHIBITOR	3.4.22.38
4DNP	CRYSTAL STRUCTURE OF DAD2	3.1
4DNQ	CRYSTAL STRUCTURE OF DAD2 S96A MUTANT	3.1
4DNY	CRYSTAL STRUCTURE OF ENTEROHEMORRHAGIC E. COLI STCE(132-251)	3.4.24
4DO3	STRUCTURE OF FAAH WITH A NON-STEROIDAL ANTI-INFLAMMATORY DRUG	3.5.1.99 3.1.1
4DO4	PHARMACOLOGICAL CHAPERONES FOR HUMAN ALPHA-N-ACETYLGALACTOSAMINIDASE	3.2.1.49
4DO5	PHARMACOLOGICAL CHAPERONES FOR HUMAN ALPHA-N-ACETYLGALACTOSAMINIDASE	3.2.1.49
4DO6	PHARMACOLOGICAL CHAPERONES FOR HUMAN ALPHA-N-ACETYLGALACTOSAMINIDASE	3.2.1.49
4DOD	THE STRUCTURE OF CBESCII CELA GH9 MODULE	3.2.1.4
4DOE	THE LIGANDED STRUCTURE OF CBESCII CELA GH9 MODULE	3.2.1.4
4DOF	STRUCTURES OF VACCINIA VIRUS URACIL-DNA GLYCOSYLASE IN NEW CRYSTAL FORMS	3.2.2.27
4DOG	STRUCTURES OF VACCINIA VIRUS URACIL-DNA GLYCOSYLASE IN NEW CRYSTAL FORMS	3.2.2.27
4DOQ	CRYSTAL STRUCTURE OF THE COMPLEX OF PORCINE PANCREATIC TRYPSIN WITH 1/2SLPI	3.4.21.4
4DOT	CRYSTAL STRUCTURE OF HUMAN HRASLS3.	3.1.1 2.3.1 3.1.1.32 3.1.1.4
4DPE	STRUCTURE OF MMP3 COMPLEXED WITH A PLATINUM-BASED INHIBITOR.	3.4.24.17
4DPF	BACE-1 IN COMPLEX WITH A HEA-MACROCYCLIC TYPE INHIBITOR	3.4.23.46
4DPI	BACE-1 IN COMPLEX WITH HEA-MACROCYCLIC INHIBITOR, MV078512	3.4.23.46
4DPR	STRUCTURE OF HUMAN LEUKOTRIENE A4 HYDROLASE IN COMPLEX WITH INHIBITOR CAPTOPRIL	3.3.2.6 3.4.11.4
4DPZ	CRYSTAL STRUCTURE OF HUMAN HRASLS2	2.3.1 3.1.1 3.1.1.32 3.1.1.4
4DQB	CRYSTAL STRUCTURE OF WILD-TYPE HIV-1 PROTEASE IN COMPLEX WITH DRV	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
4DQC	CRYSTAL STRUCTURE OF (G16C/L38C) HIV-1 PROTEASE IN COMPLEX WITH DRV	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
4DQE	CRYSTAL STRUCTURE OF (G16C/L38C) HIV-1 PROTEASE IN COMPLEX WITH DRV	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
4DQF	CRYSTAL STRUCTURE OF (G16A/L38A) HIV-1 PROTEASE IN COMPLEX WITH DRV	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
4DQG	CRYSTAL STRUCTURE OF APO(G16C/L38C) HIV-1 PROTEASE	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
4DQH	CRYSTAL STRUCTURE OF (R14C/E65C) HIV-1 PROTEASE IN COMPLEX WITH DRV	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
4DR8	CRYSTAL STRUCTURE OF A PEPTIDE DEFORMYLASE FROM SYNECHOCOCCUS ELONGATUS	3.5.1.88
4DR9	CRYSTAL STRUCTURE OF A PEPTIDE DEFORMYLASE FROM SYNECHOCOCCUS ELONGATUS IN COMPLEX WITH ACTINONIN	3.5.1.88
4DRU	HCV NS5B IN COMPLEX WITH MACROCYCLIC INDOLE INHIBITOR	2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13
4DSA	CRYSTAL STRUCTURE OF DPP-IV WITH COMPOUND C1	3.4.14.5
4DSN	SMALL-MOLECULE LIGANDS BIND TO A DISTINCT POCKET IN RAS AND INHIBIT SOS-MEDIATED NUCLEOTIDE EXCHANGE ACTIVITY	3.6 3.6.5.2
4DSO	SMALL-MOLECULE LIGANDS BIND TO A DISTINCT POCKET IN RAS AND INHIBIT SOS-MEDIATED NUCLEOTIDE EXCHANGE ACTIVITY	3.6 3.6.5.2
4DST	SMALL-MOLECULE LIGANDS BIND TO A DISTINCT POCKET IN RAS AND INHIBIT SOS-MEDIATED NUCLEOTIDE EXCHANGE ACTIVITY	3.6 3.6.5.2
4DSU	SMALL-MOLECULE LIGANDS BIND TO A DISTINCT POCKET IN RAS AND INHIBIT SOS-MEDIATED NUCLEOTIDE EXCHANGE ACTIVITY	3.6 3.6.5.2
4DSY	CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH MAYBRIDGE FRAGMENT CC24201	3.1.3.2
4DSZ	CRYSTAL STRUCTURE OF DPP-IV WITH COMPOUND C2	3.4.14.5
4DT2	CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH MAYBRIDGE FRAGMENT CC27209	3.1.3.2
4DT3	CRYSTAL STRUCTURE OF ZINC-CHARGED LYSOZYME	3.2.1.17
4DT7	CRYSTAL STRUCTURE OF THROMBIN BOUND TO THE ACTIVATION DOMAIN QEDQVDPRLIDGKMTRRGDS OF PROTEIN C	3.4.21.5
4DTC	CRYSTAL STRUCTURE OF DPP-IV WITH COMPOUND C5	3.4.14.5
4DTJ	RB69 DNA POLYMERASE TERNARY COMPLEX WITH DTTP OPPOSITE AN ABASIC SITE AND DDT/DA AS THE PENULTIMATE BASE-PAIR	2.7.7.7 3.1.11
4DTM	RB69 DNA POLYMERASE TERNARY COMPLEX WITH DCTP OPPOSITE AN ABASIC SITE AND DDG/DC AS THE PENULTIMATE BASE-PAIR	2.7.7.7 3.1.11
4DTN	RB69 DNA POLYMERASE TERNARY COMPLEX WITH DATP OPPOSITE AN ABASIC SITE AND DDA/DT AS THE PENULTIMATE BASE-PAIR	2.7.7.7 3.1.11
4DTO	RB69 DNA POLYMERASE TERNARY COMPLEX WITH DCTP OPPOSITE AN ABASIC SITE AND DDA/DT AS THE PENULTIMATE BASE-PAIR	2.7.7.7 3.1.11
4DTP	RB69 DNA POLYMERASE TERNARY COMPLEX WITH DGTP OPPOSITE AN ABASIC SITE AND DDA/DT AS THE PENULTIMATE BASE-PAIR	2.7.7.7 3.1.11
4DTR	RB69 DNA POLYMERASE TERNARY COMPLEX WITH DATP OPPOSITE AN ABASIC SITE AND DDC/DG AS THE PENULTIMATE BASE-PAIR	2.7.7.7 3.1.11
4DTS	RB69 DNA POLYMERASE TERNARY COMPLEX WITH DCTP OPPOSITE AN ABASIC SITE AND DDC/DG AS THE PENULTIMATE BASE-PAIR	2.7.7.7 3.1.11
4DTU	RB69 DNA POLYMERASE TERNARY COMPLEX WITH DGTP OPPOSITE AN ABASIC SITE AND DDC/DG AS THE PENULTIMATE BASE-PAIR	2.7.7.7 3.1.11
4DTX	RB69 DNA POLYMERASE TERNARY COMPLEX WITH DTTP OPPOSITE AN ABASIC SITE AND DDC/DG AS THE PENULTIMATE BASE-PAIR	2.7.7.7 3.1.11
4DU1	RB69 DNA POLYMERASE TERNARY COMPLEX WITH DATP OPPOSITE DT	2.7.7.7 3.1.11
4DU3	RB69 DNA POLYMERASE TERNARY COMPLEX WITH DDTP OPPOSITE DT WITH 3-DEAZA-ADENINE AT THE N-1 POSITION OF TEMPLATE STRAND	2.7.7.7 3.1.11
4DU4	RB69 DNA POLYMERASE TERNARY COMPLEX WITH DATP OPPOSITE DT WITH 3-DEAZA-ADENINE AT THE N-3 POSITION OF PRIMER STRAND	2.7.7.7 3.1.11
4DU6	CRYSTAL STRUCTURE OF GTP CYCLOHYDROLASE I FROM YERSINIA PESTIS COMPLEXED WITH GTP	3.5.4.16
4DU9	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS I92A/V74A AT CRYOGENIC TEMPERATURE	3.1.31.1
4DUK	CARBOXYPEPTIDASE T WITH L-BENZYLSUCCINIC ACID	3.4.17.18
4DUR	THE X-RAY CRYSTAL STRUCTURE OF FULL-LENGTH TYPE II HUMAN PLASMINOGEN	3.4.21.7
4DUS	STRUCTURE OF BACE-1 (BETA-SECRETASE) IN COMPLEX WITH N-((2S,3R)-1-(4-FLUOROPHENYL)-3-HYDROXY-4-((6'-NEOPENTYL-3',4'-DIHYDROSPIRO[CYCLOBUTANE-1,2'-PYRANO[2,3-B]PYRIDIN]-4'-YL)AMINO)BUTAN-2-YL)ACETAMIDE	3.4.23.46
4DUU	THE X-RAY CRYSTAL STRUCTURE OF FULL-LENGTH TYPE I HUMAN PLASMINOGEN	3.4.21.7
4DUW	E. COLI (LACZ) BETA-GALACTOSIDASE (G974A) IN COMPLEX WITH ALLOLACTOSE	3.2.1.23
4DV8	ANTHRAX LETHAL FACTOR METALLOPROTEINASE IN COMPLEX WITH THE HYDROXAMIC ACID BASED SMALL MOLECULE PT8421	3.4.24.83
4DV9	CRYSTAL STRUCTURE OF BACE1 WITH ITS INHIBITOR	3.4.23.46
4DVA	THE CRYSTAL STRUCTURE OF HUMAN UROKINASE-TYPE PLASMINOGEN ACTIVATOR CATALYTIC DOMAIN	3.4.21.73
4DVF	CRYSTAL STRUCTURE OF BACE1 WITH ITS INHIBITOR	3.4.23.46
4DVG	CRYSTAL STRUCTURE OF E. HISTOLYTICA FORMIN1 BOUND TO EHRHO1-GTPGAMMAS	3.6.5.2
4DVK	CRYSTAL STRUCTURE OF THE GLYCOPROTEIN ERNS FROM THE PESTIVIRUS BVDV-1 STRAIN NCP-7	3.4.22 3.4.21.113 3.6.1.15 3.6.4.13 2.7.7.48
4DVL	CRYSTAL STRUCTURE OF THE GLYCOPROTEIN ERNS FROM THE PESTIVIRUS BVDV-1 IN COMPLEX WITH 2'-3'-CYCLO-UMP	3.4.22 3.4.21.113 3.6.1.15 3.6.4.13 2.7.7.48
4DVN	CRYSTAL STRUCTURE OF THE GLYCOPROTEIN ERNS FROM THE PESTIVIRUS BVDV-1 IN COMPLEX WITH 2'-UMP	3.4.22 3.4.21.113 3.6.1.15 3.6.4.13 2.7.7.48
4DW3	CRYSTAL STRUCTURE OF THE GLYCOPROTEIN ERNS FROM THE PESTIVIRUS BVDV-1 IN COMPLEX WITH 5'-CMP	3.4.22 3.4.21.113 3.6.1.15 3.6.4.13 2.7.7.48
4DW4	CRYSTAL STRUCTURE OF THE GLYCOPROTEIN ERNS FROM THE PESTIVIRUS BVDV-1 IN COMPLEX WITH 5'-UMP	3.4.22 3.4.21.113 3.6.1.15 3.6.4.13 2.7.7.48
4DW5	CRYSTAL STRUCTURE OF THE GLYCOPROTEIN ERNS FROM THE PESTIVIRUS BVDV-1 IN COMPLEX WITH A NON-CLEAVABLE CPU DINUCLEOTIDE	3.4.22 3.4.21.113 3.6.1.15 3.6.4.13 2.7.7.48
4DW7	CRYSTAL STRUCTURE OF AN ACTIVE-SITE MUTANT OF THE GLYCOPROTEIN ERNS FROM THE PESTIVIRUS BVDV-1 IN COMPLEX WITH A CPU DINUCLEOTIDE	3.4.22 3.4.21.113 3.6.1.15 3.6.4.13 2.7.7.48
4DW8	CRYSTAL STRUCTURE OF A HALOACID DEHALOGENASE-LIKE HYDROLASE (TARGET EFI-900331) FROM BACTEROIDES THETAIOTAOMICRON WITH BOUND NA CRYSTAL FORM I	3.8.1
4DWA	CRYSTAL STRUCTURE OF AN ACTIVE-SITE MUTANT OF THE GLYCOPROTEIN ERNS FROM THE PESTIVIRUS BVDV-1 IN COMPLEX WITH A CPUPC TRINUCLEOTIDE	3.4.22 3.4.21.113 3.6.1.15 3.6.4.13 2.7.7.48
4DWC	CRYSTAL STRUCTURE OF THE GLYCOPROTEIN ERNS FROM THE PESTIVIRUS BVDV-1 IN COMPLEX WITH ZN IONS	3.4.22 3.4.21.113 3.6.1.15 3.6.4.13 2.7.7.48
4DWM	CRYSTAL STRUCTURE OF THE COMPLEX OF TYPE I RIBOSOME INACTIVATING PROTEIN WITH N-ACETYLGLUCOSAMINE AT 1.62 A RESOLUTION	3.2.2.22
4DWO	CRYSTAL STRUCTURE OF A HALOACID DEHALOGENASE-LIKE HYDROLASE (TARGET EFI-900331) FROM BACTEROIDES THETAIOTAOMICRON WITH BOUND MG CRYSTAL FORM II	3.8.1
4DWQ	RNA LIGASE RTCB-GMP/MN(2+) COMPLEX	6.5.1 6.5.1.8 3.1
4DWR	RNA LIGASE RTCB/MN2+ COMPLEX	6.5.1 6.5.1.8 3.1
4DWS	CRYSTAL STRUCTURE OF A CHITINASE FROM THE YERSINIA ENTOMOPHAGA TOXIN COMPLEX	3.2.1.14
4DWW	CRYSTAL STRUCTURE OF NATTOKINASE FROM BACILLUS SUBTILIS NATTO	3.4.21.62
4DWX	CRYSTAL STRUCTURE OF A FAMILY GH-19 CHITINASE FROM RYE SEEDS	3.2.1.14
4DXA	CO-CRYSTAL STRUCTURE OF RAP1 IN COMPLEX WITH KRIT1	3.6.5.2
4DXB	2.29A STRUCTURE OF THE ENGINEERED MBP TEM-1 FUSION PROTEIN RG13 IN COMPLEX WITH ZINC, P1 SPACE GROUP	3.5.2.6
4DXC	CRYSTAL STRUCTURE OF THE ENGINEERED MBP TEM-1 FUSION PROTEIN RG13, C2 SPACE GROUP	3.5.2.6
4DXU	CRYSTAL STRUCTURE OF C-LOBE OF BOVINE LACTOFERRIN COMPLEXED WITH AMINOCAPROIC ACID AT 1.46 A RESOLUTION	3.4.21
4DYG	CRYSTAL STRUCTURE OF A FAMILY GH-19 CHITINASE FROM RYE SEEDS IN COMPLEX WITH (GLCNAC)4	3.2.1.14
4DYH	CRYSTAL STRUCTURE OF GLYCOSYLATED LIPASE FROM HUMICOLA LANUGINOSA AT 2 ANGSTROM RESOLUTION	3.1.1.3
4DYO	CRYSTAL STRUCTURE OF HUMAN ASPARTYL AMINOPEPTIDASE (DNPEP) IN COMPLEX WITH ASPARTIC ACID HYDROXAMATE	3.4.11.21
4DZ4	X-RAY CRYSTAL STRUCTURE OF A HYPOTHETICAL AGMATINASE FROM BURKHOLDERIA THAILANDENSIS	3.5.3.11
4DZD	CRYSTAL STRUCTURE OF THE CRISPR-ASSOCIATED PROTEIN CAS6E FROM ESCHERICHIA COLI STR. K-12	3.1
4DZT	AQUALYSIN I: THE CRYSTAL STRUCTURE OF A SERINE PROTEASE FROM AN EXTREME THERMOPHILE, THERMUS AQUATICUS YT-1	3.4.21.111
4E05	ANOPHELIN FROM THE MALARIA VECTOR INHIBITS THROMBIN THROUGH A NOVEL REVERSE-BINDING MECHANISM	3.4.21.5
4E06	ANOPHELIN FROM THE MALARIA VECTOR INHIBITS THROMBIN THROUGH A NOVEL REVERSE-BINDING MECHANISM	3.4.21.5
4E11	CRYSTAL STRUCTURE OF KYNURENINE FORMAMIDASE FROM DROSOPHILA MELANOGASTER	3.5.1.9
4E14	CRYSTAL STRUCTURE OF KYNURENINE FORMAMIDASE CONJUGATED WITH PHENYLMETHYLSULFONYL FLUORIDE	3.5.1.9
4E15	CRYSTAL STRUCTURE OF KYNURENINE FORMAMIDASE CONJUGATED WITH AN INHIBITOR	3.5.1.9
4E19	CRYSTAL STRUCTURE OF RNASE H1 FROM HALOPHILIC ARCHAEON HALOBACTERIUM SALINARUM NRC-1	3.1.26.4
4E1M	CRYSTAL STRUCTURE OF HIV-1 INTEGRASE WITH A NON-CATAYLTIC SITE INHIBITOR	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
4E1N	CRYSTAL STRUCTURE OF HIV-1 INTEGRASE WITH A NON-CATAYLTIC SITE INHIBITOR	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
4E2O	CRYSTAL STRUCTURE OF ALPHA-AMYLASE FROM GEOBACILLUS THERMOLEOVORANS, GTA, COMPLEXED WITH ACARBOSE	3.2.1.1
4E36	CRYSTAL STRUCTURE OF THE HUMAN ENDOPLASMIC RETICULUM AMINOPEPTIDASE 2 VARIANT N392K	3.4.11
4E3I	CRYSTAL STRUCTURE OF AMPC BETA-LACTAMASE IN COMPLEX WITH A DESIGNED 3-CARBOXYL BENZYL SULFONAMIDE BORONIC ACID INHIBITOR	3.5.2.6
4E3J	CRYSTAL STRUCTURE OF AMPC BETA-LACTAMASE IN COMPLEX WITH A DESIGNED 4-TETRAZOLYL BENZENE SULFONAMIDE BORONIC ACID INHIBITOR	3.5.2.6
4E3K	CRYSTAL STRUCTURE OF AMPC BETA-LACTAMASE IN COMPLEX WITH A DESIGNED 4-TETRAZOLYL PYRIDINE SULFONAMIDE BORONIC ACID INHIBITOR	3.5.2.6
4E3L	CRYSTAL STRUCTURE OF AMPC BETA-LACTAMASE IN COMPLEX WITH A 3-CHLORO-4-TETRAZOLYL BENZENE SULFONAMIDE BORONIC ACID INHIBITOR	3.5.2.6
4E3M	CRYSTAL STRUCTURE OF AMPC BETA-LACTAMASE IN COMPLEX WITH A 2-CHLORO-4-TETRAZOLYL BENZENE SULFONAMIDE BORONIC ACID INHIBITOR	3.5.2.6
4E3N	CRYSTAL STRUCTURE OF AMPC BETA-LACTAMASE IN COMPLEX WITH A 2-TRIFLUOROMETHYL-4-TETRAZOLYL BENZENE SULFONAMIDE BORONIC ACID INHIBITOR	3.5.2.6
4E3O	CRYSTAL STRUCTURE OF AMPC BETA-LACTAMASE IN COMPLEX WITH A SMALL CHLOROMETHYL SULFONAMIDE BORONIC ACID INHIBITOR	3.5.2.6
4E3S	RB69 DNA POLYMERASE TERNARY COMPLEX WITH DQTP OPPOSITE DT	2.7.7.7 3.1.11
4E3T	ROUND 18 ARYLESTERASE VARIANT OF PHOSPHOTRIESTERASE WITH BOUND TRANSITION STATE ANALOG	3.1.8.1
4E3U	CRYSTAL STRUCTURE OF HEN EGG WHITE LYSOZYME CRYOPROTECTED IN PROLINE	3.2.1.17
4E3W	CRYSTAL STRUCTURE FRANCISELLA TULARENSIS HISTIDINE ACID PHOSPHATASE CRYOPROTECTED WITH PROLINE	3.1.3.2
4E3Y	X-RAY STRUCTURE OF THE SERRATIA MARCESCENS ENDONUCLEASE AT 0.95 A RESOLUTION	3.1.30.2
4E43	HIV PROTEASE (PR) DIMER WITH ACETATE IN EXO SITE AND PEPTIDE IN ACTIVE SITE	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
4E46	STRUCTURE OF RHODOCOCCUS RHODOCHROUS HALOALKANE DEHALOGENASE DHAA IN COMPLEX WITH 2-PROPANOL	3.8.1.5
4E4C	CRYSTAL STRUCTURE OF NOTEXIN AT 1.8 A RESOLUTION	3.1.1.4
4E4P	SECOND NATIVE STRUCTURE OF XYLANASE A1 FROM PAENIBACILLUS SP. JDR-2	3.2.1.8
4E55	CRYSTAL STRUCTURE OF SPACER REMOVED CEPHALOSPORIN ACYLASE MUTANT	3.5.1.93
4E56	CRYSTAL STRUCTURE OF SPACER 8AA-SHORTENED CEPHALOSPORIN ACYLASE MUTANT	3.5.1.93
4E57	CRYSTAL STRUCTURE OF SPACER 6AA-SHORTENED CEPHALOSPORIN ACYLASE MUTANT	3.5.1.93
4E5E	CRYSTAL STRUCTURE OF AVIAN INFLUENZA VIRUS PAN APO	3.1
4E5F	CRYSTAL STRUCTURE OF AVIAN INFLUENZA VIRUS PAN BOUND TO COMPOUND 1	3.1
4E5G	CRYSTAL STRUCTURE OF AVIAN INFLUENZA VIRUS PAN BOUND TO COMPOUND 2	3.1
4E5H	CRYSTAL STRUCTURE OF AVIAN INFLUENZA VIRUS PAN BOUND TO COMPOUND 3	3.1
4E5I	CRYSTAL STRUCTURE OF AVIAN INFLUENZA VIRUS PAN BOUND TO COMPOUND 4	3.1
4E5J	CRYSTAL STRUCTURE OF AVIAN INFLUENZA VIRUS PAN BOUND TO COMPOUND 5	3.1
4E5L	CRYSTAL STRUCTURE OF AVIAN INFLUENZA VIRUS PAN BOUND TO COMPOUND 6	3.1
4E5S	CRYSTAL STRUCTURE OF MCCFLIKE PROTEIN (BA_5613) FROM BACILLUS ANTHRACIS STR. AMES	3.4.21
4E6I	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT NVIAGA V99G AT CRYOGENIC TEMPERATURE	3.1.31.1
4E6W	CLBP IN COMPLEX WITH 3-AMINOPHENYL BORONIC ACID	3.5.2.6
4E6X	CLBP IN COMPLEX BORON-BASED INHIBITOR	3.5.2.6
4E76	APO CRYSTAL STRUCTURE OF HCV NS5B GENOTYPE 2A JFH-1 ISOLATE WITH BETA HAIRPIN LOOP DELETION	2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13
4E78	CRYSTAL STRUCTURE OF A PRODUCT STATE ASSEMBLY OF HCV NS5B GENOTYPE 2A JFH-1 ISOLATE WITH BETA HAIRPIN LOOP DELETION BOUND TO PRIMER-TEMPLATE RNA WITH 3'-DG	2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13
4E7A	CRYSTAL STRUCTURE OF A PRODUCT STATE ASSEMBLY OF HCV NS5B GENOTYPE 2A JFH-1 ISOLATE WITH BETA HAIRPIN DELETION BOUND TO PRIMER-TEMPLATE RNA WITH A 2',3'-DDC	2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13
4E7H	PFV INTASOME PRIOR TO 3'-PROCESSING, APO FORM (UI-APO)	2.7.7.49 2.7.7.7 3.1.26.4 3.4.23 2.7.7 3.1
4E7I	PFV INTASOME FREEZE-TRAPPED PRIOR TO 3'-PROCESSING, MN-BOUND FORM (UI-MN)	2.7.7.49 2.7.7.7 3.1.26.4 3.4.23 2.7.7 3.1
4E7J	PFV INTEGRASE TARGET CAPTURE COMPLEX, APO FORM (TCC-APO), AT 3.15 A RESOLUTION	2.7.7.49 2.7.7.7 3.1.26.4 3.4.23 2.7.7 3.1
4E7K	PFV INTEGRASE TARGET CAPTURE COMPLEX (TCC-MN), FREEZE-TRAPPED PRIOR TO STRAND TRANSFER, AT 3.0 A RESOLUTION	2.7.7.49 2.7.7.7 3.1.26.4 3.4.23 2.7.7 3.1
4E7L	PFV INTEGRASE STRAND TRANSFER COMPLEX (STC-MN*) FOLLOWING REACTION IN CRYSTALLO, AT 3.0 A RESOLUTION.	2.7.7.49 2.7.7.7 3.1.26.4 3.4.23 2.7.7 3.1
4E7N	CRYSTAL STRUCTURE OF AHV_TL-I, A GLYCOSYLATED SNAKE-VENOM THROMBIN-LIKE ENZYME FROM AGKISTRODON HALYS	3.4.21
4E7R	THROMBIN IN COMPLEX WITH 3-AMIDINOPHENYLALANINE INHIBITOR	3.4.21.5
4E89	CRYSTAL STRUCTURE OF RNASEH FROM GAMMARETROVIRUS	3.1.26.4 3.4.23 2.7.7.49 2.7.7.7 2.7.7 3.1
4E8C	CRYSTAL STRUCTURE OF STREPTOCOCCAL BETA-GALACTOSIDASE IN COMPLEX WITH GALACTOSE	3.2.1.23
4E90	HUMAN PHOSPHODIESTERASE 9 IN COMPLEX WITH INHIBITORS	3.1.4.35
4E91	CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAIN OF HIV-1 CAPSID IN COMPLEX WITH INHIBITOR BD3	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
4E92	CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAIN OF HIV-1 CAPSID IN COMPLEX WITH INHIBITOR BM4	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
4E97	T4 LYSOZYME L99A/M102H WITH 2-MERCAPTOETHANOL BOUND	3.2.1.17
4E9A	STRUCTURE OF PEPTIDE DEFORMYLASE FORM HELICOBACTER PYLORI IN COMPLEX WITH INHIBITOR	3.5.1.88
4E9B	STRUCTURE OF PEPTIDE DEFORMYLASE FORM HELICOBACTER PYLORI IN COMPLEX WITH ACTINONIN	3.5.1.88
4E9E	STRUCTURE OF THE GLYCOSYLASE DOMAIN OF MBD4	3.2.2
4E9F	STRUCTURE OF THE GLYCOSYLASE DOMAIN OF MBD4 BOUND TO AP SITE CONTAINING DNA	3.2.2
4E9G	STRUCTURE OF THE GLYCOSYLASE DOMAIN OF MBD4 BOUND TO THYMINE CONTAINING DNA	3.2.2
4E9H	STRUCTURE OF GLYCOSYLASE DOMAIN OF MBD4 BOUND TO 5HMU CONTAINING DNA	3.2.2
4EA4	STRUCTURE OF THE GLYCOSYLASE DOMAIN OF MBD4 BOUND TO 5HMU-CONTAINING DNA	3.2.2
4EA5	STRUCTURE OF THE GLYCOSLYASE DOMAIN OF MBD4 BOUND TO A 5HMU CONTAINING DNA	3.2.2
4EA6	CRYSTAL STRUCTURE OF FUNGAL LIPASE FROM THERMOMYCES(HUMICOLA) LANUGINOSA AT 2.30 ANGSTROM RESOLUTION.	3.1.1.3
4EAM	1.70A RESOLUTION STRUCTURE OF APO BETA-GLYCOSIDASE (W33G) FROM SULFOLOBUS SOLFATARICUS	3.2.1.23
4EAN	1.75A RESOLUTION STRUCTURE OF INDOLE BOUND BETA-GLYCOSIDASE (W33G) FROM SULFOLOBUS SOLFATARICUS	3.2.1.23
4EAW	HCV NS5B IN COMPLEX WITH IDX375	2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13
4EB0	CRYSTAL STRUCTURE OF LEAF-BRANCH COMPOST BACTERIAL CUTINASE HOMOLOG	3.1.1.74 3.1.1.101
4EB2	CRYSTAL STRUCTURE MISTLETOE LECTIN I FROM VISCUM ALBUM IN COMPLEX WITH N-ACETYL-D-GLUCOSAMINE AT 1.94 A RESOLUTION.	3.2.2.22
4EBB	STRUCTURE OF DPP2	3.4.14.2
4EBL	BLAC E166A FAROPENEM ACYL-INTERMEDIATE COMPLEX	3.5.2.6
4EBN	BLAC AMOXICILLIN ACYL-INTERMEDIATE COMPLEX	3.5.2.6
4EBP	BLAC E166A CEFOTAXIME ACYL-INTERMEDIATE COMPLEX	3.5.2.6
4ECA	ASPARAGINASE FROM E. COLI, MUTANT T89V WITH COVALENTLY BOUND ASPARTATE	3.5.1.1
4ECP	X-RAY CRYSTAL STRUCTURE OF INORGANIC PYROPHOSPHATE PPA FROM MYCOBACTERIUM LEPRAE	3.6.1.1
4EE9	CRYSTAL STRUCTURE OF THE RBCEL1 ENDO-1,4-GLUCANASE	3.2.1.4
4EFA	CRYSTAL STRUCTURE OF THE HETEROTRIMERIC EGCHEAD PERIPHERAL STALK COMPLEX OF THE YEAST VACUOLAR ATPASE - SECOND CONFORMATION	3.6.3.14
4EFJ	CRYSTAL STRUCTURE OF I-GZEII LAGLIDADG HOMING ENDONUCLEASE IN COMPLEX WITH DNA TARGET SITE	3.1
4EFL	CRYSTAL STRUCTURE OF H-RAS WT IN COMPLEX WITH GPPNHP (STATE 1)	3.6.5.2
4EFM	CRYSTAL STRUCTURE OF H-RAS G12V IN COMPLEX WITH GPPNHP (STATE 1)	3.6.5.2
4EFN	CRYSTAL STRUCTURE OF H-RAS Q61L IN COMPLEX WITH GPPNHP (STATE 1)	3.6.5.2
4EFS	HUMAN MMP12 IN COMPLEX WITH L-GLUTAMATE MOTIF INHIBITOR	3.4.24.65
4EFZ	CRYSTAL STRUCTURE OF A HYPOTHETICAL METALLO-BETA-LACTAMASE FROM BURKHOLDERIA PSEUDOMALLEI	3
4EG2	2.2 ANGSTROM CRYSTAL STRUCTURE OF CYTIDINE DEAMINASE FROM VIBRIO CHOLERAE IN COMPLEX WITH ZINC AND URIDINE	3.5.4.5
4EGT	CRYSTAL STRUCTURE OF MAJOR CAPSID PROTEIN P DOMAIN FROM RABBIT HEMORRHAGIC DISEASE VIRUS	3.4.22.66
4EHA	ALLOSTERIC MODULATION OF CASPASE-3 THROUGH MUTAGENESIS	3.4.22.56
4EHD	ALLOSTERIC MODULATION OF CASPASE-3 THROUGH MUTAGENESIS	3.4.22.56
4EHF	ALLOSTERIC MODULATION OF CASPASE-3 THROUGH MUTAGENESIS	3.4.22.56
4EHH	ALLOSTERIC MODULATION OF CASPASE-3 THROUGH MUTAGENESIS	3.4.22.56
4EHI	AN X-RAY CRYSTAL STRUCTURE OF A PUTATIVE BIFUNCTIONAL PHOSPHORIBOSYLAMINOIMIDAZOLECARBOXAMIDE FORMYLTRANSFERASE/IMP CYCLOHYDROLASE	2.1.2.3 3.5.4.10
4EHK	ALLOSTERIC MODULATION OF CASPASE-3 THROUGH MUTAGENESIS	3.4.22.56
4EHL	ALLOSTERIC MODULATION OF CASPASE-3 THROUGH MUTAGENESIS	3.4.22.56
4EHN	ALLOSTERIC MODULATION OF CASPASE-3 THROUGH MUTAGENESIS	3.4.22.56
4EHT	ACTIVATOR OF THE 2-HYDROXYISOCAPROYL-COA DEHYDRATASE FROM CLOSTRIDIUM DIFFICILE WITH BOUND ADP	3
4EHU	ACTIVATOR OF THE 2-HYDROXYISOCAPROYL-COA DEHYDRATASE FROM CLOSTRIDIUM DIFFICILE WITH BOUND ADPNP	3
4EI7	CRYSTAL STRUCTURE OF BACILLUS CEREUS TUBZ, GDP-FORM	3.6.5
4EI8	CRYSTAL STRUCTURE OF BACILLUS CEREUS TUBZ, APO-FORM	3.6.5
4EIA	ACTIVATOR OF THE 2-HYDROXYISOCAPROYL-COA DEHYDRATASE FROM CLOSTRIDIUM DIFFICILE WITHOUT NUCLEOTIDE	3
4EIB	CRYSTAL STRUCTURE OF CIRCULAR PERMUTED CBM21 (CP90) GIVES INSIGHT INTO THE ALTERED SELECTIVITY ON CARBOHYDRATE BINDING.	3.2.1.3
4EIX	STRUCTURAL STUDIES OF THE TERNARY COMPLEX OF PHASPHOLIPASE A2 WITH NIMESULIDE AND INDOMETHACIN	3.1.1.4
4EJ4	STRUCTURE OF THE DELTA OPIOID RECEPTOR BOUND TO NALTRINDOLE	3.2.1.17
4EJ5	CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF BOTULINUM NEUROTOXIN BONT/A WILD-TYPE	3.4.24.69
4EJ8	APO HIV PROTEASE (PR) DIMER IN CLOSED FORM WITH FRAGMENT 1F1 IN THE OUTSIDE/TOP OF FLAP	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
4EJD	HIV PROTEASE (PR) DIMER IN CLOSED FORM WITH PEPSTATIN IN ACTIVE SITE AND FRAGMENT 1F1 IN THE OUTSIDE/TOP OF FLAP	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
4EJF	ALLOSTERIC PEPTIDES THAT BIND TO A CASPASE ZYMOGEN AND MEDIATE CASPASE TETRAMERIZATION	3.4.22.59
4EJK	HIV PROTEASE (PR) DIMER IN CLOSED FORM WITH PEPSTATIN IN ACTIVE SITE AND FRAGMENT 1F1-N IN THE OUTSIDE/TOP OF FLAP	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
4EJL	APO HIV PROTEASE (PR) DIMER IN CLOSED FORM WITH FRAGMENT 1F1-N IN THE OUTSIDE/TOP OF FLAP	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
4EJR	CRYSTAL STRUCTURE OF MAJOR CAPSID PROTEIN S DOMAIN FROM RABBIT HEMORRHAGIC DISEASE VIRUS	3.4.22.66
4EJY	STRUCTURE OF MBOGG1 IN COMPLEX WITH HIGH AFFINITY DNA LIGAND	3.2.2
4EJZ	STRUCTURE OF MBOGG1 IN COMPLEX WITH LOW AFFINITY DNA LIGAND	3.2.2
4EK7	HIGH SPEED X-RAY ANALYSIS OF PLANT ENZYMES AT ROOM TEMPERATURE	3.2.1.125 2.4.1.219
4EKC	STRUCTURE OF HUMAN REGULATOR OF G PROTEIN SIGNALING 2 (RGS2) IN COMPLEX WITH MURINE GALPHA-Q(R183C)	3.6.5.1
4EKD	STRUCTURE OF HUMAN REGULATOR OF G PROTEIN SIGNALING 2 (RGS2) IN COMPLEX WITH MURINE GALPHA-Q(R183C)	3.6.5.1
4EKF	STRUCTURE OF THE INACTIVE ADENOVIRUS PROTEINASE AT 0.98 ANGSTROM RESOLUTION	3.4.22.39
4EKJ	CRYSTAL STRUCTURE OF A MONOMERIC BETA-XYLOSIDASE FROM CAULOBACTER CRESCENTUS CB15	3.2.1.37
4EKP	T4 LYSOZYME L99A/M102H WITH NITROBENZENE BOUND	3.2.1.17
4EKQ	T4 LYSOZYME L99A/M102H WITH 4-NITROPHENOL BOUND	3.2.1.17
4EKR	T4 LYSOZYME L99A/M102H WITH 2-CYANOPHENOL BOUND	3.2.1.17
4EKS	T4 LYSOZYME L99A/M102H WITH ISOXAZOLE BOUND	3.2.1.17
4EL4	CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF BOTULINUM NEUROTOXIN BONT/A C134S/C165S DOUBLE MUTANT	3.4.24.69
4EL8	THE UNLIGANDED STRUCTURE OF C.BESCII CELA GH48 MODULE	3.2.1.4
4ELC	CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF BOTULINUM NEUROTOXIN BONT/A C134 MUTANT WITH MTSEA MODIFIED CYS-165	3.4.24.69
4EMF	CRYSTAL STRUCTURE OF THE COMPLEX OF TYPE I RIBOSOME INACTIVATING PROTEIN IN COMPLEX WITH 7N-METHYL-8-HYDROGUANOSINE-5-P-DIPHOSPHATE AT 1.77 A	3.2.2.22
4EMN	CRYSTAL STRUCTURE OF RPFB CATALYTIC DOMAIN IN COMPLEX WITH BENZAMIDINE	3
4EMR	CRYSTAL STRUCTURE DETERMINATION OF TYPE1 RIBOSOME INACTIVATING PROTEIN COMPLEXED WITH 7-METHYLGUANOSINE-TRIPHOSPHATE AT 1.75A	3.2.2.22
4ENG	STRUCTURE OF ENDOGLUCANASE V CELLOHEXAOSE COMPLEX	3.2.1.4
4EO6	HCV NS5B POLYMERASE INHIBITORS: TRI-SUBSTITUTED ACYLHYDRAZINES AS TERTIARY AMIDE BIOISOSTERES	2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13
4EO8	HCV NS5B POLYMERASE INHIBITORS: TRI-SUBSTITUTED ACYLHYDRAZINES AS TERTIARY AMIDE BIOISOSTERES	2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13
4EOB	STRUCTURE OF THE TYPE VI PEPTIDOGLYCAN AMIDASE EFFECTOR TSE1 FROM PSEUDOMONAS AERUGINOSA	3.4.19.11
4EOF	LYSOZYME IN THE PRESENCE OF ARGININE	3.2.1.17
4EOX	X-RAY STRUCTURE OF POLYPEPTIDE DEFORMYLASE BOUND TO A ACYLPROLINAMIDE INHIBITOR	3.5.1.88
4EP2	CRYSTAL STRUCTURE OF INACTIVE SINGLE CHAIN WILD-TYPE HIV-1 PROTEASE IN COMPLEX WITH THE SUBSTRATE RT-RH	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
4EP3	CRYSTAL STRUCTURE OF INACTIVE SINGLE CHAIN WILD-TYPE HIV-1 PROTEASE IN COMPLEX WITH THE SUBSTRATE CA-P2	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
4EP4	THERMUS THERMOPHILUS RUVC STRUCTURE	3.1.22.4
4EP5	THERMUS THERMOPHILUS RUVC STRUCTURE	3.1.22.4
4EP8	INITIAL UREASE STRUCTURE FOR RADIATION DAMAGE EXPERIMENT AT 100 K	3.5.1.5
4EPB	FINAL UREASE STRUCTURE FOR RADIATION DAMAGE EXPERIMENT AT 100 K	3.5.1.5
4EPC	CRYSTAL STRUCTURE OF AUTOLYSIN REPEAT DOMAINS FROM STAPHYLOCOCCUS EPIDERMIDIS	3.5.1.28 3.2.1.96
4EPD	INITIAL UREASE STRUCTURE FOR RADIATION DAMAGE EXPERIMENT AT 300 K	3.5.1.5
4EPE	FINAL UREASE STRUCTURE FOR RADIATION DAMAGE EXPERIMENT AT 300 K	3.5.1.5
4EPI	THE CRYSTAL STRUCTURE OF PESTICIN-T4 LYSOZYME HYBRID STABILIZED BY ENGINEERED DISULFIDE BONDS	3.2.1.17
4EPJ	CRYSTAL STRUCTURE OF INACTIVE SINGLE CHAIN WILD-TYPE HIV-1 PROTEASE IN COMPLEX WITH THE SUBSTRATE P2-NC	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
4EPP	CANONICAL POLY(ADP-RIBOSE) GLYCOHYDROLASE FROM TETRAHYMENA THERMOPHILA.	3.2.1.143
4EPQ	CANONICAL POLY(ADP-RIBOSE) GLYCOHYDROLASE RBPI INHIBITOR COMPLEX FROM TETRAHYMENA THERMOPHILA	3.2.1.143
4EPR	DISCOVERY OF SMALL MOLECULES THAT BIND TO K-RAS AND INHIBIT SOS-MEDIATED ACTIVATION.	3.6.5.2
4EPT	DISCOVERY OF SMALL MOLECULES THAT BIND TO K-RAS AND INHIBIT SOS-MEDIATED ACTIVATION	3.6.5.2
4EPV	DISCOVERY OF SMALL MOLECULES THAT BIND TO K-RAS AND INHIBIT SOS-MEDIATED ACTIVATION	3.6.5.2
4EPW	DISCOVERY OF SMALL MOLECULES THAT BIND TO K-RAS AND INHIBIT SOS-MEDIATED ACTIVATION	3.6.5.2
4EPX	DISCOVERY OF SMALL MOLECULES THAT BIND TO K-RAS AND INHIBIT SOS-MEDIATED ACTIVATION	3.6.5.2
4EPY	DISCOVERY OF SMALL MOLECULES THAT BIND TO K-RAS AND INHIBIT SOS-MEDIATED ACTIVATION	3.6.5.2
4EQ0	CRYSTAL STRUCTURE OF INACTIVE SINGLE CHAIN VARIANT OF HIV-1 PROTEASE IN COMPLEX WITH THE SUBSTRATE P2-NC	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
4EQ8	CRYSTAL STRUCTURE OF PA1844 FROM PSEUDOMONAS AERUGINOSA PAO1	3.4.19.11
4EQA	CRYSTAL STRUCTURE OF PA1844 IN COMPLEX WITH PA1845 FROM PSEUDOMONAS AERUGINOSA PAO1	3.4.19.11
4EQE	CRYSTAL STRUCTURE OF HISTIDINE TRIAD NUCLEOTIDE-BINDING PROTEIN 1 (HINT1) FROM HUMAN COMPLEXED WITH LYS-AMS	3
4EQG	CRYSTAL STRUCTURE OF HISTIDINE TRIAD NUCLEOTIDE-BINDING PROTEIN 1 (HINT1) FROM HUMAN COMPLEXED WITH ALA-AMS	3
4EQH	CRYSTAL STRUCTURE OF HISTIDINE TRIAD NUCLEOTIDE-BINDING PROTEIN 1 (HINT1) FROM HUMAN COMPLEXED WITH TRP-AMS	3
4EQI	CRYSTAL STRUCTURE OF SERRATIA FONTICOLA CARBAPENEMASE SFC-1	3.5.2.6
4EQN	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS V23E/I72K AT CRYOGENIC TEMPERATURE	3.1.31.1
4EQO	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS V99D AT CRYOGENIC TEMPERATURE	3.1.31.1
4EQP	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS I72D AT CRYOGENIC TEMPERATURE	3.1.31.1
4ER1	THE ACTIVE SITE OF ASPARTIC PROTEINASES	3.4.23.6 3.4.23.22
4ER2	THE ACTIVE SITE OF ASPARTIC PROTEINASES	3.4.23.6 3.4.23.22
4ER4	HIGH-RESOLUTION X-RAY ANALYSES OF RENIN INHIBITOR-ASPARTIC PROTEINASE COMPLEXES	3.4.23.6 3.4.23.22
4ERC	STRUCTURE OF VHZ BOUND TO METAVANADATE	3.1.3.16 3.1.3.48
4ERN	CRYSTAL STRUCTURE OF THE C-TERMINAL DOMAIN OF HUMAN XPB/ERCC-3 EXCISION REPAIR PROTEIN AT 1.80 A	3.6.4.12
4ERX	CRYSTAL STRUCTURE OF THE COMPLEX OF PEPTIDYL-TRNA HYDROLASE FROM PSEUDOMONAS AERUGINOSA WITH DIETHYLENE GLYCOL AT 2.5 ANGSTROM RESOLUTION	3.1.1.29
4ES1	DOUBLE-STRANDED ENDONUCLEASE ACTIVITY IN B. HALODURANS CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEATS (CRISPR)-ASSOCIATED CAS2 PROTEIN	3.1
4ES2	DOUBLE-STRANDED ENDONUCLEASE ACTIVITY IN B. HALODURANS CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEATS (CRISPR)-ASSOCIATED CAS2 PROTEIN	3.1
4ES3	DOUBLE-STRANDED ENDONUCLEASE ACTIVITY IN B. HALODURANS CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEATS (CRISPR)-ASSOCIATED CAS2 PROTEIN	3.1
4ESI	STRUCTURE OF RICIN A CHAIN BOUND WITH N-((1H-1,2,3-TRIAZOL-4-YL)METHYL-2-AMINO-4-OXO-3,4-DIHYDROPTERIDINE-7-CARBOXAMIDE	3.2.2.22
4ESJ	RESTRICTION ENDONUCLEASE DPNI IN COMPLEX WITH TARGET DNA	3.1.21.4
4EST	CRYSTAL STRUCTURE OF THE COVALENT COMPLEX FORMED BY A PEPTIDYL ALPHA,ALPHA-DIFLUORO-BETA-KETO AMIDE WITH PORCINE PANCREATIC ELASTASE AT 1.78-ANGSTROMS RESOLUTION	3.4.21.36
4ET0	CRYSTAL STRUCTURE OF CIRCULARLY PERMUTED HUMAN ASPARAGINASE-LIKE PROTEIN 1	3.5.1.1 3.4.19.5
4ET8	HEN EGG-WHITE LYSOZYME SOLVED FROM 40 FS FREE-ELECTRON LASER PULSE DATA	3.2.1.17
4ET9	HEN EGG-WHITE LYSOZYME SOLVED FROM 5 FS FREE-ELECTRON LASER PULSE DATA	3.2.1.17
4ETA	LYSOZYME, ROOM TEMPERATURE, 400 KGY DOSE	3.2.1.17
4ETB	LYSOZYME, ROOM TEMPERATURE, 200 KGY DOSE	3.2.1.17
4ETC	LYSOZYME, ROOM TEMPERATURE, 24 KGY DOSE	3.2.1.17
4ETD	LYSOZYME, ROOM-TEMPERATURE, ROTATING ANODE, 0.0026 MGY	3.2.1.17
4ETE	LYSOZYME, ROOM-TEMPERATURE, ROTATING ANODE, 0.0021 MGY	3.2.1.17
4ETI	CRYSTAL STRUCTURE OF YWLE FROM BACILLUS SUBTILIS	3.1.3.48 3.9.1.2
4ETM	CRYSTAL STRUCTURE OF YFKJ FROM BACILLUS SUBTILIS	3.1.3.48
4ETN	CRYSTAL STRUCTURE OF YWLE MUTANT FROM BACILLUS SUBTILIS	3.1.3.48 3.9.1.2
4ETW	STRUCTURE OF THE ENZYME-ACP SUBSTRATE GATEKEEPER COMPLEX REQUIRED FOR BIOTIN SYNTHESIS	3.1.1.85
4EUG	CRYSTALLOGRAPHIC AND ENZYMATIC STUDIES OF AN ACTIVE SITE VARIANT H187Q OF ESCHERICHIA COLI URACIL DNA GLYCOSYLASE: CRYSTAL STRUCTURES OF MUTANT H187Q AND ITS URACIL COMPLEX	3.2.2.3 3.2.2.27
4EUZ	CRYSTAL STRUCTURE OF SERRATIA FONTICOLA CARBAPENEMASE SFC-1 S70A-MEROPENEM COMPLEX	3.5.2.6
4EV4	CRYSTAL STRUCTURE OF SERRATIA FONTICOLA CARBAPENEMASE SFC-1 E166A MUTANT WITH THE ACYLENZYME INTERMEDIATE OF MEROPENEM	3.5.2.6
4EVO	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT NVIAGA/E122G AT CRYOGENIC TEMPERATURE	3.1.31.1
4EVV	MOUSE MBD4 GLYCOSYLASE DOMAIN IN COMPLEX WITH A G:T MISMATCH	3.2.2
4EW0	MOUSE MBD4 GLYCOSYLASE DOMAIN IN COMPLEX WITH A G:5HMU (5-HYDROXYMETHYLURACIL) MISMATCH	3.2.2
4EW4	MOUSE MBD4 GLYCOSYLASE DOMAIN IN COMPLEX WITH DNA CONTAINING A RIBOSE SUGAR	3.2.2
4EWL	CRYSTAL STRUCTURE OF MSHB WITH GLYCEROL AND ACETATE BOUND IN THE ACTIVE SITE	3.5.1.103
4EWO	DESIGN AND SYNTHESIS OF POTENT HYDROXYETHYLAMINE (HEA) BACE-1 INHIBITORS	3.4.23.46
4EWT	THE CRYSTAL STRUCTURE OF A PUTATIVE AMINOHYDROLASE FROM METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS	3.5.1.14
4EXG	DESIGN AND SYNTHESIS OF POTENT HYDROXYETHYLAMINE (HEA) BACE-1 INHIBITORS	3.4.23.46
4EXH	THE CRYSTAL STRUCTURE OF XMRV PROTEASE COMPLEXED WITH ACETYL-PEPSTATIN	2.7.7.49 2.7.7.7 3.1.26.4
4EXM	THE CRYSTAL STRUCTURE OF AN ENGINEERED PHAGE LYSIN CONTAINING THE BINDING DOMAIN OF PESTICIN AND THE KILLING DOMAIN OF T4-LYSOZYME	3.2.1.17
4EXS	CRYSTAL STRUCTURE OF NDM-1 BOUND TO L-CAPTOPRIL	3.5.2.6
4EXY	CRYSTAL STRUCTURE OF NDM-1 BOUND TO ETHYLENE GLYCOL	3.5.2.6
4EY0	STRUCTURE OF TANDEM SH2 DOMAINS FROM PLCGAMMA1	3.1.4.11
4EY2	CRYSTAL STRUCTURE OF NDM-1 BOUND TO HYDROLYZED METHICILLIN	3.5.2.6
4EY4	CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE IN THE APO STATE	3.1.1.7
4EY5	CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE IN COMPLEX WITH (-)-HUPERZINE A	3.1.1.7
4EY6	CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE IN COMPLEX WITH (-)-GALANTAMINE	3.1.1.7
4EY7	CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE IN COMPLEX WITH DONEPEZIL	3.1.1.7
4EY8	CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE IN COMPLEX WITH FASCICULIN-2	3.1.1.7
4EYB	CRYSTAL STRUCTURE OF NDM-1 BOUND TO HYDROLYZED OXACILLIN	3.5.2.6
4EYF	CRYSTAL STRUCTURE OF NDM-1 BOUND TO HYDROLYZED BENZYLPENICILLIN	3.5.2.6
4EYL	CRYSTAL STRUCTURE OF NDM-1 BOUND TO HYDROLYZED MEROPENEM	3.5.2.6
4EYR	CRYSTAL STRUCTURE OF MULTIDRUG-RESISTANT CLINICAL ISOLATE 769 HIV-1 PROTEASE IN COMPLEX WITH RITONAVIR	2.7.7.49 3.1.26.13
4EZE	CRYSTAL STRUCTURE OF HAD FAMILY HYDROLASE T0658 FROM SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHI (TARGET EFI-501419)	3.1.3.3
4F0R	CRYSTAL STRUCTURE OF AN ADENOSINE DEAMINASE HOMOLOG FROM CHROMOBACTERIUM VIOLACEUM (TARGET NYSGRC-019589) BOUND ZN AND 5'-METHYLTHIOADENOSINE (UNPRODUCTIVE COMPLEX)	3.5.4.28 3.5.4.31
4F0S	CRYSTAL STRUCTURE OF AN ADENOSINE DEAMINASE HOMOLOG FROM CHROMOBACTERIUM VIOLACEUM (TARGET NYSGRC-019589) WITH BOUND INOSINE.	3.5.4.28 3.5.4.31
4F0V	CRYSTAL STRUCTURE OF TYPE EFFECTOR TSE1 FROM PSEUDOMONAS AERUGINOUSA	3.4.19.11
4F0W	CRYSTAL STRUCTURE OF TYPE EFFECTOR TSE1 C30A MUTANT FROM PSEUDOMONAS AERUGINOUSA	3.4.19.11
4F0Z	CRYSTAL STRUCTURE OF CALCINEURIN IN COMPLEX WITH THE CALCINEURIN-INHIBITING DOMAIN OF THE AFRICAN SWINE FEVER VIRUS PROTEIN A238L	3.1.3.16
4F1H	CRYSTAL STRUCTURE OF TDP2 FROM DANIO RERIO COMPLEXED WITH A SINGLE STRAND DNA	3.1.4
4F1I	CRYSTAL STRUCTURE OF SEMET TDP2 FROM CAENORHABDITIS ELEGANS	3.1.4
4F1R	STRUCTURE ANALYSIS OF THE GLOBAL METABOLIC REGULATOR CRC FROM PSEUDOMONAS AERUGINOS	3.1.11.2
4F1W	CRYSTAL STRUCTURE OF 5'-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE NUCLEOSIDASE FROM SALMONELLA ENTERICA WITH ADENINE	3.2.2.9
4F21	CRYSTAL STRUCTURE OF CARBOXYLESTERASE/PHOSPHOLIPASE FAMILY PROTEIN FROM FRANCISELLA TULARENSIS	3.1.1
4F2F	CRYSTAL STRUCTURE OF THE METAL BINDING DOMAIN (MBD) OF THE STREPTOCOCCUS PNEUMONIAE D39 CU(I) EXPORTING P-TYPE ATPASE COPA WITH CU(I)	3.6.3.4
4F2P	CRYSTAL STRUCTURE OF 5'-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE NUCLEOSIDASE FROM SALMONELLA ENTERICA WITH DIETGLYCOL-THIO-DADME-IMMUCILLIN-A	3.2.2.9
4F2W	CRYSTAL STRUCTURE OF 5'-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE NUCLEOSIDASE FROM SALMONELLA ENTERICA WITH METHYL-THIO-DADME-IMMUCILLIN-A	3.2.2.9
4F2Z	CRYSTAL STRUCTURE OF RPE65 IN A LIPID ENVIRONMENT	3.1.1.64 5.3.3.22
4F30	STRUCTURE OF RPE65: P6522 CRYSTAL FORM GROWN IN AMMONIUM PHOSPHATE SOLUTION	3.1.1.64 5.3.3.22
4F38	CRYSTAL STRUCTURE OF GERANYLGERANYLATED RHOA IN COMPLEX WITH RHOGDI IN ITS ACTIVE GPPNHP-BOUND FORM	3.6.5.2
4F3A	STRUCTURE OF RPE65: P6522 CRYSTAL FORM, IRIDIUM DERIVATIVE	3.1.1.64 5.3.3.22
4F3C	CRYSTAL STRUCTURE OF 5'-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE NUCLEOSIDASE FROM SALMONELLA ENTERICA WITH BUTYL-THIO-DADME-IMMUCILLIN-A	3.2.2.9
4F3D	STRUCTURE OF RPE65: P65 CRYSTAL FORM GROWN IN FOS-CHOLINE-10	3.1.1.64 5.3.3.22
4F3K	CRYSTAL STRUCTURE OF 5'-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE NUCLEOSIDASE FROM SALMONELLA ENTERICA WITH HOMOCYSTEINE-DADME-IMMUCILLIN-A	3.2.2.9
4F3T	HUMAN ARGONAUTE-2 - MIR-20A COMPLEX	3.1.26
4F3W	CRYSTAL STRUCTURE OF CYTIDINE DEAMINASE CDD FROM MYCOBACTERIUM MARINUM	3.5.4.5
4F49	2.25A RESOLUTION STRUCTURE OF TRANSMISSIBLE GASTROENTERITIS VIRUS PROTEASE CONTAINING A COVALENTLY BOUND DIPEPTIDYL INHIBITOR	3.4.22 3.4.19.12
4F4C	THE CRYSTAL STRUCTURE OF THE MULTI-DRUG TRANSPORTER	3.6.3.44 7.6.2.2
4F4M	STRUCTURE OF THE TYPE VI PEPTIDOGLYCAN AMIDASE EFFECTOR TSE1 (C30A) FROM PSEUDOMONAS AERUGINOSA	3.4.19.11
4F4U	THE BICYCLIC INTERMEDIATE STRUCTURE PROVIDES INSIGHTS INTO THE DESUCCINYLATION MECHANISM OF SIRT5	3.5.1 2.3.1
4F56	THE BICYCLIC INTERMEDIATE STRUCTURE PROVIDES INSIGHTS INTO THE DESUCCINYLATION MECHANISM OF SIRT5	3.5.1 2.3.1
4F5Z	CRYSTAL STRUCTURE OF RHODOCOCCUS RHODOCHROUS HALOALKANE DEHALOGENASE MUTANT (L95V, A172V).	3.8.1.5
4F60	CRYSTAL STRUCTURE OF RHODOCOCCUS RHODOCHROUS HALOALKANE DEHALOGENASE MUTANT (T148L, G171Q, A172V, C176F).	3.8.1.5
4F66	THE CRYSTAL STRUCTURE OF 6-PHOSPHO-BETA-GLUCOSIDASE FROM STREPTOCOCCUS MUTANS UA159 IN COMPLEX WITH BETA-D-GLUCOSE-6-PHOSPHATE.	3.2.1.86
4F6H	MUTAGENESIS OF ZINC LIGAND RESIDUE CYS221 REVEALS PLASTICITY IN THE IMP-1 METALLO-B-LACTAMASE ACTIVE SITE	3.5.2.6
4F6O	CRYSTAL STRUCTURE OF THE YEAST METACASPASE YCA1	3.4.22
4F6P	CRYSTAL STRUCTURE OF THE YEAST METACASPASE YCA1 C276A MUTANT	3.4.22
4F6Z	MUTAGENESIS OF ZINC LIGAND RESIDUE CYS221 REVEALS PLASTICITY IN THE IMP-1 METALLO-B-LACTAMASE ACTIVE SITE	3.5.2.6
4F73	CRYSTAL STRUCTURE OF ACTIVE HIV-1 PROTEASE IN COMPLEX WITH THE N TERMINAL PRODUCT OF CA-P2 CLEAVAGE SITE	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
4F74	CRYSTAL STRUCTURE OF ACTIVE HIV-1 PROTEASE IN COMPLEX WITH THE N TERMINAL PRODUCT OF THE SUBSTRATE MA-CA.	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
4F75	CRYSTAL STRUCTURE OF ACTIVE HIV-1 PROTEASE IN COMPLEX WITH THE N TERMINAL PRODUCT OF THE SUBSTRATE RH-IN	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
4F76	CRYSTAL STRUCTURE OF THE ACTIVE HIV-1 PROTEASE IN COMPLEX WITH THE PRODUCTS OF P1-P6 SUBSTRATE	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
4F79	THE CRYSTAL STRUCTURE OF 6-PHOSPHO-BETA-GLUCOSIDASE MUTANT (E375Q) IN COMPLEX WITH SALICIN 6-PHOSPHATE	3.2.1.86
4F7O	CRYSTAL STRUCTURE OF CSN5	3.4
4F7X	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS I92A/L25A AT CRYOGENIC TEMPERATURE	3.1.31.1
4F8M	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS V23I/I92V AT CRYOGENIC TEMPERATURE	3.1.31.1
4F8X	PENICILLIUM CANESCENS ENDO-1,4-BETA-XYLANASE XYLE	3.2.1.8
4F8Z	CARBOXYPEPTIDASE T WITH BOC-LEU	3.4.17.18
4F91	BRR2 HELICASE REGION	3.6.4.13
4F92	BRR2 HELICASE REGION S1087L	3.6.4.13
4F93	BRR2 HELICASE REGION S1087L, MG-ATP	3.6.4.13
4F94	STRUCTURE OF THE CLASS D BETA-LACTAMASE OXA-24 K84D IN ACYL-ENZYME COMPLEX WITH OXACILLIN	3.5.2.6
4F95	CRYSTAL STRUCTURE OF HUMAN INOSINE TRIPHOSPHATE PYROPHOSPHATASE P32T VARIANT	3.6.1.19 3.6.1.9
4F9D	STRUCTURE OF ESCHERICHIA COLI PGAB 42-655 IN COMPLEX WITH NICKEL	3.5.1
4F9J	STRUCTURE OF ESCHERICHIA COLI PGAB 42-655 IN COMPLEX WITH IRON	3.5.1
4F9N	CRYSTAL STRUCTURE OF THE COMPLEX OF TYPE I RIBOSOME INACTIVATING PROTEIN FROM MOMORDICA BALSAMINA WITH N7-METHYLATED GUANINE AT 2.65 A RESOLUTION	3.2.2.22
4F9U	STRUCTURE OF GLYCOSYLATED GLUTAMINYL CYCLASE FROM DROSOPHILA MELANOGASTER	2.3.2.5 3.4
4F9V	STRUCTURE OF C113A/C136A MUTANT VARIANT OF GLYCOSYLATED GLUTAMINYL CYCLASE FROM DROSOPHILA MELANOGASTER	2.3.2.5 3.4
4FA0	CRYSTAL STRUCTURE OF HUMAN ADPLA TO 2.65 A RESOLUTION	3.1.1.32 3.1.1.4 2.3.1
4FAE	SUBSTRATE P2/NC IN COMPLEX WITH A HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 PROTEASE VARIANT	3.4.23.16 2.7.7.49 3.1.26.13
4FAF	SUBSTRATE CA/P2 IN COMPLEX WITH A HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 PROTEASE VARIANT	3.4.23.16 2.7.7.49 3.1.26.13
4FAI	CRYSTAL STRUCTURE OF MITOCHONDRIAL ISOFORM OF GLUTAMINYL CYCLASE FROM DROSOPHILA MELANOGASTER	2.3.2.5 3.4
4FB3	POLYOMAVIRUS T-AG BINDS SYMMETRICAL REPEATS AT THE VIRAL ORIGIN IN AN ASYMMETRICAL MANNER	3.6.4
4FB9	STRUCTURE OF MUTANT RIP FROM BARLEY SEEDS	3.2.2.22
4FBA	STRUCTURE OF MUTANT RIP FROM BARLEY SEEDS IN COMPLEX WITH ADENINE	3.2.2.22
4FBB	STRUCTURE OF MUTANT RIP FROM BARLEY SEEDS IN COMPLEX WITH ADENINE (AMP-INCUBATED)	3.2.2.22
4FBC	STRUCTURE OF MUTANT RIP FROM BARLEY SEEDS IN COMPLEX WITH AMP	3.2.2.22
4FBE	CRYSTAL STRUCTURE OF THE C136A/C164A VARIANT OF MITOCHONDRIAL ISOFORM OF GLUTAMINYL CYCLASE FROM DROSOPHILA MELANOGASTER	2.3.2.5 3.4
4FBH	STRUCTURE OF RIP FROM BARLEY SEEDS	3.2.2.22
4FBN	INSIGHTS INTO STRUCTURAL INTEGRATION OF THE PLCGAMMA REGULATORY REGION AND MECHANISM OF AUTOINHIBITION AND ACTIVATION BASED ON KEY ROLES OF SH2 DOMAINS	3.1.4.11
4FBP	CONFORMATIONAL TRANSITION OF FRUCTOSE-1,6-BISPHOSPHATASE: STRUCTURE COMPARISON BETWEEN THE AMP COMPLEX (T FORM) AND THE FRUCTOSE 6-PHOSPHATE COMPLEX (R FORM)	3.1.3.11
4FC2	CRYSTAL STRUCTURE OF MOUSE POLY(ADP-RIBOSE) GLYCOHYDROLASE (PARG) CATALYTIC DOMAIN	3.2.1.143
4FC8	CRYSTAL STRUCTURE OF TRANSCRIPTION REGULATOR PROTEIN RTR1 FROM KLUYVEROMYCES LACTIS	3.1.3.16
4FCB	POTENT AND SELECTIVE PHOSPHODIESTERASE 10A INHIBITORS	3.1.4.17 3.1.4.35
4FCD	POTENT AND SELECTIVE PHOSPHODIESTERASE 10A INHIBITORS	3.1.4.17 3.1.4.35
4FCF	K234R: APO STRUCTURE OF INHIBITOR RESISTANT BETA-LACTAMASE	3.5.2.6
4FCI	CRYSTAL STRUCTURE OF THE MN2+2-HUMAN ARGINASE I-AGPA COMPLEX	3.5.3.1
4FCJ	CRYSTAL STRUCTURE OF THE NTF2-LIKE DOMAIN OF HUMAN G3BP1	3.6.4.12 3.6.4.13
4FCK	CRYSTAL STRUCTURE OF THE CO2+2-HUMAN ARGINASE I-AGPA COMPLEX	3.5.3.1
4FCM	CRYSTAL STRUCTURE OF THE NTF2-LIKE DOMAIN OF HUMAN G3BP1 IN COMPLEX WITH A PEPTIDE	3.6.4.12 3.6.4.13
4FCO	CRYSTAL STRUCTURE OF BACE1 WITH ITS INHIBITOR	3.4.23.46
4FCY	CRYSTAL STRUCTURE OF THE BACTERIOPHAGE MU TRANSPOSOSOME	3.1.22 6.5.1
4FD8	STRUCTURE OF APO S70C SHV BETA-LACTAMASE	3.5.2.6
4FDG	CRYSTAL STRUCTURE OF AN ARCHAEAL MCM FILAMENT	3.6.4.12
4FDI	THE MOLECULAR BASIS OF MUCOPOLYSACCHARIDOSIS IV A	3.1.6.4
4FDJ	THE MOLECULAR BASIS OF MUCOPOLYSACCHARIDOSIS IV A, COMPLEX WITH GALNAC	3.1.6.4
4FDL	CRYSTAL STRUCTURE OF CASPASE-7	3.4.22.60
4FDM	CRYSTALLIZATION AND 3D STRUCTURE ELUCIDATION OF THERMOSTABLE L2 LIPASE FROM THERMOPHILIC LOCALLY ISOLATED BACILLUS SP. L2.	3.1.1.3
4FE3	STRUCTURE OF MURINE CYTOSOLIC 5'-NUCLEOTIDASE III COMPLEXED WITH URIDININE MONOPHOSPHATE	3.1.3.5 3.1.3.91
4FE6	CRYSTAL STRUCTURE OF HIV-1 PROTEASE IN COMPLEX WITH AN ENAMINO-OXINDOLE INHIBITOR	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
4FEA	CRYSTAL STRUCTURE OF CASPASE-7 IN COMPLEX WITH ALLOSTERIC INHIBITOR	3.4.22.60
4FFJ	THE CRYSTAL STRUCTURE OF SPDHBPS FROM S.PNEUMONIAE	4.1.99.12 3.5.4.25
4FFS	CRYSTAL STRUCTURE OF 5'-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE NUCLEOSIDASE FROM HELICOBACTER PYLORI WITH BUTYL-THIO-DADME-IMMUCILLIN-A	3.2.2.9 3.2.2.30
4FFY	CRYSTAL STRUCTURE OF DENV1-E111 SINGLE CHAIN VARIABLE FRAGMENT BOUND TO DENV-1 DIII, STRAIN 16007.	3.4.21.91 3.6.1.15 3.6.4.13
4FG0	STRUCTURE OF THE ST. LOUIS ENCEPHALITIS VIRUS ENVELOPE PROTEIN IN THE FUSOGENIC TRIMER CONFORMATION.	3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48
4FGA	DESIGN OF PEPTIDE INHIBITORS OF GROUP II PHOSPHOLIPASE A2: CRYSTAL STRUCTURE OF THE COMPLEX OF PHOSPHOLIPSAE A2 WITH A DESIGNED TRIPEPTIDE, ALA- TYR- LYS AT 2.3 A RESOLUTION	3.1.1.4
4FGD	STRUCTURE OF THE EFFECTOR PROTEIN TSE1 FROM PSEUDOMONAS AERUGINOSA, SELENOMETHIONINE VARIANT	3.4.19.11
4FGE	STRUCTURE OF THE EFFECTOR PROTEIN TSE1 FROM PSEUDOMONAS AERUGINOSA	3.4.19.11
4FGI	STRUCTURE OF THE EFFECTOR - IMMUNITY SYSTEM TSE1 / TSI1 FROM PSEUDOMONAS AERUGINOSA	3.4.19.11
4FGM	CRYSTAL STRUCTURE OF THE AMINOPEPTIDASE N FAMILY PROTEIN Q5QTY1 FROM IDIOMARINA LOIHIENSIS. NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET ILR60.	3.4.11.2
4FGN	CRYSTAL STRUCTURE OF THE SV40 LARGE T-ANTIGEN ORIGIN BINING DOMAIN BOUND TO SITE I DNA	3.6.4
4FGU	CRYSTAL STRUCTURE OF PROLEGUMAIN	3.4.22.34
4FGX	CRYSTAL STRUCTURE OF BACE1 WITH NOVEL INHIBITOR	3.4.23.46
4FH2	STRUCTURE OF S70C BETA-LACTAMASE BOUND TO SULBACTAM	3.5.2.6
4FH4	HIGH-RESOLUTION STRUCTURE OF APO WT SHV-1 BETA-LACTAMASE	3.5.2.6
4FHZ	CRYSTAL STRUCTURE OF A CARBOXYL ESTERASE AT 2.0 ANGSTROM RESOLUTION	3.1.1.1
4FIM	CRYSTAL STRUCTURE OF C-LOBE OF BOVINE LACTOFERRIN COMPLEXED WITH CELECOXIB ACID AT 1.80 A RESOLUTION	3.4.21
4FIN	CRYSTAL STRUCTURE OF ETTA (FORMERLY YJJK) - AN E. COLI ABC-TYPE ATPASE	3.6.1
4FIO	CRYSTAL STRUCTURE OF METHENYLTETRAHYDROMETHANOPTERIN CYCLOHYDROLASE FROM METHANOBREVIBACTER RUMINANTIUM	3.5.4.27
4FIT	FHIT-APO	3.6.1.29
4FIV	FIV PROTEASE COMPLEXED WITH AN INHIBITOR LP-130	3.4.23.16 2.7.7.49 3.1.13.2 3.1.26.13
4FJ5	RB69 DNA POLYMERASE TERNARY COMPLEX WITH DATP/DT	2.7.7.7 3.1.11
4FJ7	RB69 DNA POLYMERASE TERNARY COMPLEX WITH DGTP/DT	2.7.7.7 3.1.11
4FJ8	RB69 DNA POLYMERASE TERNARY COMPLEX WITH DCTP/DT	2.7.7.7 3.1.11
4FJ9	RB69 DNA POLYMERASE TERNARY COMPLEX WITH DTTP/DT	2.7.7.7 3.1.11
4FJC	STRUCTURE OF THE SAGA UBP8/SGF11(1-72, DELTA-ZNF)/SUS1/SGF73 DUB MODULE	3.4.19.12
4FJG	RB69 DNA POLYMERASE TERNARY COMPLEX WITH DATP/DC	2.7.7.7 3.1.11
4FJH	RB69 DNA POLYMERASE TERNARY COMPLEX WITH DGTP/DC	2.7.7.7 3.1.11
4FJI	RB69 DNA POLYMERASE TERNARY COMPLEX WITH DCTP/DC	2.7.7.7 3.1.11
4FJJ	RB69 DNA POLYMERASE TERNARY COMPLEX WITH DTTP/DC	2.7.7.7 3.1.11
4FJK	RB69 DNA POLYMERASE TERNARY COMPLEX WITH DATP/DA	2.7.7.7 3.1.11
4FJL	RB69 DNA POLYMERASE TERNARY COMPLEX WITH DGTP/DA	2.7.7.7 3.1.11
4FJM	RB69 DNA POLYMERASE TERNARY COMPLEX WITH DCTP/DA	2.7.7.7 3.1.11
4FJN	RB69 DNA POLYMERASE TERNARY COMPLEX WITH DTTP/DA	2.7.7.7 3.1.11
4FJP	CRYSTAL STRUCTURE OF C-LOBE OF BOVINE LACTOFERRIN COMPLEXED WITH NAPROXEN AT 1.68 A RESOLUTION	3.4.21
4FJR	MODE OF INTERACTION OF MEROCYANINE 540 WITH HEW LYSOZYME	3.2.1.17
4FJV	CRYSTAL STRUCTURE OF HUMAN OTUBAIN2 AND UBIQUITIN COMPLEX	3.4.19.12
4FJX	RB69 DNA POLYMERASE TERNARY COMPLEX WITH DATP/DG	2.7.7.7 3.1.11
4FK0	RB69 DNA POLYMERASE TERNARY COMPLEX WITH DCTP/DG	2.7.7.7 3.1.11
4FK2	RB69 DNA POLYMERASE TERNARY COMPLEX WITH DTTP/DG	2.7.7.7 3.1.11
4FK4	RB69 DNA POLYMERASE TERNARY COMPLEX WITH DGTP/DG	2.7.7.7 3.1.11
4FK5	STRUCTURE OF THE SAGA UBP8(S144N)/SGF11/SUS1/SGF73 DUB MODULE	3.4.19.12
4FK9	HIGH RESOLUTION STRUCTURE OF THE CATALYTIC DOMAIN OF MANNANASE SACTE_2347 FROM STREPTOMYCES SP. SIREXAA-E	3.2.1.4
4FKB	AN ORGANIC SOLVENT TOLERANT LIPASE 42	3.1.1.3
4FKE	CRYSTAL STRUCTURE OF PORCINE AMINOPEPTIDASE-N	3.4.11.2
4FKH	CRYSTAL STRUCTURE OF PORCINE AMINOPEPTIDASE-N COMPLEXED WITH ALANINE	3.4.11.2
4FKK	CRYSTAL STRUCTURE OF PORCINE AMINOPEPTIDASE-N COMPLEXED WITH BESTATIN	3.4.11.2
4FL8	HIV-1 PROTEASE COMPLEXED WITH GEM-DIOL-AMINE TETRAHEDRAL INTERMEDIATE	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
4FLF	STRUCTURE OF THREE PHASE PARTITION TREATED LIPASE FROM THERMOMYCES LANUGINOSA AT 2.15A RESOLUTION.	3.1.1.3
4FLG	HIV-1 PROTEASE MUTANT I47V COMPLEXED WITH REACTION INTERMEDIATE	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
4FLI	HUMAN METAP1 WITH BENGAMIDE ANALOG Y16, IN MN FORM	3.4.11.18
4FLJ	HUMAN METAP1 WITH BENGAMIDE ANALOG Y08, IN MN FORM	3.4.11.18
4FLK	HUMAN METAP1 WITH BENGAMIDE ANALOG Y10, IN MN FORM	3.4.11.18
4FLL	HUMAN METAP1 WITH BENGAMIDE ANALOG YZ6, IN MN FORM	3.4.11.18
4FLM	S-FORMYLGLUTATHIONE HYDROLASE W197I VARIANT CONTAINING COPPER	3.1.2.12
4FLN	CRYSTAL STRUCTURE OF PLANT PROTEASE DEG2	3.4.21
4FM6	HIV-1 PROTEASE MUTANT V32I COMPLEXED WITH REACTION INTERMEDIATE	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
4FM7	CRYSTAL STRUCTURE OF BACE WITH COMPOUND 14G	3.4.23.46
4FM8	CRYSTAL STRUCTURE OF BACE WITH COMPOUND 12A	3.4.23.46
4FMB	VIRA-RAB1 COMPLEX STRUCTURE	3.4.22
4FMP	CRYSTAL STRUCTURE OF THERMOSTABLE, ORGANIC-SOLVENT TOLERANT LIPASE FROM GEOBACILLUS SP. STRAIN ARM	3.1.1.3
4FMV	CRYSTAL STRUCTURE ANALYSIS OF A GH30 ENDOXYLANASE FROM CLOSTRIDIUM PAPYROSOLVENS C71	3.2.1.136 3.2.1.4
4FN6	STRUCTURAL CHARACTERIZATION OF THIAMINASE TYPE II TENA FROM STAPHYLOCOCCUS AUREUS	3.5.99.2
4FNC	HUMAN TDG IN A POST-REACTIVE COMPLEX WITH 5-HYDROXYMETHYLURACIL (5HMU)	3.2.2.29
4FNG	THE ALPHA-ESTERASE-7 CARBOXYLESTERASE, E3, FROM THE BLOWFLY LUCILIA CUPRINA	3.1.1
4FNM	THE ALPHA-ESTERASE-7 CARBOXYLESTERASE, E3, FROM THE BLOWFLY LUCILIA CUPRINA	3.1.1
4FNO	CRYSTAL STRUCTURE OF PEPTIDYL T-RNA HYDROLASE FROM PSEUDOMONAS AERUGINOSA AT 2.2 ANGSTROM RESOLUTION	3.1.1.29
4FNP	CRYSTAL STRUCTURE OF GH36 ALPHA-GALACTOSIDASE AGAA A355E FROM GEOBACILLUS STEAROTHERMOPHILUS	3.2.1.22
4FNQ	CRYSTAL STRUCTURE OF GH36 ALPHA-GALACTOSIDASE AGAB FROM GEOBACILLUS STEAROTHERMOPHILUS	3.2.1.22
4FNS	CRYSTAL STRUCTURE OF GH36 ALPHA-GALACTOSIDASE AGAA A355E FROM GEOBACILLUS STEAROTHERMOPHILUS IN COMPLEX WITH 1-DEOXYGALACTONOJIRIMYCIN	3.2.1.22
4FNU	CRYSTAL STRUCTURE OF GH36 ALPHA-GALACTOSIDASE AGAA A355E D478A FROM GEOBACILLUS STEAROTHERMOPHILUS IN COMPLEX WITH STACHYOSE	3.2.1.22
4FO7	PSEUDOMONAS AERUGINOSA METAP, IN MN FORM	3.4.11.18
4FO8	PSEUDOMONAS AERUGINOSA METAP WITH MET, IN MN FORM	3.4.11.18
4FOL	S-FORMYLGLUTATHIONE HYDROLASE VARIANT H160I	3.1.2.12
4FON	HIGH ENERGY REMOTE SAD STRUCTURE SOLUTION OF PROTEINASE K FROM THE 37.8 KEV TELLURIUM K EDGE	3.4.21.64
4FOP	CRYSTAL STRUCTURE OF PEPTIDYL-TRNA HYDROLASE FROM ACINETOBACTER BAUMANNII AT 1.86 A RESOLUTION	3.1.1.29
4FOQ	CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH 2-AMINOETHANESULFONIC ACID	3.2.1.18
4FOR	CRYSTAL STRUCTURE OF C-LOBE OF BOVINE LACTOFERRIN COMPLEXED WITH FLURBIPROFEN AT 1.58 A RESOLUTION	3.4.21
4FOT	CRYSTAL STRUCTURE OF PEPTIDYL- TRNA HYDROLASE FROM ACINETOBACTER BAUMANNII AT 2.20 A RESOLUTION	3.1.1.29
4FOV	CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH 3-CYCLOHEXYL-1-PROPYLSULFONIC ACID	3.2.1.18
4FOW	CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH 3-AMMONIOPROPANE-1-SULFONATE	3.2.1.18
4FOY	CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH 2-(BENZYLAMMONIO)ETHANESULFONATE	3.2.1.18
4FOZ	CRYSTAL STRUCTURE OF OCCD1 (OPRD) Y282R/D307H	3.4.21
4FP2	CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH 2[(CYCLOHEXYLMETHYL)AMMONIO]SULFONATE	3.2.1.18
4FP3	CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH 2-[(FURAN-2-YLMETHYL)AMMONIO]SULFONATE	3.2.1.18
4FPC	CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH 2-[(4-CHLOROBENZYL)AMMONIO]ETHANESULFONATE	3.2.1.18
4FPE	CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH 2-[(4-METHOXYBENZYL)AMMONIO]ETHANESULFONATE	3.2.1.18
4FPF	CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH 2-[(3-CHLOROBENZYL)AMMONIO]ETHANESULFONATE	3.2.1.18
4FPG	CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH 2-[(3-HYDROXYBENZYL)AMMONIO]ETHANESULFONATE	3.2.1.18
4FPH	CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH 2-[(3-FLUOROBENZYL)AMMONIO]ETHANESULFONATE	3.2.1.18
4FPJ	CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH 2-[(3-METHOXYBENZYL)AMMONIO]ETHANESULFONATE	3.2.1.18
4FPK	CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH 2-[(3-METHYLBENZYL)AMMONIO]ETHANESULFONATE	3.2.1.18
4FPL	CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH 2-[(3,4-DICHLOROBENZYL)AMMONIO]ETHANESULFONATE	3.2.1.18
4FPO	CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH 2-[(3-CHLORO-4-METHOXYBENZYL)AMMONIO]ETHANESULFONATE	3.2.1.18
4FPV	CRYSTAL STRUCTURE OF D. RERIO TDP2 COMPLEXED WITH SINGLE STRAND DNA PRODUCT	3.1.4
4FPY	CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH 2-[(3-BROMOBENZYL)AMMONIO]ETHANESULFONATE	3.2.1.18
4FQ4	CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH 2-[(4-FLUORO-3-METHYLBENZYL)AMMONIO]ETHANESULFONATE	3.2.1.18
4FQA	CRYSTAL STRUCTURE OF TOXIC EFFECTOR TSE1	3.4.19.11
4FQB	CRYSTAL STRUCTURE OF TOXIC EFFECTOR TSE1 IN COMPLEX WITH IMMUNE PROTEIN TSI1	3.4.19.11
4FRI	CRYSTAL STRUCTURE OF BACE1 IN COMPLEX WITH BIARYLSPIRO AMINOOXAZOLINE 6	3.4.23.46
4FRJ	CRYSTAL STRUCTURE OF BACE1 IN COMPLEX WITH AMINOOXAZOLINE XANTHENE 9L	3.4.23.46
4FRK	CRYSTAL STRUCTURE OF BACE1 IN COMPLEX WITH AMINOOXAZOLINE XANTHENE 11A	3.4.23.46
4FRS	STRUCTURE OF BACE IN COMPLEX WITH (S)-4-(3-CHLORO-5-(5-(PROP-1-YN-1-YL)PYRIDIN-3-YL)THIOPHEN-2-YL)-1,4-DIMETHYL-6-OXOTETRAHYDROPYRIMIDIN-2(1H)-IMINIUM	3.4.23.46
4FS4	STRUCTURE OF BACE BOUND TO (S)-4-(3'-METHOXY-[1,1'-BIPHENYL]-3-YL)-1,4-DIMETHYL-6-OXOTETRAHYDROPYRIMIDIN-2(1H)-IMINIUM	3.4.23.46
4FSE	CRYSTAL STRUCTURE OF BETA-SITE APP-CLEAVING ENZYME 1 (BACE-WT) COMPLEX WITH N-(N-(4-AMINO-3,5- DICHLOROBENZYL)CARBAMIMIDOYL)-3-(4-METHOXYPHENYL)-5- METHYL-4-ISOTHIAZOLECARBOXAMIDE	3.4.23.46
4FSF	CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA PBP3 COMPLEXED WITH COMPOUND 14	3.4.16.4
4FSJ	CRYSTAL STRUCTURE OF THE VIRUS LIKE PARTICLE OF FLOCK HOUSE VIRUS	3.4.23.44
4FSL	CRYSTAL STRUCTURE OF BETA-SITE APP-CLEAVING ENZYME 1 (BACE-DB-MUT) COMPLEX WITH N-(N-(4- ACETAMIDO-3-CHLORO-5-METHYLBENZYL)CARBAMIMIDOYL)-3-(4- METHOXYPHENYL)-5-METHYL-4-ISOTHIAZOLECARBOXAMIDE	3.4.23.46
4FTB	CRYSTAL STRUCTURE OF THE AUTHENTIC FLOCK HOUSE VIRUS PARTICLE	3.4.23.44
4FTE	CRYSTAL STRUCTURE OF THE D75N MUTANT CAPSID OF FLOCK HOUSE VIRUS	3.4.23.44
4FTS	CRYSTAL STRUCTURE OF THE N363T MUTANT OF THE FLOCK HOUSE VIRUS CAPSID	3.4.23.44
4FTW	CRYSTAL STRUCTURE OF A CARBOXYL ESTERASE N110C/L145H AT 2.3 ANGSTROM RESOLUTION	3.1.1.1
4FU4	HUMAN COLLAGENASE 3 (MMP-13) WITH PEPTIDE FROM PRO-DOMAIN	3.4.24
4FU7	CRYSTAL STRUCTURE OF THE UROKINASE	3.4.21.73
4FU8	CRYSTAL STRUCTURE OF THE UROKINASE	3.4.21.73
4FU9	CRYSTAL STRUCTURE OF THE UROKINASE	3.4.21.73
4FUB	CRYSTAL STRUCTURE OF THE UROKINASE	3.4.21.73
4FUC	CRYSTAL STRUCTURE OF THE UROKINASE	3.4.21.73
4FUD	CRYSTAL STRUCTURE OF THE UROKINASE	3.4.21.73
4FUE	CRYSTAL STRUCTURE OF THE UROKINASE	3.4.21.73
4FUF	CRYSTAL STRUCTURE OF THE UROKINASE	3.4.21.73
4FUG	CRYSTAL STRUCTURE OF THE UROKINASE	3.4.21.73
4FUH	CRYSTAL STRUCTURE OF THE UROKINASE	3.4.21.73
4FUI	CRYSTAL STRUCTURE OF THE UROKINASE	3.4.21.73
4FUJ	CRYSTAL STRUCTURE OF THE UROKINASE	3.4.21.73
4FUK	AMINOPEPTIDASE FROM TRYPANOSOMA BRUCEI	3.4.11.18
4FUR	CRYSTAL STRUCTURE OF UREASE SUBUNIT GAMMA 2 FROM BRUCELLA MELITENSIS BIOVAR ABORTUS 2308	3.5.1.5
4FUS	THE X-RAY STRUCTURE OF HAHELLA CHEJUENSIS FAMILY 48 GLYCOSYL HYDROLASE	3.2.1.4
4FVA	CRYSTAL STRUCTURE OF TRUNCATED CAENORHABDITIS ELEGANS TDP2	3.1.4
4FVB	CRYSTAL STRUCTURE OF EV71 2A PROTEINASE C110A MUTANT	3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48
4FVD	CRYSTAL STRUCTURE OF EV71 2A PROTEINASE C110A MUTANT IN COMPLEX WITH SUBSTRATE	3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48
4FVK	STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF NEURAMINIDASE-LIKE MOLECULE N10 DERIVED FROM BAT INFLUENZA A VIRUS	3.2.1.18
4FVL	HUMAN COLLAGENASE 3 (MMP-13) FULL FORM WITH PEPTIDES FROM PRO-DOMAIN	3.4.24
4FVT	HUMAN SIRT3 BOUND TO AC-ACS PEPTIDE AND CARBA-NAD	3.5.1 2.3.1.286
4FVU	STRUCTURAL BASIS FOR THE DSRNA SPECIFICITY OF THE LASSA VIRUS NP EXONUCLEASE	3.1.13
4FW1	CRYSTAL STRUCTURE OF TWO-DOMAIN RSV INTEGRASE COVALENTLY LINKED WITH DNA	3.4.23 2.7.7.49 2.7.7.7 3.1.26.4 2.7.7 3.1
4FW2	CRYSTAL STRUCTURE OF RSV THREE-DOMAIN INTEGRASE WITH DISORDERED N-TERMINAL DOMAIN	3.4.23 2.7.7.49 2.7.7.7 3.1.26.4 2.7.7 3.1
4FW3	CRYSTAL STRUCTURE OF THE LPXC IN COMPLEX WITH N-[(2S)-3-AMINO-1-(HYDROXYAMINO)-1-OXOPROPAN-2-YL]-4-(4-PHENYLBUTA-1,3-DIYN-1-YL)BENZAMIDE INHIBITOR	3.5.1 3.5.1.108
4FW4	CRYSTAL STRUCTURE OF THE LPXC IN COMPLEX WITH N-[(1S,2R)-2-HYDROXY-1-(HYDROXYCARBAMOYL)PROPYL]-4-(4-PHENYLBUTA-1,3-DIYN-1-YL)BENZAMIDE INHIBITOR	3.5.1 3.5.1.108
4FW5	CRYSTAL STRUCTURE OF THE LPXC IN COMPLEX WITH 4'-BROMO-N-[(2S,3R)-3-HYDROXY-1-(HYDROXYAMINO)-1-OXOBUTAN-2-YL]BIPHENYL-4-CARBOXAMIDE INHIBITOR	3.5.1 3.5.1.108
4FW6	CRYSTAL STRUCTURE OF THE LPXC IN COMPLEX WITH N-[(2S,3R)-3-HYDROXY-1-(HYDROXYAMINO)-1-OXOBUTAN-2-YL]-4-(PHENYLETHYNYL)BENZAMIDE INHIBITOR	3.5.1 3.5.1.108
4FW7	CRYSTAL STRUCTURE OF THE LPXC IN COMPLEX WITH N-[(2S,3R)-3-HYDROXY-1-(HYDROXYAMINO)-1-OXOBUTAN-2-YL]BIPHENYL-4-CARBOXAMIDE INHIBITOR	3.5.1 3.5.1.108
4FW9	CRYSTAL STRUCTURE OF THE LON-LIKE PROTEASE MTALONC	3.4.21.53
4FWB	STRUCTURE OF RHODOCOCCUS RHODOCHROUS HALOALKANE DEHALOGENASE MUTANT DHAA31 IN COMPLEX WITH 1, 2, 3 - TRICHLOROPROPANE	3.8.1.5
4FWD	CRYSTAL STRUCTURE OF THE LON-LIKE PROTEASE MTALONC IN COMPLEX WITH BORTEZOMIB	3.4.21.53
4FWG	CRYSTAL STRUCTURE OF THE LON-LIKE PROTEASE MTALONC IN COMPLEX WITH LACTACYSTIN	3.4.21.53
4FWH	CRYSTAL STRUCTURE OF THE LON-LIKE PROTEASE MTALONC IN COMPLEX WITH MG262	3.4.21.53
4FWU	CRYSTAL STRUCTURE OF GLUTAMINYL CYCLASE FROM DROSOPHILA MELANOGASTER IN SPACE GROUP I4	2.3.2.5 3.4
4FWV	CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAIN OF THE LON-LIKE PROTEASE MTALONC	3.4.21.53
4FXA	CRYSTAL STRUCTURE OF THE COMPLEX OF RIBOSOME INACTIVATING PROTEIN FROM MOMORDICA BALSAMINA WITH N-ACETYL ARGININE AT 1.7 ANGSTROM RESOLUTION	3.2.2.22
4FXH	CRYSTAL STRUCTURE OF THE ISOLATED E. COLI RELE TOXIN, P212121 FORM	3.1
4FXI	CRYSTAL STRUCTURE OF THE ISOLATED E. COLI RELE TOXIN, P21 FORM	3.1
4FXO	ZINC-MEDIATED ALLOSTERIC INHIBITON OF CASPASE-6	3.4.22.59
4FXY	CRYSTAL STRUCTURE OF RAT NEUROLYSIN WITH BOUND PYRAZOLIDIN INHIBITOR	3.4.24.16
4FYE	CRYSTAL STRUCTURE OF A LEGIONELLA PHOSPHOINOSITIDE PHOSPHATASE, SIDF	3.1.3.67
4FYF	STRUCTURAL BASIS FOR SUBSTRATE RECOGNITION BY A NOVEL LEGIONELLA PHOSPHOINOSITIDE PHOSPHATASE	3.1.3.67
4FYG	STRUCTURAL BASIS FOR SUBSTRATE RECOGNITION BY A NOVEL LEGIONELLA PHOSPHOINOSITIDE PHOSPHATASE	3.1.3.67
4FYH	CRYSTAL STRUCTURE OF RCL WITH PHOSPHO-TRICIRIBINE	3.2.2
4FYI	CRYSTAL STRUCTURE OF RCL WITH 6-CYCLOPENTYL-AMP	3.2.2
4FYJ	CRYSTAL STRUCTURE OF P. AERUGINOSA PEPTIDYL-TRNA HYDROLASE	3.1.1.29
4FYK	CRYSTAL STRUCTURE OF RCL WITH 5'-PHIOSPHOROTHIOATE-ADENOSINE	3.2.2
4FYQ	HUMAN AMINOPEPTIDASE N (CD13)	3.4.11.2
4FYR	HUMAN AMINOPEPTIDASE N (CD13) IN COMPLEX WITH BESTATIN	3.4.11.2
4FYS	HUMAN AMINOPEPTIDASE N (CD13) IN COMPLEX WITH ANGIOTENSIN IV	3.4.11.2
4FYT	HUMAN AMINOPEPTIDASE N (CD13) IN COMPLEX WITH AMASTATIN	3.4.11.2
4FZ2	CRYSTAL STRUCTURE OF THE FOURTH TYPE OF ARCHAEAL TRNA SPLICING ENDONUCLEASE FROM CANDIDATUS MICRARCHAEUM ACIDIPHILUM ARMAN-2	3.1.27.9
4FZ3	CRYSTAL STRUCTURE OF SIRT3 IN COMPLEX WITH ACETYL P53 PEPTIDE COUPLED WITH 4-AMINO-7-METHYLCOUMARIN	3.5.1 2.3.1.286
4FZ9	CRYSTAL STRUCTURE OF THE COMPLEX OF RIBOSOME INACTIVATING PROTEIN FROM MOMORDICA BALSAMINA WITH DISACCHARIDE, N-ACETYLGLUCOSAMINE (BETA-1, 4) MANNOSE AT 1.7 A RESOLUTION	3.2.2.22
4FZH	STRUCTURE OF THE ULSTER STRAIN NEWCASTLE DISEASE VIRUS HEMAGGLUTININ-NEURAMINIDASE REVEALS AUTO-INHIBITORY INTERACTIONS ASSOCIATED WITH LOW VIRULENCE	3.2.1.18
4FZY	EXONUCLEASE X IN COMPLEX WITH 12BP BLUNT-ENDED DSDNA	3.1.11
4FZZ	EXONUCLEASE X IN COMPLEX WITH 5' OVERHANGING DUPLEX DNA	3.1.11
4G0A	CRYSTALLOGRAPHIC ANALYSIS OF ROTAVIRUS NSP2-RNA COMPLEX REVEALS SPECIFIC RECOGNITION OF 5'-GG SEQUENCE FOR RTPASE ACTIVITY	3.6.4
4G0D	HUMAN COLLAGENASE 3 (MMP-13) FULL FORM WITH PEPTIDES FROM PRO-DOMAIN	3.4.24
4G0N	CRYSTAL STRUCTURE OF WT H-RAS-GPPNHP BOUND TO THE RBD OF RAF KINASE	3.6.5.2
4G1C	HUMAN SIRT5 BOUND TO SUCC-IDH2 AND CARBA-NAD	3.5.1 2.3.1
4G1P	STRUCTURAL AND MECHANISTIC BASIS OF SUBSTRATE RECOGNITION BY NOVEL DI-PEPTIDASE DUG1P FROM SACCHAROMYCES CEREVISIAE	3.4.13
4G1Q	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH RILPIVIRINE (TMC278, EDURANT), A NON-NUCLEOSIDE RT-INHIBITING DRUG	2.7.7.49 2.7.7.7 3.1.26.13 3.4.23.16 3.1.13.2 2.7.7 3.1
4G23	CRYSTAL STRUCTURE OF PROTEINACEOUS RNASE P 1 (PRORP1) FROM A. THALIANA WITH MN	3.1.26.5
4G24	CRYSTAL STRUCTURE OF PROTEINACEOUS RNASE P 1 (PRORP1) FROM A. THALIANA WITH MN	3.1.26.5
4G25	CRYSTAL STRUCTURE OF PROTEINACEOUS RNASE P 1 (PRORP1) FROM A. THALIANA, SEMET SUBSTITUTED FORM WITH SR	3.1.26.5
4G26	CRYSTAL STRUCTURE OF PROTEINACEOUS RNASE P 1 (PRORP1) FROM A. THALIANA WITH CA	3.1.26.5
4G2D	CRYSTAL STRUCTURE OF THE HYPERTHERMOPHILIC SULFOLOBUS ISLANDICUS PLL SISLAC	3.1.8.1
4G2J	HUMAN PDE9 IN COMPLEX WITH SELECTIVE COMPOUND	3.1.4.35
4G2L	HUMAN PDE9 IN COMPLEX WITH SELECTIVE COMPOUND	3.1.4.35
4G2W	CRYSTAL STRUCTURE OF PDE5A IN COMPLEX WITH ITS INHIBITOR	3.1.4.35
4G2Y	CRYSTAL STRUCTURE OF PDE5A COMPLEXED WITH ITS INHIBITOR	3.1.4.35
4G2Z	CRYSTAL STRUCTURE OF C-LOBE OF BOVINE LACTOFERRIN COMPLEXED WITH MEFENAMIC ACID AT 1.90 A RESOLUTION	3.4.21
4G3H	CRYSTAL STRUCTURE OF HELICOBACTER PYLORI ARGINASE	3.5.3.1
4G3M	COMPLEX STRUCTURE OF BACILLUS SUBTILIS RIBG: THE DEAMINATION PROCESS IN RIBOFLAVIN BIOSYNTHESIS	3.5.4.26 1.1.1.193
4G3X	CRYSTAL STRUCTURE OF Q61L H-RAS-GPPNHP BOUND TO THE RBD OF RAF KINASE	3.6.5.2
4G41	CRYSTAL STRUCTURE OF S-ADENOSYLHOMOCYSTEINE NUCLEOSIDASE FROM STREPTOCOCCUS PYOGENES IN COMPLEX WITH 5-METHYLTHIOTUBERICIDIN	3.2.2.16 3.2.2.9
4G49	ROOM TEMPERATURE X-RAY DIFFRACTION OF CISPLATIN BINDING TO HEWL IN AQUEOUS MEDIA AFTER 15 MONTHS OF CRYSTAL STORAGE	3.2.1.17
4G4B	ROOM TEMPERATURE X-RAY DIFFRACTION STUDY OF CISPLATIN BINDING TO HEWL IN DMSO MEDIA WITH NAG AFTER 7 MONTHS OF CRYSTAL STORAGE	3.2.1.17
4G4C	ROOM TEMPERATURE X-RAY DIFFRACTION STUDY OF CARBOPLATIN BINDING TO HEWL IN DMSO MEDIA AFTER 13 MONTHS OF CRYSTAL STORAGE	3.2.1.17
4G4G	CRYSTAL STRUCTURE OF RECOMBINANT GLUCURONOYL ESTERASE FROM SPOROTRICHUM THERMOPHILE DETERMINED AT 1.55 A RESOLUTION	3.1.1
4G4H	100K X-RAY DIFFRACTION STUDY OF CARBOPLATIN BINDING TO HEWL IN DMSO MEDIA AFTER 13 MONTHS OF CRYSTAL STORAGE	3.2.1.17
4G4I	CRYSTAL STRUCTURE OF GLUCURONOYL ESTERASE S213A MUTANT FROM SPOROTRICHUM THERMOPHILE DETERMINED AT 1.9 A RESOLUTION	3.1.1
4G4J	CRYSTAL STRUCTURE OF GLUCURONOYL ESTERASE S213A MUTANT FROM SPOROTRICHUM THERMOPHILE IN COMPLEX WITH METHYL 4-O-METHYL-BETA-D-GLUCOPYRANURONATE DETERMINED AT 2.35 A RESOLUTION	3.1.1
4G4N	MUTM CONTAINING M77A MUTATION BOUND TO UNDAMAGED DNA	3.2.2.23 4.2.99.18
4G4O	MUTM CONTAINING M77A MUTATION BOUND TO OXOG-CONTAINING DNA	3.2.2.23 4.2.99.18
4G4Q	MUTM CONTAINING F114A MUTATION BOUND TO UNDAMAGED DNA	3.2.2.23 4.2.99.18
4G4R	MUTM CONTAINING F114A MUTATION BOUND TO OXOG-CONTAINING DNA	3.2.2.23 4.2.99.18
4G57	STAPHYLOCOCCAL NUCLEASE DOUBLE MUTANT I72L, I92L	3.1.31.1
4G5I	CRYSTAL STRUCTURE OF PORCINE PANCREATIC PLA2 IN COMPLEX WITH DBP	3.1.1.4
4G61	CRYSTAL STRUCTURE OF IMPASE/NADP PHOSPHATASE COMPLEXED WITH MG2+ AND PHOSPHATE	3.1.3.25
4G6C	CRYSTAL STRUCTURE OF BETA-HEXOSAMINIDASE 1 FROM BURKHOLDERIA CENOCEPACIA J2315	3.2.1.52
4G77	CRYSTAL STRUCTURE OF C-LOBE OF BOVINE LACTOFERRIN COMPLEXED WITH TOLFENAMIC ACID AT 1.98 A RESOLUTION	3.4.21
4G7E	CRYSTAL STRUCTURE OF PIGEON PEA UREASE	3.5.1.5
4G89	CRYSTAL STRUCTURE OF K. PNEUMONIAE MTA/ADOHCY NUCLEOSIDASE IN COMPLEX WITH FRAGMENTED S-ADENOSYL-L-HOMOCYSTEINE	3.2.2.9
4G8A	CRYSTAL STRUCTURE OF HUMAN TLR4 POLYMORPHIC VARIANT D299G AND T399I IN COMPLEX WITH MD-2 AND LPS	3.2.2.6
4G8H	CRYSTAL STRUCTURE OF C-LOBE OF BOVINE LACTOFERRIN COMPLEXED WITH LICOFELONE AT 1.88 A RESOLUTION	3.4.21
4G8K	INTACT SENSOR DOMAIN OF HUMAN RNASE L IN THE INACTIVE SIGNALING STATE	3.1.26
4G8V	CRYSTAL STRUCTURE OF RIBONUCLEASE A IN COMPLEX WITH 5A	3.1.27.5 4.6.1.18
4G8Y	CRYSTAL STRUCTURE OF RIBONUCLEASE A IN COMPLEX WITH 5B	3.1.27.5 4.6.1.18
4G90	CRYSTAL STRUCTURE OF RIBONUCLEASE A IN COMPLEX WITH 5E	3.1.27.5 4.6.1.18
4G9L	STRUCTURE OF MMP3 COMPLEXED WITH NNGH INHIBITOR.	3.4.24.17
4G9O	CRYSTAL STRUCTURE OF H234A MUTANT OF STATIONARY PHASE SURVIVAL PROTEIN (SURE) FROM SALMONELLA TYPHIMURIUM	3.1.3.5 3.1.3.6 3.6.1.11
4G9S	CRYSTAL STRUCTURE OF ESCHERICHIA COLI PLIG IN COMPLEX WITH ATLANTIC SALMON G-TYPE LYSOZYME	3.2.1.17
4G9Z	LASSA NUCLEOPROTEIN WITH DSRNA REVEALS NOVEL MECHANISM FOR IMMUNE SUPPRESSION	3.1.13
4GAA	STRUCTURE OF LEUKOTRIENE A4 HYDROLASE FROM XENOPUS LAEVIS COMPLEXED WITH INHIBITOR BESTATIN	3.3.2.6
4GAD	CRYSTAL STRUCTURE OF D230A/H234A MUTANT OF STATIONARY PHASE SURVIVAL PROTEIN (SURE) FROM SALMONELLA TYPHIMURIUM	3.1.3.5 3.1.3.6 3.6.1.11
4GAH	HUMAN ACYL-COA THIOESTERASES 4 IN COMPLEX WITH UNDECAN-2-ONE-COA INHIBITOR	3.1.2.20 3.1.2.2
4GAZ	CRYSTAL STRUCTURE OF A JUMONJI DOMAIN-CONTAINING PROTEIN JMJD5	1.14.11.27 1.14.11 3.4
4GB1	SYNTHESIS AND EVALUATION OF NOVEL 3-C-ALKYLATED-NEU5AC2EN DERIVATIVES AS PROBES OF INFLUENZA VIRUS SIALIDASE 150-LOOP FLEXIBILITY	3.2.1.18
4GB2	HIV-1 PROTEASE (MUTANT Q7K L33I L63I) IN COMPLEX WITH A BICYCLIC PYRROLIDINE INHIBITOR	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
4GB3	HUMAN COXSACKIEVIRUS B3 STRAIN RD COAT PROTEIN	3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48
4GBG	CRYSTAL STRUCTURE OF ETHYL ACETOACETATE TREATED LIPASE FROM THERMOMYCES LANUGINOSA AT 2.9 A RESOLUTION	3.1.1.3
4GBV	CRYSTAL STRUCTURE OF AMP COMPLEXES OF PORCINE LIVER FRUCTOSE-1,6-BISPHOSPHATASE MUTANT A54L WITH 1,2-ETHANEDIOL AS CRYO-PROTECTANT	3.1.3.11
4GBW	CRYSTAL STRUCTURE OF AMP COMPLEXES OF PORCINE LIVER FRUCTOSE-1,6-BISPHOSPHATASE MUTANT A54L WITH 1,2-PROPANEDIOL AS CRYO-PROTECTANT	3.1.3.11
4GC3	CRYSTAL STRUCTURE OF L-HISTIDINOL PHOSPHATE PHOSPHATASE (HISK) FROM LACTOCOCCUS LACTIS SUBSP. LACTIS IL1403 COMPLEXED WITH ZN AND SULFATE	3.1.3.15
4GCB	100K X-RAY DIFFRACTION STUDY OF A 6-FOLD MOLAR EXCESS OF A CISPLATIN/CARBOPLATIN MIXTURE BINDING TO HEWL	3.2.1.17
4GCC	ROOM TEMPERATURE X-RAY DIFFRACTION STUDY OF A 6-FOLD MOLAR EXCESS OF A CISPLATIN/CARBOPLATIN MIXTURE BINDING TO HEWL, DATASET 1	3.2.1.17
4GCD	ROOM TEMPERATURE X-RAY DIFFRACTION STUDY OF A 6-FOLD MOLAR EXCESS OF A CISPLATIN/CARBOPLATIN MIXTURE BINDING TO HEWL, DATASET 2	3.2.1.17
4GCE	ROOM TEMPERATURE X-RAY DIFFRACTION STUDY OF A 6-FOLD MOLAR EXCESS OF A CISPLATIN/CARBOPLATIN MIXTURE BINDING TO HEWL, DATASET 3	3.2.1.17
4GCF	ROOM TEMPERATURE X-RAY DIFFRACTION STUDY OF A 6-FOLD MOLAR EXCESS OF A CISPLATIN/CARBOPLATIN MIXTURE BINDING TO HEWL, DATASET 4	3.2.1.17
4GCH	STRUCTURE AND ACTIVITY OF TWO PHOTOREVERSIBLE CINNAMATES BOUND TO CHYMOTRYPSIN	3.4.21.1
4GCW	CRYSTAL STRUCTURE OF RNASE Z IN COMPLEX WITH PRECURSOR TRNA(THR)	3.1.26.11
4GCY	STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS DUTPASE H21W MUTANT	3.6.1.23
4GD6	SHV-1 BETA-LACTAMASE IN COMPLEX WITH PENAM SULFONE SA1-204	3.5.2.6
4GD8	SHV-1 BETA-LACTAMASE IN COMPLEX WITH PENAM SULFONE SA3-53	3.5.2.6
4GDB	SHV-1 IN COMPLEX WITH 4H-PYRAZOLO[1,5-C][1,3]THIAZOLE CONTAINING PENEM INHIBITOR	3.5.2.6
4GDF	A CRYSTAL STRUCTURE OF SV40 LARGE T ANTIGEN	3.6.4
4GDI	A SUBTYPE N10 NEURAMINIDASE-LIKE PROTEIN OF A/LITTLE YELLOW-SHOULDERED BAT/GUATEMALA/164/2009	3.2.1.18
4GDJ	A SUBTYPE N10 NEURAMINIDASE-LIKE PROTEIN OF A/LITTLE YELLOW-SHOULDERED BAT/GUATEMALA/060/2010	3.2.1.18
4GDN	STRUCTURE OF FMTA-LIKE PROTEIN	3.5
4GDX	CRYSTAL STRUCTURE OF HUMAN GAMMA-GLUTAMYL TRANSPEPTIDASE--GLUTAMATE COMPLEX	2.3.2.2 3.4.19.13 3.4.19.14
4GE2	CRYSTAL STRUCTURE OF HUMAN PROTEIN TYROSINE PHOSPHATASE PTPN9 (MEG2) COMPLEX WITH COMPOUND 3	3.1.3.48
4GE5	CRYSTAL STRUCTURE OF HUMAN PROTEIN TYROSINE PHOSPHATASE PTPN9 (MEG2) COMPLEX WITH COMPOUND 5	3.1.3.48
4GE6	CRYSTAL STRUCTURE OF HUMAN PROTEIN TYROSINE PHOSPHATASE PTPN9 (MEG2) COMPLEX WITH COMPOUND 7	3.1.3.48
4GEL	CRYSTAL STRUCTURE OF ZUCCHINI	3.1.4
4GEM	CRYSTAL STRUCTURE OF ZUCCHINI (K171A)	3.1.4
4GEN	CRYSTAL STRUCTURE OF ZUCCHINI (MONOMER)	3.1.4
4GER	CRYSTAL STRUCTURE OF GENTLYASE, THE NEUTRAL METALLOPROTEASE OF PAENIBACILLUS POLYMYXA	3.4.24.4 3.4.24.28
4GEW	CRYSTAL STRUCTURE OF TDP2 FROM C. ELEGANS	3.1.4
4GFV	PTPN18 IN COMPLEX WITH HER2-PY1196 PHOSPHOR-PEPTIDES	3.1.3.48
4GFY	DESIGN OF PEPTIDE INHIBITORS OF PHOSPHOLIPASE A2: CRYSTAL STRUCTURE OF PHOSPHOLIPASE A2 COMPLEXED WITH A DESIGNED TETRAPEPTIDE VAL - ILU- ALA - LYS AT 2.7 A RESOLUTION	3.1.1.4
4GG2	THE CRYSTAL STRUCTURE OF GLUTAMATE-BOUND HUMAN GAMMA-GLUTAMYLTRANSPEPTIDASE 1	2.3.2.2 3.4.19.13 3.4.19.14
4GGJ	CRYSTAL STRUCTURE OF ZUCCHINI FROM MOUSE (MZUC / PLD6 / MITOPLD)	3.1.4 3.1
4GGK	CRYSTAL STRUCTURE OF ZUCCHINI FROM MOUSE (MZUC / PLD6 / MITOPLD) BOUND TO TUNGSTATE	3.1.4 3.1
4GGM	STRUCTURE OF LPXI	3.6.1.54
4GH4	CRYSTAL STRUCTURE OF FOOT AND MOUTH DISEASE VIRUS A22 SEROTYPE	2.7.7.48 3.4.22.28 3.4.22.46 3.6.1.15
4GH6	CRYSTAL STRUCTURE OF THE PDE9A CATALYTIC DOMAIN IN COMPLEX WITH INHIBITOR 28	3.1.4.35
4GHO	CRYSTAL STRUCTURE ANALYSIS OF STREPTOMYCES AUREOFACIENS RIBONUCLEASE S24A MUTANT	3.1.27.3 4.6.1.24
4GHQ	CRYSTAL STRUCTURE OF EV71 3C PROTEINASE	3.4.22.28 3.4.22.29 3.6.1.15 2.7.7.48
4GHT	CRYSTAL STRUCTURE OF EV71 3C PROTEINASE IN COMPLEX WITH AG7088	3.4.22.28 3.4.22.29 3.6.1.15 2.7.7.48
4GHW	CRYSTAL STRUCTURE OF THE COMPLEX OF FUNGAL LIPASE FROM THERMOMYCES LANUGINOSA WITH DECANOIC ACID AT 2.6 A RESOLUTION	3.1.1.3
4GI1	STRUCTURE OF THE COMPLEX OF THREE PHASE PARTITION TREATED LIPASE FROM THERMOMYCES LANUGINOSA WITH 16-HYDROXYPALMITIC ACID AT 2.4 A RESOLUTION	3.1.1.3
4GID	STRUCTURE OF BETA-SECRETASE COMPLEXED WITH INHIBITOR	3.4.23.46
4GIJ	CRYSTAL STRUCTURE OF PSEUDOURIDINE MONOPHOSPHATE GLYCOSIDASE COMPLEXED WITH SULFATE	3.2 4.2.1.70
4GIK	CRYSTAL STRUCTURE OF PSEUDOURIDINE MONOPHOSPHATE GLYCOSIDASE/LINEAR R5P ADDUCT	3.2 4.2.1.70
4GIL	CRYSTAL STRUCTURE OF PSEUDOURIDINE MONOPHOSPHATE GLYCOSIDASE/LINEAR PSEUDOURIDINE 5'-PHOSPHATE ADDUCT	3.2 4.2.1.70
4GIM	CRYSTAL STRUCTURE OF PSEUDOURIDINE MONOPHOSPHATE GLYCOSIDASE COMPLEXED WITH PSEUDOURIDINE 5'-PHOSPHATE	3.2 4.2.1.70
4GIT	CRYSTAL STRUCTURE OF ALPHA SUB-DOMAIN OF LON PROTEASE FROM BREVIBACILLUS THERMORUBER	3.4.21.53
4GJ5	CRYSTAL STRUCTURE OF RENIN IN COMPLEX WITH NVP-AMQ838 (COMPOUND 5)	3.4.23.15
4GJ6	CRYSTAL STRUCTURE OF RENIN IN COMPLEX WITH NVP-AYZ832 (COMPOUND 6A)	3.4.23.15
4GJ7	CRYSTAL STRUCTURE OF RENIN IN COMPLEX WITH NVP-BCA079 (COMPOUND 12A)	3.4.23.15
4GJ8	CRYSTAL STRUCTURE OF RENIN IN COMPLEX WITH PKF909-724 (COMPOUND 3)	3.4.23.15
4GJ9	CRYSTAL STRUCTURE OF RENIN IN COMPLEX WITH GP055321 (COMPOUND 4)	3.4.23.15
4GJA	CRYSTAL STRUCTURE OF RENIN IN COMPLEX WITH NVP-AYL747 (COMPOUND 5)	3.4.23.15
4GJB	CRYSTAL STRUCTURE OF RENIN IN COMPLEX WITH NVP-BBV031 (COMPOUND 6)	3.4.23.15
4GJC	CRYSTAL STRUCTURE OF RENIN IN COMPLEX WITH NVP-BCH965 (COMPOUND 9)	3.4.23.15
4GJD	CRYSTAL STRUCTURE OF RENIN IN COMPLEX WITH NVP-BGQ311 (COMPOUND 12)	3.4.23.15
4GJY	JMJD5 IN COMPLEX WITH N-OXALYLGLYCINE	1.14.11.27 1.14.11 3.4
4GJZ	JMJD5 IN COMPLEX WITH 2-OXOGLUTARATE	1.14.11.27 1.14.11 3.4
4GK6	X-RAY CRYSTAL STRUCTURE OF A HYPOTHETICAL DEOXYURIDINE 5-TRIPHOSPHATE NUCLEOTIDOHYDROLASE FROM MYCOBACTERIUM ABSCESSUS	3.6.1.23
4GK8	CRYSTAL STRUCTURE OF HISTIDINOL PHOSPHATE PHOSPHATASE (HISK) FROM LACTOCOCCUS LACTIS SUBSP. LACTIS IL1403 COMPLEXED WITH ZN AND L-HISTIDINOL ARSENATE	3.1.3.15
4GKL	CRYSTAL STRUCTURE OF A NONCANONIC MALTOGENIC ALPHA-AMYLASE AMYB FROM THERMOTOGA NEAPOLITANA	3.2.1.1
4GKU	CRYSTAL STRUCTURE OF BETA LACTAMASE IN PET-15B	3.5.2.6
4GL2	STRUCTURAL BASIS FOR DSRNA DUPLEX BACKBONE RECOGNITION BY MDA5	3.6.4.13
4GLA	OBODY NL8 BOUND TO HEN EGG-WHITE LYSOZYME	3.2.1.17
4GLB	STRUCTURE OF P-NITROBENZALDEHYDE INHIBITED LIPASE FROM THERMOMYCES LANUGINOSA AT 2.69 A RESOLUTION	3.1.1.3
4GLD	CRYSTAL STRUCTURE OF THE COMPLEX OF TYPE II PHOSPHOLIPASE A2 WITH A DESIGNED PEPTIDE INHIBITOR PHE - LEU - ALA - TYR - LYS AT 1.69 A RESOLUTION	3.1.1.4
4GLE	SACUVDE IN COMPLEX WITH 6-4PP-CONTAINING DNA	3
4GLK	STRUCTURE AND ACTIVITY OF ABIQ, A LACTOCOCCAL ANTI-PHAGE ENDORIBONUCLEASE BELONGING TO THE TYPE-III TOXIN-ANTITOXIN SYSTEM	3.1
4GLV	OBODY AM3L09 BOUND TO HEN EGG-WHITE LYSOZYME	3.2.1.17
4GLY	HUMAN UROKINASE-TYPE PLASMINOGEN ACTIVATOR UPA IN COMPLEX WITH THE TWO-DISULFIDE BRIDGE PEPTIDE UK504	3.4.21.73
4GM5	CARBOXYPEPTIDASE T WITH SULPHAMOIL ARGININE	3.4.17.18
4GMC	CRYSTAL STRUCTURE OF HCV NS5B POLYMERASE IN COMPLEX WITH A THUMB INHIBITOR	2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13
4GMH	CRYSTAL STRUCTURE OF STAPHYLOCOCCUS AUREUS 5'-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE NUCLEOSIDASE	3.2.2.9
4GMI	BACE-1 IN COMPLEX WITH HEA-TYPE MACROCYCLIC INHIBITOR, MV078571	3.4.23.46
4GN2	CRYSTAL STRUCTURE OF OXA-45, A CLASS D BETA-LACTAMASE WITH EXTENDED SPECTRUM ACTIVITY	3.5.2.6
4GN4	OBODY AM2EP06 BOUND TO HEN EGG-WHITE LYSOZYME	3.2.1.17
4GN7	MOUSE SMP30/GNL	3.1.1.17
4GN8	MOUSE SMP30/GNL-1,5-AG COMPLEX	3.1.1.17
4GN9	MOUSE SMP30/GNL-GLUCOSE COMPLEX	3.1.1.17
4GNA	MOUSE SMP30/GNL-XYLITOL COMPLEX	3.1.1.17
4GNB	HUMAN SMP30/GNL	3.1.1.17
4GNC	HUMAN SMP30/GNL-1,5-AG COMPLEX	3.1.1.17
4GNU	CRYSTAL STRUCTURE OF GES-5 CARBAPENEMASE	3.5.2.6
4GNV	CRYSTAL STRUCTURE OF BETA-HEXOSAMINIDASE 1 FROM BURKHOLDERIA CENOCEPACIA J2315 WITH BOUND N-ACETYL-D-GLUCOSAMINE	3.2.1.52
4GOA	CRYSTAL STRUCTURE OF JACK BEAN UREASE INHIBITED WITH FLUORIDE	3.5.1.5
4GOG	CRYSTAL STRUCTURE OF THE GES-1 IMIPENEM ACYL-ENZYME COMPLEX	3.5.2.6
4GPG	X/N JOINT REFINEMENT OF ACHROMOBACTER LYTICUS PROTEASE I FREE FORM AT PD8.0	3.4.21.50
4GPI	CRYSTAL STRUCTURE OF HUMAN B TYPE PHOSPHOGLYCERATE MUTASE	3.1.3.13 5.4.2.1 5.4.2.4 5.4.2.11
4GPN	THE CRYSTAL STRUCTURE OF 6-P-BETA-D-GLUCOSIDASE (E375Q MUTANT) FROM STREPTOCOCCUS MUTANS UA150 IN COMPLEX WITH GENTIOBIOSE 6-PHOSPHATE.	3.2.1.86
4GPS	CRYSTAL STRUCTURE OF K. LACTIS DXO1 (YDR370C)	3.6.1 3.1.13
4GPU	CRYSTAL STRUCTURE OF K. LACTIS DXO1 (YDR370C) IN COMPLEX WITH MANGANESE	3.6.1 3.1.13
4GPZ	CRYSTAL STRUCTURE OF HUMAN B TYPE PHOSPHOGLYCERATE MUTASE H11 PHOSPHORYLATED FORM	3.1.3.13 5.4.2.1 5.4.2.4 5.4.2.11
4GQL	CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MMP12 IN COMPLEX WITH SELECTIVE PHOSPHINIC INHIBITOR RXP470.1	3.4.24.65
4GQQ	HUMAN PANCREATIC ALPHA-AMYLASE WITH BOUND ETHYL CAFFEATE	3.2.1.1
4GQR	HUMAN PANCREATIC ALPHA-AMYLASE IN COMPLEX WITH MYRICETIN	3.2.1.1
4GR0	CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MMP12 IN COMPLEX WITH SELECTIVE PHOSPHINIC INHIBITOR RXP470B	3.4.24.65
4GR3	CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MMP12 IN COMPLEX WITH SELECTIVE PHOSPHINIC INHIBITOR RXP470A	3.4.24.65
4GR8	CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MMP12 IN COMPLEX WITH SELECTIVE PHOSPHINIC INHIBITOR RXP470C	3.4.24.65
4GRK	CRYSTAL STRUCTURE OF C-LOBE OF BOVINE LACTOFERRIN COMPLEXED WITH KETOROLAC AT 1.68 A RESOLUTION	3.4.21
4GRV	THE CRYSTAL STRUCTURE OF THE NEUROTENSIN RECEPTOR NTS1 IN COMPLEX WITH NEUROTENSIN (8-13)	3.2.1.17
4GRY	CRYSTAL STRUCTURE OF SHP1 CATALYTIC DOMAIN WITH SO4	3.1.3.48
4GRZ	CRYSTAL STRUCTURE OF SHP1 CATALYTIC DOMAIN WITH PO4	3.1.3.48
4GS0	CRYSTAL STRUCTURE OF SHP1 CATALYTIC DOMAIN WITH JAK1 ACTIVATION LOOP PEPTIDE	3.1.3.48
4GS8	STRUCTURE ANALYSIS OF CYSTEINE FREE INSULIN DEGRADING ENZYME (IDE) WITH COMPOUND BDM43079 [{[(S)-2-(1H-IMIDAZOL-4-YL)-1-METHYLCARBAMOYL-ETHYLCARBAMOYL]-METHYL}-(3-PHENYL-PROPYL)-AMINO]-ACETIC ACID	3.4.24.56
4GSC	STRUCTURE ANALYSIS OF INSULIN DEGRADING ENZYME WITH COMPOUND BDM41559 ((S)-2-[2-(CARBOXYMETHYL-PHENETHYL-AMINO)-ACETYLAMINO]-3-(1H-IMIDAZOL-4-YL)-PROPIONIC ACID METHYL ESTER)	3.4.24.56
4GSM	CRYSTAL STRUCTURE OF NI2+2-HUMAN ARGINASE I	3.5.3.1
4GSO	STRUCTURE OF JARARACUSSIN-I	3.4.21
4GSP	RIBONUCLEASE T1 COMPLEXED WITH 2',3'-CGPS + 3'-GMP, 7 DAYS	3.1.27.3 4.6.1.24
4GSV	CRYSTAL STRUCTURE OF THE NI2+2-HUMAN ARGINASE I-ABH COMPLEX	3.5.3.1
4GSX	HIGH RESOLUTION STRUCTURE OF DENGUE VIRUS SEROTYPE 1 SE CONTAINING STEM	3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48
4GSZ	CRYSTAL STRUCTURE OF THE ZN2+5-HUMAN ARGINASE I-ABH COMPLEX	3.5.3.1
4GT0	STRUCTURE OF DENGUE VIRUS SEROTYPE 1 SE CONTAINING STEM TO RESIDUE 421	3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48
4GT1	CRYSTAL STRUCTURE OF A MEAB- AND MMAA-LIKE GTPASE FROM MYCOBACTERIUM TUBERCULOSIS BOUND TO 2'-DEOXYGUANOSINE DIPHOSPHATE	3.6
4GTW	CRYSTAL STRUCTURE OF MOUSE ENPP1 IN COMPLEX WITH AMP	3.1.4.39 3.1.4.1 3.6.1.9
4GTX	CRYSTAL STRUCTURE OF MOUSE ENPP1 IN COMPLEX WITH TMP	3.1.4.39 3.1.4.1 3.6.1.9
4GTY	CRYSTAL STRUCTURE OF MOUSE ENPP1 IN COMPLEX WITH GMP	3.1.4.39 3.1.4.1 3.6.1.9
4GTZ	CRYSTAL STRUCTURE OF MOUSE ENPP1 IN COMPLEX WITH CMP	3.1.4.39 3.1.4.1 3.6.1.9
4GUA	ALPHAVIRUS P23PRO-ZBD	2.1.1 2.7.7 3.1.3.33 3.4.22 3.6.1.15 3.6.4.13 2.7.7.48 3.1.3.84 2.7.7.19
4GUD	CRYSTAL STRUCTURE OF AMIDOTRANSFERASE HISH FROM VIBRIO CHOLERAE	2.4.2 4.3.2.10 3.5.1.2
4GUW	CRYSTAL STRUCTURE OF TYPE 1 RIBOSOME INACTIVATING PROTEIN FROM MOMORDICA BALSAMINA WITH LIPOPOLYSACCHARIDE AT 1.6 ANGSTROM RESOLUTION	3.2.2.22
4GUX	CRYSTAL STRUCTURE OF TRYPSIN:MCOTI-II COMPLEX	3.4.21.4
4GUY	HUMAN MMP12 CATALYTIC DOMAIN IN COMPLEX WITH*N*-HYDROXY-2-(2-(4-METHOXYPHENYL)ETHYLSULFONAMIDO)ACETAMIDE	3.4.24.65
4GV3	STRUCTURES OF LASSA AND TACARIBE VIRAL NUCLEOPROTEINS WITH OR WITHOUT 5 TRIPHOSPHATE DSRNA SUBSTRATE REVEAL A UNIQUE 3 -5 EXORIBONUCLEASE MECHANISM TO SUPPRESS TYPE I INTERFERON PRODUCTION	3.1.13
4GV6	STRUCTURES OF LASSA AND TACARIBE VIRAL NUCLEOPROTEINS WITH OR WITHOUT 5 TRIPHOSPHATE DSRNA SUBSTRATE REVEAL A UNIQUE 3 -5 EXORIBONUCLEASE MECHANISM TO SUPPRESS TYPE I INTERFERON PRODUCTION	3.1.13
4GV8	DUTPASE FROM PHAGE PHI11 OF S.AUREUS: VISUALIZATION OF THE SPECIES-SPECIFIC INSERT	3.6.1.23
4GV9	LASSA NUCLEOPROTEIN C-TERMINAL DOMAIN IN COMPLEX WITH TRIPHOSPHATED DSRNA SOAKING FOR 5 MIN	3.1.13
4GVE	TACARIBE NUCLEOPROTEIN STRUCTURE	3.1.13
4GVF	CRYSTAL STRUCTURE OF SALMONELLA TYPHIMURIUM FAMILY 3 GLYCOSIDE HYDROLASE (NAGZ) BOUND TO GLCNAC	3.2.1.52
4GVG	CRYSTAL STRUCTURE OF SALMONELLA TYPHIMURIUM FAMILY 3 GLYCOSIDE HYDROLASE (NAGZ)	3.2.1.52
4GVH	CRYSTAL STRUCTURE OF SALMONELLA TYPHIMURIUM FAMILY 3 GLYCOSIDE HYDROLASE (NAGZ) COVALENTLY BOUND TO 5-FLUORO-GLCNAC.	3.2.1.52
4GVI	CRYSTAL STRUCTURE OF MUTANT (D248N) SALMONELLA TYPHIMURIUM FAMILY 3 GLYCOSIDE HYDROLASE (NAGZ) IN COMPLEX WITH GLCNAC-1,6-ANHMURNAC	3.2.1.52
4GVM	HIV-1 INTEGRASE CATALYTIC CORE DOMAIN A128T MUTANT COMPLEXED WITH ALLOSTERIC INHIBITOR	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
4GVQ	X-RAY STRUCTURE OF THE ARCHAEOGLOBUS FULGIDUS METHENYL-TETRAHYDROMETHANOPTERIN CYCLOHYDROLASE IN COMPLEX WITH TETRAHYDROMETHANPTERIN	3.5.4.27
4GVR	X-RAY STRUCTURE OF THE ARCHAEOGLOBUS FULGIDUS METHENYL-TETRAHYDROMETHANOPTERIN CYCLOHYDROLASE	3.5.4.27
4GVS	X-RAY STRUCTURE OF THE ARCHAEOGLOBUS FULGIDUS METHENYL-TETRAHYDROMETHANOPTERIN CYCLOHYDROLASE IN COMPLEX WITH N5-FORMYL-TETRAHYDROMETHANOPTERIN	3.5.4.27
4GVU	LYNGBYASTATIN 7-PORCINE PANCREATIC ELASTASE CO-CRYSTAL STRUCTURE	3.4.21.36
4GW3	CRYSTAL STRUCTURE OF THE LIPASE FROM PROTEUS MIRABILIS	3.1.1.3
4GW6	HIV-1 INTEGRASE CATALYTIC CORE DOMAIN COMPLEXED WITH ALLOSTERIC INHIBITOR	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
4GWA	CRYSTAL STRUCTURE OF A GH7 FAMILY CELLOBIOHYDROLASE FROM LIMNORIA QUADRIPUNCTATA	3.2.1.91
4GWC	CRYSTAL STRUCTURE OF MN2+2,ZN2+-HUMAN ARGINASE I	3.5.3.1
4GWD	CRYSTAL STRUCTURE OF THE MN2+2,ZN2+-HUMAN ARGINASE I-ABH COMPLEX	3.5.3.1
4GWF	CRYSTAL STRUCTURE OF THE TYROSINE PHOSPHATASE SHP-2 WITH Y279C MUTATION	3.1.3.48
4GWL	STRUCTURE OF THREE PHASE PARTITION TREATED LIPASE FROM THERMOMYCES LANUGINOSA AT 2.55A RESOLUTION	3.1.1.3
4GWM	CRYSTAL STRUCTURE OF HUMAN PROMEPRIN BETA	3.4.24.63
4GWN	CRYSTAL STRUCTURE OF HUMAN MATURE MEPRIN BETA	3.4.24.63
4GWS	CRYSTAL STRUCTURE OF AMP COMPLEXES OF PORCINE LIVER FRUCTOSE-1,6-BISPHOSPHATASE WITH FILLED CENTRAL CAVITY	3.1.3.11
4GWU	CRYSTAL STRUCTURE OF FRU 2,6-BISPHOSPHATE COMPLEXES OF PORCINE LIVER FRUCTOSE-1,6-BISPHOSPHATASE WITH FILLED CENTRAL CAVITY	3.1.3.11
4GWW	CRYSTAL STRUCTURE OF PRODUCT COMPLEXES OF PORCINE LIVER FRUCTOSE-1,6-BISPHOSPHATASE WITH BLOCKED SUBUNIT PAIR ROTATION	3.1.3.11
4GWX	CRYSTAL STRUCTURE OF PRODUCT COMPLEXES OF PORCINE LIVER FRUCTOSE-1,6-BISPHOSPHATASE WITH RESTRAINED SUBUNIT PAIR ROTATION	3.1.3.11
4GWY	CRYSTAL STRUCTURE OF AMP COMPLEXES OF PORCINE LIVER FRUCTOSE-1,6-BISPHOSPHATASE WITH BLOCKED SUBUNIT PAIR ROTATION	3.1.3.11
4GWZ	CRYSTAL STRUCTURE OF AMP COMPLEXES OF PORCINE LIVER FRUCTOSE-1,6-BISPHOSPHATASE WITH RESTRAINED SUBUNIT PAIR ROTATION	3.1.3.11
4GX3	PRODUCT COMPLEXES OF PORCINE LIVER FRUCTOSE-1,6-BISPHOSPHATASE WITH MUTATION R22M REVEAL A T-STATE CONFORMATION	3.1.3.11
4GX4	AMP COMPLEXES OF PORCINE LIVER FRUCTOSE-1,6-BISPHOSPHATASE WITH MUTATION R22M	3.1.3.11
4GX6	AMP COMPLEXES OF PORCINE LIVER FRUCTOSE-1,6-BISPHOSPHATASE WITH MUTATION E192Q	3.1.3.11
4GXH	CRYSTAL STRUCTURE OF A PYRROLIDONE-CARBOXYLATE PEPTIDASE 1 (TARGET ID NYSGRC-012831) FROM XENORHABDUS BOVIENII SS-2004	3.4.19.3
4GXN	DIETHYLPHOSPHONATE INHIBITED STRUCTURE OF THE PROTEUS MIRABILIS LIPASE	3.1.1.3
4GXP	CHIMERIC FAMILY 1 BETA-GLUCOSIDASE MADE WITH NON-CONTIGUOUS SCHEMA	3.2.1.21
4GXW	CRYSTAL STRUCTURE OF A COG1816 AMIDOHYDROLASE (TARGET EFI-505188) FROM BURKHODERIA AMBIFARIA, WITH BOUND ZN	3.5.4.4
4GY0	ROUND 18 ARYLESTERASE VARIANT OF PHOSPHOTRIESTERASE	3.1.8.1
4GY1	ROUND 18 ARYLESTERASE VARIANT OF PHOSPHOTRIESTERASE WITH BOUND CACODYLATE	3.1.8.1
4GY7	CRYSTALLOGRAPHIC STRUCTURE ANALYSIS OF UREASE FROM JACK BEAN (CANAVALIA ENSIFORMIS) AT 1.49 A RESOLUTION	3.5.1.5
4GYE	MDR 769 HIV-1 PROTEASE IN COMPLEX WITH REDUCED P1F	3.4.23.16
4GYF	CRYSTAL STRUCTURE OF HISTIDINOL PHOSPHATE PHOSPHATASE (HISK) FROM LACTOCOCCUS LACTIS SUBSP. LACTIS IL1403 COMPLEXED WITH ZN, L-HISTIDINOL AND PHOSPHATE	3.1.3.15
4GYJ	CRYSTAL STRUCTURE OF MUTANT (D318N) BACILLUS SUBTILIS FAMILY 3 GLYCOSIDE HYDROLASE (NAGZ) IN COMPLEX WITH GLCNAC-MURNAC (SPACE GROUP P1)	3.2.1.52
4GYK	CRYSTAL STRUCTURE OF MUTANT (D318N) BACILLUS SUBTILIS FAMILY 3 GLYCOSIDE HYDROLASE (NAGZ) IN COMPLEX WITH GLCNAC-MURNAC (SPACE GROUP P1211)	3.2.1.52
4GYL	THE E142L MUTANT OF THE AMIDASE FROM GEOBACILLUS PALLIDUS SHOWING THE RESULT OF MICHAEL ADDITION OF ACRYLAMIDE AT THE ACTIVE SITE CYSTEINE	3.5.1.4
4GYN	THE E142L MUTANT OF THE AMIDASE FROM GEOBACILLUS PALLIDUS	3.5.1.4
4GYO	CRYSTAL STRUCTURE OF RAP PROTEIN COMPLEXED WITH COMPETENCE AND SPORULATION FACTOR	3.1
4GYQ	CRYSTAL STRUCTURE OF NEW DELHI METALLO-BETA-LACTAMASE-1 D223A MUTANT FROM KLEBSIELLA PNEUMONIAE	3.5.2.6
4GYR	GRANULIBACTER BETHESDENSIS ALLOPHANATE HYDROLASE APO	3.5.1.54
4GYS	GRANULIBACTER BETHESDENSIS ALLOPHANATE HYDROLASE CO-CRYSTALLIZED WITH MALONATE	3.5.1.54
4GYU	CRYSTAL STRUCTURE OF NEW DELHI METALLO-BETA-LACTAMASE-1 A121F MUTANT FROM KLEBSIELLA PNEUMONIAE	3.5.2.6
4GYZ	MUS MUSCULUS TDP2 BOUND TO DAMP AND MG2+	3.1.4
4GZ0	MUS MUSCULUS TDP2-DNA SUBSTRATE ANALOG (5'-6-AMINOHEXANOL) COMPLEX	3.1.4
4GZ1	MUS MUSCULUS TDP2 REACTION PRODUCT (5'-PHOSPHORYLATED DNA)-MG2+ COMPLEX AT 1.5 ANGSTROMS RESOLUTION	3.1.4
4GZ2	MUS MUSCULUS TDP2 EXCLUDED SSDNA COMPLEX	3.1.4
4GZB	CRYSTAL STRUCTURE OF NATIVE AMPC BETA-LACTAMASE FROM PSEUDOMONAS AERUGINOSA PAO1	3.5.2.6
4GZF	MULTI-DRUG RESISTANT HIV-1 PROTEASE 769 VARIANT WITH REDUCED LRF PEPTIDE	3.4.23.16
4GZI	ACTIVE-SITE MUTANT OF POTATO ENDO-1,3-BETA-GLUCANASE IN COMPLEX WITH LAMINARATRIOSE	3.2.1.39
4GZJ	ACTIVE-SITE MUTANT OF POTATO ENDO-1,3-BETA-GLUCANASE IN COMPLEX WITH LAMINARATRIOSE AND LAMINARATETROSE	3.2.1.39
4GZL	CRYSTAL STRUCTURE OF RAC1 Q61L MUTANT	3.6.5.2
4GZM	CRYSTAL STRUCTURE OF RAC1 F28L MUTANT	3.6.5.2
4GZO	N2 NEURAMINIDASE OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH HEPES	3.2.1.18
4GZP	N2 NEURAMINIDASE OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH OSELTAMIVIR CARBOXYLATE	3.2.1.18
4GZQ	N2 NEURAMINIDASE OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH SIALIC ACID	3.2.1.18
4GZS	N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH HEPES	3.2.1.18
4GZT	N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH OSELTAMIVIR CARBOXYLATE	3.2.1.18
4GZW	N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH AVIAN SIALIC ACID RECEPTOR	3.2.1.18
4GZX	N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH HUMAN SIALIC ACID RECEPTOR	3.2.1.18
4H04	LACTO-N-BIOSIDASE FROM BIFIDOBACTERIUM BIFIDUM	3.2.1.140 3.2.1.52
4H0D	NEW DELHI METALLO-BETA-LACTAMASE-1 COMPLEXED WITH MN FROM KLEBSIELLA PNEUMONIAE	3.5.2.6
4H0S	CRYSTAL STRUCTURE ANALYSIS OF A BASIC PHOSPHOLIPASE A2 FROM TRIMERESURUS STEJNEGERI VENOM	3.1.1.4
4H0Z	CRYSTAL STRUCTURE OF THE COMPLEX OF RIBOSOME INACTIVATING PROTEIN FROM MOMORDICA BALSAMINA WITH N-ACETYL MURAMIC ACID AT 2.0 ANGSTROM RESOLUTION	3.2.2.22
4H1D	COCRYSTAL STRUCTURE OF GLPG AND DFP	3.4.21.105
4H1E	STRUCTURE OF BACE-1 BOUND TO (7AR)-6-BENZOYL-7A-(4-(3-CYANOPHENYL)THIOPHEN-2-YL)-3-METHYL-4-OXOHEXAHYDRO-1H-PYRROLO[3,4-D]PYRIMIDIN-2(3H)-IMINIUM	3.4.23.46
4H1O	CRYSTAL STRUCTURE OF THE TYROSINE PHOSPHATASE SHP-2 WITH D61G MUTATION	3.1.3.48
4H1P	USE OF EUROPIUM FOR SAD PHASING AT THE CU K ALPHA WAVELENGTH	3.2.1.17
4H1Q	CRYSTAL STRUCTURE OF MUTANT MMP-9 CATALYTIC DOMAIN IN COMPLEX WITH A TWIN INHIBITOR.	3.4.24.35
4H1U	NUCLEOTIDE-FREE HUMAN DYNAMIN-1-LIKE PROTEIN GTPASE-GED FUSION	3.6.5.5
4H1V	GMP-PNP BOUND DYNAMIN-1-LIKE PROTEIN GTPASE-GED FUSION	3.6.5.5
4H1W	E1 STRUCTURE OF THE (SR) CA2+-ATPASE IN COMPLEX WITH SARCOLIPIN	3.6.3.8 7.2.2.10
4H1Y	HUMAN ECTO-5'-NUCLEOTIDASE (CD73): CRYSTAL FORM II (OPEN) IN COMPLEX WITH PSB11552	3.1.3.5
4H2B	HUMAN ECTO-5'-NUCLEOTIDASE (CD73): CRYSTAL FORM II (OPEN) IN COMPLEX WITH BAICALIN	3.1.3.5
4H2E	CRYSTAL STRUCTURE OF AN MMP TWIN INHIBITOR COMPLEXING TWO MMP-9 CATALYTIC DOMAINS	3.4.24.35
4H2F	HUMAN ECTO-5'-NUCLEOTIDASE (CD73): CRYSTAL FORM I (OPEN) IN COMPLEX WITH ADENOSINE	3.1.3.5
4H2G	HUMAN ECTO-5'-NUCLEOTIDASE (CD73): CRYSTAL FORM II (OPEN) IN COMPLEX WITH ADENOSINE	3.1.3.5
4H2I	HUMAN ECTO-5'-NUCLEOTIDASE (CD73): CRYSTAL FORM III (CLOSED) IN COMPLEX WITH AMPCP	3.1.3.5
4H2K	CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF SUCCINYL-DIAMINOPIMELATE DESUCCINYLASE FROM HAEMOPHILUS INFLUENZAE	3.5.1.18
4H30	CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-12 IN COMPLEX WITH A TWIN INHIBITOR.	3.4.24.65
4H34	CRYSTAL STRUCTURE OF THE TYROSINE PHOSPHATASE SHP-2 WITH Q506P MUTATION	3.1.3.48
4H35	FERULOYL ESTERASE DOMAIN OF XYNY FROM CLOSTRIDIUM THERMOCELLUM BEFORE EXPOSURE TO 266NM UV LASER	3.2.1.8
4H3F	STRUCTURE OF BACE BOUND TO 3-(5-((7AR)-2-IMINO-6-(6-METHOXYPYRIDIN-2-YL)-3-METHYL-4-OXOOCTAHYDRO-1H-PYRROLO[3,4-D]PYRIMIDIN-7A-YL)THIOPHEN-3-YL)BENZONITRILE	3.4.23.46
4H3G	STRUCTURE OF BACE BOUND TO 2-((7AR)-7A-(4-(3-CYANOPHENYL)THIOPHEN-2-YL)-2-IMINO-3-METHYL-4-OXOHEXAHYDRO-1H-PYRROLO[3,4-D]PYRIMIDIN-6(2H)-YL)NICOTINONITRILE	3.4.23.46
4H3I	STRUCTURE OF BACE BOUND TO 3-(5-((7AR)-2-IMINO-6-(3-METHOXYPYRIDIN-2-YL)-3-METHYL-4-OXOOCTAHYDRO-1H-PYRROLO[3,4-D]PYRIMIDIN-7A-YL)THIOPHEN-3-YL)BENZONITRILE	3.4.23.46
4H3J	STRUCTURE OF BACE BOUND TO 2-FLUORO-5-(5-(2-IMINO-3-METHYL-4-OXO-6-PHENYLOCTAHYDRO-1H-PYRROLO[3,4-D]PYRIMIDIN-7A-YL)THIOPHEN-2-YL)BENZONITRILE	3.4.23.46
4H3X	CRYSTAL STRUCTURE OF AN MMP BROAD SPECTRUM HYDROXAMATE BASED INHIBITOR CC27 IN COMPLEX WITH THE MMP-9 CATALYTIC DOMAIN	3.4.24.35
4H42	SYNTHESIS OF A WEAK BASIC UPA INHIBITOR AND CRYSTAL STRUCTURE OF COMPLEX WITH UPA	3.4.21.73
4H45	PRODUCT COMPLEXES OF PORCINE LIVER FRUCTOSE-1,6-BISPHOSPHATASE WITH MUTATION E192Q	3.1.3.11
4H46	CRYSTAL STRUCTURE OF AMP COMPLEXES OF NEM MODIFIED PORCINE LIVER FRUCTOSE-1,6-BISPHOSPHATASE	3.1.3.11
4H49	CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-12 IN COMPLEX WITH A TWIN INHIBITOR.	3.4.24.65
4H4A	CRYSTAL STRUCTURE OF THE C-TERMINAL DOMAIN OF DROSOPHILA MELANOGASTER ZUCCHINI	3.1.4
4H4B	HUMAN CYTOSOLIC 5'-NUCLEOTIDASE II IN COMPLEX WITH ANTHRAQUINONE-2,6- DISULFONIC ACID	3.1.3.5
4H4F	CRYSTAL STRUCTURE OF HUMAN CHYMOTRYPSIN C (CTRC) BOUND TO INHIBITOR EGLIN C FROM HIRUDO MEDICINALIS	3.4.21.2
4H4M	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH (E)-3-(3-CHLORO-5-(4-CHLORO-2-(2-(2,4-DIOXO-3,4- DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)PHENOXY)PHENYL)ACRYLONITRILE (JLJ494), A NON-NUCLEOSIDE INHIBITOR	2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 3.4.23.16 2.7.7 3.1
4H4O	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH (E)-3-(3-(2-(2-(2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)- 4-FLUOROPHENOXY)-5-FLUOROPHENYL)ACRYLONITRILE (JLJ506), A NON-NUCLEOSIDE INHIBITOR	2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 3.4.23.16 2.7.7 3.1
4H52	WILD-TYPE INFLUENZA N2 NEURAMINIDASE COVALENT COMPLEX WITH 3-FLUORO-NEU5AC	3.2.1.18
4H53	INFLUENZA N2-TYR406ASP NEURAMINIDASE IN COMPLEX WITH BETA-NEU5AC	3.2.1.18
4H57	THERMOLYSIN INHIBITION	3.4.24.27
4H5U	STRUCTURAL INSIGHTS INTO YEAST NIT2: WILD-TYPE YEAST NIT2	3.5 3.5.1.128
4H6S	CRYSTAL STRUCTURE OF THROMBIN MUTANT E14EA/D14LA/E18A/S195A	3.4.21.5
4H6T	CRYSTAL STRUCTURE OF PRETHROMBIN-2 MUTANT E14EA/D14LA/E18A/S195A	3.4.21.5
4H76	CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MMP12 IN COMPLEX WITH A BROAD SPECTRUM HYDROXAMATE INHIBITOR	3.4.24.65
4H77	CRYSTAL STRUCTURE OF HALOALKANE DEHALOGENASE LINB FROM SPHINGOBIUM SP. MI1205	3.8.1.5
4H7B	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE MUTANT I72V/V99L	3.1.31.1
4H7D	CRYSTAL STRUCTURE OF HALOALKANE DEHALOGENASE LINB T81A MUTANT FROM SPHINGOBIUM SP. MI1205	3.8.1.5
4H7E	CRYSTAL STRUCTURE OF HALOALKANE DEHALOGENASE LINB V112A MUTANT FROM SPHINGOBIUM SP. MI1205	3.8.1.5
4H7F	CRYSTAL STRUCTURE OF HALOALKANE DEHALOGENASE LINB V134I MUTANT FROM SPHINGOBIUM SP. MI1205	3.8.1.5
4H7H	CRYSTAL STRUCTURE OF HALOALKANE DEHALOGENASE LINB T135A MUTANT FROM SPHINGOBIUM SP. MI1205	3.8.1.5
4H7I	CRYSTAL STRUCTURE OF HALOALKANE DEHALOGENASE LINB L138I MUTANT FROM SPHINGOBIUM SP. MI1205	3.8.1.5
4H7J	CRYSTAL STRUCTURE OF HALOALKANE DEHALOGENASE LINB H247A MUTANT FROM SPHINGOBIUM SP. MI1205	3.8.1.5
4H7K	CRYSTAL STRUCTURE OF HALOALKANE DEHALOGENASE LINB I253M MUTANT FROM SPHINGOBIUM SP. MI1205	3.8.1.5
4H7M	THE X-RAY CRYSTAL STRUCTURE OF THE TRICHODERMA HARZIANUM ENDOGLUCANASE 3 FROM FAMILY GH12	3.2.1.4
4H7W	CRYSTAL STRUCTURE OF HUMAN C16ORF57	3.1.4
4H82	CRYSTAL STRUCTURE OF MUTANT MMP-9 CATALYTIC DOMAIN IN COMPLEX WITH A TWIN INHIBITOR.	3.4.24.35
4H84	CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MMP12 IN COMPLEX WITH A SELECTIVE CARBOXYLATE BASED INHIBITOR.	3.4.24.65
4H8K	CRYSTAL STRUCTURE OF LC11-RNASE H1 IN COMPLEX WITH RNA/DNA HYBRID	3.1.26.4
4H8R	IMIPENEM COMPLEX OF GES-5 CARBAPENEMASE	3.5.2.6
4H8X	RADIATION DAMAGE STUDY OF LYSOZYME - 0.07 MGY	3.2.1.17
4H8Y	RADIATION DAMAGE STUDY OF LYSOZYME- 0.14 MGY	3.2.1.17
4H8Z	RADIATION DAMAGE STUDY OF LYSOZYME - 0.21 MGY	3.2.1.17
4H90	RADIATION DAMAGE STUDY OF LYSOZYME - 0.28 MGY	3.2.1.17
4H91	RADIATION DAMAGE STUDY OF LYSOZYME - 0.35 MGY	3.2.1.17
4H92	RADIATION DAMAGE STUDY OF LYSOZYME- 0.42 MGY	3.2.1.17
4H93	RADIATION DAMAGE STUDY OF LYSOZYME - 0.49 MGY	3.2.1.17
4H94	RADIATION DAMAGE IN LYSOZYME - 0.56 MGY	3.2.1.17
4H9A	RADIATION DAMAGE STUDY OF LYSOZYME - 0.63 MGY	3.2.1.17
4H9B	RADIATION DAMAGE STUDY OF LYSOZYME - 0.70 MGY	3.2.1.17
4H9C	RADIATION DAMAGE STUDY OF LYSOZYME - 0.77 MGY	3.2.1.17
4H9E	RADIATION DAMAGE STUDY OF LYSOZYME - 0.84 MGY	3.2.1.17
4H9F	RADIATION DAMAGE STUDY OF LYSOZYME - 0.91 MGY	3.2.1.17
4H9G	PROBING EF-TU WITH A VERY SMALL BROMINATED FRAGMENT LIBRARY IDENTIFIES THE CCA POCKET	3.6.5.3
4H9H	RADIATION DAMAGE STUDY OF LYSOZYME - 0.98 MGY	3.2.1.17
4H9I	RADIATION DAMAGE STUDY OF LYSOZYME - 1.05 MGY	3.2.1.17
4H9J	CRYSTAL STRUCTURE OF N-TERMINAL PROTEASE (NPRO) OF CLASSICAL SWINE FEVER VIRUS.	2.7.7.48 3.4.21.113 3.6.1.15 3.6.4.13
4H9K	CRYSTAL STRUCTURE OF CLEAVAGE SITE MUTANT OF NPRO OF CLASSICAL SWINE FEVER VIRUS.	2.7.7.48 3.4.21.113 3.6.1.15 3.6.4.13
4H9M	THE FIRST JACK BEAN UREASE (CANAVALIA ENSIFORMIS) COMPLEX OBTAINED AT 1.52 RESOLUTION	3.5.1.5
4H9T	STRUCTURE OF GEOBACILLUS KAUSTOPHILUS LACTONASE, MUTANT E101N WITH BOUND N-BUTYRYL-DL-HOMOSERINE LACTONE	3.5
4H9U	STRUCTURE OF GEOBACILLUS KAUSTOPHILUS LACTONASE, WILD-TYPE WITH ZN2+	3.5
4H9V	STRUCTURE OF GEOBACILLUS KAUSTOPHILUS LACTONASE, MUTANT E101G/R230C WITH ZN2+	3.5
4H9X	STRUCTURE OF GEOBACILLUS KAUSTOPHILUS LACTONASE, MUTANT E101G/R230C/D266N WITH ZN2+ AND BOUND N-BUTYRYL-DL-HOMOSERINE LACTONE	3.5
4H9Y	STRUCTURE OF GEOBACILLUS KAUSTOPHILUS LACTONASE, MUTANT E101N WITH ZN2+	3.5
4H9Z	STRUCTURE OF GEOBACILLUS KAUSTOPHILUS LACTONASE, MUTANT E101N WITH MN2+	3.5
4HA0	STRUCTURE OF GEOBACILLUS KAUSTOPHILUS LACTONASE, MUTANT R230D WITH ZN2+	3.5
4HA3	STRUCTURE OF BETA-GLYCOSIDASE FROM ACIDILOBUS SACCHAROVORANS IN COMPLEX WITH TRIS	3.2.1.23
4HA4	STRUCTURE OF BETA-GLYCOSIDASE FROM ACIDILOBUS SACCHAROVORANS IN COMPLEX WITH GLYCEROL	3.2.1.23
4HA5	STRUCTURE OF BACE BOUND TO (S)-3-(5-(2-IMINO-1,4-DIMETHYL-6-OXOHEXAHYDROPYRIMIDIN-4-YL)THIOPHEN-3-YL)BENZONITRILE	3.4.23.46
4HAA	STRUCTURE OF RIBONUCLEASE BINASE GLU43ALA/PHE81ALA MUTANT	3.1.27
4HAI	CRYSTAL STRUCTURE OF HUMAN SOLUBLE EPOXIDE HYDROLASE COMPLEXED WITH N-CYCLOHEPTYL-1-(MESITYLSULFONYL)PIPERIDINE-4-CARBOXAMIDE.	3.3.2.10 3.1.3.76
4HAP	CRYSTAL STRUCTURE OF A GH7 FAMILY CELLOBIOHYDROLASE FROM LIMNORIA QUADRIPUNCTATA IN COMPLEX WITH CELLOBIOSE	3.2.1.91
4HAQ	CRYSTAL STRUCTURE OF A GH7 FAMILY CELLOBIOHYDROLASE FROM LIMNORIA QUADRIPUNCTATA IN COMPLEX WITH CELLOBIOSE AND CELLOTRIOSE	3.2.1.91
4HBT	CRYSTAL STRUCTURE OF NATIVE CTX-M-15 EXTENDED-SPECTRUM BETA-LACTAMASE	3.5.2.6
4HBU	CRYSTAL STRUCTURE OF CTX-M-15 EXTENDED-SPECTRUM BETA-LACTAMASE IN COMPLEX WITH AVIBACTAM (NXL104)	3.5.2.6
4HCB	THE METAL-FREE FORM OF CRYSTAL STRUCTURE OF E.COLI EXOI-SSDNA COMPLEX	3.1.11.1
4HCC	THE ZINC ION BOUND FORM OF CRYSTAL STRUCTURE OF E.COLI EXOI-SSDNA COMPLEX	3.1.11.1
4HD0	MRE11 ATLD17/18 MUTATION RETAINS TEL1/ATM ACTIVITY BUT BLOCKS DNA DOUBLE-STRAND BREAK REPAIR	3.1
4HD8	CRYSTAL STRUCTURE OF HUMAN SIRT3 IN COMPLEX WITH FLUOR-DE-LYS PEPTIDE AND PICEATANNOL	3.5.1 2.3.1.286
4HDA	CRYSTAL STRUCTURE OF HUMAN SIRT5 IN COMPLEX WITH FLUOR-DE-LYS PEPTIDE AND RESVERATROL	3.5.1 2.3.1
4HDB	CRYSTAL STRUCTURE OF HIV-1 PROTEASE MUTANTS D30N COMPLEXED WITH INHIBITOR GRL-0519	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
4HDD	DOMAIN SWAPPING IN THE CYTOPLASMIC DOMAIN OF THE ESCHERICHIA COLI RHOMBOID PROTEASE	3.4.21.105
4HDF	CRYSTAL STRUCTURE OF HIV-1 PROTEASE MUTANTS V82A COMPLEXED WITH INHIBITOR GRL-0519	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
4HDG	CRYSTAL STRUCTURE OF VIRAL RDRP IN COMPLEX WITH GTP	2.7.7.48 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57
4HDH	CRYSTAL STRUCTURE OF VIRAL RDRP IN COMPLEX WITH ATP	2.7.7.48 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57
4HDP	CRYSTAL STRUCTURE OF HIV-1 PROTEASE MUTANTS I50V COMPLEXED WITH INHIBITOR GRL-0519	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
4HE0	CRYSTAL STRUCTURE OF HUMAN MUSCLE FRUCTOSE-1,6-BISPHOSPHATASE	3.1.3.11
4HE1	CRYSTAL STRUCTURE OF HUMAN MUSCLE FRUCTOSE-1,6-BISPHOSPHATASE Q32R MUTANT COMPLEX WITH FRUCTOSE-6-PHOSPHATE AND PHOSPHATE	3.1.3.11
4HE2	CRYSTAL STRUCTURE OF HUMAN MUSCLE FRUCTOSE-1,6-BISPHOSPHATASE Q32R MUTANT COMPLEX WITH AMP	3.1.3.11
4HE9	CRYSTAL STRUCTURE OF HIV-1 PROTEASE MUTANTS I54M COMPLEXED WITH INHIBITOR GRL-0519	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
4HEB	THE CRYSTAL STRUCTURE OF MAF PROTEIN OF BACILLUS SUBTILIS	3.6.1.9
4HEC	CRYSTAL STRUCTURE OF A PUTATIVE UNCHARACTERIZED PROTEIN FROM MYCOBACTERIUM TUBERCULOSIS	3.1.13
4HEF	STRUCTURE OF AVIBACTAM BOUND TO PSEUDOMONAS AERUGINOSA AMPC	3.5.2.6
4HEG	CRYSTAL STRUCTURE OF HIV-1 PROTEASE MUTANTS R8Q COMPLEXED WITH INHIBITOR GRL-0519	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
4HEU	CRYSTAL STRUCTURE OF PDE10A WITH A BIARYL ETHER INHIBITOR ((1-(3-(4-((1H-BENZO[D]IMIDAZOL-2-YL)AMINO)PHENOXY)PYRIDIN-2-YL)PIPERIDIN-4-YL)METHANOL)	3.1.4.35 3.1.4.17
4HEV	CLOSTRIDIUM BOTULINUM SEROTYPE A LIGHT CHAIN INHIBITED BY ADAMANTANE HYDROXAMATE	3.4.24.69
4HF4	CRYSTAL STRUCTURE OF PDE10A WITH A BIARYL ETHER INHIBITOR (1-(1-(3-(4-(BENZO[D]THIAZOL-2-YLAMINO)PHENOXY)PYRAZIN-2-YL)PIPERIDIN-4-YL)ETHANOL)	3.1.4.17 3.1.4.35
4HFP	STRUCTURE OF THROMBIN MUTANT S195A BOUND TO THE ACTIVE SITE INHIBITOR ARGATROBAN	3.4.21.5
4HG3	STRUCTURAL INSIGHTS INTO YEAST NIT2: WILD-TYPE YEAST NIT2 IN COMPLEX WITH ALPHA-KETOGLUTARATE	3.5 3.5.1.128
4HG5	STRUCTURAL INSIGHTS INTO YEAST NIT2: WILD-TYPE YEAST NIT2 IN COMPLEX WITH OXALOACETATE	3.5 3.5.1.128
4HG9	CRYSTAL STRUCTURE OF AHV_BPA, A BASIC PLA2 FROM AGKISTRODON HALYS PALLAS VENOM	3.1.1.4
4HGC	CRYSTAL STRUCTURE OF BOVINE TRYPSIN COMPLEXED WITH SFTI-1 ANALOG CONTAINING A PEPTOID RESIDUE AT POSITION P1	3.4.21.4
4HGD	STRUCTURAL INSIGHTS INTO YEAST NIT2: C169S MUTANT OF YEAST NIT2 IN COMPLEX WITH AN ENDOGENOUS PEPTIDE-LIKE LIGAND	3.5 3.5.1.128
4HGN	CRYSTAL STRUCTURE OF 2-KETO-3-DEOXYOCTULOSONATE 8-PHOSPHATE PHOSPHOHYDROLASE FROM BACTEROIDES THETAIOTAOMICRON	3.1.3.45
4HGO	2-KETO-3-DEOXY-D-GLYCERO-D-GALACTONONONATE-9-PHOSPHATE PHOSPHOHYDROLASE FROM BACTEROIDES THETAIOTAOMICRON IN COMPLEX WITH TRANSITION STATE MIMIC	3.1.3.103
4HGP	CRYSTAL STRUCTURE OF 2-KETO-3-DEOXYOCTULOSONATE 8-PHOSPHATE PHOSPHOHYDROLASE FROM HAEMOPHILUS INFLUENZAE IN COMPLEX WITH TRANSITION STATE MIMIC	3.1.3.45
4HGQ	CRYSTAL STRUCTURE OF E56A MUTANT OF 2-KETO-3-DEOXY-D-GLYCERO-D-GALACTONONONATE-9-PHOSPHATE PHOSPHOHYDROLASE FROM BACTEROIDES THETAIOTAOMICRON	3.1.3.103
4HGR	CRYSTAL STRUCTURE OF E56A/K67A MUTANT OF 2-KETO-3-DEOXY-D-GLYCERO-D-GALACTONONONATE-9-PHOSPHATE PHOSPHOHYDROLASE FROM BACTEROIDES THETAIOTAOMICRON	3.1.3.103
4HHJ	DENGUE SEROTYPE 3 RNA-DEPENDENT RNA POLYMERASE	2.7.7.48 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57
4HHO	SERUM PARAOXONASE-1 BY DIRECTED EVOLUTION WITH THE H115W MUTATION	3.1.1.2 3.1.8.1 3.1.1.25
4HHQ	SERUM PARAOXONASE-1 BY DIRECTED EVOLUTION WITH THE H115Q AND H134Q MUTATIONS	3.1.1.2 3.1.8.1 3.1.1.25
4HHT	T. MARITIMA RNASE H2 G21S IN COMPLEX WITH NUCLEIC ACID SUBSTRATE AND CALCIUM IONS	3.1.26.4
4HI1	CRYSTAL STRUCTURE OF ACYLPHOSPHATASE C20R MUTANT FROM VIBRIO CHOLERAE0395	3.6.1.7
4HI2	CRYSTAL STRUCTURE OF AN ACYLPHOSPHATASE PROTEIN CAGE	3.6.1.7
4HI3	CRYSTAL STRUCTURE OF DIMERIC R298A MUTANT OF SARS CORONAVIRUS MAIN PROTEASE	3.4.22 3.4.19.12 3.4.22.69
4HIZ	PHAGE PHI92 ENDOSIALIDASE	3.2.1.129
4HJP	SHP-1 CATALYTIC DOMAIN WPD LOOP OPEN	3.1.3.48
4HJQ	SHP-1 CATALYTIC DOMAIN WPD LOOP CLOSED	3.1.3.48
4HK8	CRYSTAL STRUCTURES OF MUTANT ENDO- -1,4-XYLANASE II COMPLEXED WITH SUBSTRATE (1.15 A) AND PRODUCTS (1.6 A)	3.2.1.8
4HK9	CRYSTAL STRUCTURES OF MUTANT ENDO-BETA-1,4-XYLANASE II COMPLEXED WITH SUBSTRATE (1.15 A) AND PRODUCTS (1.6 A)	3.2.1.8
4HKE	CRYSTAL STRUCTURE OF MOXT OF BACILLUS ANTHRACIS	3.1
4HKL	CRYSTAL STRUCTURES OF MUTANT ENDO-BETA-1,4-XYLANASE II COMPLEXED WITH SUBSTRATE (1.15 A) AND PRODUCTS (1.6 A)	3.2.1.8
4HKO	CRYSTAL STRUCTURES OF MUTANT ENDO-BETA-1,4-XYLANASE II (E177Q) IN THE APO FORM	3.2.1.8
4HKQ	XMRV REVERSE TRANSCRIPTASE IN COMPLEX WITH RNA/DNA HYBRID	2.7.7.49 2.7.7.7 3.1.26.4 3.4.23 2.7.7 3.1
4HKW	CRYSTAL STRUCTURES OF MUTANT ENDO-BETA-1,4-XYLANASE II COMPLEXED WITH SUBSTRATE AND PRODUCTS	3.2.1.8
4HKY	NEW DELHI METALLO-BETA-LACTAMASE-1, COMPLEXED WITH CD AND FAROPENEM	3.5.2.6
4HL1	CRYSTAL STRUCTURE OF NEW DELHI METALLO-BETA-LACTAMASE-1, COMPLEXED WITH CD AND AMPICILLIN	3.5.2.6
4HL2	NEW DELHI METALLO-BETA-LACTAMASE-1 1.05 A STRUCTURE COMPLEXED WITH HYDROLYZED AMPICILLIN	3.5.2.6
4HLA	CRYSTAL STRUCTURE OF WILD TYPE HIV-1 PROTEASE IN COMPLEX WITH DARUNAVIR	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
4HLU	STRUCTURE OF THE ECFA-A' HETERODIMER BOUND TO ADP	3.6.3 7
4HMA	CRYSTAL STRUCTURE OF AN MMP TWIN CARBOXYLATE BASED INHIBITOR LC20 IN COMPLEX WITH THE MMP-9 CATALYTIC DOMAIN	3.4.24.35
4HMB	CRYSTAL STRUCTURE OF THE COMPLEX OF GROUP II PHOSPHOLIPASE A2 WITH A 3-{3-[(DIMETHYLAMINO)METHYL]-1H-INDOL-7-YL}PROPAN-1-OL AT 2.21 A RESOLUTION	3.1.1.4
4HMC	CRYSTAL STRUCTURE OF COLD-ADAPTED CHITINASE FROM MORITELLA MARINA	3.2.1.14
4HMD	CRYSTAL STRUCTURE OF COLD-ADAPTED CHITINASE FROM MORITELLA MARINA WITH A REACTION INTERMEDIATE - OXAZOLINIUM ION (NGO)	3.2.1.14
4HME	CRYSTAL STRUCTURE OF COLD-ADAPTED CHITINASE FROM MORITELLA MARINA WITH A REACTION PRODUCT - NAG2	3.2.1.14
4HMI	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS V99K AT CRYOGENIC TEMPERATURE	3.1.31.1
4HMJ	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS L36D AT CRYOGENIC TEMPERATURE	3.1.31.1
4HNO	HIGH RESOLUTION CRYSTAL STRUCTURE OF DNA APURINIC/APYRIMIDINIC (AP) ENDONUCLEASE IV NFO FROM THERMATOGA MARITIMA	3.1.21.2
4HNZ	CRYSTAL STRUCTURE OF EUKARYOTIC HSLV FROM TRYPANOSOMA BRUCEI	3.4.25 3.4.25.2
4HO7	CRYSTAL STRUCTURE OF EUKARYOTIC HSLV FROM TRYPANOSOMA BRUCEI	3.4.25 3.4.25.2
4HOA	CRYSTAL STRUCTURE OF THE COMPLEX OF TYPE 1 RIBOSOME INACTIVATING PROTEIN FROM MOMORDICA BALSAMINA WITH B-D-GALACTOPYRANOSYL-(1-4)-D-GLUCOSE AT 2.0 A RESOLUTION	3.2.2.22
4HOH	RIBONUCLEASE T1 (THR93ALA MUTANT) COMPLEXED WITH 2'GMP	3.1.27.3 4.6.1.24
4HOM	CRYSTAL STRUCTURE OF PORCINE AMINOPEPTIDASE-N COMPLEXED WITH SUBSTANCE P	3.4.11.2
4HOY	CRYSTAL STRUCTURE OF PEPTIDYL- TRNA HYDROLASE FROM ACINETOBACTER BAUMANNII AT 1.78 A RESOLUTION	3.1.1.29
4HP0	CRYSTAL STRUCTURE OF HEN EGG WHITE LYSOZYME IN COMPLEX WITH GN3-M	3.2.1.17
4HPG	CRYSTAL STRUCTURE OF A GLYCOSYLATED BETA-1,3-GLUCANASE (HEV B 2), AN ALLERGEN FROM HEVEA BRASILIENSIS	3.2.1.39
4HPI	CRYSTAL STRUCTURE OF HEN EGG WHITE LYSOZYME COMPLEX WITH GN2-M	3.2.1.17
4HPK	CRYSTAL STRUCTURE OF CLOSTRIDIUM HISTOLYTICUM COLG COLLAGENASE COLLAGEN-BINDING DOMAIN 3B AT 1.35 ANGSTROM RESOLUTION IN PRESENCE OF CALCIUM NITRATE	3.4.24.3
4HPS	CRYSTAL STRUCTURE OF A PYRROLIDONE-CARBOXYLATE PEPTIDASE 1 (TARGET ID NYSGRC-012831) FROM XENORHABDUS BOVIENII SS-2004 IN SPACE GROUP P21	3.4.19.3
4HQ0	CRYSTAL STRUCTURE OF MUTANT FORM OF CASPASE-7	3.4.22.60
4HQR	CRYSTAL STRUCTURE OF MUTANT FORM OF CASPASE-7	3.4.22.60
4HRF	ATOMIC STRUCTURE OF DUSP26	3.1.3.16 3.1.3.48
4HRI	CRYSTAL STRUCTURE OF HETR IN COMPLEX WITH A 21-BP PALINDROMIC DNA AT THE UPSTREAM OF THE HETP PROMOTER FROM ANABAENA	3.4.21
4HS9	METHANOL TOLERANT MUTANT OF THE PROTEUS MIRABILIS LIPASE	3.1.1.3
4HSB	S. POMBE 3-METHYLADENINE DNA GLYCOSYLASE-LIKE PROTEIN MAG2 BOUND TO DAMAGED DNA	3.2.2.21
4HSC	CRYSTAL STRUCTURE OF A CHOLESTEROL DEPENDENT CYTOLYSIN	3.2.2.5
4HSF	LYSOZYME WITH ARGININE AT 318K	3.2.1.17
4HTC	THE REFINED STRUCTURE OF THE HIRUDIN-THROMBIN COMPLEX	3.4.21.5
4HTH	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+VIAGLA AT CRYOGENIC TEMPERATURE	3.1.31.1
4HTI	CRYSTALLOGRAPHIC STRUCTURE OF THE MEMBRANE-PROXIMAL ECTODOMAIN OF THE HUMAN RECEPTOR-TYPE PROTEIN-TYROSINE PHOSPHATASE PHOGRIN	3.1.3.48 3.1.3
4HTJ	CRYSTALLOGRAPHIC STRUCTURE OF THE MEMBRANE-PROXIMAL ECTODOMAIN OF THE HUMAN RECEPTOR-TYPE PROTEIN-TYROSINE PHOSPHATASE PHOGRIN AT PH 4.6	3.1.3.48 3.1.3
4HTK	MITIGATION OF X-RAY DAMAGE IN MACROMOLECULAR CRYSTALLOGRAPHY BY SUBMICROMETER LINE FOCUSING; TOTAL DOSE 2.17 X 10E+12 X-RAY PHOTONS	3.2.1.17
4HTN	MITIGATION OF X-RAY DAMAGE IN MACROMOLECULAR CRYSTALLOGRAPHY BY SUBMICROMETER LINE FOCUSING; TOTAL DOSE 1.32 X 10E+12 X-RAY PHOTONS	3.2.1.17
4HTQ	MITIGATION OF X-RAY DAMAGE IN MACROMOLECULAR CRYSTALLOGRAPHY BY SUBMICROMETER LINE FOCUSING; TOTAL DOSE 6.70 X 10E+11 X-RAY PHOTONS	3.2.1.17
4HTT	CRYSTAL STRUCTURE OF TWIN ARGININE TRANSLOCASE RECEPTOR- TATC IN DDM	3.2.1.17
4HTU	STRUCTURE OF 5-CHLOROURACIL MODIFIED A:U BASE PAIR	3.1.26.4
4HTX	CRYSTAL STRUCTURE OF PDE2 CATALYTIC DOMAIN IN COMPLEX WITH BAY60-7550	3.1.4.17
4HTZ	CRYSTAL STRUCTURE OF PDE2 CATALYTIC DOMAIN IN SPACE GROUP P1	3.1.4.17
4HU3	CRYSTAL STRUCTURE OF EAL DOMAIN OF THE E. COLI DOSP - MONOMERIC FORM	3.1.4.52
4HU4	CRYSTAL STRUCTURE OF EAL DOMAIN OF THE E. COLI DOSP - DIMERIC FORM	3.1.4.52
4HUE	STRUCTURE OF 5-CHLOROURACIL MODIFIED G:U BASE PAIR	3.1.26.4
4HUF	STRUCTURE OF 5-CHLOROURACIL MODIFIED A:U BASE PAIR	3.1.26.4
4HUG	STRUCTURE OF 5-CHLOROURACIL MODIFIED A:U BASE PAIRS	3.1.26.4
4HUO	STRUCTURE OF RICIN A CHAIN BOUND WITH N-(N-(PTERIN-7-YL)CARBONYLGLYCYL)-L-PHENYLALANINE	3.2.2.22
4HUP	STRUCTURE OF RICIN A CHAIN BOUND WITH N-(N-(PTERIN-7-YL)CARBONYLGLYCYL)-L-PHENYLALANYL)-L-PHENYLALANINE	3.2.2.22
4HUQ	CRYSTAL STRUCTURE OF A TRANSPORTER	3.6.3
4HV1	LASER-INDUCED MICROFRAGMENTATION OF LYSOZYME CRYSTALS ALLOWS X-RAY NANODIFFRACTION CHARACTERIZATION OF INDIVIDUAL DOMAINS (LB4)	3.2.1.17
4HV2	LASER-INDUCED MICROFRAGMENTATION OF LYSOZYME CRYSTALS ALLOWS X-RAY NANODIFFRACTION CHARACTERIZATION OF INDIVIDUAL DOMAINS (LB5)	3.2.1.17
4HV3	STRUCTURE OF RICIN A CHAIN BOUND WITH N-(N-(PTERIN-7-YL)CARBONYL-L-SERINYL)-L-TRYPTOPHAN	3.2.2.22
4HV7	STRUCTURE OF RICIN A CHAIN BOUND WITH N-(N-(PTERIN-7-YL)CARBONYLGLYCYL)GLYCINE	3.2.2.22
4HVA	MECHANISTIC AND STRUCTURAL UNDERSTANDING OF UNCOMPETITIVE INHIBITORS OF CASPASE-6	3.4.22.59
4HVJ	CRYSTAL STRUCTURE OF A PUTATIVE UNCHARACTERIZED PROTEIN FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH AMP	3.1.13
4HVP	STRUCTURE OF COMPLEX OF SYNTHETIC HIV-1 PROTEASE WITH A SUBSTRATE-BASED INHIBITOR AT 2.3 ANGSTROMS RESOLUTION	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
4HVT	STRUCTURE OF A POST-PROLINE CLEAVING ENZYME FROM RICKETTSIA TYPHI	3.4.21.26
4HVY	A THERMOSTABLE VARIANT OF HUMAN NUDT18 NUDIX DOMAIN OBTAINED BY HOT COLONY FILTRATION	3.6.1 3.6.1.58
4HWW	CRYSTAL STRUCTURE OF HUMAN ARGINASE-1 COMPLEXED WITH INHIBITOR 9	3.5.3.1
4HWY	TRYPANOSOMA BRUCEI PROCATHEPSIN B SOLVED FROM 40 FS FREE-ELECTRON LASER PULSE DATA BY SERIAL FEMTOSECOND X-RAY CRYSTALLOGRAPHY	3.4.22
4HX2	CRYSTAL STRUCTURE OF STREPTOMYCES CAESPITOSUS SERMETSTATIN IN COMPLEX WITH BACILLUS LICHENIFORMIS SUBTILISIN	3.4.21.62
4HX3	CRYSTAL STRUCTURE OF STREPTOMYCES CAESPITOSUS SERMETSTATIN IN COMPLEX WITH S. CAESPITOSUS SNAPALYSIN	3.4.24.77
4HXD	DIVERSITY OF UBIQUITIN AND ISG15 SPECIFICITY AMONGST NAIROVIRUSES VIRAL OVARIAN TUMOR DOMAIN PROTEASES	3.4.19.12
4HXE	PYROCOCCUS HORIKOSHII ACYLAMINOACYL PEPTIDASE (UNCOMPLEXED)	3.4.19.1
4HXF	ACYLAMINOACYL PEPTIDASE IN COMPLEX WITH Z-GLY-GLY-PHE-CHLOROMETHYL KETONE	3.4.19.1
4HXQ	CRYSTAL STRUCTURE OF HUMAN ARGINASE-1 COMPLEXED WITH INHIBITOR 14	3.5.3.1
4HXV	CRYSTAL STRUCTURE OF 3'(2'),5'-BISPHOSPHATE NUCLEOTIDASE1 FROM ENTAMOEBA HISTOLYTICA IN COMPLEX WITH AMP AND METAL IONS	3.1.3.7
4HXX	PYRIDINYLPYRIMIDINES SELECTIVELY INHIBIT HUMAN METHIONINE AMINOPEPTIDASE-1	3.4.11.18
4HYQ	CRYSTAL STRUCTURE OF PHOSPHOLIPASE A1 FROM STREPTOMYCES ALBIDOFLAVUS NA297	3.1.1.32
4HZ6	CRYSTAL STRUCTURE OF BGLB	3.2.1.21
4HZ7	CRYSTAL STRUCTURE OF BGLB WITH GLUCOSE	3.2.1.21
4HZ8	CRYSTAL STRUCTURE OF BGLB WITH NATURAL SUBSTRATE	3.2.1.21
4HZE	CRYSTAL STRUCTURE OF HUMAN ARGINASE-2 COMPLEXED WITH INHIBITOR 9	3.5.3.1
4HZG	STRUCTURE OF HALOALKANE DEHALOGENASE DHAA FROM RHODOCOCCUS RHODOCHROUS	3.8.1.5
4HZM	CRYSTAL STRUCTURE OF SALMONELLA TYPHIMURIUM FAMILY 3 GLYCOSIDE HYDROLASE (NAGZ) BOUND TO N-[(3S,4R,5R,6R)-4,5-DIHYDROXY-6-(HYDROXYMETHYL)PIPERIDIN-3-YL]BUTANAMIDE	3.2.1.52
4HZT	STRUCTURE-BASED DESIGN OF NOVEL DIHYDROISOQUINOLINE BACE-1 INHIBITORS THAT DO NOT ENGAGE THE CATALYTIC ASPARTATES	3.4.23.46
4HZU	STRUCTURE OF A BACTERIAL ENERGY-COUPLING FACTOR TRANSPORTER	3.6.3 7
4HZV	THE CRYSTAL STRUCTURE OF INFLUENZA A NEURAMINIDASE N3	3.2.1.18
4HZW	CRYSTAL STRUCTURE OF INFLUENZA A NEURAMINIDASE N3 COMPLEXED WITH LANINAMIVIR	3.2.1.18
4HZX	CRYSTAL STRUCTURE OF INFLUENZA A NEURAMINIDASE N3 COMPLEXED WITH OSELTAMIVIR	3.2.1.18
4HZY	CRYSTAL STRUCTURE OF INFLUENZA A NEURAMINIDASE N3-H274Y	3.2.1.18
4HZZ	CRYSTAL STRUCTURE OF INFLUENZA NEURAMINIDASE N3-H274Y COMPLEXED WITH OSELTAMIVIR	3.2.1.18
4I00	CRYSTAL STRUCTURE OF INFLUENZA A NEURAMINIDASE N3-H274Y COMPLEXED WITH ZANAMIVIR	3.2.1.18
4I03	HUMAN MMP12 IN COMPLEX WITH A PEG-LINKED BIFUNCTIONAL L-GLUTAMATE MOTIF INHIBITOR	3.4.24.65
4I04	STRUCTURE OF ZYMOGEN OF CATHEPSIN B1 FROM SCHISTOSOMA MANSONI	3.4.22.1
4I05	STRUCTURE OF INTERMEDIATE PROCESSING FORM OF CATHEPSIN B1 FROM SCHISTOSOMA MANSONI	3.4.22.1
4I06	CRYSTAL STRUCTURE OF HUMAN ARGINASE-2 COMPLEXED WITH INHIBITOR 14	3.5.3.1
4I07	STRUCTURE OF MATURE FORM OF CATHEPSIN B1 FROM SCHISTOSOMA MANSONI	3.4.22.1
4I0C	THE STRUCTURE OF THE CAMELID ANTIBODY CABHUL5 IN COMPLEX WITH HUMAN LYSOZYME	3.2.1.17
4I0D	DESIGN AND SYNTHESIS OF THIOPHENE DIHYDROISOQUINOLINS AS NOVEL BACE-1 INHIBITORS	3.4.23.46
4I0E	DESIGN AND SYNTHESIS OF THIOPHENE DIHYDROISOQUINOLINS AS NOVEL BACE-1 INHIBITORS	3.4.23.46
4I0F	DESIGN AND SYNTHESIS OF THIOPHENE DIHYDROISOQUINOLINS AS NOVEL BACE-1 INHIBITORS	3.4.23.46
4I0G	DESIGN AND SYNTHESIS OF THIOPHENE DIHYDROISOQUINOLINS AS NOVEL BACE-1 INHIBITORS	3.4.23.46
4I0H	SPR AND STRUCTURAL ANALYSIS YIELD INSIGHT TOWARDS MECHANISM OF INHIBITION OF BACE INHIBITORS.	3.4.23.46
4I0I	SPR AND STRUCTURAL ANALYSIS YIELD INSIGHT TOWARDS MECHANISM OF INHIBITION OF BACE INHIBITORS	3.4.23.46
4I0J	SPR AND STRUCTURAL ANALYSIS YIELD INSIGHT TOWARDS MECHANISM OF INHIBITION OF BACE INHIBITORS	3.4.23.46
4I0W	STRUCTURE OF THE CLOSTRIDIUM PERFRINGENS CSPB PROTEASE	3.4
4I0Z	STRUCTURE-BASED DESIGN OF NOVEL DIHYDROISOQUINOLINE BACE-1 INHIBITORS THAT DO NOT ENGAGE THE CATALYTIC ASPARTATES	3.4.23.46
4I10	STRUCTURE-BASED DESIGN OF NOVEL DIHYDROISOQUINOLINE BACE-1 INHIBITORS THAT DO NOT ENGAGE THE CATALYTIC ASPARTATES	3.4.23.46
4I11	STRUCTURE-BASED DESIGN OF NOVEL DIHYDROISOQUINOLINE BACE-1 INHIBITORS THAT DO NOT ENGAGE THE CATALYTIC ASPARTATES.	3.4.23.46
4I12	DESIGN AND SYNTHESIS OF THIOPHENE DIHYDROISOQUINOLINS AS NOVEL BACE-1 INHIBITORS	3.4.23.46
4I14	CRYSTAL STRUCTURE OF MTB-RIBA2 (RV1415)	4.1.99.12 3.5.4.25
4I15	CRYSTAL STRUCTURE OF TBRPDEB1	3.1.4
4I1A	CRYSTAL STRUCTURE OF THE APO FORM OF RAPI	3.1
4I1C	DESIGN AND SYNTHESIS OF THIOPHENE DIHYDROISOQUINOLINS AS NOVEL BACE-1 INHIBITORS	3.4.23.46
4I1P	HUMAN MALT1 (CASPASE-IG3) IN COMPLEX WITH ACTIVITY BASED-PROBE	3.4.22
4I1R	HUMAN MALT1 (CASPASE-IG3) IN COMPLEX WITH THIORIDAZINE	3.4.22
4I1S	MELANOMA DIFFERENTIATION ASSOCIATED PROTEIN-5 HELICASE DOMAIN COMPLEX WITH INHIBITOR NON-STRUCTURAL PROTEIN V	3.6.4.13
4I27	TERNARY COMPLEX OF MOUSE TDT WITH SSDNA AND INCOMING NUCLEOTIDE	2.7.7.31 3.1.11
4I28	BINARY COMPLEX OF MOUSE TDT WITH SSDNA AND ZN++	2.7.7.31 3.1.11
4I29	BINARY COMPLEX OF MOUSE TDT WITH SSDNA AND MN++	2.7.7.31 3.1.11
4I2A	BINARY COMPLEX OF MOUSE TDT WITH SSDNA IN ABSENCE OF DIVALENT TRANSITION METAL ION	2.7.7.31 3.1.11
4I2B	TERNARY COMPLEX OF MOUSE TDT WITH SSDNA AND AMPCPP	2.7.7.31 3.1.11
4I2C	TERNARY COMPLEX OF MOUSE TDT WITH SSDNA AND AMPCPP	2.7.7.31 3.1.11
4I2D	BINARY COMPLEX OF MOUSE TDT WITH AMPCPP	2.7.7.31 3.1.11
4I2E	TERNARY COMPLEX OF MOUSE TDT WITH SSDNA AND AMPCPP	2.7.7.31 3.1.11
4I2F	BINARY COMPLEX OF MOUSE TDT WITH SSDNA	2.7.7.31 3.1.11
4I2G	BINARY COMPLEX OF MOUSE TDT WITH SSDNA	2.7.7.31 3.1.11
4I2H	TERNARY COMPLEX OF MOUSE TDT WITH SSDNA AND AMPCPP	2.7.7.31 3.1.11
4I2I	BINARY COMPLEX OF MOUSE TDT WITH AP5A	2.7.7.31 3.1.11
4I2J	BINARY COMPLEX OF MOUSE TDT WITH DCTP	2.7.7.31 3.1.11
4I2P	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH RILPIVIRINE (TMC278) BASED ANALOGUE	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
4I2Q	CRYSTAL STRUCTURE OF K103N/Y181C MUTANT OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH RILPIVIRINE (TMC278) ANALOGUE	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
4I31	CRYSTAL STRUCTURE OF HCV NS3/NS4A PROTEASE COMPLEXED WITH COMPOUND 4	3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48
4I32	CRYSTAL STRUCTURE OF HCV NS3/4A D168V PROTEASE COMPLEXED WITH COMPOUND 4	3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48
4I33	CRYSTAL STRUCTURE OF HCV NS3/4A R155K PROTEASE COMPLEXED WITH COMPOUND 4	3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48
4I35	THE CRYSTAL STRUCTURE OF SERRALYSIN	3.4.24.40
4I3E	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL IMPASE - I COMPLEXED WITH PRODUCTS.	3.1.3.25
4I3Y	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL INOSITOL MONOPHOSPHATASE-1: 100 MM LICL SOAKED INHIBITORY COMPLEX	3.1.3.25
4I40	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL INOSITOL MONOPHOSPHATASE-1: 50MM LICL INHIBITED COMPLEX	3.1.3.25
4I47	CRYSTAL STRUCTURE OF THE RIBOSOME INACTIVATING PROTEIN COMPLEXED WITH METHYLATED GUANINE	3.2.2.22
4I4C	CRYSTAL STRUCTURE OF THE PROTEIN FRSA COMPLEXED WITH UNKNOWN LIGAND	3.1.1.1
4I5I	CRYSTAL STRUCTURE OF THE SIRT1 CATALYTIC DOMAIN BOUND TO NAD AND AN EX527 ANALOG	3.5.1 2.3.1.286 2.3.1
4I5R	CRYSTAL STRUCTURE OF A FUNGAL CHIMERIC CELLOBIOHYDROLASE CEL6A	3.2.1 3.2.1.91
4I5U	CRYSTAL STRUCTURE OF A FUNGAL CHIMERIC CELLOBIOHYDROLASE CEL6A	3.2.1.91 3.2.1
4I65	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE MUTANT V23I/L25V/I72V/I92V	3.1.31.1
4I67	CRYSTAL STRUCTURE OF THE RRM DOMAIN OF RNA HELICASE HERA FROM T. THERMOPHILUS IN COMPLEX WITH GGGC RNA	3.6.4.13
4I68	CRYSTAL STRUCTURE OF THE R444A / R449A DOUBLE MUTANT OF THE HERA RNA HELICASE RRM DOMAIN	3.6.4.13
4I69	CRYSTAL STRUCTURE OF THE K463A MUTANT OF THE RRM DOMAIN OF RNA HELICASE HERA FROM T. THERMOPHILUS	3.6.4.13
4I6L	CRYSTAL STRUCTURE OF OTUB1 IN COMPLEX WITH UBIQUITIN VARIANT	3.4.19.12
4I70	CRYSTAL STRUCTURE OF THE TRYPANOSOMA BRUCEI INOSINE-ADENOSINE-GUANOSINE NUCLEOSIDE HYDROLASE	3.2.2.1
4I71	CRYSTAL STRUCTURE OF THE TRYPANOSOMA BRUCEI INOSINE-ADENOSINE-GUANOSINE NUCLEOSIDE HYDROLASE IN COMPLEX WITH A TRYPANOCIDAL COMPOUND	3.2.2.1
4I72	CRYSTAL STRUCTURE OF THE TRYPANOSOMA BRUCEI INOSINE-ADENOSINE-GUANOSINE NUCLEOSIDE HYDROLASE IN COMPLEX WITH IMMUCILLIN A	3.2.2.1
4I73	CRYSTAL STRUCTURE OF THE TRYPANOSOMA BRUCEI INOSINE-ADENOSINE-GUANOSINE NUCLEOSIDE HYDROLASE IN COMPLEX WITH COMPOUND UAMC-00312	3.2.2.1
4I74	CRYSTAL STRUCTURE OF THE TRYPANOSOMA BRUCEI INOSINE-ADENOSINE-GUANOSINE NUCLEOSIDE HYDROLASE IN COMPLEX WITH COMPOUND UAMC-00312 AND ALLOSTERICALLY INHIBITED BY A NI2+ ION	3.2.2.1
4I75	CRYSTAL STRUCTURE OF THE TRYPANOSOMA BRUCEI INOSINE-ADENOSINE-GUANOSINE NUCLEOSIDE HYDROLASE IN COMPLEX WITH THE NITRIS METALORGANIC COMPLEX	3.2.2.1
4I7F	HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH A PHOSPHONATE ANALOG OF NEVIRAPINE	2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
4I7J	T4 LYSOZYME L99A/M102H WITH BENZENE BOUND	3.2.1.17
4I7K	T4 LYSOZYME L99A/M102H WITH TOLUENE BOUND	3.2.1.17
4I7L	T4 LYSOZYME L99A/M102H WITH PHENOL BOUND	3.2.1.17
4I7M	T4 LYSOZYME L99A/M102H WITH 2-ALLYLPHENOL BOUND	3.2.1.17
4I7N	T4 LYSOZYME L99A/M102H WITH 1-PHENYL-2-PROPYN-1-OL BOUND	3.2.1.17
4I7O	T4 LYSOZYME L99A/M102H WITH 2-AMINO-5-CHLOROTHIAZOLE BOUND	3.2.1.17
4I7P	T4 LYSOZYME L99A/M102H WITH 4-BROMOIMIDAZOLE BOUND	3.2.1.17
4I7Q	T4 LYSOZYME L99A/M102H WITH 4-TRIFLUOROMETHYLIMIDAZOLE BOUND	3.2.1.17
4I7R	T4 LYSOZYME L99A/M102H WITH 2-(PYRAZOLO-1-YL) ETHANOL BOUND	3.2.1.17
4I7S	T4 LYSOZYME L99A/M102H WITH 3-TRIFLUOROMETHYL-5-METHYL PYRAZOLE BOUND	3.2.1.17
4I7T	T4 LYSOZYME L99A/M102H WITH 2-BROMO-5-HYDROXYBENZALDEHYDE BOUND	3.2.1.17
4I8D	CRYSTAL STRUCTURE OF BETA-D-GLUCOSIDE GLUCOHYDROLASE FROM TRICHODERMA REESEI	3.2.1.21
4I8G	BOVINE TRYPSIN AT 0.8 RESOLUTION	3.4.21.4
4I8H	BOVINE TRYPSIN AT 0.75 RESOLUTION	3.4.21.4
4I8J	BOVINE TRYPSIN AT 0.87 A RESOLUTION	3.4.21.4
4I8K	BOVINE TRYPSIN AT 0.85 RESOLUTION	3.4.21.4
4I8L	BOVINE TRYPSIN AT 0.87 RESOLUTION	3.4.21.4
4I8N	CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B IN COMPLEX WITH AN INHIBITOR [(4-{(2S)-2-(1,3-BENZOXAZOL-2-YL)-2-[(4-FLUOROPHENYL)SULFAMOYL]ETHYL}PHENYL)AMINO](OXO)ACETIC ACID	3.1.3.48
4I8O	CRYSTAL STRUCTURE OF THE TOXIN RNLA FROM ESCHERICHIA COLI	3.1
4I8S	HEN LYSOZYME PROTEIN CRYSTALLIZATION VIA STANDARD HANGING DROP VAPOR DIFFUSION	3.2.1.17
4I8W	CRYSTAL STRUCTURE OF WILD TYPE HIV-1 PROTEASE IN COMPLEX WITH NON-PEPTIDIC INHIBITOR, GRL007	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
4I8Z	CRYSTAL STRUCTURE OF WILD TYPE HIV-1 PROTEASE IN COMPLEX WITH NON-PEPTIDIC INHIBITOR, GRL008	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
4I9C	CRYSTAL STRUCTURE OF ASPARTYL PHOSPHATE PHOSPHATASE F FROM B.SUBTILIS IN COMPLEX WITH ITS INHIBITORY PEPTIDE	3.1
4I9D	X-RAY STRUCTURE OF NIKA IN COMPLEX WITH FE-N,N'-BIS(2-PYRIDYLMETHYL)-N-CARBOXYMETHYL-N'-METHYL	3.6.3.24
4I9E	CRYSTAL STRUCTURE OF ASPARTYL PHOSPHATE PHOSPHATASE F FROM BACILLUS SUBTILIS	3.1
4I9G	CRYSTAL STRUCTURE OF GLYCEROL PHOSPHATE PHOSPHATASE RV1692 FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH MAGNESIUM	3.1.3.21
4I9L	CRYSTAL STRUCTURE OF THE D714A MUTANT OF RB69 DNA POLYMERASE	2.7.7.7 3.1.11
4I9Z	CRYSTAL STRUCTURE OF THE PDE5A1 CATALYTIC DOMAIN IN COMPLEX WITH NOVEL INHIBITORS	3.1.4.35
4IA0	CRYSTAL STRUCTURE OF THE PDE5A1 CATALYTIC DOMAIN IN COMPLEX WITH NOVEL INHIBITORS	3.1.4.35
4IAL	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS H121E AT CRYOGENIC TEMPERATURE	3.1.31.1
4IAO	CRYSTAL STRUCTURE OF SIR2 C543S MUTANT IN COMPLEX WITH SID DOMAIN OF SIR4	3.5.1 2.3.1.286
4IAP	CRYSTAL STRUCTURE OF PH DOMAIN OF OSH3 FROM SACCHAROMYCES CEREVISIAE	3.2.1.17
4IAS	HEW LYSOZYME BY LANGMUIR- BLODGETT MODIFIED VAPOUR DIFFUSION	3.2.1.17
4IAT	HEW LYSOZYME BY LANGMUIR- BLODGETT MODIFIED VAPOUR DIFFUSION	3.2.1.17
4IAV	G215S, A251G, T257A, D260G, T262D MUTANT OF CARBOXYPEPTIDASE T FROM THERMOACTINOMYCES VULGARIS WITH N-SULFAMOYL-L-PHENYLALANINE	3.4.17.18
4IBL	RUBIDIUM SITES IN BLOOD COAGULATION FACTOR VIIA	3.4.21.21
4IBN	CRYSTAL STRUCTURE OF LC9-RNASE H1, A TYPE 1 RNASE H WITH THE TYPE 2 ACTIVE-SITE MOTIF	3.1.26.4
4IBR	CRYSTAL STRUCTURE OF STABILIZED TEM-1 BETA-LACTAMASE VARIANT V.13 CARRYING G238S/E104K MUTATIONS	3.5.2.6
4IC1	CRYSTAL STRUCTURE OF SSO0001	3.1.12.1
4IC5	CRYSTAL STRUCTURE OF DEG5	3.4.21
4IC6	CRYSTAL STRUCTURE OF DEG8	3.4.21
4ICK	CRYSTAL STRUCTURE OF HUMAN AP4A HYDROLASE E58A MUTANT	3.6.1.17
4ICL	HIV-1 REVERSE TRANSCRIPTASE WITH BOUND FRAGMENT AT THE INCOMING DNTP BINDING SITE	2.7.7.49 2.7.7.7 3.1.26.13 3.4.23.16 3.1.13.2 2.7.7 3.1
4ICQ	STRUCTURAL BASIS FOR SUBSTRATE RECOGNITION AND REACTION MECHANISM OF BACTERIAL AMINOPEPTIDASE PEPS	3.4.11
4ICR	STRUCTURAL BASIS FOR SUBSTRATE RECOGNITION AND REACTION MECHANISM OF BACTERIAL AMINOPEPTIDASE PEPS	3.4.11
4ICS	CRYSTAL STRUCTURE OF PEPS FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH A SUBSTRATE	3.4.11
4ICZ	HER2 1221/1222 PHOSPHORYLATION REGULATED BY PTPN9	3.1.3.48
4ID1	HIV-1 INTEGRASE CATALYTIC CORE DOMAIN COMPLEXED WITH ALLOSTERIC INHIBITOR	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
4ID4	CRYSTAL STRUCTURE OF CHIMERIC BETA-LACTAMASE CTEM-17M	3.5.2.6
4ID5	HIV-1 REVERSE TRANSCRIPTASE WITH BOUND FRAGMENT AT THE RNASE H PRIMER GRIP SITE	2.7.7.49 2.7.7.7 3.1.26.13 3.4.23.16 3.1.13.2 2.7.7 3.1
4ID6	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE MUTANT V23I/I72L	3.1.31.1
4IDK	HIV-1 REVERSE TRANSCRIPTASE WITH BOUND FRAGMENT AT THE 428 SITE	2.7.7.49 2.7.7.7 3.1.26.13 3.4.23.16 3.1.13.2 2.7.7 3.1
4IDN	HUMAN ATLASTIN-1 1-446, C-HIS6, GPPNHP	3.6.5
4IDO	HUMAN ATLASTIN-1 1-446, C-HIS6, GDPALF4-	3.6.5
4IDP	HUMAN ATLASTIN-1 1-446, N440T, GPPNHP	3.6.5
4IDQ	HUMAN ATLASTIN-1 1-446, N440T, GDPALF4-	3.6.5
4IDY	MYCOBACTERIUM TUBERCULOSIS METHIONINE AMINOPEPTIDASE TYPE 1C IN COMPLEX WITH 2-HYDROXYETHYL DISULFIDE	3.4.11.18
4IE1	CRYSTAL STRUCTURE OF HUMAN ARGINASE-1 COMPLEXED WITH INHIBITOR 1H	3.5.3.1
4IE2	CRYSTAL STRUCTURE OF HUMAN ARGINASE-2 COMPLEXED WITH INHIBITOR 1H	3.5.3.1
4IE3	CRYSTAL STRUCTURE OF HUMAN ARGINASE-2 COMPLEXED WITH INHBITOR 1O	3.5.3.1
4IEC	CYS105 COVALENT MODIFICATION BY 2-HYDROXYETHYL DISULFIDE IN MYCOBACTERIUM TUBERCULOSIS METHIONINE AMINOPEPTIDASE TYPE 1C	3.4.11.18
4IED	CRYSTAL STRUCTURE OF FUS-1 (OXA-85), A CLASS D BETA-LACTAMASE FROM FUSOBACTERIUM NUCLEATUM SUBSP. POLYMORPHUM	3.5.2.6
4IEM	HUMAN APURINIC/APYRIMIDINIC ENDONUCLEASE (APE1) WITH PRODUCT DNA AND MG2+	3.1 4.2.99.18
4IEN	CRYSTAL STRUCTURE OF ACYL-COA HYDROLASE FROM NEISSERIA MENINGITIDIS FAM18	3.1.2.20
4IF6	STRUCTURE OF NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-1 (CLOSED STATE, 2.25 A)	3.5.1 2.3.1.286 2.3.1
4IF7	MYCOBACTERIUM TUBERCULOSIS METHIONINE AMINOPEPTIDASE TYPE 1C IN COMPLEX WITH HOMOCYSTEINE-METHYL DISULFIDE	3.4.11.18
4IFV	DETECTING ALLOSTERIC SITES OF HIV-1 REVERSE TRANSCRIPTASE BY X-RAY CRYSTALLOGRAPHIC FRAGMENT SCREENING	2.7.7.49 2.7.7.7 3.1.26.13 3.4.23.16 3.1.13.2 2.7.7 3.1
4IFY	HIV-1 REVERSE TRANSCRIPTASE WITH BOUND FRAGMENT AT THE KNUCKLES SITE	2.7.7.49 2.7.7.7 3.1.26.13 3.4.23.16 3.1.13.2 2.7.7 3.1
4IG0	HIV-1 REVERSE TRANSCRIPTASE WITH BOUND FRAGMENT AT THE 507 SITE	2.7.7.49 2.7.7.7 3.1.26.13 3.4.23.16 3.1.13.2 2.7.7 3.1
4IG3	HIV-1 REVERSE TRANSCRIPTASE WITH BOUND FRAGMENT NEAR KNUCKLES SITE	2.7.7.49 2.7.7.7 3.1.26.13 3.4.23.16 3.1.13.2 2.7.7 3.1
4IG9	STRUCTURE OF NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-1 (OPEN STATE, 2.64 A)	3.5.1 2.3.1.286 2.3.1
4IGD	CRYSTAL STRUCTURE OF THE ZYMOGEN CATALYTIC REGION OF HUMAN MASP-1	3.4.21
4IH4	CRYSTAL STRUCTURE OF ARABIDOPSIS DWARF14 ORTHOLOGUE, ATD14	3.1
4IH5	HEPATITIS C VIRUS POLYMERASE NS5B (BK) WITH FRAGMENT-BASED COMPOUNDS	2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13
4IH7	HEPATITIS C VIRUS POLYMERASE NS5B (BK) WITH FRAGMENT-BASED COMPOUNDS	2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13
4IH9	CRYSTAL STRUCTURE OF RICE DWARF14 (D14)	3.1
4IHA	CRYSTAL STRUCTURE OF RICE DWARF14 (D14) IN COMPLEX WITH A GR24 HYDROLYSIS INTERMEDIATE	3.1
4IHD	CRYSTAL STRUCTURE OF UNCLEAVED THNT T282C, DERIVATIZED AT THE ACTIVE SITE WITH ETHG	3.5.1.92
4IHE	CRYSTAL STRUCTURE OF UNCLEAVED THNT T282A	3.5.1.92
4IHM	G215S, A251G, T257A, D260G, T262D MUTANT OF CARBOXYPEPTIDASE T FROM THERMOACTINOMYCES VULGARIS	3.4.17.18
4IHQ	ARCHAELLUM ASSEMBLY ATPASE FLAI BOUND TO ADP	3.6.1.4
4II8	LYSOZYME WITH BENZYL ALCOHOL	3.2.1.17
4IIA	LOW RESOLUTION CRYSTAL STRUCTURE OF THE NTF2-LIKE DOMAIN OF HUMAN G3BP1	3.6.4.12 3.6.4.13
4IIB	CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS	3.2.1.21
4IIC	CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH ISOFAGOMINE	3.2.1.21
4IID	CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH 1-DEOXYNOJIRIMYCIN	3.2.1.21
4IIE	CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH CALYSTEGINE B(2)	3.2.1.21
4IIF	CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH CASTANOSPERMINE	3.2.1.21
4IIG	CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH D-GLUCOSE	3.2.1.21
4IIH	CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH THIOCELLOBIOSE	3.2.1.21
4IIK	LEGIONELLA PNEUMOPHILA EFFECTOR	3.1.4
4IIP	LEGIONELLA PNEUMOPHILA EFFECTOR	3.1.4
4IIS	CRYSTAL STRUCTURE OF A GLYCOSYLATED BETA-1,3-GLUCANASE (HEV B 2), AN ALLERGEN FROM HEVEA BRASILIENSIS (SPACE GROUP P41)	3.2.1.39
4IIX	STRUCTURE OF MCCF IN COMPLEX WITH GLUTAMYL SULFAMOYL GUANOSINE	3.4
4IIY	STRUCTURE OF MCCF IN COMPLEX WITH GLUTAMYL SULFAMOYL INOSINE	3.4
4IJ4	CRYSTAL STRUCTURE OF A FAMILY GH19 CHITINASE FROM BRYUM CORONATUM IN COMPLEX WITH (GLCNAC)4	3.2.1.14
4IJ5	CRYSTAL STRUCTURE OF A NOVEL-TYPE PHOSPHOSERINE PHOSPHATASE FROM HYDROGENOBACTER THERMOPHILUS TK-6	3.1.3.3
4IJ6	CRYSTAL STRUCTURE OF A NOVEL-TYPE PHOSPHOSERINE PHOSPHATASE MUTANT (H9A) FROM HYDROGENOBACTER THERMOPHILUS TK-6 IN COMPLEX WITH L-PHOSPHOSERINE	3.1.3.3
4IJO	UNRAVELING HIDDEN ALLOSTERIC REGULATORY SITES IN STRUCTURALLY HOMOLOGUES METALLOPROTEASES	3.4.24.65
4IJX	CRYSTAL STRUCTURE OF HUMAN AP4A HYDROLASE E58A MUTANT COMPLEXED WITH DPO	3.6.1.17
4IK2	G215S, A251G, T257A, D260G, T262D MUTANT OF CARBOXYPEPTIDASE T FROM THERMOACTINOMYCES VULGARIS WITH N-BOC-L-LEU	3.4.17.18
4IKA	CRYSTAL STRUCTURE OF EV71 3DPOL-VPG	3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48
4IKC	CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF PTPRQ	3.1.3.48 3.1.3
4IKF	PFV INTASOME WITH INHIBITOR MB-76	2.7.7 2.7.7.49 2.7.7.7 3.1.26.4 3.4.23 3.1
4IKO	STRUCTURE OF PEPTIDYL- TRNA HYDROLASE FROM ACINETOBACTER BAUMANNII AT 1.90 A RESOLUTION	3.1.1.29
4IKR	CRYSTAL STRUCTURE OF TYPE 1 HUMAN METHIONINE AMINOPEPTIDASE IN COMPLEX WITH 2-(4-(5-CHLORO-6-METHYL-2-(PYRIDIN-2-YL)PYRIMIDIN-4-YL)PIPERAZIN-1-YL)ETHANOL	3.4.11.18
4IKS	CRYSTAL STRUCTURE OF TRUNCATED (DELTA 1-89) HUMAN METHIONINE AMINOPEPTIDASE TYPE 1 IN COMPLEX WITH N1-(5-CHLORO-6-METHYL-2-(PYRIDIN-2-YL)PYRIMIDIN-4-YL)-N2-(6-(TRIFLUOROMETHYL)PYRIDIN-2-YL)ETHANE-1,2-DIAMINE	3.4.11.18
4IKT	CRYSTAL STRUCTURE OF TRUNCATED (DELTA 1-89) HUMAN METHIONINE AMINOPEPTIDASE TYPE 1 IN COMPLEX WITH N1-(5-CHLORO-6-METHYL-2-(PYRIDIN-2-YL)PYRIMIDIN-4-YL)-N2-(5-(TRIFLUOROMETHYL)PYRIDIN-2-YL)ETHANE-1,2-DIAMINE	3.4.11.18
4IKU	CRYSTAL STRUCTURE OF TRUNCATED (DELTA 1-89) HUMAN METHIONINE AMINOPEPTIDASE TYPE 1 IN COMPLEX WITH 2-((5-CHLORO-6-METHYL-2-(PYRIDIN-2-YL)PYRIMIDIN-4-YL)AMINO)-3-PHENYLPROPANAMIDE	3.4.11.18
4IL3	CRYSTAL STRUCTURE OF S. MIKATAE STE24P	3.4.24.84
4ILD	CRYSTAL STRUCTURE OF TRUNCATED BOVINE VIRAL DIARRHEA VIRUS 1 E2 ENVELOPE PROTEIN	3.4.22 3.4.21.113 3.6.1.15 3.6.4.13 2.7.7.48
4ILL	RECOGNITION AND CLEAVAGE OF A NON-STRUCTURED CRISPR RNA BY ITS PROCESSING ENDORIBONUCLEASE CAS6	3.1
4ILQ	2.60A RESOLUTION STRUCTURE OF CT771 FROM CHLAMYDIA TRACHOMATIS	3
4ILR	RECOGNITION AND CLEAVAGE OF A NON-STRUCTURED CRISPR RNA BY ITS PROCESSING ENDORIBONUCLEASE CAS6	3.1
4ILY	ABUNDANTLY SECRETED CHITOSANASE FROM STREPTOMYCES SP. SIREXAA-E	3.2.1.132
4IM4	MULTIFUNCTIONAL CELLULASE, XYLANASE, MANNANASE	3.2.1.4 3.1.1 3.1.1.72
4IMQ	STRUCTURAL BASIS OF SUBSTRATE SPECIFICITY AND PROTEASE INHIBITION IN NORWALK VIRUS	3.4.22.66 3.6.1.15 2.7.7.48
4IMV	RICIN A-CHAIN VARIANT 1-33/44-198 WITH ENGINEERED DISULFIDE BOND, R48C/T77C/D75N	3.2.2.22
4IMZ	STRUCTURAL BASIS OF SUBSTRATE SPECIFICITY AND PROTEASE INHIBITION IN NORWALK VIRUS	3.6.1.15 3.4.22.66 2.7.7.48
4IN1	STRUCTURAL BASIS OF SUBSTRATE SPECIFICITY AND PROTEASE INHIBITION IN NORWALK VIRUS	3.4.22.66 3.6.1.15 2.7.7.48
4IN2	STRUCTURAL BASIS OF SUBSTRATE SPECIFICITY AND PROTEASE INHIBITION IN NORWALK VIRUS	3.4.22.66 3.6.1.15 2.7.7.48
4IN9	STRUCTURE OF KARILYSIN MMP-LIKE CATALYTIC DOMAIN IN COMPLEX WITH INHIBITORY TETRAPEPTIDE SWFP	3.4.24
4INC	HUMAN HISTIDINE TRIAD NUCLEOTIDE BINDING PROTEIN 2	3
4INH	STRUCTURAL BASIS OF SUBSTRATE SPECIFICITY AND PROTEASE INHIBITION IN NORWALK VIRUS	3.6.1.15 3.4.22.66 2.7.7.48
4INI	HUMAN HISTIDINE TRIAD NUCLEOTIDE BINDING PROTEIN 2 WITH BOUND AMP	3
4INK	CRYSTAL STRUCTURE OF SPLD PROTEASE FROM STAPHYLOCOCCUS AUREUS AT 1.56 A RESOLUTION	3.4.21
4INL	CRYSTAL STRUCTURE OF SPLD PROTEASE FROM STAPHYLOCOCCUS AUREUS AT 2.1 A RESOLUTION	3.4.21
4INZ	THE CRYSTAL STRUCTURE OF M145A MUTANT OF AN EPOXIDE HYDROLASE FROM BACILLUS MEGATERIUM	3.2.2.10
4IO0	CRYSTAL STRUCTURE OF F128A MUTANT OF AN EPOXIDE HYDROLASE FROM BACILLUS MEGATERIUM COMPLEXED WITH ITS PRODUCT (R)-3-[1]NAPHTHYLOXY-PROPANE-1,2-DIOL	3.2.2.10
4IOF	CRYSTAL STRUCTURE ANALYSIS OF FAB-BOUND HUMAN INSULIN DEGRADING ENZYME (IDE)	3.4.24.56
4IOU	CRYSTAL STRUCTURE OF THE HIV-1 VIF BINDING, CATALYTICALLY ACTIVE DOMAIN OF APOBEC3F	3.5.4 3.5.4.38
4IOX	THE STRUCTURE OF THE HERPES SIMPLEX VIRUS DNA-PACKAGING MOTOR PUL15 C-TERMINAL NUCLEASE DOMAIN PROVIDES INSIGHTS INTO CLEAVAGE OF CONCATEMERIC VIRAL GENOME PRECURSORS	3.1
4IPL	THE CRYSTAL STRUCTURE OF 6-PHOSPHO-BETA-GLUCOSIDASE BGLA-2 FROM STREPTOCOCCUS PNEUMONIAE	3.2.1.86
4IPM	CRYSTAL STRUCTURE OF A GH7 FAMILY CELLOBIOHYDROLASE FROM LIMNORIA QUADRIPUNCTATA IN COMPLEX WITH THIOCELLOBIOSE	3.2.1.91
4IPN	THE COMPLEX STRUCTURE OF 6-PHOSPHO-BETA-GLUCOSIDASE BGLA-2 WITH THIOCELLOBIOSE-6P FROM STREPTOCOCCUS PNEUMONIAE	3.2.1.86
4IPY	HIV CAPSID C-TERMINAL DOMAIN	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
4IQP	CRYSTAL STRUCTURE OF HCRA-W1266A	3.4.24.69
4IQT	TDT CORE IN COMPLEX WITH INHIBITOR 6-[4-(3-FLUOROBENZOYL)-1H-PYRROL-2-YL]-2-HYDROXY-4-OXOHEXA-2,5-DIENOIC ACID	2.7.7.31 3.1.11
4IQU	TDT CORE IN COMPLEX WITH INHIBITOR (2Z,5E)-6-[4-(4-FLUOROBENZOYL)-1H-PYRROL-2-YL]-2-HYDROXY-4-OXOHEXA-2,5-DIENOIC ACID	2.7.7.31 3.1.11
4IQV	TDT CORE IN COMPLEX WITH INHIBITOR 6-[4-(3-FLUOROBENZOYL)-1H-PYRROL-2-YL]-2-HYDROXY-4-OXOHEXA-2,5-DIENOIC ACID AND SSDNA	2.7.7.31 3.1.11
4IQW	TDT CORE IN COMPLEX WITH INHIBITOR (2Z,5E)-6-[4-(4-FLUOROBENZOYL)-1H-PYRROL-2-YL]-2-HYDROXY-4-OXOHEXA-2,5-DIENOIC ACID AND SSDNA	2.7.7.31 3.1.11
4IQX	MUTANT P44S P169S M296I OF FOOT-AND-MOUTH DISEASE VIRUS RNA-DEPENDENT RNA POLYMERASE	2.7.7.48 3.4.22.28 3.4.22.46 3.6.1.15
4IQY	CRYSTAL STRUCTURE OF THE HUMAN PROTEIN-PROXIMAL ADP-RIBOSYL-HYDROLASE MACROD2	3.5.1 3.2.2
4IR8	1.85 ANGSTROM CRYSTAL STRUCTURE OF PUTATIVE SEDOHEPTULOSE-1,7 BISPHOSPHATASE FROM TOXOPLASMA GONDII	3.1.3.37
4IRB	CRYSTAL STRUCTURE OF VACCINIA VIRUS URACIL DNA GLYCOSYLASE MUTANT DEL171-172D4	3.2.2.27
4IRU	CRYSTAL STRUCTURE OF LEPB GAP CORE IN A TRANSITION STATE MIMETIC COMPLEX WITH RAB1A AND ALF3	3.6.5.2
4IS5	CRYSTAL STRUCTURE OF THE LIGAND-FREE INACTIVE MATRIPTASE	3.4.21.109
4IS9	CRYSTAL STRUCTURE OF THE ESCHERICHIA COLI LPXC/L-161,240 COMPLEX	3.5.1
4ISA	CRYSTAL STRUCTURE OF THE ESCHERICHIA COLI LPXC/BB-78485 COMPLEX	3.5.1
4ISH	STRUCTURE OF FACTOR VIIA IN COMPLEX WITH THE INHIBITOR BMS-593214 ALSO KNOWN AS 2'-[(6R,6AR,11BR)-2-CARBAMIMIDOYL-6,6A,7,11B-TETRAHYDRO-5H-INDENO[2,1-C]QUINOLIN-6-YL]-5'-HYDROXY-4'-METHOXYBIPHENYL-4-CARBOXYLIC ACID	3.4.21.21
4ISI	STRUCTURE OF FACTOR VIIA IN COMPLEX WITH THE INHIBITOR (6S)-N-(4-CARBAMIMIDOYLBENZYL)-1-CHLORO-3-(CYCLOBUTYLAMINO)-8,8-DIETHYL-4-OXO-4,6,7,8-TETRAHYDROPYRROLO[1,2-A]PYRAZINE-6-CARBOXAMIDE	3.4.21.21
4ISJ	RNA LIGASE RTCB IN COMPLEX WITH MN(II)	6.5.1 3.1 6.5.1.8
4ISL	CRYSTAL STRUCTURE OF THE INACTIVE MATRIPTASE IN COMPLEX WITH ITS INHIBITOR HAI-1	3.4.21.109
4ISN	CRYSTAL STRUCTURE OF MATRIPTASE IN COMPLEX WITH ITS INHIBITOR HAI-1	3.4.21.109
4ISO	CRYSTAL STRUCTURE OF MATRIPTASE IN COMPLEX WITH ITS INHIBITOR HAI-1	3.4.21.109
4ISS	SEMET-SUBSTITUTED KLUYVEROMYCES LACTIS ALLOPHANATE HYDROLASE	3.5.1.54
4IST	S177A KLUYVEROMYCES LACTIS ALLOPHANATE HYDROLASE	3.5.1.54
4ISZ	RNA LIGASE RTCB IN COMPLEX WITH GTP ALPHAS AND MN(II)	6.5.1 3.1 6.5.1.8
4IT0	STRUCTURE OF THE RNA LIGASE RTCB-GMP/MN(II) COMPLEX	6.5.1 3.1 6.5.1.8
4ITC	CRYSTAL STRUCTURE ANALYSIS OF THE K1 CLEAVED ADHESIN DOMAIN OF LYS-GINGIPAIN (KGP) FROM PORPHYROMONAS GINGIVALIS W83	3.4.22.47
4ITR	CRYSTAL STRUCTURE OF IBPAFIC2-H3717A IN COMPLEX WITH ADENYLYLATED CDC42	2.7.7.1 2.7.7 3.4.22
4ITY	CRYSTAL STRUCTURE OF LEISHMANIA MEXICANA ARGINASE	3.5.3.1
4IU0	CRYSTAL STRUCTURE OF LEISHMANIA MEXICANA ARGINASE IN COMPLEX WITH INHIBITOR ABH	3.5.3.1
4IU1	CRYSTAL STRUCTURE OF LEISHMANIA MEXICANA ARGINASE IN COMPLEX WITH INHIBITOR NOR-NOHA	3.5.3.1
4IU4	CRYSTAL STRUCTURE OF LEISHMANIA MEXICANA ARGINASE IN COMPLEX WITH INHIBITOR BEC	3.5.3.1
4IU5	CRYSTAL STRUCTURE OF LEISHMANIA MEXICANA ARGINASE IN COMPLEX WITH CATALYTIC PRODUCT L-ORNITHINE	3.5.3.1
4IU6	HUMAN METHIONINE AMINOPEPTIDASE IN COMPLEX WITH FZ1: PYRIDINYLQUINAZOLINES SELECTIVELY INHIBIT HUMAN METHIONINE AMINOPEPTIDASE-1	3.4.11.18
4IUG	CRYSTAL STRUCTURE OF BETA-GALACTOSIDASE FROM ASPERGILLUS ORYZAE IN COMPLEX WITH GALACTOSE	3.2.1.23
4IUJ	STRUCTURE OF POLYMERASE ACID PROTEIN (PA) FROM INFLUENZAVIRUS A INFLUENZA A VIRUS A, WILSON-SMITH/1933 (H1N1)	3.1
4IUM	EQUINE ARTERITIS VIRUS PAPAIN-LIKE PROTEASE 2 (PLP2) COVALENTLY BOUND TO UBIQUITIN	3.4.22 3.4.19.12 3.4.21 2.7.7.48 3.6.4.12 3.6.4.13
4IUN	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS R126E AT CRYOGENIC TEMPERATURE	3.1.31.1
4IUW	CRYSTAL STRUCTURE OF PEPO FROM LACTOBACILLUS RHAMNOSIS HN001 (DR20)	3.4.24
4IV1	CRYSTAL STRUCTURE OF RECOMBINANT FOOT-AND-MOUTH-DISEASE VIRUS A22 EMPTY CAPSID	2.7.7.48 3.4.22.28 3.4.22.46 3.6.1.15
4IV3	CRYSTAL STRUCTURE OF RECOMBINANT FOOT-AND-MOUTH-DISEASE VIRUS A22-H2093C EMPTY CAPSID	2.7.7.48 3.4.22.28 3.4.22.46 3.6.1.15
4IVI	CRYSTAL STRUCTURE OF A FAMILY VIII CARBOXYLESTERASE.	3.1.1.1
4IVK	CRYSTAL STRUCTURE OF A FAMMILY VIII CARBOXYLESTERASE IN A COMPLEX WITH CEPHALOTHIN.	3.1.1.1
4IVS	CRYSTAL STRUCTURE OF BACE1 WITH ITS INHIBITOR	3.4.23.46
4IVT	CRYSTAL STRUCTURE OF BACE1 WITH ITS INHIBITOR	3.4.23.46
4IVV	CATALYTIC AMIDASE DOMAIN OF THE MAJOR AUTOLYSIN LYTA FROM STREPTOCOCCUS PNEUMANIAE	3.5.1.28
4IWT	CRYSTAL STRUCTURE OF THE C-TEMINAL CHOLINE-BINDING DOMAIN OF THE STREPTOCOCCUS PNEUMONIAE PROPHAGE LYTA	3.5.1.28